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Poster Session I: Diabetes Acute and Chronic
Complications I
P/001/WED
The effect of age at onset type 1 diabetes on the
development of diabetic nephropathy in children and
adolescents with T1DM
T. Shiryaeva
Endocrinology Research Center, Moscow, Russian Federation
Objective: To analyze the impact of age at onset on the
development of diabetic nephropathy children and adolescents
with T1DM.
Methods: We studied children and adolescents in whom type 1
diabetes mellitus (T1DM) was diagnosed before the age of 15 years
between 1992 and 2005 years in a Moscow district. MAY screening
[albumin excretion rate (AER) in three timed overnight samples:
mean AER ‡30 mg/day and £300 mg/day)] was performed yearly
after 10 years of age from diagnosis. For the analysis, the patients
were divided into three groups: those who were aged <5 years
(n = 95), 5–10 years (n = 106) and >10 years at diagnosis
(n = 62) enabled the evaluation of the effect of diabetes duration
and on the development of MAY. Kaplan-Meier survival analyses
(log-rank test) estimated the probability of developing MAY.
Results: Two hundred and sixty-three (263) T1DM children and
adolescents, mean age of 12.9 years, mean diabetes duration of
5.8 years and mean age at onset of diabetes of 6.9 years were
selected for the study. Cumulative probability for MAY was
10.2% after 10 years. Among those aged <5 years at diabetes
onset, the probability for MAY was 5.4% after 10 years of
diabetes duration. This same probability was achieved after only
1 year among those who were diagnosed with diabetes>10 years
of age. MAY remained constant over time among the oldest age-
at-onset group (5–10 years, ->10 years), while in the youngest
age-at-onset group (<5 years), the cumulative probability for
MAY started to increase after a period of 8 years of diabetes.
After 10 years of diabetes, in the group with a diagnosis before
the age of 5 compared with the two other groups, cumulative
probability of microalbuminuria was lower (age at diagnosis
<5 years: 5.4%; 5–10 years: 28.5%; >10 years: 33%; log rank
test P < 0.05).
Conclusions: Children diagnosed with T1DM at younger age seem
to prolong the time for developing MAY.
P/002/WED
Improved outcomes in DKA management in an
intermediate care unit
D.N. Anderson & M.S. Agus
Children's Hospital Boston, Intermediate Care Program, Boston, USA
Background: The mortality rate from diabetes ketoacidosis (DKA)
in children is 0.15–0.30%. The knowledge and expertise of the
medical and nursing staff is essential to the safe and effective
resolution of DKA.
Objectives: To evaluate quality of care outcomes specific to DKA
therapy in a pediatric intermediate care unit (InCU) with staff
specially trained in DKA management.
Methods: In a retrospective chart review, 30 consecutive patients
treated in the InCU at Children¢s Hospital Boston (CHB) were
compared with a similar cohort of patients treated in the Intensive
Care Unit (ICU) and the ward. Factors compared were duration of
time spent on an insulin infusion to resolution of DKA (anion gap
<12), time to first subcutaneous insulin dose, rates of
hypoglycemia (<60 mg/dl) and hypokalemia (<3 mmol/l).
Results: In the InCU as compared to ward and ICU, mean time in
hours to resolution of DKA was reduced (InCU 6:58 ± 3:30 vs.
ward 13:16 ± 4:03, P = 0.003; InCU vs. ICU 10:37 ± 6:04,
P = 0.007), mean time to first SC insulin was reduced (InCU
13:42 ± 5:23 vs. ward 19:49 ± 9:08 hours, P = 0.003; InCU vs.
ICU 21:55 ± 11:52, P = 0.001), hypoglycemia was eradicated in
the InCU (InCU 0% vs. ward 5% vs. ICU 3%), and hypokalemia
rate was increased in InCU and ICU (InCU 31% vs. ward 13% vs.
ICU 72%). Incidence of cerebral edema in the InCU over 5 years
was 0.5%.
Conclusions: The centralization of DKA care in an InCU resulted
in significant improvements in outcomes. As international
standards for these measurements have yet to be established,
comparison is only currently possible within our institution.
Reducing the duration of DKA may enhance patient safety by
increasing time for diabetes teaching and shortening hospital
length of stay. Increased incidence of hypokalemia may be
attributable to fluid changes that were designed to reduce the
hypoglycemia rate. Further research is needed to establish the
longer term benefits of these interventions and their applicability in
institutions outside our own.
P/003/WED
Factors contributing to terminal digital preference in
91398 patients with diabetes mellitus in Germany and
Austria: possible impact on therapeutic decisions
A. Dost1, S. Hofer2, A. Herbst3, R. Stachow4, E. Schober5, U.A. Mller6 &
R.W. Holl7, Initiative DPV-Science
1Friedrich Schiller University, Dept. of Pediatrics, Jena, Germany,
2Medical University, Dept. of Pediatrics, Innsbruck, Austria, 3Klinikum
Leverkusen, Childrens Hospital, Leverkusen, Germany, 4Rehabilitation
Clinic for Children and Adolescents, Westerland, Germany, 5University
of Vienna, Dept. of Pediatrics, Vienna, Austria, 6Friedrich Schiller
University, Dept. of Internal Medicine, Jena, Germany, 7University of
Ulm, Institute of Epidemiology, Ulm, Germany
Aims: Correct blood pressure measurements are decisive for
appropriate diabetes management. The accuracy of blood
pressure (BP) readings might be negatively influenced by
systematic errors such as terminal digital preference (TDP). TDP
describes an observer’s tendency to record the measurements using
certain digits. As TDP might interfere with diabetes treatment, we
used the binational Diabetes databank DPV to study the rate of
and factors contributing to TDP.
Methods: A total of 580578 BP readings were documented in 286
participating centers, 494301 measurements from patients with
type 1 and 86277 from patients with type 2.
Results: Total TDP for the digits ‘‘0’’ and ‘‘5’’ was 55 ± 50% and
more frequent in smaller centers, rehabilitation centers, in non
academic and in outpatient centers. A lower rate for TDP was
found in Pediatric centers and centers treating patients with type 1
diabetes, in Austrian and West German centers compared to East
German centers. Within the last 14 years, TDP increased with age
and declined in type 1diabetes, but not in type 2 diabetes centers.
Levels of systolic BP were significantly lower in centers positive for
TDP.
Conclusions: TDP is common among German diabetes centers.
Profound differences between centers depending on the type of
diabetes and the regional differences were found. Pediatric centers
appear to be less susceptible for TDP. As TDP might be associated
with insufficient BP management BP readings need to be improved
by training academic and non-academic employees and by using
automated BP devices.
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P/004/WED
Evaluation of blood b-ketone measurementb in diabetic
ketoacidosis
M.H.M.F. El-Hefnawy
National Institute of Diabetes & Endocrinology, Pediatric Department,
Cairo, Egypt
The accumulation of ketones in the blood is called ketosis and may
lead to diabetic ketoacidosis (DKA). If untreated, DKA can lead
to coma and death. b-hydroxybutyrate (b-OHB) and acetoacetate
are the two main ketone bodies. Acetone, the third ketone body, is
present in much lower concentration. The aim of this study was to
evaluate the use of blood beta b-ketone strips during the diagnosis
and follow up of type 1 diabetic patients with DKA. This study had
been applied on 120 capillary blood samples in comparison to
blood glucose, blood PH, blood gasses, and urine sample for
glucose & acetone. The results showed that the new b-ketone test
strips provided accurate results in fingertip samples and it was
more predictable than urine acetone. The blood b-ketone test strips
was correlated with more accuracy with the blood pH, blood
electrolytes and dehydration state. All the indices of DKA was
significantly correlated with the measurements of b-ketone bodies
test strips, while urine acetone gave a lot of false results that make
it undependable for the daily diagnosis and follow up of the DKA.
It was recommended to use these b-ketone strips for diagnosis and
follow up of diabetic patients with DKA as it takes only 10 seconds
per test, easy to use, mostly painless, requires less blood, and the
blood results give a numerical result, which may be easier to
interpretation than comparing a color to a chart that reduces the
use error due to timming or visual interpretation of colors and
gives more accurate clinical information.
P/005/WED
Evaluation of the effect of type 1 diabetes mellitus on
the auxological data of children
K. Demir1, A. Altincik1, A. Abaci1, E. Bober1 & A. Buyukgebiz2
1Dokuz Eylul University, Department of Pediatric Endocrinology, Izmir,
Turkey, 2Acibadem Health Group, Department of Pediatric
Endocrinology, Istanbul, Turkey
Objective: To evaluate the effect of type 1 diabetes on growth and
other auxological data in children.
Subjects and methods: The inclusion criteria were: (i) A follow-up
duration of at least 1 year, (ii) not having achieved near-final height
at the presentation, and (iii) not having an associated disorder (e.g.
celiac disease, pubertal delay) that could affect growth. The
patients followed in our center since the diagnosis were included
in Group A while the others in Group B. Then, for each disease
year, the patients in Group A were divided into two subgroups as
Group A1 (those who maintained or improved their height SDS)
and Group A2 (height SDS of whom deteriorated).
Results: A total of 248 patients with type 1 diabetes were included.
The study consisted of 130 patients (M/F:70/60) after excluding
118 patients. The mean age at the diagnosis was 8.4 ± 3.6 years.
Group B consisted of 29 cases (22%, M/F:15/14), who presented
after a mean of 3.8 ± 2.6 years following diagnosis. The mean
values of auxological variables at the diagnosis in Group A (M/
F:55/45) were as follows: Weight SDS: -0.3 ± 1.1, height SDS
0.3 ± 1.1, BMI SDS -0.6 ± 1.4. Their mean target height SDS
was -0.2 ± 0.8. The mean height SDS of the patients in Group A
did not change significantly during the follow-up. Additionally,
weight and BMI SD scores were similar during the course of the
disease, except a significant rise observed by the end of first year.
The comparisons between Groups A1 and A2 revealed that
diagnosis following ketoacidosis was significantly associated with
maintaining or gaining height SDS at the 4th year of diagnosis
(P = 0.03). On the other hand, mean HbA1c level was modestly
negatively correlated with the course of height SDS at the 3rd year
of diagnosis (r = -0.3, P = 0.03).
Conclusion: No significant deteriorative effect of type 1 diabetes on
auxological parameters was observed. Some clinical and laboratory
variables related with metabolic control were found to correlate
with growth.
P/006/WED
Adiponectin, leptin, and lipid profile in type 1 diabetic
children and adolescents
M.H.M.F. El-Hefnawy1 & A.I. Amin2
1National Institute of Diabetes & Endocrinology, Pediatric Department,
Cairo, Egypt, 2National Institute of Diabetes & Endocrinology, Clinical
Pathology, Cairo, Egypt
Background: Adipose tissue is known to produce and secrete a
variety of bioactive substances known as adipocytokines.
Adiponectin and leptin are considered to be among the most
important adipocytokines: Objectives: To explore the relationships
between adipocytokines (adiponectin and leptin), lipid profile and
diabetic control indices in type 1 diabetic subjects.
Subjects and methods: In this study 63 clinically diagnosed type 1
diabetic subjects and 30 age and sex-matched healthy control
subjects were analyzed. Age, sex, diabetic duration, family history
of diabetes, daily insulin dose, weight, height, body mass index,
systolic and diastolic blood pressure were recorded. Fasting blood
glucose, glycated hemoglobin A1c, total hemoglobin, Lipid profile
and plasma levels of adiponectin and leptin were measured in type
1 diabetic subjects and control subjects.
Results: In this study a significant increase in triglycerides and
HDL-cholesterol of type 1 diabetics as compared to normal control
subjects. In type 1 diabetic subjects, plasma adiponectin was
significantly elevated while leptin showed a significant decrease as
compared to normal control group. Leptin showed a positive
correlation with body mass index, and systolic blood pressure,
while it showed a negative correlation with both fasting blood
glucose and glycated hemoglobinA1c.
Conclusion: The results of this study revealed that leptin but not
adiponectin has a significant correlation with glycemic control
indices.
Key words: adipocytokines, adiponectin, leptin, lipid profile and
glycemic control indices.
P/007/WED
Challenges of foot care in Cameroon
J.N. Menang1 & S. Njimogu2
1Divine Providence Low Cost Clinic, Diabetes, Buea, Cameroon,
2Baptist Hospital Mutengene, Dental, Tiko, Cameroon
Background: Previously common foot ulcers in Cameroon were
tropical ulcers mainly infested with streptococcal bacteria or mixed
streptococcal and staphylococcal pathogens, but the emergence and
prevalence of HIV/AIDS epidemic has now resulted in high
prevalence of Kaposi sarcoma. The leading diabetes complications
here are foot ulcers and if studies (University of Capetown-
UCT2006) proof that highly active anti-retroviral therapy
(HAART) increases the chances of type 2 diabetes mellitus (T2D),
then many more ulcers will be seen in diabetes clinic in the near
future, perhaps with high chances of lower limb amputations.
Poster Sessions
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Method: The clinic archives were analysed for the prevalence of
HIV, diabetes, dual diagnosis of diabetes and HIV, frequency of
ulcers and the sero-status of the general patients seen at the clinic
as well as their fasting plasma glucose tests.
Result: Factors noted to be responsible for the steadily rising foot
ulcers especially with diabetics is prior history of obesity mostly
secondary to sedentary lifestyles, poor sugar results due to either
poverty or ignorance, lack of foot exam and vascular assessment in
clinics, HIV in diabetes, injuries from farms ranging from minor to
severe.
Conclusion: The leading complication of diabetes here is the foot.
Approach of HIV advocacy is seemingly successful through
education and sensitization which we are looking forward to
adopting the method for diabetes and obesity advocacy. Through
these, diabetes epidemic maybe successfully slowed, coaster-roller
glucose improved with HbA1Cs which can drastically reduce
ulcers. Other factors influencing obesity like cultural and





Huge transient elevation of liver enzymes during
diabetic ketoacidosis
S. Tenoutasse, H. Tagzirt & H. Dorchy
ULB University Children Hospital Queen Fabiola, Diabetology Clinic,
Brussels, Belgium
Introduction: Abnormalities of hepatic function have been
reported in diabetic children with ketoacidosis. We report the
story of a 13.5 years old boy with type 1 diabetes and transient
fulminant hepatitis.
Case report: Our patient, with diabetes onset at 11.5 years had a
poor metabolic control: HbA1c varied between 11 and 14.4%, due
to non-compliance and omission of insulin injections. The normal
mean daily insulin dose was supposed to be 1.1 U/kg. The staturo-
ponderal evolution was normal. There were no complications. The
teenager has been followed in our diabetology clinic for 1 year. At
13.2 years, he was hospitalised in another clinic for ketoacidosis;
the hepatic enzymes were normal. Two months later, he was
rehospitalised for severe ketoacidosis: the pH was at 6.9 with
bicarbonate at 6 mEq/L; HbA1c rose to 14.4%. He developed a
fulminant hepatitis. Liver enzymes were extremely increased: AST:
3448 UI/l (N: 15-40), ALT: 934 UI/l (N: 10-40), gGT: 782 UI/l
(<17) and LD: 2861 UI/l (N: 240-480). Hepatomegaly with
steatosis was confirmed by ultrasound examination. Infectious,
metabolic or autoimmune origins were excluded. After 72 hours of
insulin, the glycemia were almost normalised, and the hepatic
enzymes dramatically decreased. Given this fast improvement of
the liver function, no hepatic biopsy was performed. After 3 weeks,
the hepatic enzymes were nearly normal and the ultasound control
showed neither hepatomegaly nor steatosis. In the literature,
authors report some histological descriptions of hepatic biopsies
showing steatosis and glycogen excess as described in some storage
diseases.
Conclusion: This 13.5 years old patient, with type 1 diabetes
having an extremely poor metabolic control, had the most severe
deterioration of the hepatic function ever described. The hepatic
enzymes returned to normal values within 3 weeks with
concomitant normalisation of blood glucose. In the event of
diabetic ketoacidosis, it is essential to monitor hepatic
function.
P/010/WED
Is better metabolic control achieved by increasing
frequency of insulin injections?
N.M. Flanagan, E. Hefferman, C. Cardwell & D.J. Carson
Royal Belfast Hospital for Sick Children, Belfast, UK
Objectives: The Diabetes Control and Complications Trial
demonstrated intensive insulin regimens delayed onset and
slowed progression of complications. Glycaemic control
improved with increased Body Mass Index (BMI) and
hypoglycaemia. The Northern Ireland Audit showed poor
control in children on 4 or more insulin injections with mean
glycosylated haemoglobin (HbA1c) level of 8.8% and 20%
HbA1c< 7.5%. Our study aimed to measure changes in HbA1c,
BMI and hypoglycaemia in patients attending the Royal Belfast
Hospital for Sick Children diabetes clinic after insulin regimen
change to 3 or more injections daily. Also, to compare with a
control group on twice daily insulin.
Methods: Data was collected on children and adolescents with type
1 diabetes attending the clinic with insulin regimen change. Patients
with newly diagnosed diabetes or frequent changes were excluded.
Paired t-tests were used to compare groups.
Results: 95 patients aged 8–21 years (mean 15 years) were on 4 or
more daily insulin injections. Regimen change at a mean of
11 years (4–16 years) from 1997. After 2 years mean HbA1c (with
standard deviation) decreased from 8.4% (1%) to 8.3% (1.1%)
with 22% HbA1c <7.5%. Mean BMI increased from 22.1 (3.9) to
22.2 (4.1).
Eighty-four patients aged 5–21 years (mean 13 years) were on 3
insulin injections from 2001, with mean age at change 10 years (3–
15 years). HbA1c levels increased from mean 8.1% (1.1%) to 9.1%
(1.5%) in 2 years with 44% HbA1c <7.5%. Mean BMI increased
from 21 (2.7) to 22.3 (3.7).
Control group of 50 patients aged 5 to 16 years (mean 9 years) on
twice daily insulin identified. Over 2 years HbA1c levels increased
from mean 7.3% (0.6%) to 8.3% (0.9%) with 41% HbA1c<7.5%.
BMI increased from 18.4 (3) to 18.2 (2). Hypoglycaemic episodes
were more frequent.
No statistical differences demonstrated.
Conclusions: No differences in HbA1c, BMI or hypoglycaemic
episodes noted. The numbers too small for positive effects. The
study does not account for confounding variables.
P/011/WED
Back to the future: a case of diabetic retinopathy
regression after 6 months of insulin pump therapy and
continuous glucose monitoring
G. Frontino1, A. Rigamonti1, M.A. Piscopo1, V. Biffi1, G. Cicenia1,
G. Zerbini2, R. Bonfanti1, M. Viscardi1, F. Meschi1 & G. Chiumello1
1San Raffaele Scientific Institute, Department of Pediatrics, Milano,
Italy, 2San Raffaele Scientific Institute, Department of Medicine,
Milano, Italy
We report a case of a patient with 19 years of poorly compen-
sated type 1 diabetes mellitus (T1D) (mean HbA1c=10%) who
showed signs of diabetic retinopathy (DR) regression after
Poster Sessions
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6 months (from diagnosis of retinopathy) of intensive insulin
treatment with insulin pump and continuous glucose monitoring
system (CSII+CGMS). Initial fundus oculi examination,
fluorangiography, and OCT scan showed signs of significant
non-proliferating DR with hemato-retinal barrier rupture and
important areas of capillary nonperfusion in the right eye. The
patients multiple injection therapy (MDI) was substituted with
CSII+CGMS, and in the following 6 months HbA1c levels
reached near normalization levels, hypo- and hyperglycaemic
events were significantly reduced (HbA1c = 6.4%, Avg
AUC>180 = 3, Avg AUC<70 = 0.5), and eye exams showed a
significant regression in the rupture of the hemato-retinal barrier
and improvement in capillary perfusion. Prolonged hyper-
glycaemia is the major pathogenetic trigger of diabetic complica-
tions (DC). However, the results of the Diabetes Control and
complication Trial showed that near normalization of glucose
control (HbA1c = 7.5%) via MDI delayed the onset of DC in
patients with short duration of diabetes, but was unable to induce
the remission of complications already present at the beginning of
the Study itself. Nontheless, hypoglycemia remained a limiting
factor in reaching optimal HbA1c. Other studies have showed that
prolonged near-normalization of glucose control (GC) via pancreas
transplantation may induce regression of diabetic nephropathy,
demonstrating the reversibility of DC. The recent improvement in
biomedical devices such as CSII+CGMS which allow the near
normalization of GC raises the possibility to induce regression of
DC using non-invasive techniques.
Poster Session II: Diabetes Acute and Chronic
Complications II
P/012/FRI
Cardiovascular autonomic neuropathy in children with
type 1 diabetes mellitus
N. Bolotova1, E. Novikova1, A. Averyanov1 & E. Ptitzkaya2
1Saratov State Medical University, Saratov, Russian Federation,
2Dorozhnaya Clinical Hospital, Saratov, Russian Federation
Diabetic cardiovascular autonomic neuropathy (DCAN) revealed
in children may determine the severe cardiovascular complications
in those as adults. Nevertheless few data exist on diagnostics and
prevalence of DCAN in children with diabetes.
Objectives: To evaluate the prevalence of cardiovascular
autonomic neuropathy in children with type 1 diabetes mellitus
(T1DM) and its possible relationship to the duration of disease and
metabolic control.
Methods: We investigated 40 patients aged 7–16 years with
T1DM. Pts were subdivided into 3 groups: group 1 (duration
of disease - <1 year, n = 12), group 2 (duration of disease – 1–
5 years, n = 16), group 3 (duration of disease - more than
5 years, n = 12). They were compared with 40 nondiabetic
subjects matched for age and sex. The battery of standard tests
and heart rate variability analysis were performed for DCAN
diagnostics.
Results: DCAN was revealed in 2 patients (12.6%) in group 2, and
5 (41.7%) in group 3. In addition: 33.3% of children in group 1,
43,8% - in group 2, and 58.3% in group 3 presented impaired
(insufficient) parasympathetic innervation according to HRV
indices. There were no specific trends of variables in nondiabetic
controls. DCAN degree was positively correlated with disease
duration (P = 0.01) and HbA1c after adjustment for the first
mentioned (P = 0.03).
Conclusions: Early signs of DCAN may be revealed in diabetic
children by HRV. The patients who present DCAN need a close
follow-up and improvement of metabolic control.
P/013/FRI
24-hour ambulatory blood pressure monitoring in
adolescents with type 1 diabetes with altered albumin
excretion ratio or hypertension
G.C. Jaimes-Parada1, J. Vila-Cots2, R. Cardona-Hernandez1, L. Suarez-
Ortega1 & M. Torres-Lacruz1
1Hospital Sant Joan de Du, Unit of Pediatric Diabetes, Esplugues de
Llobregat. Barcelona, Spain, 2Hospital Sant Joan de Du, Pediatric
Nefrology, Esplugues de Llobregat. Barcelona, Spain
Background: Ambulatory blood pressure monitoring (ABPM) can
identify alterations in the circadian pattern of blood pressure (BP)
and hypertension in people with type 1 diabetes (T1DM).
Furthermore, poor glycemic control is an important predictor for
development of microalbuminuria (MA).
Aims: To describe disturbances in ABPM and metabolic features
in adolescents with T1DM and altered albumin excretion and/or
hypertension.
Methods: ABPM was performed in 16 pediatric subjects with MA
and/or hypertension. Systolic nondippers were defined as a <10%
and diastolic nondippers as a <20% fall in BP during the night.
Hypertension was defined when systolic and/or diastolic BP was
higher than 90th percentile for age, gender and height in more than
40% of records as recommended by Second Task Force on Blood
Pressure Control in Children. MA was defined when albumin-to-
creatinine ratio was higher than 3 mg/mmol.
Results: Mean age of the subjects was 14.6 (10.9–17.8) years. Mean
diabetes duration was 7.2 (2.6–12.5) years; mean BMI-SDS 0.36
(-0.89 - 3.02), insulin dosage was 1.1 U/Kg/d (0.6–1.5) and average
HbA1C 9.1 (7.5–13.5)%. Girls had shorter diabetes duration (6.89
vs. 8.2 years). Mean BMI SDS was higher in female subjects (0.57
vs. -0.25) and so was median HbA1C (9.3 vs 8.5). The prevalence
for MA was 56.2% (7/12 girls and 3/4 boys). Mean systolic
nondippers was 7.9% and mean diastolic nondippers was 14.7%.
The mean systolic non-dippers was 7.4% in girls and 9.5% in boys.
Mean diastolic nondippers was present in 3 out 4 boys while mean
systolic nondippers was in 8 out 12 girls. Systolic hypertension was
present in 2 out 16 subjects and diastolic hypertension was in 3.
Conclusions: Girls had worse BMI-SDS, HbA1C and systolic
nondippers probably due to an increased insulin resistance
during puberty, but boys had a higher MA excretion. Our
findings suggest that adolescents might present MA and




Screening of autoimmune pathology associated with
diabetes mellitus type 1 in children and adolescents
M. Marazan, I. Micle, R. Giurescu, E. Pop, J. John & S. Hanini
Children Emergency Hospital Louis Turcanu, Timisoara, Romania
Aim: Screening of autoimmune pathology associated with diabetes
mellitus type 1 (T1DM).
Poster Sessions
ª 2009 The Authors
Journal Compilation ª 2009 John Wiley & Sons A ⁄ S Pediatric Diabetes (2009) 10 (Suppl. 11): 30–109 33
Material and method: It is a prospective study covering the period
2003–2008.
The study group: 112 children with age between 3–8 years were
divided into two subgroups: A. 24/112 children (21.42%) with
T1DM onset in the last 5 years and B. 88/112 children (79.58%)
already diagnosed with T1DM at the commencement of the
screening. The subgroup A children underwent annual screening of
the associated autoimmune pathology from the onset of T1DM
while those in the subgroup B followed the elaborated protocol of
ISPAD. Thyroid exploratory tests were performed: functional
status (TSH, FT4), serological markers-antithyroid peroxidase
antibodies (anti-TPO) and thyroid echography. Tissue transgluta-
minase antibody (TGA) and anti-endomysium (EMA) were also
tested. Adrenal autoimmune markers (21 hydroxylase antibody-
AA21-OH) was determined in 37 adolescents.
Results: The study group had the following characteristics:
average age 12.65 ± 3.06 years, duration of T1DM 5.54 ±
3.45 years. In the subgroup A, TSH value was 3.01 ± 2.6 lU/
ml and FT4 1.93 ± 0.086 ng/ml, anti TPO was positive in 5/24
children.Two children presented with Goiter, one with
hyperthyroidism and the other euthyroidism. The diagnostic
workup of autoimmune thyroiditis has been: euthyroidism in 3/24
children, hyperthyroidism in 1/24 and subclinical hypothyroidism
in 1/24. The screening performed in the subgroup B revealed
TSH value 2.03 ± 1.53 lU/ml and FT4 1.32 ± 1.3 ng/ml, anti-
TPO was positive in 11.36%. TGA and EMA was positive in 1/
24 in subgroup A and 4.54% in subgroup B. Celiac disease
histological confirmation was seen in 1 child- subgroup B who
also follows a gluten free diet. Five adolescents (subgroup B)
with T1DM evolution over 10 years presented positive AA21-
OH.
Conclusions: T1DM has an autoimmune etiology and is associated
with other endocrine entities. Autoimmune pathology screening
should be performed from the onset of T1DM.
P/016/FRI
Type 1 diabetes and graves ophthalmopathy in a
16-year-old girl: therapeutic challenges of a rare
disease association
C. Scarabello1,2, N. Datz1, T. Kracht1, O. Kordonouri1, S. Heger1,
V. Pauli3, M. Morlot4 & T. Danne1
1Kinderkrankenhaus auf der Bult, Diabetes Centre for Children and
Adolescents, Hannover, Germany, 2University of Parma, Interuniversity
and Regional Centre for Diabetes Care and Research in Children and
Adolescents, Parma, Italy, 3Ophthalmologic Outpatient Clinic ``Selle-
Pauli-Kaczmarek'', Hannover, Germany, 4Endokrinologikum, Hannover,
Germany
Introduction: Graves¢ disease (GD) is uncommon in the pediatric
age, but children have about the same risk as adults to develop
Graves¢ophthalmopathy (GO). Patients with type 1 diabetes
mellitus (T1DM) have an increased incidence of autoimmune
thyroid disease (30%). We report on a rare case of severe GD in a
16-years-old girl with T1DM.
Case presentation: The patient was referred to our centre at the age
of 16 years (height: 171.5 cm, SDS 1.33; weight: 6.1 kg, SDS 1.27).
She had T1DM since 10 years, treated with multiple daily
injections. At the age of 14 years she developed prominent
exophthalmos and lid retraction. She had hyperthyroidism (T3:
396 ng/dl, T4: 16.7 lg/dl, TSH < 0.01 lIE/ml), positive TSH
receptor antibodies (TSHrAb 2.8 U/l) and thyroid enlargement.
She received thiamazol 20 mg/day for 1 year, avoiding
propylthiouracil as first line treatment because of the risk of liver
failure in children. Treatment succeeded in controlling
hyperthyroidism, but failed in treating GO. At time of referral to
us the girl had poor glycemic control (HbA1c: 10.6%), was
euthyroid, had GO grade 2 with severe keratoconjunctivitis sicca
and corneal ulcerations, but no ocular hypertension. A MRI
showed no involvement of the extraocular muscles and no optic
nerve pathology. The patient received intravenous prednisone
500 mg/weekly for 6 weeks. After the first administration she
experienced marked hyperglycemia that was treated with
fractionated subcutaneous injection of rapid insulin analog.
From the second administration we increased the basal insulin to
30% of the usual dose and were able to avoid severe
hyperglycemia. Already after the first course of therapy the
patients¢GO showed a clear improvement.
Conclusion: High dose corticosteroid treatment was successful in
treating a rare case of GO in a youth with T1DM. Close
monitoring of blood glucose levels and a marked increase in
insulin doses are necessary to avoid glycaemic dysregulation.
P/017/FRI
Cerebral crisis in severe diabetic ketoacidosis (dka)
despite adequate fluid and insulin therapy
N. Datz, W.V. Schuetz, O. Kordonouri, C. Nestoris, S. Hethey,
G. Engelcke, & T. Danne
Kinderkrankenhaus auf der Bult Hannover, Pdiatrische Diabetologie,
Hannover, Germany
Introduction: DKA is the main reason for a higher rate of
mortality of children with type 1 diabetes mellitus (T1DM). The
pathophysiology of the developing cerebral edema is not
completely elucidated. We describe the occurrence of a cerebral
edema in a patient with severe ketoacidosis in spite of treatment
strictly according to the guidelines.
Case presentation: A 13 years old girl (T1DM since 4 years)
presented at our hospital with vomiting. Her standard treatment
consisted of Insulin detemir 50units (U) in the morning and Insulin
aspart 3U per carbohydrate (carb) in the morning and evening and
2 U per carb at noontime. She appeared in a poor general health
(weight 34 kg (<3.perc.), height 153 cm (10.perc.) without any
neurological deficits. The laboratory findings showed the
following results: pH 7.08; BE-21.8 mmol/l; blood glucose (BG)
430 mg/dl; bicarbonate 6.4 mmol/l, lactate 2.3 mmol/l; pCO2
21.9 mmHg; Na+ 128 mmol/l; corrected Na+ 135 mmol/l; K+
4.3 mmol/l; HbA1c 9.5%, creatinine 1.1 mg/dl; urea 56 mg/dl.
Initial rehydration with 500 ml ringer lactate (15 ml/kg/h) and i.v.
insulin infusion (0.1 U/kg/h). After 1 hour reduction of fluid to
7.5 ml/kg/h, dose of insulin did not change. 2.5 hours after
initiation of therapy the clinical condition of the girl
deteriorated. She was somnolent with mydriasis and did not
show any reactions to pain. BG was 269 mg/dl. Mannitol 20%
100 ml i.v. was given immediately over 15 minutes, the
tomography revealed cerebral edema, the EEG showed a general
bilateral alteration, particularly in the frontocerebral region. The
girl recovered without sequelae.
Conclusion: This case report demonstrates that cerebral edema in
DKA may present even when fluid and insulin therapy is
administered according to current clinical guidelines. Thus, close
neurological follow-up in DKA is mandatory. Clinical signs of
cerebral edema should be treated immediately. As DKA presents a
serious health challenge every effort of DKA prevention should
have the highest priority.
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P/018/FRI
Treatment of diabetic ketoacidosis (DKA) in two
different centers with different regimens regarding
fluid substitution and insulin dosing
T. Kapellen1, D. Telleis1, W. Kiess1 & C. Vogel2
1Universittsklinik und Poliklinik fr Kinder und Jugendliche, Leipzig,
Germany, 2klinikum Chemnitz, Hospital for Children and Adolescents,
Chemnitz, Germany
Objectives: We analyzed the treatment outcomes of DKA therapy
in two German centers for pediatric diabetology in respect to
duration until resolution of ketoacidosis, hypoglycemia during
treatment and hypokalemia during initial treatment.
Methods: Retrospective analysis of all cases of diabetic
ketoacidosis treated in the intensive care units in children and
adolescents with diabetes with an age of 0–18 years in 1998–2005 in
the children¢s hospitals in Leipzig and Chemnitz, Germany, using a
standardized, computerized assessment form.
Results: 64 children and adolescents (23 in Center A and 41 in
Center B) with a mean age of 11.4 years had been treated for
DKA. Mean pH at diagnosis was 7.1 (6.84–7.29) initial
bicarbonate was 8.5. Insulin substitution was started with
0.03 IU/kg in center A and 0.1 IU/kg in center B whereas
initial fluid was 4.5 ml/kg in the first hour in center A and 10 ml
in center B. Bicarbonate treatment was initiated in 16 patients of
center A (70%) and in 8 patients in center B (17%). The different
treatment regimens resulted in a slightly shorter duration of
acidosis (8 hours in center A versus 6.5 hours in center B, not
significant) but a significantly faster normalization of blood
glucose in one center (18 hours vs. 10.5 hours). In addition, there
was a significant difference regarding the development of
hypoglycemia and hypokalemia between the treatment regimens.
One patient (from center B) developed cerebral edema with minor
sequelae.
Conclusion: Comparison of different treatment regimens of DKA
in different centers will help to standardize and harmonize regional
treatment schemes following international guidelines.
P/019/FRI
Relation profile of blood pressure and heart rate with
microalbuminuria and metabolic control in children
and adolescents with type 1 diabetes
M.D. JeÐić1, S. Sajić1, V. Zdravković1, V. Bojić1, M.M. JeÐić2 & S. Necić1
1University Childrens Hospital, Endocrinology, Belgrade, Serbia,
2University Childrens Hospital, Neonatology, Belgrade, Serbia
Introduction: The prevention of diabetic nephropathy is aimed at
early detection of risk factors for the development of
microalbuminuria, the most significant predictor of nephropathy.
Aim: To assess the frequency of microalbuminuria and
relationship with other risk factors (HbA1c, blood pressure,
BMI, duration of diabetes, puberty) for the development of
diabetic nephropathy.
Methodology: In a cross-section study involving a group of 60
children and adolescence of both sexes, mean age
15.31 ± 2.43 years and with mean duration of type 1 diabetes
7.74 ± 3.44 years, we assessed the presence of microalbuminuria.
Microalbuminuria was determined in 2–3 samples of the first
morning urine in the period below 6 months, using turbidimetric
method, in which the normal value was below 15 mg/l.
Ambulatory blood pressure was monitored (SpaceLabs 90207).
Results: Of all our patients, microalbuminuria developed in 8
(13.3%) patients, mostly adolescents with completed sexual
development, statistically significantly poorer metabolic control
(9.79% vs. 8.70%) and higher BMI (23.59 kg/m2 vs. 20.85 kg/m2)
than in the patients with normoalbuminuria. The duration of
diabetes was statistically significantly related to urine albumin
excretion (UAE), with a high statistical significance of the
correlation between HbA1c and UAE and between BMI and
UAE (P < 0.01). Mean night systolic blood pressure (SBP) was
statistically significantly higher in microalbuminuria patients than
in normoalbuminuria patients. Heart rate was statistically
significantly related to night SBP. Mean arterial pressure
nondipping was more frequent in the patients with
microalbuminuria than in the patients with normoalbuminuria
(62.5% vs. 38.5%), but without statistical significance.
Conclusion: Using univariant logistic regression, in our patients
statistically significant risk factors for the development of
microalbuminuria were: high HbA1c, BMI and night SBP.
P/020/FRI
Tracking of serum lipids in children with type 1
diabetes; effects of glycemic control, family history and
diet
C.L.H. Brackel & W.M. Bakker-van Waarde
Beatrix Children's Hospital, University Medical Center Groningen,
Pediatric Endocrinology, Groningen, Netherlands
Background: In patients with type 1 diabetes (DM1) poor
glycemic control and abnormal lipid concentrations are
associated with macro-and micro vascular complications. In the
normal population, 50–70% of children with high lipid levels
keep elevated concentrations at adult age. In DM1-children little
is known about tracking of lipids and factors influencing lipid
levels.
Objective: Tracking of lipid levels in DM1-children was evaluated
and associated with glycemic control. Lipid concentrations were
related to glycemic control, familial factors, BMI and diet.
Methods: In 116 DM1-children, lipid concentrations and glycemic
control were retrospectively investigated from 1996–2007. In a
subgroup of 38 children diet and family history was assessed. As
control group we used 17 children without DM1 and data from
literature.
Results: Cholesterol- and LDL-cholesterol concentrations were
elevated (>5.2 mmol/l, >3.4 mmol/l) in 10.6% and 6.4% of
DM1-patients. These values remained increased in respectively
50% and 83% of DM1-children. A high variability in HbA1c
percentage correlated positively with a high variability in
cholesterol concentrations. Cholesterol concentrations were
positively associated with DM1 duration, age and HbA1c-
percentage, but not with BMI or diet. Children with a positive
family history for diabetes or cardiovascular disease had higher
cholesterol-, LDL-Cholesterol- and lower HDL-Cholesterol-
concentrations.
Conclusions: Tracking of lipid levels was shown in DM1-children
and was associated with glycemic control. Regular monitoring of
lipid concentrations in DM1-children and checking for associated
cardiovascular risk factors is mandatory to identify DM1-children
at high-risk for atherosclerosis. In these patients optimization of
glycemic control should be pursued and treatment with lipid-
lowering medication should be considered.
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P/021/FRI
Does the age of children in the moment of diagnosis the
diabetes may influence on abnormalities of growth
hormone axis in children with IDDM
M. Szalecki
Children's Memorial Health Hospital, Clinic of Metabolism,
Endocrinology and Diabetology, Warsaw, Poland
The abnormalities of growth hormone axis play a great role in
IDDM patients-in pathogenesis, complications, insulin resistance,
dawn phenomenon and fat disorders.
The aim of the study was to estimate the influence of age, duration
of diabetes and the age at the moment of diagnosis on growth
hormone axis abnormalities in children with IDDM.
Material and methods: Seventh-seven patients and 15 age matched
healthy children were included into the study. All children were
prepubertal, suffering for IDDM for more than two years, without
any coexisting diseases. All patients were divided into groups
according to the kind of therapy.22 were treated with conventional
insulin therapy, 21 with multiple insulin injection and 24 with
continuous subcutaneous insulin infusion.There were no
statistically significant differentials between groups as to the
metabolic control,age,duration of diabetes,age at the moment of
diagnosis of diabetes,weight,height and BMI. Blood and urine
samples were taken between 7.30 and 8.30 a.m. in hospital in
normoglycemia after the night without episodes of hyper or
hypoglycemia. All analysis were made by RIA or ELISA
commercial kits.
Results: The positive correlation between age at the moment of
diagnosis and the dose of insulin and concentrations of IGF-1 and
IGFBP-6 and negative correlation with the concentration of
IGFBP-1 were observed in IDDM children whereas the age
correlated positively only with IGF-1 concentration and negatively
with IGFBP-1 and duration of diabetes only positively with
IGFBP-1.In CSII group the positive correlations between age at
the moment of diagnosis and GHBP and IGFBP-3 concentrations
were also observed.
Conclusions: 1. The age of children in the moment of diagnosis the
diabetes better correlate with growth hormone axis than the age
and duration of diabetes. 2. The age of children in the moment of
diagnosis the diabetes may influence on abnormalities of growth
hormone axis in children with IDDM.
P/022/FRI
Diabetic ketoacidosis in children with newly
diagnosed type 1 diabetes mellitus
A. Szypowska & E. Pańkowska
Medical University of Warsaw, Warsaw, Poland
Objectives: Despite considerable advances in diabetes diagnosis,
diabetic ketoacidosis (DKA) remains still a severe complication
associated with significant morbidity and mortality.
The aim of the study was to determine the prevalence and
predictors of DKA in children with newly recognized type 1
diabetes mellitus (T1DM).
Methods: The study group consisted of 187 children (95 girls, 92
boys) with the new recognition of T1DM, admitted to our hospital
between January 2006 and March 2008, mean age 8.9 ± 4.6 years
(0.8–17.8). In all children HbA1c, blood pH and fasting c-peptide
were measured. DKA was defined as a capillary pH value of less
than 7.3. Statistical analysis was performed by using Unpaired
t-test, Mann–Whitney Test, Spearman Rank Correlation,
P < 0.05 was considered as significant.
Results: DKA was noted in 26% of children with newly recognized
diabetes mellitus. Children with DKA were not significantly
younger than children without DKA 8.05 vs. 9.15 years
P = 0.15, but had lower c-peptide level 0.49 vs. 0.65 nmol/l
respectively (P = 0.003). There was significant correlation between
c-peptide and age r = 0.41. P < 0.0001. In patients under 2 years
DKA occurred in 70% of children. C-peptide was significantly
lower in children <2 years vs. >2 years: 0.15 vs. 0.64 nmol/ l
respectively (P < 0.0001). There was significant difference in pH
value between children <2 years and >2 years: 7.21 vs. 7.34
respectively (P < 0.0002). In children <2 years HbA1c was
significantly lower 10.4% vs.11.3%. P < 0.03.
Conclusion: Over one of fourth diabetic children at diagnosis of
T1DM have ketoacidosis. The most susceptible to DKA are
children younger than 2 years of age, what might reflect a more
aggressive beta cell destruction in infants and toddlers.
Poster Session I: Diabetes Acute and Chronic
Complications III
P/023/WED
A national, population based study of the double
diagnosis of celiac disease and type 1 diabetes in
children and adolescents
M.D. Tonga1, I. Ellingsrud1, C. Brunborg2, T. Skrivarhaug3,
H. D. Margeirsdottir4, M. Graue5 & K. Dahl-Jorgensen1,4, Norwegian
Childhood Diabetes Registry
1University of Oslo, Faculty of Medicine, Oslo, Norway, 2Oslo University
Hospital, Ulleval Department of Medical Statistics, Oslo, Norway, 3Oslo
University Hospital, Norwegian Childhood Diabetes Registry, Ulleval
Pediatric Department, Oslo, Norway, 4Oslo University Hospital, Ulleval
Pediatric Department, Oslo, Norway, 5Bergen University College,
Faculty of Health and Social Sciences, Bergen, Norway
Aims: Investigate the relationship between type 1 diabetes and
celiac disease and explore the extent of symptoms, treatment and
diabetes-related quality of life.
Methods: Two previously validated questionnaires (Canadian
Celiac Survey and Diabetes Group Quality of Life) were used.
In The Norwegian Childhood Diabetes Quality Register
comprising more then 85% of all patients in the country
(n = 1810) a standardized examination with centrally measured
HbA1c and celiac screening by transglutaminase test is performed
annually. 146 patients 0–20 years of age were registered with the
double diagnosis, and 82 (56%) responded. Mean age 13 years,
62% were girls. Clinical data were compared to all patients in the
register.
Results: The prevalence of celiac disease in children was 8%.
23% had first-degree relatives with type 1 diabetes or celiac
disease. 65% had the diagnosis by screening, followed by biopsy.
73% got diabetes first. The most common symptoms at diagnosis
were abdominal pain, gas, weakness, problems with blood
glucose, mood swings and poor growth. 90% ate strictly
glutenfree food. 65% experienced improved health after
initiating glutenfree diet. 7% found it hard to follow the diet.
Half of the patients felt always/frequently/some times excluded by
their peers, two third felt different, embarrased, angry,
misunderstood. Nearly half will avoid visiting restaurants, 15%
avoid travelling. This is however not significantly different from
patients with celiac disease only. The quality of life was generally
good and was not significantly different from patients with
diabetes only. Frequency of severe hypoglycemia (6 vs. 7%),
DKA (5 vs. 5%) and mean HbA1c was not significantly different
Poster Sessions
ª 2009 The Authors
36 Journal Compilation ª 2009 John Wiley & Sons A ⁄ S Pediatric Diabetes (2009) 10 (Suppl.11): 30–109
between patients with or without celiac disease respectively:
HbA1c 8.3 (SD 1.1)% vs 8.5 (SD 1.4)%.
Conclusion: Celiac disease is an additional burden to the patient
and their family, but did not significantly impaire patients¢ general
health status compared to patients with diabetes only.
P/024/WED
Screening detected elevated anti tissue
transglutaminase antibodies in asymptomatic children
with type 1 diabetes – when to biopsy?
T. Savage1,2, E.F. Roche1, K. McCarthy3 & H. Hoey1
1National Children's Hospital, Dublin, Ireland, 2University of Auckland,
Auckland, New Zealand, 3Trinity College Dublin, Dublin, Ireland
When screening for coeliac disease (CD) in asymptomatic children
with type 1 diabetes (T1DM), a marginally elevated serum
antibody to tissue transglutaminase (TTG) level is a relatively
common finding.
Aims: 1. To establish whether all children with an isolated raised
TTG should undergo intestinal biopsy. 2. To compare them to
children with histologically proven CD and matched controls.
Methods: All patients with T1DM in a tertiary paediatric centre
were screened annually for CD over a 5 year period by
determination of Anti-TTG Antibody and IgA anti endomysial
antibody (EMA). Each biopsy positive and biopsy negative case
was matched for sex, age and duration of diabetes with 2 control
subjects. Clinical and laboratory outcomes were measured for 1
year pre and 2 years post Gluten free diet (GFD).
Results: 9/253 (3.5%) children had biopsy confirmed CD. These
children had a raised TTG, symptoms of CD and/or were EMA+.
In the year pre GFD, cases had similar weight and height gain,
HbA1c, Insulin dose and haemoglobin when compared to controls.
In the 2 years post GFD, cases demonstrated significant weight
gain (P = 0.03) but no significant change in height (P = 0.11),
HbA1c (P = 0.83), haemoglobin (P = 0.22) or insulin dose
(P = 0.7) when compared to controls. 9 asymptomatic, screening
detected subjects had raised TTG levels (EMA -), with subsequent
negative histology on intestinal biopsy. TTG levels in all 9 subjects
subsequently spontaneously normalised. All 9 had no significant
difference in clinical or laboratory characteristics when compared
to controls. A further 40 / 253 (15%) of the clinic population had a
raised TTG on at least one occasion which resolved spontaneously.
Conclusion: We suggest that a higher threshold value for TTG is
applied when considering intestinal biopsy in asymptomatic
children with an isolated, elevated TTG detected on routine
screening. This will avoid unnecessary or premature intestinal
biopsies.
P/025/WED
Severe subcutaneous insulin infusion resistance in a
13 year old child – a case-report of successfully
performed therapy with a diaportTM-system
D. Hilgard & A. Laengler
Gemeinschaftskrankenhaus, Univ. Hospital, Pediatrics, Herdecke,
Germany
Introduction: Extreme subcutaneous insulin infusion resistance
(SIR) is rarely reported in pediatrics. It is characterized by
severe resistance for subcutaneously applicated insulin while
insulin sensitivity for i.v. insulin is normal. Pathophysiology is
unclear, an accelerated subcutaneous degradation of insulin is
most likely.
Case-report: After 4 years of T1DMwithout any problems (insulin
requirement 0.8 IU/kg/d, treated with CSII, otherwise healthy, no
acanthosis nigricans) in a 13 year old girl the insulin requirement
suddenly increased massively up to 4.2 IU/kg/d by ongoing
hyperglycemia and ketosis. Under i.v. Insulin application the
insulin requirement could be reduced to 0.8 Iu/kg/d. No
improvement by Biguanids or change of the type of insulin could
be achieved. Switching back to s.c. application of insulin was not
successful. After 7 weeks inpatient therapy a DiaportTM-System
with continuous intraperitoneal insulin infusion (CIPII) was
implanted. The daily insulin need by this is 0,6 IU/kg Kg/d.
Diagnostic considerations: There were no clinical or anamnestic
signs of PCOS or other relevant syndromes (e.g. Donohue‘s
Syndrom, Rabson-Mendenhall Syndrom, Typ A und B Syndrome,
Lipodystrophy-Syndrome Berardinelli-Seip, Barraquer-Simons,
Lawrence). Extensive laboratory diagnostics gave no indication
for endocrinological or immunological causes.
Discussion: This might be a recurrent form of SIR in a child.
Further diagnostic examinations will be necessary in order to find
the cause of the problem. CIPII is a cost effective treatment with
marked improvement of live quality for a period of time. Intra-
abdominal adhesions and infections are the risks which are limiting
this therapy.
Conclusion: This was the first treatment of a postpubertal girl in
Germany with SIR. In order to solve this therapeutical dilemma we
performed an intra-peritoneal insulininfusion by Diaport
successfully.
P/026/WED
Modifiable risk factor in type 1 diabetes – adolescence
to adulthood: a follow up study
P.Z. Benitez-Aguirre, M. Craig, J. Cusumano, A. Pryke & K.C. Donaghue
The Children's Hospital at Westmead, Institute of Endocrionology and
Diabetes, Sydney, Australia
Aim: Risk factors other than A1C may play important roles in the
incidence and progression of microvascular complications in T1D.
An adolescent cohort was restudied as young adults to determine
putative risk factors during adolescence for microvascular
complications in adulthood.
Methods: One hundred fifty-two and young adults (69 M) with
T1D screened between 1997–2002 (T1) participated in follow-up in
2007–2008 (T2). Non-participants had higher A1C (8.9 ± 1.4 vs.
8.6 ± 1.5, P = 0.003) but no other baseline differences were
observed. Retinopathy was assessed by 7-field stereoscopic fundal
photography and albumin excretion rate (AER) from 3 timed
overnight urine specimens. Multiple regression models were used to
evaluate risk factors for complications (age, BP, HbA1c,
cholesterol, BMI, duration).
Results: Median age was 15.1 years [IQR 13.5–16.8] at T1 and
23.5 years [21.0–25.6] at T2; Duration of diabetes 7.8 years [4.5–
11.0] at T1and 15.4 years [12.5–19.5] at T2. A1C decreased from
8.6 ± 1.4% to 8.04 ± 1.4% (P < 0.001), BMI increased from
22.4 to 25.7, (P < 0.001). Retinopathy increased from 31 to 53%
(P < 0.001) and early elevation of AER (>5 ug/min) from 49 to
63% (P = 0.03). Males had a higher prevalence of BMI >85%
(59% vs. 47%) at T2. Retinopathy at T2 was predicted by Baseline
BMI (OR 1.189, 1.065–1.328) and A1C (1.345, 1.027–1.761) at T1.
Incidence and progression of retinopathy were predicted
by Baseline A1C (OR 1.4; 1.0–1.8) and systolic BP (OR 1.1; 1.0–
1.1). An increase in AER at T2 was associated with A1C at T1
(1.19, 1.07–1.32) and T2 (1.16, 1.04–1.29).
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Conclusions: Despite improved glycaemic control; rates of
retinopathy, early elevation of AER and overweight/obesity
increased over 8 years. Adolescent BMI, A1C and BP predicted
retinopathy but only A1C predicted an increase in AER in this
group. Other therapeutic avenues for metabolic control and risk
reduction need to be explored at transition to adult care to delay
progression of microvascular disease.
P/027/WED
Nocturnal glycemic pattern and blood pressure
nocturnal decline in t1d adolescents
P. Wagner1, S. Chiaravalli1, M. Cosentino2, R. Bombelli2, F. Marino2 &
A. Salvatoni1
1Paediatric Clinic - University of the Insubria, Varese, Italy,
2Experimental and Clinical Pharmacology - University of the Insubria,
Varese, Italy
Objectives: The loss of nocturnal decline of blood pressure has
been reported in T1D patients in intensive treatment associated
with a nocturnal rise in cathecolamines. Prolonged nocturnal
hypoglycemia or wide blood glucose changes during the night were
observed in patient during continuous glucose monitoring. Aim of
this study is to establish whether the type of blood glucose pattern,
with particular reference to severe hypo- or hyperglycemia, during
the night could be responsible of impairment of the physiological
blood pressure nocturnal decline.
Methods: We studied 12 T1D adolescents (12 boys) 12 to 21-years
old (median 18.5) with a disease duration from 50 to 160 months
(median 106.5), HbA1c from 6.2 to 9.6 (median 7.95) and insulin
requirement from 0.5 to 1.2 (median 0.9). In all patients we
simultaneously performed a continous monitoring during 24 hours
of glucose (CGMS-Medtronic, Inc.) and blood pressure (TM-2430.
A&D instruments). Diurnal and nocturnal HBGI and LBGI were
also calculated. The analysis of cathecolamines (free dopamine,
free norepinephrine, free epinephrine, total metanephrine, VMA
and HVA) was done in urines collected in the same night. Simple
regression analysis was used for statistical evaluation.
Results: We did not observe any severe or prolonged hypoglycemic
event. The magnitude of the nocturnal decline of systolic and
diastolic blood pressure resulted directly correlated to mean
nocturnal blood glucose and HBGI (P < 0.02). Mean nocturnal
blood glucose, HBGI, LBGI and nocturnal blood pressure decline
were not correlated to nocturnal urinary cathecolamines. A
significant direct correlation was observed between nocturnal
blood pressure decline and nocturnal urine volume.
Conclusions: According to our results nocturnal blood pressure
decline is more depending on osmotic diuresis than on
hypoglycemia induced cathecolamines.
P/028/WED
Serum levels of adiponectin in children and
adolescents with type 1 diabetes: impact of pubertal
stage, metabolic control and microvascular
complications
E. M. Sherif1, A. Adly1, N. Hussein1 & H. Ghareeb2
1Ain Shams University, Pediatric Department- Diabetes Unit, Cairo,
Egypt, 2Ain Shams University, Pathology Department, Cairo, Egypt
Objectives: To determine serum adiponectin level in children and
adolescents with type1 diabetes and to study its impact on
pubertal stage, metabolic control as well as microvascular
complications.
Methods: This was a cross sectional study that included 80 type
1 diabetic children and adolescents (age: 7–17 years with a mean
of 13.35 ± 2.83 years).They were compared to 75 non diabetic,
age, sex and pubertal stage matched controls. All participants
were subjected to history taking, clinical examination.
Laboratory investigations included haemoglobinA1c, mean
blood glucose, fasting lipid profile and urinary albumin
excretion. Adiponectin was measured by enzyme linked
immunosorbant assay.
Results: Mean adiponectin levels were significantly higher in
diabetic patients compared to controls (P < 0.0001).Adiponectin
levels were significantly elevated in females compared to male
diabetics(P = 0.02).Serum adiponectin levels did not differ
significantly in different pubertal stages. Adiponectin levels were
inversely correlated with body mass index standared deviation
score (BMI SDS, r = -0.35, P = 0.024), weight SDS (r = -0.32,
P = 0.047), while it was positively correlated with HbA1c
(r = 0.81, P = 0.0001), urinary albumin excretion (r = 0.61,
P < 0.0001). There was no any differences in adiponectin
concentrations whether or not the patients were taking
angiotensin converting enzyme inhibitors. Diabetics with
peripheral neuropathy showed significantly higher adiponectin
levels compared to patients without neuropathy (P = 0.005).
Conclusions: Adiponectin is elevated in children and adolescents
with type1 diabetes compared to controls. Higher levels were
detected in females, with no impact of puberty. Adiponectin
concentrations correlated with glycemic control and
microvascular complications (nephropathy and peripheral
neuropathy).
P/029/WED
Outcome of metabolic control, complications
and associated conditions in our previous
pediatric patients after the transition to the
adult centre
S. Zucchini1, S. Salardi2, G. Maltoni1, M. Scipione1, A. Rollo1,
I. Bettocchi1, G. Forlani3, A. Ciavarella4 & A. Cicognani1
1S.Orsola-Malpighi Hospital, University of Bologna, Pediatrics,
Bologna, Italy, 2University of Bologna, Pediatrics, Bologna, Italy,
3S.Orsola-Malpighi Hospital, Metabolic diseases, Bologna, Italy,
4S.Orsola-Malpighi Hospital, Diabetology, Bologna, Italy
Objectives: Few data on follow-up of pediatric patients (pts) after
the transition to the adult centre are available. We collected data of
69/94 of our previous pts living in Bologna area with onset between
1972 and 1992 and transferred to the local adult centre. M/F ratio
was 32/37, age at onset 8.4 ± 3.8 years, at transition 23.8 ±
3.9 years, present 34.1 ± 4.6 years, disease duration 25.9 ±
5.1 years (15.9 ± 5.5 years at our centre and 8.4 ± 6.1 at adult
centre).
Methods: Data on metabolic control (current and mean of all),
retinopathy, nephropathy, other associated conditions or
psychosocial aspects were collected.
Results: Current HbA1c was 8.1 ± 1.5%, similar to the value at
transition (8.3 ± 1.4%). In 40% of cases HbA1c improved of at
least 0.5%, in 53% worsened of at least 0.5%.
The pts without retinopathy had a mean of all HbA1c values
significantly lower (P = 0.004) despite a longer disease duration
(P = 0.0001). The same was true for nephropathy. 2 pts were
blind. The first 3 associated conditions included thyroiditis
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(18.8%), depression (13%) and ovarian cysts (10.8%). 17/69 of pts
(24.6%) had suffered at least once of significant psychosocial
disturbances: depression, panic attacks, eating disorders and drug









No retinopathy 7.9 24 49.7
Non proliferative retinopathy 8.6 20 36.2
Proliferative retinopathy/blindness 9.9 16 14.1
No nephropathy 8.1 26 81.1
Micro/macroalbuminuria 9.3 19 13.2
Renal disease 9.5 17 5.7
Conclusions: Metabolic control of our previous patients showed
minor variations after a mean period of 8 years after transition to
the adult centre. 20% of the patients showed severe retinopathy
associated with persistently poor metabolic control. Severe
psychological and psychosocial problems were unexpectedly
frequent in our group of adult patients.
P/030/WED
Plasma adrenomedullin level in Egyptian children and
adolescents with type 1 diabetes mellitus: relationship
to microvascular complications
S.A. El Habashy1, R.M. Matter1, E.S. El Hadidi2 & H.R. Afifi1
1Ain Shams University, Pediatrics, Cairo, Egypt, 2Ain Shams University,
Clinical Pathology, Cairo, Egypt
Background: Adrenomedullin (AM) is known to be elevated in
different clinical situations including diabetes mellitus (DM), but
its potential role in the pathogenesis of vascular complications in
diabetic children and adolescents is to be clarified.
Objectives: The study aimed at assessment of plasmaadrenomedullin
levels in children and adolescents with type 1 DM and correlation
of these levels with metabolic control and diabetic microvascular
complications
Methods: The study was performed in the Diabetes Specialized
Clinic, Children¢s Hospital of Ain Shams University, Cairo,
Egypt. The study included 35 diabetic children and adolescents
(mean age 14.3 years). They were subdivided into 20 with no
microvascular complications (MCV) and 15 with MCV patients.
Thirty healthy subjects, age-and sex- matched were included as
control group (mean age 11.46 years).Patients and controls were
assessed for glycated hemoglobin (HbA1c), urinary micro-
albumin, and plasma adrenomedullin assay using ELISA
technique.
Results: Mean plasma AM levels were significantly increased in
diabetic patients with & without MCV compared to control group,
(110.6 pg/ml, 60.25 pg/ml. 39.2 pg/ml respectively) (P < 0.01) and
in those with complications compared to diabetics without
(P < 0.05).Plasma AM levels were positively correlated with
both duration of diabetes (r = 0.498, P < 0.05) and glycemic
control (HbA1c) (r = 0.04, P < 0.05).
Conclusion: Higher plasma AM levels in diabetics with MCV & its
correlation with diabetes duration and metabolic control may
indicate the role of AM in diabetic vasculopathy.
P/031/WED
Folic acid, vitamin B12 and homocysteine levels fasting
and after methionine load in patients with type 1
diabetes mellitus
A. Giannattasio1, M. G. Calevo2, G. Minniti1, D. Gianotti3, M. Cotellessa1,
F. Napoli1, R. Lorini1 & G. dAnnunzio1
1G. Gaslini Institute, University of Genoa, Pediatric Clinic, Genoa, Italy,
2G. Gaslini Institute, Epidemiology and Biostatistics Service, Genoa,
Italy, 3University of Parma, Parma, Italy
Objectives: To assess plasma concentrations of folic acid, vitamin
B12 and total plasma homocysteine (tHCY) during fasting and
after methionine load in young patients with type 1 diabetes
mellitus (T1DM).
Methods: We enrolled 41 young patients with T1DM without any
sign of microvascular complications and 123 healthy controls in a
1:3 cross-sectional case control study. Fasting and postmethionine
load (PML) tHCY, folic acid and vitamin B12 levels were
measured in both groups. Data regarding chronological age,
metabolic control (assessed by mean values of Hemoglobin A1c in
the last 12 months) and disease duration were also recorded.
Results: Fasting and PML tHCY levels were significantly lower in
patients than in controls: 7.3 ± 2.7 lmol/l vs. 8.3 ± 2.5 lmol/l
(P = 0.01), and 16.7 ± 5.8 lmol/l vs. 17.3 ± 4.3 lmol/l (P =
0.01), respectively. No correlation was found between fasting and
PML tHCY levels and chronological age, disease duration,
metabolic control, and insulin requirement. Patients had
significantly higher vitamin B12 levels compared to controls:
767 ± 318 vs. 628 ± 236 pg/ml (P = 0.003), while folic acid
turned out to be lower in patients than in controls: 5.3 ± 1.9 vs.
7.5 ± 2.6 nmol/l (P < 0.0001).
Conclusions: Adolescents and young adults with T1DM without
microvascular complications showed lower tHCY both during
fasting and after methionine load. Lower folate concentrations in
these patients might benefit from food fortification.
P/032/WED
Risk factors for microalbuminuria in adolescents with
type 1 diabetes
M.D. JeÐić1, S. Sajić1, M.M. JeÐić2, V. Zdravković1, V. Bojić1 & S. Necić1
1University Childrens Hospital, Endocrinology, Belgrade, Serbia,
2University Childrens Hospital, Neonatology, Belgrade, Serbia
Objectives: Microalbuminuria is the most serious predictive sign of
nephropathy. The aim of our cross section study is to determine the
frequency of microalbuminuria in adolescents with type 1 diabetes
mellitus after a period of remission of the disease and determine the
relation between microalbuminuria and other risk factors for the
development of diabetic nephropathy: HbA1c, blood pressure
(BP), insulin doses, BMI, diabetes duration.
Methods: The existence of microalbuminuria was examined in a
cross section study of 60 adolescents of the mean age of 15.3 ± 2.4
(11.0–19.7) years with type 1 diabetes mellitus of the mean duration
of 7.7 ± 3.4 (3.5–17.0). Microalbuminuria was determined in 2–3
samples of the first morning urine in the period below 6 months,
using turbidimetric method, in which the normal value was below
15 mg/l. Ambulatory blood pressure was monitored (SpaceLabs
90207).
Results: Of all our patients, microalbuminuria developed in 13.3%
of adolescents with completed sexual development, statistically
significantly poorer metabolic control (9.79% vs. 8.7%) and higher
BMI (23.59 kg/m2 vs. 20.85 kg/m2) than in the patients with
normoalbuminuria (P < 0.05). The mean value of night-time
systolic blood pressure was statistically significantly higher in
patients with microalbuminuria than in those with
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normoalbuminuria (113.62 ± 10.98 vs. 106.77 ± 7.93, P < 0.05),
whereas for the other mean values of blood pressure we did not
find a statistically significant .The duration of diabetes and insulin
doses are in statistically significant correlation with systolic night-
time blood pressure (P = 0.313, P = 0.01; P = 0.269, P = 0.03)
and diastolic night-time blood pressure (P = 0.301, P = 0.02;
P = 0.331, P = 0.01).
Conclusions: These adolescents require attention in order to
minimize associated factors of high HbA1c, elevated BMI and
night-time SBP in the development of incipient nephropathy.
P/033/WED
Antioxidant factors and endothelial function in children
and adolescents with type 1 diabetes mellitus
L. Iughetti1, A. Lasagni1, R. Rossi2, P. Appio1, G. Delle Donne2, A. Nuzzo2,
V. Patianna1, A. Salvini1, M. G. Modena2, B. Bergamini3 & B. Predieri1
1University of Modena and Reggio Emilia, Pediatrics, Modena, Italy,
2University of Modena and Reggio Emilia, Cardiology, Modena, Italy,
3University of Modena and Reggio Emilia, Biomedical Sciences,
Modena, Italy
Chronic hyperglycemia increases production of free radical inter-
mediates which in turn augments oxidative stress. The oxidative
stress can play a key role in diabetic complications affecting also
vascular function.
We evaluated lipid levels, antioxidant factors and parameters
related to oxidative stress, and endothelial function to assess the
relationships between these parameters and metabolic control in
children and adolescents with T1DM. A total of 58 T1DM patient
(11.5 ± 3.49 year) and 36 healthy children (9.60 ± 3.21 years)
were studied.
In all children total cholesterol (TC), low-density lipoprotein-
cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-
C), triglycerides (TG), Lipoprotein (a) [Lp(a)], homocysteine,
fibrinogen, MDA, Vitamin E (VitE), beta-carotene, lycopene,
retinol, Vitamin C reduced (Vit C-Red) and oxidized (VitC-Oxid)
and hemoglobin glycosilated (HbA1c) were measured. Vascular
function was assessed by measurement of endothelium-dependent
vasodilatation of brachial artery (FMD) using an ultrasound
system. There was no significant difference in TC, LDL-C and
HDL-C between diabetic patients and controls, while TG in
T1DM subjects were significantly lower than in control ones. Total
antioxidant status (VitE, beta-carotene, lycopene, retinol, Vit
C-Red) don¢t showed significant difference between groups. Only
levels of VitC-Oxid were significant higher in patiens with T1DM.
Moreover, prepuberal T1DM subjects showed higher MDA
concentration than controls (P < 0.01). FMD (7.99 ± 1.06%)
was impaired in 46% of T1DM subjects. There was a negative
correlation between FMD and LDL-C. Diabetic patients showed
increased oxidative parameters (MDA, VitC-Oxid). Even if FMD
was not apparently related to antioxidant status, the relationship
with lipid values emphasizes the role of a global metabolic control
to optimize the vascular health of these patients.
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P/034/FRI
Cardiac mass and function and carotid artery intima-
media thickness in children with type 1 diabetes
H.A. Atwa1, G. Selmi2 & H. Kamal3
1Faculty of Medicine, Suez Canal University, Pediatric, Ismailia, Egypt,
2Faculy of Medicine, Suez Canal University, Diagnostic Radiology,
Ismailia, Egypt, 3Faculty of Medicine, Suez Canal University, Cardiology,
Ismailia, Egypt
Background: Individuals with type 1 diabetes have a two- to
fourfold increased risk of developing atherosclerotic diseases.
Aim: To evaluate carotid intima- media thickness, cardiac mass
and function in children with type 1 diabetes.
Subjects and methods: Sixty-five children with type 1 diabetes and
30 healthy control age and sex matched children were included.
Their mean age was (11.56 ± 4.03) and (11.66 ± 3.17)
respectively. The mean duration of diabetes was (2.6 ± 1.4)
years and mean HbA1c was (8.9 ± 1.8%).
Results: None of the children had hypercholesterolemia. Blood
pressure (BP) measurement, Lipids profile and glycosylated
hemoglobin (HbA1c) was assayed. Carotid artery intima-media
thickness (cIMT) was measured using High-resolution ultrasound.
Evaluate of function was performed. Cardiac mass was calculated
using the Devereux formula. Carotid IMT was significantly higher
in children with diabetes than control (0.44 ± 0.08 vs.
0.41 ± 0.02 mm) (P 0.001). The mean cIMT was positively
correlated with patient’s age, diabetes duration, BMI, BP, LDL
cholesterol and HbA1c. High density lipoprotein cholesterol
(HDL) was negatively correlated with cIMT. In a multivariate
analysis, duration of diabetes (P 0.000), BMI (P 0.001), lower
HDL cholesterol (P 0.003) and HbA1c (P 0.000) were an
independent risk factors for increased carotid IMT in diabetic
children. No significant difference was found between both groups
as regards cardiac mass, systolic and diastolic functions.
Conclusion: Although there was no alteration in cardiac mass and
function in diabetic children in the first few years after diagnosis,
type 1 diabetes can be considered a risk factor for early
atherosclerotic vascular changes in those children.
P/035/FRI
Role of blink reflex in detection of subclinical cranial
neuropathy in type 1 diabetic patients with peripheral
neuropathy
E.M. Sherif, S. Hassanein & D. Toaima
Ain Shams University, Pediatric Department- Diabetes Unit, Cairo,
Egypt
Objectives: The aim of this study was to evaluate the usefulness of
electrophysiological assessment by blink reflex (BR) for early
diagnosis of cranial neuropathy in type I diabetic patients
presenting with peripheral neuropathy.
Methods: The study included 58 children and adolescents with type
I diabetes mellitus and peripheral neuropathy (mean age:
14.53 ± 2.51 years). They were chosen from those attending the
Pediatric Diabetes Clinic, Children¢s Hospital, Ain Shams
University and sixty healthy matched controls. All were subjected
to complete history taking and physical examination, with special
emphasis on neurological examination. Laboratory investigations
included; random blood glucose, glycated hemoglobin (HbA1c), as
well as quantitative determination of urinary microalbumin. Nerve
conduction studies of median and tibial nerves, and BR were
carried out for all participants.
Results: All diabetic patients showed significantly abnormal
electrophysiological parameters of nerve conduction studies, as
well as BR. Although significant correlation has been found
between nerve conduction and degree of glycemic control and
microalbuminuria, no significant correlation was detected between
these laboratory parameters and abnormalities of BR. Blink reflex
abnormalities have been observed to be more associated with
median nerve conduction delay, especially the late component R2
contralateral (P < 0.001).
Conclusions: Blink reflex is a simple and non invasive test that can
give an early idea about cranial nerve affection in type 1 diabetic
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patients with peripheral neuropathy. Patients with motor
conduction abnormalities (especially of the median nerve) have a
higher chance of demonstrating abnormal blink reflex response
than those without such conduction abnormalities.
P/036/FRI
Somatic development and follow-up of children with
type-1 diabetes mellitus and biopsy confirmed celiac
disease in a multicenter survey from Germany and
Austria
E.E. Frçhlich-Reiterer1, S. Kaspers2, S. Hofer3, E. Schober4,
O. Kordonouri5, S. Bechtold-Dalla Pozza6, M. Grabert7 & R. Holl7,
DPV-Wiss Study Group
1Medical University of Graz, Department of Paediatrics, Graz, Austria,
2Pfizer Pharma GmbH, Medical Affairs, Karlsruhe, Germany, 3Medical
University of Innsbruck, Department of Paediatrics, Innsbruck, Austria,
4Medical University of Vienna, Department of Paediatrics, Vienna,
Austria, 5Children's Hospital Hannover, Hannover, Germany,
6Universitiy of Munich, Munich, Germany, 7University of Ulm, Institute
of Epidemiology, Ulm, Germany
Objectives: Children and adolescents with type 1-diabetes mellitus
(T1DM) are at increased risk for developing celiac disease (CD).
The aim of this longitudinal study was to evaluate the influence of
biopsy confirmed CD on somatic development and metabolic
parameters in T1DM children in a multicenter survey.
Methods: The DPV-Wiss-Project consists of anonymous data
taken from patients with diabetes. Data from 41 911 patients
with T1DM and <20 years of age (52% males, mean age
13.9 years; mean duration of diabetes 5.5 years) were collected in
297 centres in Germany and Austria from 1991 to March 2009 and
available for analysis. The most recent year of observation was
evaluated.
Results: 406 patients (0.9%; 58% females) out of 41 911 patients
were diagnosed with biopsy confirmed CD. In comparison to non-
CD patients, patients with CD were significantly younger at
diabetes onset (5.9 vs. 8.4 years), had a significantly lower weight
SDS (0.19 vs. 0.41) and height SDS (-0.28 vs.-0.05) (P < 0.001). In
contrast no differences were found in BMI SDS, HbA1c or
numbers of severe hypoglycaemic episodes. Screening frequency
for CD (17% of patients in 1998; 68% of patients in 2008) and the
number of biopsies in CD antibody positive patients (4% in 1998;
8% in 2008) have increased over time. In a 3-year follow-up of a
subgroup of 15 696 patients (233 of them with biopsy confirmed
CD) significantly lower height SDS (-0.1 vs. 0.1) and weight SDS
(0.2 vs. 0.4) were found again in patients with CD (P < 0.001).
There were still no differences in BMI SDS and HbA1c.
Conclusion: In this multicenter analysis 406 T1DM children
(0.9%) were diagnosed with biopsy confirmed CD. Patients with
CD have lower anthropometric parameters such as height and
weight SDS, which was still present after a 3-year follow-up. In
contrast no differences in metabolic parameters such as HbA1c and
frequency of severe hypoglycaemia have been found.
P/037/FRI
Impaired diffusing capacity for carbon monoxide in
children and adolescents with type 1 diabetes (T1DM):
is this the first sign of long-term complications?
M. Morelli1, A.E. Scaramuzza1, M. Rizzi2, S. Borgonovo1, C. Mameli1,
A. De Palma1 & G.V. Zuccotti1
1University of Milano - Luigi Sacco Hospital, Paediatrics, Milano, Italy,
2University of Milano - Luigi Sacco Hospital, Pulmonology, Milano, Italy
Objectives: To assess the presence of lung dysfunction in
adolescents with T1DM, and if the alteration of the pulmonary
capacity depends more on the reduction of the diffusing capacity of
the alveolar-capillary membrane (A-CM) or of the pulmonary
capillary (PC) blood volume.
Methods: We evaluated 42 consecutive young patients (23 males),
ages 15 ± 3 years, with T1DM for 8 ± 5 years (height
164 ± 12 cm, weight 59 ± 15 kg). As controls we evaluated 30
healthy age and sex-matched peers. Both patients and controls
were non smokers and didn’t report any lung disease. Lung
volumes and spirometric dynamic parameters were assessed by
plethysmography. Single-breath DLCO was measured. Double
measurements were accepted when estimates of DLCO and
effective alveolar volume differ by 5%. The interval between
measurements was 5 minutes and the tests were performed in the
standing position. The CO transfer coefficient (KCO) was derived.
The diffusing capacity of the A-CM and the PC blood volume were
calculated using the Roughton and Foster equation.
Results:
Table 1 Respiratory function values in TIDM patients and controls
Patients with
T1DM (n = 42)
Controls
(n = 30) Significance
FVC (%predicted) 101 € 14 120 € 5 0.0001
FEV1 (% predicted) 95 € 13 114 € 7 0.0001
TLCO (% predicted) 107 € 14 115 € 13 0.05
RV/TLCO (% predicted) 107 € 24 99 € 12 NS
DLCO (% predicted) 78 € 16 120 € 1 0.0001
KCO (% predicted) 86 € 15 115 € 12 0.0001
DM (ml/mim/mmHg) 23 € 14 26 € 3 NS
Vc (ml) 34 € 20 88 € 18 0.0001
NS, not significant.
Conclusion: Lung volumes, the transfer factor (TLCO), KCO and
the pulmonary capillary blood volume (Vc) were significantly
reduced in young patients with T1DM when compared to controls.
However, when differentiating the A-CM component and the PC
blood volume component, we observed a significant impairment
only about PC blood volume component. If this might be seen as
the ¢first¢ sign of microangiopathic involvement in patients with
T1DM have to be confirmed on larger groups but is still
fascinating.
P/038/FRI
Prospective cross-sectional study on the frequency of
parietal cell antibodies in children and adolescents
with type 1 diabetes mellitus compared to healthy
controls
E.E. Frçhlich-Reiterer1, J. Huber1, E. Suppan1, B. Obermayer-Pietsch2,
A. Deutschmann1, U. Demel3, B. Acham-Roschitz1, G. Weinhandl1,
A. Hauer1 & H.M. Borkenstein1
1Medical University of Graz, Department of Pediatrics, Graz, Austria,
2Medical University of Graz, Division of Endocrinology and Nuclear
Medicine; Department of Internal Medicine, Graz, Austria, 3Medical
University of Graz, Clinical Immunology, Graz, Austria
Objective: Studies in adults have shown a higher prevalence of
parietal cell antibodies (PCA, up to 20%) in patient with type 1
diabetes mellitus (T1DM) compared to healthy controls (1%).
PCA are the principal markers of autoimmune gastritis (AG),
leading to pernicious anaemia and iron deficiency. The aim of this
study was to evaluate the frequency of PCA in children and
adolescents with T1DM compared to healthy controls and to
evaluate clinical findings in PCA positive patients with T1DM.
Methods: We studied 170 patients (87 male) with T1DM (mean age
12.9 years, mean duration of diabetes 4.9 years) and 101 healthy
controls (49 male), mean age 13.0 years. PCA, free T4, free T3,
TSH, TPOAb and TgAb were measured in all patients. Gastrin,
Poster Sessions
ª 2009 The Authors
Journal Compilation ª 2009 John Wiley & Sons A ⁄ S Pediatric Diabetes (2009) 10 (Suppl. 11): 30–109 41
pepsiongen I, iron, ferritin, vitamin B12 and folate were measured
in T1DM patients only. Gastroscopies with multiple biopsies and
Helicobacter tests were carried out in T1DM patients with high
(>100 U/ml) PCA.
Results: The occurence of PCA in patients with T1DM was 5.3%
compared to 1.9% in healthy controls. We found a strong
correlation between PCA and TPOAb as well as PCA and
gastrin (P = 0.001). Age, sex, diabetes duration and age at
diabetes onset could not be identified as risk factors for
developing PCA. Hypochromic microcytic anaemia was present
in 4 out of 9 patients from the PCA+ group compared to 4 out of
160 patients from the PCA- group (ns). Hypergastrinemia was
found in 2 patients from the PCA+ group compared to none out
of the PCA- group. None of the patients had low pepsinogen I
levels. Out of 4 patients, who underwent gastroscopy, one girl had
early signs of AG.
Conclusion: Compared to healthy controls, children and
adolescents with T1DM are at increased risk for developing
PCA, in particular if positive for TPOAb. Young T1DM patients
with positive PCA have early signs of AG, as iron deficiency
anaemia and hypergastrinemia. We therefore recommend screening
for PCA at diabetes onset and later on in the adolescent years.
P/039/FRI
Endothelial dysfunction, increased carotid
intima-media thickness and blood pressure are
early preclinical vascular abnormalities in young
subjects with type 1 diabetes mellitus and satisfactory
glycemic control
G. Federico1, L. Gnesi1, C. Morizzo2, M. Kozakova2, F. Massart1, R. Di
Stefano3, E. Malshi2, P. Spontoni3, F. Santini2, G. Saggese1 &
C. Palombo2
1University of Pisa, Section of Pediatric Endocrinology and Diabetes,
Pisa, Italy, 2University of Pisa, Department of Internal Medicine, Pisa,
Italy, 3University of Pisa, Cardiac, Thoracic and Vascular Department,
Pisa, Italy
Objectives: This study was designed to investigate early
cardiovascular involvement in adolescents and young adults with
childhood-onset T1DM free of comorbidities and overt vascular
complications.
Methods: Thirty T1DM normotensive patients (age =19 ± 3,
BMI=22 ± 3, disease duration= 10.7 ± 5.4, HbA1c = 7.7 ±
1.1%) without micro- and macrovascular complications, and 38
controls (C) of comparable age and BMI (age=20 ± 2,
BMI=22 ± 3) were studied. LV geometry and function were
evaluated by Doppler echocardiography. Intima-media thickness
(IMT) of common carotid artery (CCA) was assessed by a
radiofrequency based technique (Q-IMT, Esaote, Genova), while
indices of arterial wave reflection (Augmentation index, AIx) and
local CCA stiffness (Peterson elastic modulus, EP, and pressure-
independent index b) were obtained by high resolution US
providing arterial diameter and distension curves (Aloka
Alpha10, Tokyo). Carotid-femoral pulse wave velocity (PWV,
Complior, Paris) was measured as an index of aortic stiffness.
Endothelial function was assessed as reactive hyperemia index
(RHI) by peripheral artery tonometry (PAT) (Endo-PAT, Cesarea,
Israel) and by circulating endothelial progenitor cells (EPCs).
Results: Compared to C, T1DM had higher systolic BP (121 ± 11
vs. 111 ± 10 mmHg), Q-IMT, PWV, AIx and EP (P < 0.03),
without differences in b. EPCs were significantly reduced in
patients vs. C (P < 0.003), while RHI was lower in patients with
HbA1c >7.5% (P < 0.004), and correlated inversely with
diastolic BP in the entire T1DM group. No differences in LV
geometry and function were observed between patients and C.
Conclusions: Our data indicate that T1DM subjects with a disease
duration as longer as 10 years and a satisfactory glycemic control
show preclinical vascular involvement represented by endothelial
dysfunction, increased arterial wave reflection and Q-IMT, and
mildly elevated BP. Pressure-independent large artery stiffness as
well as LV geoemtry and function appear still unaffected.
P/040/FRI
The prevalence of peripheral sensation abnormalities
in children and adolescents with type 1 diabetes
(T1DM)
M. Louraki1, K. Karavanaki1, M. Katsalouli2, E. Tsouvalas1, P. Karanika1,
A. Papathanasiou3 & C. Karayianni1, 38 children and adolescents with
diabetes and 24 healthy age- and sex-matched controls
1Second Pediatric Department University of Athens, ``P&A Kyriakou''
Children's Hospital, Athens, Greece, 2Neurologic Department, ``Aghia
Sophia'' Children's Hospital, Athens, Greece, 3Department of Pediatric
Endocrinology, ``P&A Kyriakou'' Children's Hospital, Athens, Greece,
Athens, Greece
Peripheral diabetic neuropathy (PDN) is a common complication
in adults with T1DM, whereas relative symptoms have not been
reported in children and adolescents.
Objectives: To study the prevalence of impaired vibration
sensation thresholds (VSTs) in children with T1DM, as an early
index of PDN. We studied 38 children and adolescents with
T1DM, with a mean (±SD) age of 14.3 ± 3.8 years and diabetes
duration of 6.2 ± 4.2 years, and also 24 age and sex-matched
controls, aged 13.5 ± 1.9 years.
Methods: VST was measured using a biothesiometer (Biomedical
Instrument, Ohio, USA) in the thumb, index finger, toe and hallux,
of the patients and controls. The growth and pubertal status were
recorded and metabolic control was assessed using HbA1c.
Results: Children with T1DM had significantly higher VSTs
compared to the controls (index finger: 3.98 vs. 2.38 lm/sec,
P = 0.001, thumb: 4.05 vs. 2.53 lm/sec, P = 0.001, toe: 3.16 vs.
2.19 lm/sec, P = 0.001, hallux: 5.92 vs. 4.33 lm/sec, P = 0.001).
Dividing the patients into two subgroups according to the HbA1c
levels, the group with HbA1c>8.0% had higher VPTs compared
with the group with HbA1c<8.0% (3.62 vs. 2.83 lm/sec,
P = 0.042).18/38 children with T1DM (47.36%) (13 boys, 5
girls) had abnormal VPTs in >/1sites, whereas 5/38 (13.15%) in all
sites measured. These children were not different in age, diabetes
duration, height and HbA1c levels from the rest of the patients.
Conclusions: In the children and adolescents with T1DM of our
study impaired indices of peripheral sensation were recorded.
These findings suggest that possibly, in the early stages of the
disease, appear early signs of subclinical PDN, which need a
regular follow-up.
P/041/FRI
Kidney size is dependent of metabolic control in
children and adolescents with type 1 diabetes
S. Van Aken, K. De Waele, M. Cools & J. De Schepper
University Hospital Ghent, Pediatric Endocrinology and Diabetelogy,
Ghent, Belgium
Background: Kidney size is increased at the diagnosis of type 1
diabetes in children and adolescents and can be reversed by
restoration of glycemic control. Renal hypertrophy has been linked
to GH hypersecretion, which occurs during poor metabolic control
and precedes in general the occurrence of microalbuminuria.
Aim: To look for disease duration, HbA1c and IGF-1 as
determinants for renal hypertrophy in normo-albuminuric type 1
diabetic children and adolescents.
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Study population: 154 children and young adults with type 1
diabetes, aged between 2 and 25 years, followed at the University
Hospital Ghent, with a disease duration at least 6 months and
without microalbuminuria were selected.
Methods: Renal volume was measured by ultrasound as described
by Dinkel E et al and was corrected to 1.73 m2 body surface. IGF-1
was measured by Immulite assay and results expressed as age
related Z-scores. Hba1c was determined by a commercial HPLC.
Results: Mean diabetes duration was 5.5 years (range 0.9–
24 years). Mean HbA1c was 7.9% (range 5.5–14.1). Mean IGF-1
Z-score was -0.59 (range -2.4–2.2). Mean renal volume was 231 ml/
1.73 m2 (range 136 to 330 ml/ 1.73 m2). Eight of the patients had
nephromegaly (>300 ml/1.73 m2). Renal volume was weakly
correlated with HbA1c (r = 0.19; P < 0.05). No correlation was
found between renal volume and age of the patients, duration of
diabetes or absolute or adjusted IGF-1 values.
Conclusion: Kidney size in type 1 diabetes is correlated with
metabolic control during the first 20 years of the disease. The low
prevalence of nephromegaly (5%) might be attributed to the absent
microalbuminuria and the better glycemic control in comparison
with earlier surveys. Further follow up will indicate whether renal
volume is a marker for subsequent nephropathy.
P/042/FRI
Trace elements, magnesium and the efficacy of
antioxidant systems in adolescent patients with type 1
diabetes mellitus and in their siblings
B. Salmonowicz1, A. Noczyńska1, M. Krzystek-Korpacka2 &
A. Zubkiewicz-Kucharska1
1Medical Univeristy of Wrocław, Endocrinology and Diabetology for
Children and Adolescents, Wrocław, Poland, 2Medical Univeristy of
Wrocław, Department of Medical Biochemistry, Wrocław, Poland
The aim of the study was to evaluate the levels of Mg, Se, Zn, Mn
and Cu and the effectiveness of antioxidant defence mechanisms
(SOD, GSHPx, CAT, TAS) in pts with DM1 in the pubertal
period. The investigated parameters were also evaluated in the
siblings of DM1 pts and in the control group.
Material and methods: Eighty seven children with DM1 aged x
13 years, who had been treated for DM1 for an average of
3.5 years. The siblings group comprised 27 children and the control
group - 41 children.
Results: Plasma levels of Mg and Zn in DM1 pts were significantly
lower in comparison to the control group (P = 0.0009 and
P = 0.046). The level of Zn was significantly lower in the group
of siblings in comparison to the control group (P = 0.040), and
the level of Cu in DM1 children was significantly higher in
comparison to controls and siblings (P = 0.0003 and P = 0.0007
respectively). The activity of CuZnSOD in DM1 pts was
significantly lower in comparison to controls (P < 0.0001). No
significant difference was observed in the level of SeGSH-Px in the
study groups. The activity of CAT was significantly higher in
diabetic children and in their siblings in comparison to controls
(P < 0.0001 vs. P = 0.0006). The level of TAS was significantly
lower in diabetic patients and in their siblings in comparison to
control subjects (P < 0.0001 vs. P < 0.0001).
Conclusions: Mg and Zn deficiency and increased level of Cu in
children with DM1 may be associated with impaired antioxidant
status. The oxidative stress in DM1 patients is accompanied by
alterations in enzymatic activity as well as non-enzymatic
mechanisms of antioxidant defence. Decreased total antioxidant
status in patients with DM1 may evidence impaired effectiveness of
non-enzymatic antioxidant system. Increased activity of CAT and
unimpaired activity of Se-GSHPx point indirectly to an enhanced
generation of ROS in DM1 children. Impaired mechanisms of
antioxidant defence in the siblings of DM1 patients may indicate
the role of genetic factors.
P/043/FRI
Transforming growth factor-beta-1 in children and
adolescents with type 1 diabetes in relation to diabetic
nephropathy
E.M. Sherif1, M. Abo-El-Asrar1, H.G. Mohamed2 & R.K. Ammar1
1Ain Shams University, Pediatrics, Cairo, Egypt, 2Ain Shams University,
Clinical Pathology, Cairo, Egypt
Objective: We evaluate serum Transforming Growth Factor Beta
1(TGFB1) in children and adolescents with and without diabetic
nephropathy and correlates the level with different biochemical
parameters.
Methods: The present study included 60 children and adolescent
with type 1 diabetes divided into two groups, group 1: composed of
30 diabetic patients with variable degree of nephropathy. This
group contains subgroup 1a, 15 patients with overt nephropathy
and subgroup 1b, 15 patients with microalbuminuria (<300 ug/
mg). Group 2: composed of 30 diabetic patients without
nephropathy (positive controls) and group 3 composed of 30 age
and sex matched healthy children and adolescents (negative
controls). Mean value of random blood glucose readingsand
mean value of HbA1c over the last year follow up, blood
cholesterol, serum creatinine, serum TGFB1 and urinary albumin
excretion were done for all studied groups.
Results: In our study biochemical results revealed that TGFB1 is
significantly higher in diabetic patients than controls, moreover it is
significantly higher in patients with nephropathy when compared
to those without nephropathy (29.13 ± 2.93, 23.01 ± 2.53,
P < 0001). Among those with nephropathy,TGFB1 was found
to be significantly higher in patients with overt nephropathy than
patients with microalbuminuria (31.22 ± 2.63, 27.05 ± 1.27,
P < 0001)and in patients with disease duration more than
10 years than those with disease duration 5–10
years(31.06 ± 3.76, 28.43 ± 2.31, P < 0.05), moreover there is
+ve significant correlation found between TGFB1 and mean value
of random blood glucse, mean value of HbA1c, blood cholesterol,
serum creatinine, and urinary albumin excretion in those with
diabetic nephropathy.
Conclusion: Our results revealed that TGFB1 may play a critical
role in the process of glomerular inflammation. Accordingly, it may
be also directly implicated in the functional deterioration of the
kidney functions seen in patients with diabetic nephropathy.
P/044/FRI
Serum angiogenin levels in type 1 diabetic children and
adolescents: relation to microvascular complications
E.M. Sherif1, R.M. Matter1, M.M. Abdel Aziz2 & H.M. Hassan1
1Ain Shams University, Pediatrics, Cairo, Egypt, 2Ain Shams University,
Clinical Pathology, Cairo, Egypt
Background: Angiogenin is one of the most potent inducers of
vascular growth. It is useful to measure its level for better
understanding of development of microangiopathy in diabetes.
Objectives: To study serum level of angiogenin in type 1 diabetic
children and adolescents and to correlate it with diabetic
microvascular complications and degree of glycemic control.
Methods: Fourty-nine type 1 diabetic children and adolescents (31
with microvascular complications (MCV) and 18 without MCV)
were recruited from the Diabetes Clinic, Children’s Hospital, Ain
Shams University. Twenty age and sex matched children and
adolescents served as control group. Diabetic patients with MCV
were subdivided into: retinopathy (n = 9), neuropathy (n = 9),
and nephropathy groups (n = 13). All patients were subjected to
Poster Sessions
ª 2009 The Authors
Journal Compilation ª 2009 John Wiley & Sons A ⁄ S Pediatric Diabetes (2009) 10 (Suppl. 11): 30–109 43
clinical examination, measurement of mean glycated hemoglobin
(HbA1C), urinary microalbumin assay and serum angiogenin
levels.
Results: Angiogenin levels were significantly higher in diabetic
patients (314.57 ± 68.57 ng/ml) compared to controls
(211.65 ± 19.99 ng/ml) (P < 0.001). Diabetic patients with
MCV showed significantly higher angiogenin levels compared to
those without (353.32 ± 53.4 ng/ml vs. 274.83 ± 28.11 ng/ml)
(P < 0.001). Retinopathy group showed the highest angiogenin
levels among the complicated groups. Patients with
microalbuminuria showed significantly higher angiogenin levels
compared to normoalbuminuric patients (375 ± 13.88 ng/ml vs.
292.75 ± 67.35 ng/ml) (P < 0.001). Angiogenin levels were
significantly higher in pubertal compared to prepubertal patients
(327.8 ± 66.46 ng/ml vs. 263 ± 52.12 ng/ml) (P < 0.001).
Significant positive correlation was shown between serum
angiogenin levels and mean HbA1C in all patients(r = 0.58),
complicated (r = 0.42) and uncomplicated diabetic patients
(r = 0.78).
Conclusion: Raised serum angiogenin levels do occur in diabetic
children and adolescents. The development of microvascular
complications are associated with markedly increased serum
angiogenin levels.
Poster Session I: Diabetes and Obesity I
P/045/WED
Adiponectin kinetics in response to complex stimulus
of insulin injection and food intake in children with
type 1 diabetes mellitus
K.A. Majewska1,2, B. Skowrońska1, P. Fichna1 & W. Stankiewicz1
1Karol Marcinkowski University of Medical Sciences in Poznań,
Department of Pediatric Endocrinology and Diabetes, Poznań, Poland,
2Karol Marcinkowski University of Medical Sciences in Poznań,
Department of Pediatric Nursing, Poznań, Poland
Objectives: One of the major factors regulating adipose tissue
function is insulin. On the other hand, adipocytes secrete
adipocytokines, that may influence insulin synthesis and action.
Adiponectin influence glucose homeostasis increasing insulin-
sensitivity. In patients with type 1 diabetes mellitus (t1DM)
physiological adipo-insular axis is replaced with exogenous
insulin-therapy, so arises question of differences in adipose tissue
function in these patients. Aim of the study was to establish the
kinetics of adiponectin concetrations in relation to insulin-
glycaemic balance, based on response to complex stimulus of
insulin injection and food intake in patients with t1DM, compared
to simple stimulus of food intake in healthy controls.
Methods: The study comprised of 25 children with t1DM, aged 7
to 17.5 years, of disease duration 1.5 to 10 years. Control group
comprised of 17 children, aged 6.5 to 18 years. Blood samples for
adiponectin (RIA), insulin and glukose were in 4 time points taken:
fasting (0min), and 60, 120 and 180 minutes. after insulin injection
and breakfast in children with t1DM, and only breakfast in healthy
controls.
Results: Mean concetrations of adiponectin in patients with t1DM
were 0 12.68 ± 7.93; 60 10.24 ± 6.92; 120 11.30 ± 8.84; 180
10.96 ± 6.38 lg/ml; while in control group: 0 8.75 ± 6.20; 60
8.51 ± 6.13; 120 9.89 ± 8.33; 180 9.39 ± 9.00 lg/ml. The only
statistically relevant difference was found in diabetic patients - the
decline between 0 and 60 time points; although, the groups were
not significantly different, despite observed differences in
insulinemia and glycemia.
Conclusions: The insulin-glycaemic balance does not influence
adiponectin kinetics in response to both: complex stimulus of
insulin injection and food intake in patients with t1DM, as well as
to simple stimulus of food intake in healthy controls. T1DM
reveals differences in adiponectinaemia, which is not observed in
healthy individuals.
P/046/WED
Effects of different types of exercise on insulin
resistance in overweight youth: a randomized
controlled trial
S. Lee, N. Guerra & S. Arslanian
Division of Weight Management & Wellness Children's Hospital of
Pittsburgh of UPMC University of Pittsburgh, School of Medicine,
Pittsburgh, USA
Objective: We examined the effects of aerobic versus resistance
exercise training on in vivo insulin sensitivity and secretion in
overweight youth.
Methods: 18 pubertal overweight (BMI ‡95th) boys [BMI (±SD):
34.6 ± 3.2 kg/m2, age: 14.7 ± 1.6 years] were randomly assigned
to one of the following three groups for 3 months: resistance
exercise (RE, n = 8), aerobic exercise (AE, n = 6), or a non-
exercise control group (n = 4). Changes in insulin sensitivity and
secretion were evaluated by a 3-hour hyperinsulinemic-euglycemic
and a 2-hour hyperglycemic (12.5 mmol/l) clamp tests, and
abdominal fat by magnetic resonance imaging. Cardiorespiratory
fitness (CRF) was measured using a graded maximal treadmill test.
Results: Compared with the control group (4.5 kg), no changes
(P > 0.1) in body weight were observed in the RE (0.1 kg) and AE
(1.2 kg) groups. CRF significantly (P < 0.5) improved within the
exercise groups [23.1% (RE) and 36% (AE)] compared with
controls. Reductions in percent body fat (-2.3%, P < 0.05) and
abdominal subcutaneous (-31.3 cm2, P < 0.05) and visceral fat (-
21.8 cm2, P < 0.05), and increases in fat free mass (2.8 kg,
P < 0.05) were observed in the RE group, but not in the AE and
control groups. Significant (P < 0.05) improvements in insulin-
stimulated glucose disposal (27.4%) and glucose-stimulated insulin
secretion (33.3%) were observed in the RE group alone (Figure 1).
Conclusions: Our preliminary data suggest that regular exercise in
the absences of weight loss or calorie restriction is beneficial to
improve CRF in previously sedentary, overweight boys. Moreover,
resistance exercise is associated with significant reductions in total
and abdominal fat, and improvement in insulin resistance. These
findings suggest that adoption of a physically active lifestyle should
be a cornerstone in the treatment and prevention of childhood
obesity and related co-morbidities in youth.
P/047/WED
Influence of elevated fat tissue content on the
incidence of particular components of metabolic
syndrome in Polish obese children
M. Szalapska1, U. Pytasz1, R. Stawerska1,2, M. Hilczer1,2 &
A. Lewinski1,3
1Polish Mother's Memorial Hospital - Research Institute, Department
of Endocrinology and Metabolic Diseases, Lodz, Poland, 2Medical
University of Lodz, Department of Pediatric Endocrinology, Lodz,
Poland, 3Medical University of Lodz, Department of Endocrinology and
Metabolic Diseases, Lodz, Poland
Recently, an increasing incidence of obesity and its complications
has been observed in children. The goal of the study was an
evaluation of the incidence of particular components of metabolic
syndrome (MS) in obese children vs. fat tissue content (FAT%).
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Material & methods: Sixty seven children (25 boys), age 11.4 ±2.7
years with simple obesity were qualified into the study. In each child
height, weight and waist circumference, blood pressure and body
mass composition by bioimpedancemethodwere determined. Lipids
profile was measured in fasting condition. Glucose and insulin
concentrations were assessed during oral glucose tolerance test
(OGTT). Following the obtained results, BMI and the waist/height
ratio (WHtR)were calculated, aswell as the insulin resistance indices
(IRI) by HOMA and Belfiore’s methods.
Fasting HDL-cholesterol, triglyceride (TG) and glucose concen-
trations were regarded to be elevated, following the criteria for MS
diagnosis in children, as proposed by Ferranti 2004.
Results: Hypertension was found in 34.2% children, abdominal
obesity in 37%. Positive correlation was demonstrated between
FAT% and WHtR. Abnormal lipids concentrations were found in
50% children, including elevated TG in 32.8% children and
lowered HDL in 32.8% ones. Negative correlation was found
between FAT% and HDL concentration. Neither increased fasting
glucose nor abnormal glucose tolerance was observed in any of the
children. Insulin resistance was found in 13% children, based on
the IRIHOMA and in 67% children acc. to IRIBelfiore. Significant,
positive correlation was found between FAT% and fasting insulin
concentration, as well as between FAT% and insulin concentration
after one hour of OGTT and between FAT% and IRI. In total, in
62.7% of the examined children, at least, two components of the
MS were observed.
Conclusions: Elevated fat tissue content in child’s organism is a
risk factor of metabolic syndrome occurrence.
P/048/WED
Prevalence of impaired glucose tolerance and type 2
diabetes in obese children and adolescents in Slovenia
N. Bratanic, P. Kotnik, M. Avbelj, N. Ursic Bratina, M. Zerjav Tansek,
C. Krzisnik & T. Battelino
University Childrens Hospital, Ljubljana, Slovenia
Objective: The number of obese children is increasing rapidly and
so is the prevalence of impaired glucose tolerance and type 2
diabetes. The prevalence of childhood obesity in Slovenia is as high
as in western European countries. We determined the prevalence of
impaired glucose tolerance and type 2 diabetes in a cohort of 411
Slovene obese (BMI SDS >2) children and adolescents (2 to
22 years of age, mean age 12.3 years), 57% were females, 300
(73%) patients were extremely obese (BMI SDS >2.5).
Methods: In all patients a standard two-hour oral glucose-
tolerance test was performed. Insulin resistance was estimated by
homeostatic model assessment (HOMA-IR), beta cell function was
assessed by insulinogenic index.The data were analyzed using
ANOVA
Results: Among 411 subjects only 6 had elevated fasting glucose
level. Impaired glucose tolerance (IGT) was detected in 8.1%
patients with extreme obesity and in 7.8% patients with BMI SDS
2 to 2.5. Except one girl and boy 9 years of age were all
adolescents, mean age 14.3 years, 60% were females. Type 2
diabetes (T2D) was identified in 1.2% of all subjects, 4 female and
1 male adolescent. The adolescents with T2D had significantly
higher fasting glucose values. There was no difference between the
groups with T2D and IGT and NGT in fasting insulin, while the
insulin levels markedly increased after the glucose chalenge in
subjects with both IGT and T2D. HOMA-IR was increased (>2.5)
in 45% subjects. HOMA-IR didn¢t differ significantly between the
groups, while significance of lower insulinogenic index in T2D
group could not be statistically confirmed due to the small number
of subjects.
Conclusions: The prevalence of IGT and T2D in obese children
and adolescents is much lower than in USA caucasians and similar
to our neibourghing countries. Insulin resistance is highly prevalent
in obese children and adolescents, but insulin levels nor HOMA-IR
are effective screening tools. An OGTT is rerequired in all subjects
with high risk.
P/049/WED
Prevalence of overweight and obesity among Nigerian
children aged 6–18 years
J.B. Elusiyan, A.S. Adegoke, W. Olowu & O. Adeodu
Obafemi Awolowo University, Paediatrics and Child Health, Ile-Ife,
Nigeria
Background: Childhood obesity appears a potential health
problem in this country because of the changing patterns of
lifestyle and affluence. It is a significant health problem with
medical and psychological consequences for children and
adolescents. This study was conducted to study the problem of
obesity and overweight among Nigerian children aged between six
and eighteen years using the cut-off BMI designed by the
International Obesity Task Force (IOTF) for children and
adolescents.
Methodology: The study was a school-based cross-sectional survey
and it employed a multi- staged random sampling method. Seven
hundred and twenty school students aged between six and eighteen
years old selected from primary and secondary schools were
included in the study.
Results: Only two (0.3%) of the 720 students that were studied
were obese and both were females. Twenty (2.8%) were overweight
of which seventeen (85.0%) were females and three (15.0%) were
Figure 1. Improvements in insulin sensitivity and secretion for
each intervention group.
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males. Females had a higher prevalence of overweight when
compared with males (P < 0.01). Obesity was seen only in the high
social classes I and II. There was a higher proportion of overweight
subjects in the higher social classes when compared with the lower
social classes (P = 0.03).
Conclusion: It is concluded that Obesity and overweight are
relatively rare problems among children in Ile-Ife with prevalence
rates of 0.3% and 2.8% respectively and it tends to have a female
preponderance. The prevalence of overweight and obesity is higher
in children from higher social classes.
P/050/WED
Metabolic syndrome in obese children
I.V. Osokina1, L.S. Evert2 & V.T. Manchouk1
1State Research Institute for Medical Studies of the North,
Endocrinology, Krasnoyarsk, Russian Federation, 2State Research
Institute for Medical Studies of the North, Pediatric, Krasnoyarsk,
Russian Federation
Introduction: Insulin resistance (IR) is a common feature of
childhood obesity and a key component of the metabolic
syndrome (MS).
Objective: The aim of this study was to evaluate the prevalence of
MS among obese children.
Methods: We examined 1760 schoolchildren at age 7–17 years.
Obesity was revealed in 91 children (5.2%). Risk factors in the
family such as DM2, hypertension, hyperlipidemia, obesity were
recorded for the first degree relatives. All children underwent
anthropometric measurements, an oral glucose tolerance test,
assessment of blood pressure, plasma lipids.
OGTT accompanied by four point of insulinemia was performed.
HOMA index was calculated according to the standard formula.
MS was diagnosed according to a classical definition (Weiss’s
criteria)
Results: In the group of obese children metabolic syndrome was
found in 18 (19.8%). BMI was 30.9 ± 3.4 kg/m2. The prevalence
of the single componentsof the MS was follows: hypertension
52.6%, hypertriglyceridemia 38.2%, glucose intolerance 17.6%, IR
revealed in 25% children. HOMA index was 4.6 ± 3.3, peak
insulinemia was 112 ± 24.1 mIU/l.
Conclusion: This study showed a high prevalence of the MS among
obese schoolchildren.
P/051/WED
Maternity obesity as a risk factor of the disturbances of
the early postnatal adaptation period of the newborns
T. Kovalenko, N. Popova & L. Zernova
Izhevsk State Medical Academy, Izhevsk, Russian Federation
Objective: The aim of the present study was to analyze the
characteristics of clinical and metabolic adaptation period of
newborn babies of obese mothers.
Methods: A total of 84 newborns of obese mothers (BMI
33.1 ± 0.8 kg/m2) were examined compare with the control
group including 81 newborns of mothers with the normal BMI
(22.2 ± 0.9 kg/m2, P < 0.001). The blood samples of pregnant
women and newborns (from the umbilical cord between 1–2 and 5–
7 days after delivery) were taking for ionized plasma calcium and
magnesium level, 25-hydroxy Vitamin D, parathyroid hormone,
glucose and conjugated and indirect bilirubin.
Results: The results showed that 78.6 ± 4.5% newborns had the
most disturbed adaptation neonatal period of the obese mothers in
higher BMI category II and III (r = 0.5; P < 0.001).
Disturbances of the neonatal adaptation period of these
newborns were associated with complicated gestation and
delivery period of their obese mothers(r = 0.7; P < 0.001).
54.4 ± 6.0% subjects were diagnosed with hypoglycaemia during
1–2 day (in control group 13.2 ± 5.5%, P < 0.001). There was a
close relationship between macrosomia and hypoglycaemia in early
neonatal period (r = 0.6; P < 0.002). 4 newborns (4.8%) were
diagnosed with diabetic fetopathy of obese mothers with gestation
diabetis insipidus. Results have showed that during the postnatal
adaptation period the newborn babies of obese mothers had early
hypocalcaemia (48.4 ± 6.4%) compare with the control group
(12.9 ± 6.0%) due to calcium and Vitamin D deficiency (mean
levels from the umbilical cord blood were 1.01 ± 0.04 mmol/l and
26.9 ± 3.6 nmol/l respectively). The low level of parathyroid
hormone (17.5 ± 3.6 ng/ml) was in the half of the newborns
with hypocalcaemia. The analyses showed that the lowest levels of
blood calcium of 1–2 day old newborns (0.66 ± 0.13 mmol/l).
Conclusion: Obesity of pregnant women is associated with
disturbances of the metabolic adaptation period of newborns
babies.
P/052/WED
The effects of a cognitive behavioral therapy program
on metabolic syndrome manifestations in obese
children aged 7–11
P. Pervanidou1, C. Kanaka-Gantenbein1, E. Bathrellou2,
M. Yannakoulia2, K. Papanikolaou3, A. Pehlivanidis4, S. Sakka1,
J. Tsiantis3, L. Sidossis2 & G. P. Chrousos1
1Athens University Medical School, First Department of Pediatrics,
Athens, Greece, 2Harokopeio University, Department of Nutrition and
Dietetics, Athens, Greece, 3Athens University Medical School,
Department of Child Psychiatry, Athens, Greece, 4Athens University
Medical School, Department of Psychiatry, Cognitive Therapy Unit,
Athens, Greece
Objectives: Cognitive Behavioral Therapy (CBT) has been
successfully applied in adult obesity and there is evidence for
long-term efficacy of behavioral intervention programs, including
dietary and physical activity modification, in children. The aim of
the study was to examine the effects of a CBT program on
metabolic abnormalities in obese children, 7–11 years old in
comparison to the outcome of usual care intervention.
Methods: Twenty-four children (20 girls, 4 boys, aged 8.9 ± 1.1,
BMI z-score: 3.21 ± 1.42) were randomly selected and received an
11-week CBT program followed by booster sessions and were
compared with 24 age- and BMI- matched controls (16 girls, 8
boys, aged 9.7 ± 1.9, BMI z-score: 3.21 ± 0.97) that received
usual care intervention. All subjects were recruited from the
Childhood Obesity Clinic of our Department. Both groups were
re-evaluated 11 months later. BMI z-score was calculated based on
the Greek BMI charts. Serum fasting insulin, glucose, HDL and
triglycerides were measured by standard methodology.
Results: BMI z-scores did not differ between the two assessments
within groups (Final BMI z-score 2.89 ± 1.32 for the CBT group
and 2.95 ± 1.38 for the usual care group). However, fasting insulin
concentrations (mU/l) significantly diminished in the CBT group
(17.13 ± 11.4 vs. 14.11 ± 6.9, P = 0.04), while no improvement
was noted in the usual care one (17.95 ± 9.97 vs. 16.75 ± 11.7).
Similarly, the CBT group showed a borderline improvement in
glucose levels (mg/dl) (84.62 ± 6.59 vs. 82.20 ± 7.36, P = 0.09)
while the usual care group did not (84.63 ± 6.62 vs.
87.31 ± 7.43). No significant changes were noted in blood
pressure and lipid profile within groups.
Conclusions: CBT improves fasting glucose and insulin
concentrations in obese children, although BMI-z-score remains
unchanged. These favourable metabolic effects are not noted in the
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obese children receiving usual care. CBT programs may favourably
affect the long-term metabolic outcome of obese children.
P/053/WED
Insulin resistance and secretion indexes in healthy
Italian children and adolescents: a multicentre study
G. dAnnunzio1, M. Vanelli2, A. Pistorio3, N. Minuto1, L. Bergamino1,
D. Iafusco4 & R. Lorini1, Diabetes Study Group of the Italian Society for
Pediatric Endocrinology and Diabetes ISPED
1G. Gaslini Institute, University of Genoa, Pediatric Clinic, Genoa, Italy,
2University of Parma, Department of Pediatrics, Parma, Italy, 3G. Gaslini
Institute, Department of Biostatistics, Genoa, Italy, 42nd University of
Naples, Department of Pediatrics, Naples, Italy
Objectives: Type 2 diabetes mellitus (T2DM) is a metabolic
disorder of heterogeneous etiology with social, behavioural and
environmental risk factors. Insulin resistance is an early
abnormality detectable in the normoglycemic, pre-diabetic state,
and that the worsening leads to fasting hyperglycemia, impaired
glucose tolerance and clinical diabetes.
Methods: We detected values of insulin resistance, secretion and
sensitivity indexes (HOMA-IR, HOMA-b% and QUICKI) based
on fasting samples in 142 healthy Italian children and adolescents
from Pediatric Centres, aged 2.7 to 19 years (10.6 ± 3.8,
Mean ± SD), with different Tanner pubertal stages (TS). None
had hypo/hyperglycemia (fasting plasma glucose 3.6–5.6 mmol/l),
obesity (BMI 17.9 ± 2.4 kg/m2 M ± SD), or family history for
DM. The following formula were used: for HOMA-IR: fasting
plasma insulin in mU/l · FPG in mmol/l/22.5; for HOMA-b%:
20· (fasting insulin in mU/l)/(fasting glucose in mmol/l - 3.5), for
QUICKI: 1/(log10 fasting plasma insulin in mU/l + log10 glucose
in mg/dl).
Results: HOMA-IR index slightly increased with TS. HOMA-b%
and QUICKI showed a weak variation throughout. No significant
correlation was observed between HOMA-IR, HOMA-b%,
QUICKI and BMI-SDS or chronologic age.
N 2.5th Median 97.5th
HOMA-IR TS 1 73 0.28 1.28 2.69
HOMA-IR TS 2–3 45 0.37 1.2 4.02
HOMA-IR TS 4–5 24 0.42 1.71 4.36
HOMA-b% TS 1 73 32.8 100.2 683.9
HOMA-b% TS 2–3 45 24.6 100.4 548.8
HOMA-b% TS 4–5 24 32.8 183.9 487.4
QUICKI TS 1 73 0.33 0.37 0.49
QUICKI TS 2–3 45 0.31 0.37 0.46
QUICKI TS 4–5 24 0.31 0.35 0.45
Conclusions: HOMA-IR, HOMA-b% and QUICKI are useful
tools in the clinical and epidemiological practice for screening and
follow-up of subjects at risk for T2DM.
P/054/WED
Postprandial lipid levels in obese children
A. Kçrner, E. Hegyi & G. Nelhbel
Semmelweis University, 1st Dept Pediatrics, Budapest, Hungary
Objectives: In the last years childhood obesity has reached
epidemic proportions worldwide. As a consequence,
cardiovascular risk factors, like dislipidemia can already be
traced in the youngest children. These phenomena have an
impact on cardiovascular morbidity and mortality later in life.
Serum lipids are generally investigated in the fasting state, while
data on postprandial lipid levels are hardly available in the
literature. The aim of our study was to investigate postprandial
lipid levels in children with obesity.
Patients and methods: Lipid loading test was performed in 31
children (17 girls and 14 boys; age (x ± SD): 13 ± 2.9 years;
BMI: (x ± SD) 34.9 ± 5.8 kg/m2) with obesity between
September 2007 and July 2008 at the 1st Department of
Pediatrics. Triglyceryde, cholesterol as well as HDL-cholesterol
levels were determined by standard laboratorial methods, LDL-
cholesterol was calculated according to Friedmann¢s formula.
Lipid loading test was performed by consuming a meal containing
82 grams of fat. Blood was withdrawn for analysis at three
different time points: (1) on admission (in fasting state), (2) 3 days
after introducing calorie-restricted diet (in fasting state), (3)
4 hours after lipid loading on the same day.
Results: On the morning of lipid loading (3 days after introducing
calorie-restricted diet) fasting triglyceride (P < 0.001), total
cholesterol (P < 0.001) and HDL-cholesterol (P < 0.05) levels
were significantly lower compared to the corresponding lipid
parameters obtained on admission. (Reduction in LDL-cholesterol
did not reach statistical significance). After lipid loading
triglyceride level increased by 0.5 mmol/l (P < 0.001), total
cholesterol by 0.16 mmol/l (NS), and HDL-cholesterol by
0.31 mmol/l (NS), while LDL-cholesterol decreased by
0.13 mmol/l (NS).
Conclusions: Already 3 days on calorie-restricted diet resulted in
significant reduction in fasting lipid levels. Lipid loading caused
significant increase only in triglyceride level.
P/055/WED
Minimal variation in exercise levels in English children
of different weights
M. Robinson & L. Blood
WWL Foundation Trust, Paediatrics, Wigan, UK
Introduction: The increasing prevalence of childhood obesity is
recognised to represent a serious health risk for today’s school
children as they grow up. It is generally thought that the rise in
obesity is due to a reduction in exercise combined with increased
calorific intake. Our study seeks to determine whether overweight
children exercise less than other children.
Methods: Children from local primary and secondary schools were
asked to wear a pedometer for one week. Baseline data including
height and weight were recorded. BMI SDS score was thus
obtained for each child. The average number of daily steps in one
week was plotted against the child’s BMI SDS score. Ethical
approval was obtained for the study.
Results: Two primary schools and a secondary school participated.
Results are shown in the table below.
Primary 1 Primary 2 Secondary
N 38 33 84
Mean age 9.4 8.7 12.6
Mean daily steps 10785 10275 10167
Mean BMI SDS 0.289 0.474 0.414
P-value 0.033 0.722 0.593
[BMI V Exercise]
The results show that in one primary school there was a significant
inverse correlation between a child’s weight and the number of
steps taken. However this was not the case in the other two schools.
Conclusions: Current government policy aims to significantly
increase activity levels in school age children. These results
indicate the need for further research into exercise levels in
children.
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P/056/WED
The influence of education programme on diet and
exercise on lifestyle and metabolic status in obese
adolescents
A. Zubkiewicz-Kucharska1, J. Chrzanowska1, M. Drzewicka2 &
A. Noczyńska1
1Medical Univeristy of Wrocław, Endocrinology and Diabetology for
Children and Adolescents, Wrocław, Poland, 2Medical Univeristy of
Wrocław, Department of Food Science and Dietetics, Wrocław, Poland
Aims: To evaluate the influence of education programme for
patients on lifestyle change, body mass and metabolic status in
obese adolescents.
Material and methods: A total of 32 patients with simple obesity,
F = 17, M = 15. Body mass (bm) and BMI were determined and
lipid profile: TGL, TC, HDL, LDL assessed. Dietary cards and
physical activity were analyzed. An education programme on
positive lifestyle change was led by a dietician. The follow-up
meeting after 3 months.
Results: Mean bm on 1st visit (B1) = 92.34 ± 20.11 kg, mean
BMI = 32.15 ± 5.56 kg/m2. 2nd visit (B2) bm and BMI did not
change (92.78 ± 19.06 kg and 32.32 ± 5.15 kg/m2, respectively)
as well as lipid profile: mean CH, TC, HDL and LDL were:
177.19 ± 42.39 mg/dl vs. 166.97 ± 27.35 mg/dl, 116.09 ± 59.95
mg/dl vs. 97.84 ± 44.97 mg/dl, 47.0 ± 10.53 mg/dl vs. 47.50 ±
11.33 mg/dl, 106.96 ± 38.99 mg/dl vs. 99.07 ± 21.45 mg/dl,
respectively. In F in B2 lower TC and CH were observed
(90.76 ± 18.69 mg/dl vs. 107.38 ± 21.44 mg/dl, P = 0.04 and
157.07 ± 25.29 mg/dl vs. 176.86 ± 26.58 mg/dl, P = 0.06). The
remaining parameters did not differ. Bm and BMI change were
similar in both groups: 1.57 ± 2.68 kg vs. 1.29 ± 5.16 kg,
0.46 ± 0.91 kg/m2 vs. (-)0.17 ± 1.90 kg/m2. Dietary analysis in
B1 revealed that energy originating from fat in M was 37.5% of
daily requirement with over dosage of cholesterol intake. One- and
polyunsaturated fatty acids intake was within 60–70% of
recommended daily dose. 70% of F and 46% of M ate £3 meals,
35% of F and 33% of M ate snacks. In B2: energy from fat was
lower of 6% with lower cholesterol intake (364.5 ± 161.8 mg/dl
vs. 234.1 ± 100.9 mg/dl, P < 0.05). The number of F who ate 4
meals increased by 24%. The number of M eating 4 meals was
lower of 13%, number of M eating 3 meals increased by 20%. 20%
of patients limited snacks. 20% more pts declared daily physical
activity.
Conclusions: Within three months of behavioral treatment, body
mass and metabolic parameters of studied population did not
change, however some nutritional mistakes were limited and
declared physical activity increased.
P/057/WED
Family factors and its role in childhood obesity
A. Solnceva & M. Vishnevskaya
Belarusian State Medical University, Minsk, Belarus
Poor family functioning will be associated with inadequate
parental monitoring and/or regulation of children’s eating and
activity patterns. We aimed to examine the relationship between a
child’s weight and a broad rang of family and maternal factors.
Methods: This cross-sectional study involved 56 obese children
(m/f = 30/26), mean age 11.05 ± 3.50 years and 56 mothers.
Obesity was defined as BMI scores at or above the 97th percentile
for age and gender. Psychological examination was conducted
(Eidemiller test of house education) and eating attitudes test (EAT-
26). All the analysis were performed with the Statistics 6.0
software, P-value <0.05 was accept as statistically significant.
ANOVA test was used for unpaired data.
Results: The full families were observed in 71.43%, incomplete
28.57% patients. BMI children was not correlated with BMI
mothers ((r > 0.1). Differences SD BMI were received depending
on mothers education: high - Me 4.77 [3.24–5.44] and secondary-
special - Me 5.67[4.68–7.20] (r = 0.0085). The significantly
differences of the test were determined on deflection SD BMI
from Me: ‘‘forbid-requirements overweening’’ (r = 0.1),
‘‘sanctions overweening’’ (r = 0.015), for girls ‘‘projection male
quality’’ (r = 0.045). By analyzing EAT-26 following data were
received: gender differences breaches of the eat behavior, concerned
with own body. Children’s psyche can catch any uncertainty in
parents correctness of the education and his place begins to occupy
society (r = 0.6). We were received negative correlations: factor
hyper patronage (r = -0.5), requirements insufficient (r = -0.61),
unsteadiness of the education styles (r = -0.52). The lack of
development of the parental feeling(r = 0.56), overweening
requirements (r = 0.6), projection on child undesirable
quality(r = 0.6).
Conclusion: Findings indicated on increase the children BMI under
using negative acceptance in household education. It was revealed
that mothers had difficulties between need of the checking and
granting to autonomies child.
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P/058/FRI
Puberty effect upon development and advancement of
diabetic peripheral sensomotor polyneuropathy in
children with type 1 diabetes
G. Svetlova, T. Kuraeva & V. Peterkova
Endocrinology Research Center, The Institute of pediatric
endocrinology, Moscow, Russian Federation
Aim: To study the effect of puberty and delayed puberty upon
advancement of diabetic peripheral sensomotor polyneuropathy
(DPN) in children and adolescents with type 1 diabetes.
Material and methods: We investigated 84 children and adolescents
with type 1 diabetes. According to puberty stage 5 groups were
selected: group with Tanner stage 1 (n = 5), group with Tanner
stage 2 (n = 17), Tanner stage 3 (n = 32), Tanner stages 4–5
(n = 62). Eleven adolescents formed the group with late puberty.
There were no difference in HbA1c level and duration of diabetes.
The disease duration was 6.1 ± 3.0 years (from 0.03 to 10.0),
HbA1c - 10.7 ± 2.3% (from 7.2 to 15.3%). Neuropathy diagnosis
has been performed according to standard methods that included
patient’s complaints evolution, sensory dysfunctions and low limbs
electromyography data.
Results: The study has demonstrated statistically significant
dependence of DPN, development from puberty stage. So,
among children, suffered from DPN 20% were in prepubertal
period, 45% with development according Tanner 2 (P < 0.05);
Tanner 3, 50%; and Tanner 4–5, 63%. In the late puberty group,
despite short duration of type 1 diabetes and Tanner stages 1-2
DPN has been revealed in 72% (P < 0.05). Marked metabolic
disorders in the first years of disease and poor control in the
following period were noticed in all the patients with late puberty.
There factors probably contributed DPN development. Higher
frequency of DPN at similar type 1 diabetes duration has been
detected in the group of children with late puberty despite puberty
absence.
Conclusion: Puberty onset is one of the risk factors, of DPN
development in children and adolescents with type 1 diabetes.
Severe decompensation of type 1 diabetes causing late puberty
might be stronger risk factor for DPN development comparing
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with puberty beginning. Puberty absence protects from diabetic
complication development only if no hard decompensation of
carbohydrate metabolism is present.
P/059/FRI
Experiences related to male adolescents with type 1
diabetes
L.E. Nikolajenko
MidCentral District Health Board, Diabetes Lifestyle Centre, Levin, New
Zealand
Type 1 diabetes is a complex disease which presents particular
challenges to male adolescents who are at a time in their lives where
they are striving to gain independence and acceptance amongst
peers. There is considerable literature discussing Type 1 diabetes
and female adolescents, however there is little exploring male
adolescents experiences particularly in the New Zealand context.
Findings from this small purposive study therefore provide an
important contribution to the literature in this area.
Objectives: The purpose of this study was to explore the
experiences of adolescent males with Type 1 diabetes in order to
identify factors that impact upon self-management. Themes
explored included perceptions of masculinity, identifying support
networks, becoming responsible for diabetes self-management and
issues that moderate these links.
Methods: A qualitative project involving individual interviews with
three 12–18 year-old males was undertaken. An exploratory
descriptive approach was utilised in order to gain an in-depth
understanding and exploration of participants experiences of this
long term condition. Thematic content analysis was used to analyse
the data, producing the overarching themes of living with Type 1
diabetes and support networks.
Results: Key findings from initial themes included ‘‘doing
masculinity’’ in the context of managing a chronic illness and
public and private perceptions of having Type 1 diabetes.
‘‘Watchful vigilance’’, acceptance of peers, and the freedoms
associated with the use of new technologies were identified by
participants as being fundamental in developing effective self
management strategies.
Conclusions: Perceptions of masculinity, new technologies and
support are major factors which impact on the lives of participants
within this small purposeful study and the findings indicate the
need for a larger study to be replicated.
P/060/FRI
5¢-Flanking regions of genes encoding selected
adipokines (ADIPOQ, LEP, RETN) investigated in obese
children
J. Cieślak1, A. Skorczyk1, M. Dragan1, M. Grześ1, P. Paczyńska1, I.
Kuna1, B. Skowrońska2, K. Majewska2, W. Stankiewicz2, P. Fichna2
& M. Świtoński1
1Poznan University of Life Sciences, Department of Animal Breeding
and Genetics, Poznan, Poland, 2Karol Marcinkowski University of
Medical Sciences in Poznań, Department of Pediatric Endocrinology
and Diabetes, Poznan, Poland
Objectives: The genes encoding adipokines are known as very
important in the background of obesity. It is proved direct and
causative relation of obesity to prediabetes and type 2 diabetes in
children. The aim of this study was searching for polymorphism in
5¢-flanking region of the ADIPOQ (adiponectin), LEP (leptin) and
RETN (resistin) genes and to compare distribution of their variants
in obese children and control non-obese patients.
Methods: DNA was isolated from blood samples of obese children
(n = 207; age 12.2 ± 3.1; 108F : 99M) with relative BMI (RBMI)
>120 and from the control group of 100 non-obese adults. Six
fragments of 5¢-flanking region of three genes (ADIPOQ, LEP,
RETN) were PCR amplified. Screening for polymorphism was
performed using SSCP and DNA sequencing techniques.
Polymorphisms found in ADIPOQ and RETN were genotyped
by RFLP test, with the use of endonucleases: Eam1104I, Csp6I,
TasI for RETN and MspI, HphI for ADIPOQ, SNPs in LEP were
genotyped by direct DNA sequencing.
Results: Polymorphic SNPs were revealed: in RETN (-1300G>A,
-1258C>T, -420C>G, -358G>A), in LEP (-2549C>T, -
2548G>A, -188A>C, 19A>G) and in ADIPOQ (-11391G>A,
-11377C>G). The polymorphism in the LEP gene (-2549C>T) is
a novel one. The pronounced association concerned distribution of
the 19A>G SNP (LEP) in relation to RBMI. There was
169.3 ± 21.8 RBMI for AA genotype and 153.8 ± 17.7 for GG
genotype (P = 0.035). Differences in genotype frequencies were
observed between obese and controls for 19A > G (LEP) and -
11377C > G (ADIPOQ). Obese patients bearing both risky
genotypes had their body mass (kg) and height (cm) greater than
in other obese children (83.8 ± 26.9 & 160.9 ± 17.9 vs.
77.6 ± 25.7 & 156.3 ± 20.1).
Conclusions: The genomic sequences of the 5¢-flanking regions of
ADIPOQ, RETN and LEP are highly polymorphic, but only two
investigated SNPs (19A>G in LEP and -11377C>G in ADIPOQ)
can be potentially related with children obesity.
Studies were supported by grant from MNiSW N407 057 32/2522
P/061/FRI
Overweight and glycaemic control in young children
with T1DM
F. Sundberg & G. Forsander
The Queen Silvia Children¢s Hospital Sahlgrenska/stra University
Hospital, Gothenburg, Sweden
Objectives: The aim of this study was to evaluate if our youngest
patients with T1DM reaches the target of HbA1c £ 7.5% and their
frequency of overweight.
Methods: The Diabetes Unit at The Queen Silvia Childrens
Hospital serves all patients with Diabetes Mellitus younger than
18 years of age living in the city of Gothenburg and the
surrounding area. 55 patients (28 boys and 27 girls) have been
diagnosed with T1DM before the age of seven years during the
period 050301-090228. Data from their latest visit before 090415
was collected. 44/55 had a diabetes duration of more than
0.3 years. HbA1c was analyzed with DCA Vantage TM Analyzer
from Siemens and translated into DCCT standard. Overweight and
obesity was defined by the ISO-BMI system in accordance with
International Obesity Task Force (Cole, BMJ 2000), which is valid
from age two years (n = 37). 18–20% of Swedish children are
overweight at age 4 and 8 years (Riksmaten barn 2003,
Livsmedelsverket).
Results: Data was obtained from all 44 patients (22 boys and 22
girls) age 6.4 (2.1–10.6) years with a diabetes duration of 2.17 (0.3–
3.8) years. 14/44 (32%) reached target HbA1c, 11 of those (25%)
reached the double target of HbA1c £ 7.5% and no overweight. 4/
37 (11%) were overweight 1month after diagnosis and 11/44 (25%)
were overweight at their latest visit. The overweight frequency
among those with HbA1c £ 7.5% was 3/14 (21%) and 8/30 (27%)
in those with higher HbA1c. 7/25 (28%) of patients with CSII
reached both HbA1c £ 7.5 and no overweight compared to 4/19
(21%) of patients on MDI. 6/25 (24%) of patients on CSII were
overweight compared to 5/19 (26%) on MDI.
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Conclusion: The increase in overweight during insulin treatment
needs further exploration. There is a tendency in association
between higher HbA1c and overweight. There was no association
between CSII and increased overweight frequency. Further
research is needed about age-specific strategies for optimizing the
insulin treatment of young children with T1DM.
P/062/FRI
Serum proinsulin is the sensitive metabolic risk factor
and correlates negatively with the age in obese
children
B. Skowrońska1, P. Fichna1, K. Majewska2 & W. Stankiewicz1
1Karol Marcinkowski University of Medical Sciences, Department of
Pediatric Endocrinology and Diabetes, Poznań, Poland, 2Karol
Marcinkowski University of Medical Sciences, Pediatric Nursery
Department, Poznań, Poland
Objectives: Proinsulin predicts insulin resistance and
cardiovascular risk independently of insulin in adults. The
proinsulin-to-insulin ratio is used to evaluate the deterioration in
glucose tolerance.
Aim: To evaluate proinsulin and PROINS/INS ratio in obese
children in correlation to the variety of obesity, insulin resistance
and prediabetes criteria.
Patients and methods: A total of 102 children (55$; 47#); age
12.6 ± 3.3; 30.4% prepubertal. OGTT with glucose, insulin and
proinsulin (PROINS; mean ± SD, pmol/l) was performed.
Children were divided: 1) by BMI-SDS: controls BMI-SDS £ 1.0,
overweight BMI-SDS +1.1 to +2.0, obese BMI-SDS >2.0; 2)
with insulin resistance (+IR) and without (nonIR); 3) with
prediabetes (IFG/IGT) or NGT. Statistics: ANOVA, Bonferroni,
Levene’s tests, Pearson’s correlations.
Results: In obese groups 0PROINS correlated with BMI-SDS
(P = 0.0001), HOMA-IR (P = 0.04), IGI (insulinogenic index)
(P = 0.007) and negativly with the age (P = 0.04); 120PROINS
correlated with BMI-SDS (P = 0.002), 120glucose (P = 0.0001),
AUCglu (P = 0.007), 120INS (P = 0.0001), AUCins (P =
0.0001), HOMA-IR (P = 0.01) and negatively with QUICKI
(P = 0.0001) and WBISI(whole body insulin sensitivity index)
(P = 0.0001). Fasting PROINS/INS correlated negativly with age
(P = 0.007). In prepubertal obese group0PROINSwas higher than
in pubertal (26.3 ± 18.9 vs.23.2 ± 11.5;P = 0.05). In+IR group:
0PROINS was higher than in nonIR (26.8 ± 14.5 vs.16.6 ± 4.5;
P = 0.006); 120PROINS was higher too (63.0 ± 21.7 vs.39.9 ±
12.3; P = 0.0001). In IFG/IGT group 120PROINS differed with
NGT (71.0 ± 18.8 vs.49.4 ± 20.9; P = 0.01).
Conclusions: 1) The increased fasting and after OGTT proinsulin
secretion is frequent disturbance of B-cell function in obese
children. 2) The hyperproinsulinemia intensified with the severity
of obesity and in patients with insulin resistance and prediabetes. 3)
0PROINS and 0PROINS/INS ratio seem to be sensitive markers
of metabolic risk in prepubertal obese children.
Supported by MNiSW N407 057 32/2522.
P/063/FRI
Serum level of EMAP-II and fibronectin in
childhood-onset type 1 diabetic patients and obese
adolescent
L. Mogylnytska
Bogomolec's Institut of Phisiology, Kiev, Ukraine
Atherosclerosis is earlier and more severe in type 1 diabetes.
Endothelial dysfunction is implicated in the pathogenesis of
diabetes and atherosclerosis. Endothelial monocyte-activating
polypeptide-II (EMAP-II) is a multifunctional polypeptide with
proinflammatory and antiangiogenic activity. Fibronectin, an
endothelium-derived protein, involved in subendothelial matrix
assembly and promote occlusive neointimale formation and
atherogenesis. EMAP-II alters fibronectin-based endothelial cell
adhesion, sprinding and matrix assembly.
We studied 30 childhood-onset type 1 diabetic patients (age:
20.26 ± 2.11); 30 obese adolescent (BMI: 36.72 ± 7.53) and 28
control subjects. Serum levels of EMAP-II and fibronectin were
determined by immunoenzyme assay. Statistical analysis was
performed by use Student’s test and Person’s. The data were
presented as mean ± SD.
We found an increase of serum level of EMAP-II in childhood-
onset type 1 diabetic patients compared to control subjects
(4.95 ± 3.33 ng/ml and 1.3 ± 1.25 ng/ml respectively,
P < 0.05); also in obese adolescent compared to control subjects
(3.32 ± 2.59 ng/ml and 1.3 ± 1.25 ng/ml respectively, P < 0.05).
Serum level of fibronectin was elevated in childhood-onset type 1
diabetic patients compared to control subjects (367.4 ± 44.04 and
226.17 ± 21.35 respectively, P < 0.05); and in obese adolescent
compared to control subjects (343.05 ± 61.26 ng/ml and
226.17 ± 21.35 ng/ml respectively, P < 0.05). Moreover, there
are significant correlation between HbAc1, triglycerides and
EMAP-II; between HbAc1, triglycerides and fibronectin levels in
group with diabetes (P < 0.05), also between BMI, triglycerides
and EMAP-II; BMI, triglycerides and fibronectin in group with
obesety (P < 0.05).
The revealed change of EMAP-II, fibronectin serum levels could
reflect an endothelial dysfunction in patients with type 1 diabetes
and obesety. Hyperglycemia, dislipidemia appears to be significant
factor to contributing elevation of EMAP-II and fibronectin.
P/064/FRI
Fasting Plasma Glucose (FPG) and the risk of impaired
glucose tolerance in obese children and adolescents
C. Maffeis1, A. Morandi1, P. Brambilla2, C. Banzato3, L. Valzolgher3,
D. Ulmi3, S. Di Candia4, B. Cammarata4, A. Sabbion5, G. Contreas5
& L. Pinelli1
1University of Verona, Regional Centre for Juvenile Diabetes,
Department of Mother & Child, Biology-Genetics, Section of Pediatrics,
Verona, Italy, 2ASL Milano 2, Milan, Italy, 3University of Verona,
Department Mother & Child, Biology-Genetics, Section of Pediatrics,
Verona, Italy, 4Vita-Salute San Raffaele University, Milan, Department
of Pediatrics, San Raffaele Scientific Institute, Milan, Italy, 5ULSS 20
Verona, Regional Centre for Juvenile Diabetes, Verona, Italy
Objective: A timely diagnosis of impaired glucose tolerance (IGT)
is desirable in obesity. The oral glucose tolerance test (OGTT), the
gold standard to diagnose this condition, may not be realistically
performed in all patients due to discomfort, labor and cost. The
aim of this study was to assess whether one or more biochemical
indices measured in fasting conditions could be used to identify
obese children at high risk of IGT.
Research design and methods: A total of 563 Caucasian obese
children and adolescents (M/F: 315/248; aged 4–17 years) were
recruited and underwent anthropometric evaluation and
OGTT.Anthropometric parameters, fasting plasma glucose
(FPG), fasting serum insulin (FSI) and homeostasis model
assessment of insulin resistance (HOMA-IR) were tested in
pursuit of a possible threshold to be used as a predictor of IGT.
Results: Thirty-seven children (6.9%) had IGT and one child
(0.1%) had type 2 diabetes. FPG, FSI and HOMA-IR were all
significantly higher in children with IGT than in children without
IGT. ROC curve analyses run for gender and puberty-adjusted
FPG, FSI and HOMA-IR were all significant: AUC (95%
Confidence Interval) equaled 0.68 (0.59–0.76), 0.66 (0.56–0.76)
and 0.68 (0.59–0.78), respectively. The three parameters did not
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show significantly different sensitivity/ specificity in the pooled
population or in the gender/puberty sub-groups. Thresholds varied
among gender/puberty sub-groups for FSI and HOMA-IR, but not
for FPG, which showed a fixed threshold of 87 mg/dl.
Conclusions: A gender/puberty independent cut-off of FPG may be
considered a screening tool to narrow clinical indication to OGTT
in obese children and adolescents.
P/065/FRI
Evaluation of the levels of adipocytokines, ghrelin and
metabolic parameters in obese and overweight
adolescents
A. Noczyńska, J. Chrzanowska & A. Zubkiewicz-Kucharska
Medical Univeristy of Wrocław, Endocrinology and Diabetology for
Children and Adolescents, Wrocław, Poland
Aims: Evaluation of the prevalence of metabolic disturbances and
assessment of the concentration of selected adipocytokines (leptins,
adiponectin, resistin) and acylated gherlin in obese adolescents.
Investigation of correlations between the adipocytokines and
markers of metabolic disturbances.
Material: A total of 79 obese adolescents and 35 children with
normal body weight as controls. Levels of leptin, adiponectin,
resistin, acylated ghrelin, hsCRP, TG, TC, HDL, LDL were
assessed as well was OGTT. HOMA-IR was calculated. The
incidence of hyperinsulinemia (HI) and metabolic syndrome (MS)
was evaluated. All the investigations were repeated after 12 months
of behavioral therapy (66 children).
Results: MS was diagnosed in 28/78, IR in 54/79, HI in 51/79
subjects. Obese children revealed higher levels of leptin and resistin
and lower levels of adiponectin and ghrelin than controls. The level
of leptin was higher in girls with IR and HI. Pts with IR, HI and
MS had lower level of adiponectin. No relationships were found
between the severity of IR and insulinemia and resistinemia. After
12 months the levels of leptin, resistin and hsCRP decreased.
Children who reduced their weight (19/66) did not display any
improvement in IR, however demonstrated a decrease of the levels
of leptin and resistin and increased levels of ghrelin. Children who
increased their body mass (25/66) reduced the levels of adiponectin
and resistin and increased HOMA-IR on the borderline of
significance. In the group of children who did not change their
body mass (n = 22) a decrease in the levels of hsCRP, leptin and
resistin were observed.
Conclusions: A gender-related association between the levels of
leptinaemia and IR and insulinemia was demontrated. A negative
correlation between the levels of adiponectin and IR and metabolic
disturbances constituting MS regardless of BMI was shown. No
relationship was found between the levels of resistin and IR and the
presence of other metabolic disturbances.
P/066/FRI
Hypothalamic obesity following craniopharyngioma
surgery: results of a pilot trial of combined Diazoxide
and Metformin therapy
J. Hamilton, L. Conwell, A. Ahmet, A. Jeffery & D. Daneman
Hospital for Sick Children, University of Toronto, Division of
Endocrinology, Toronto, Canada
Background: Obesity is common following neurosurgery for
craniopharyngioma. One proposed mechanism is insulin
hypersecretion due to hypothalamic damage-induced pancreatic
vagal stimulation. Diazoxide decreases insulin release and in
combination with the insulin sensitizer metformin may minimize
the risk of hyperglycaemia.
Objective: To assess the effect of combined diazoxide-metformin
therapy on body weight in adolescents with obesity and
craniopharyngioma.
Methods: This was a prospective open-label pilot treatment
trial conducted in a tertiary-care pediatric hospital. Nine obese
subjects, age 9–19 years previously treated for craniopharyngioma
were treated with diazoxide (2 mg/kg divided b.i.d., maximum
200 mg/day) and metformin (1000 mg b.i.d.) orally for 6 months.
All received standardized dietary and exercise counseling prior
to- and during the study. Whole-body-insulin-sensitivity-index
(WBISI) and area-under-the-curve insulin (AUCins) were
calculated at study start and end using an oral glucose tolerance
test. Major outcome was the comparison of weight and BMI in
the 6 months prior to study entry and after taking study
medication.
Results: Seven subjects completed the study: 4M/3F, mean ± SD
age 15.0 ± 2.9 years, weight 99.7 ± 26.3 kg, and body mass index
(BMI) 35.5 ± 5.6 kg/m2. Two subjects withdrew due to vomiting
and peripheral edema. Of participants completing the study, the
mean ± SD weight gain and mean BMI during the 6 months were
significantly reduced compared to the 6 months pre-study
(+1.2 ± 5.9 vs. +9.5 ± 2.7 kg, P = 0.004 and -0.3 ± 2.3 vs.
+2.2 ± 1.5 kg/m2, P = 0.04, respectively). AUCins at study
commencement correlated with weight loss (r = 0.82, P = 0.02)
and BMI decrease (r = 0.96, P = 0.009).
Conclusions: Combineddiazoxide-metformin therapywasassociated
with reduced weight gain in patients with hypothalamic obesity.
AUCins predicted effectiveness of the treatment. The results of this
pilot trial justify further investigation.
P/067/FRI
Evaluating the accelerator hypothesis at diagnosis of
type 1 diabetes mellitus in children of a mediterranean
area during the period 1990–2008
R. Cardona-Hernandez, L. Suarez-Ortega, R. Diaz-Naderi &
M. Torres-Lacruz
Hospital Sant Joan de Du, Unit of Pediatric Diabetes, Barcelona,
Spain
Objectives: The Accelerator Hypothesis argues that type 1 and
type 2 diabetes are the same disorder because the process of
developing type 1 diabetes is accelerated by obesity-associated
insulin resistance. We aimed to test the hypothesis in a cohort of
children with type 1 diabetes by establishing whether a decreased
birth weight or an increased BMI at diabetes presentation was
associated with an earlier age of diabetes onset.
Methods: A total of 277 Caucasian subjects, aged 1–19 years with
diabetes onset between 1990–2008 and positive results for anti-
GAD and/or anti-IA2 antibodies were examined in the context of
birth weight, weight and BMI at diagnosis, all expressed as SD
scores. Measurements were performed 4–6 months after diagnosis.
Statistical analyses were performed after controlling for other
potential confounding variables such as sex, fasting C Peptide
(FCP) or antibodies levels.
Results: No significant association was observed between age at
diagnosis and decreased birth weight (P = 0.145) or BMI SDS at
diabetes onset (P = 0.5). No statistical differences were observed
when multiple linear regression, adjusted for FCP, sex and/or
antibodies levels was performed.
Conclusions: In contrast with the experience with Anglo–Saxon
and central European populations, our study with children of a
Mediterranean area does not support the Accelerator Hypothesis.
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It is likely that the genetic background and other environmental
factors may influence the process of developing type 1 diabetes.
P/068/FRI
Metabolic profile in obese children and adolescents
F. Mohsin, B. Zabeen, J. Nahar, S. Akhter, T. Begum, K. Azad &
N. Nahar
Bangladesh Institute of Research and Rehabilitation in Diabetes,
Endocrine and Metabolic Disorders (BIRDEM), Paediatrics, Dhaka,
Bangladesh
Objectives: Childhood obesity, an epidemic in developed country is
also emerging as a health problem in developing countries like
Bangladesh. The study was undertaken to see the metabolic profile
of children and adolescents with obesity, attending the Paediatric
Endocrine OPD, BIRDEM.
Methods: A cross sectional study from January 2006 to December
2008 was conducted among obese children and adolescents (6–
18 years). Children with any other endocrine disorder,
dysmorphism/syndrome were excluded. Obesity was defined as
BMI ‡ 95th centile for age and sex using CDC growth chart.
Children underwent two-hour oral glucose tolerance test with
1.75 g/kg or 75 g of glucose, anthropometric and blood pressure
measurement. Fasting serum insulin and lipid profile were
measured. Impaired glucose tolerance (IGT) was defined as
fasting plasma glucose (FPG) <7 mmol/l and 2 hour post
glucose load ‡7.8 mmol/l to<11.1 mmol/l. Metabolic syndrome
was identified if 3 or more of following criteria were met: BMI
>97th percentile, triglyceride (TG)>150 mg/dl, HDL cholesterol
<40 mg/dl, Systolic or diastolic blood pressure >95th percentile,
IGT. Data were analysed using SPSS software (version 12).
Results: A total of 161 children presented with obesity. Male to
female ratio was 1.3 : 1. Mean age was 10.3 ± 2.5 years. Mean
BMI was 27.86 ± 4.1 kg/m2. IGT was found in16.9% (24 out of
142) and diabetes mellitus in 2.1% of subjects (3 out of 142). Total
cholesterol was >200 mg/dl in 26.3%, TG was >150 mg/dl in
40.9%, HDL cholesterol was <40 mg/dl in 50.4% and LDL
cholesterol was >130 mg/dl in 23.3% of subjects. Systolic
hypertension was present in 15.5% and diastolic hypertension in
20.4% of subjects. Metabolic syndrome was found in 36.5% of
subjects.
Conclusions: The high rate of IGT, dyslipidaemia and metabolic
syndrome in this cohort is of concern. Factors contributing
towards obesity needs to be identified and strategies should be
planned for prevention and management of this health problem.
P/069/FRI
Metabolic syndrome predictors in obese children
A. Averyanov & N. Bolotova
Saratov State Medical University, Saratov, Russian Federation
Defining children with metabolic syndrome (MS) is a significant
measure to reveal high-risk group for type 2 diabetes and
cardiovascular diseases in future. Nevertheless therapeutic inter-
vention at earlier stage becomes more effective for prevention of
metabolic and vascular complications in obese children.
Aims: To reveal predictors for metabolic syndrome in children.
Methods: We examined 204 children (M/F: 118/86) aged 10–
16 years, Tanner 2–5, with BMI-SDS>2.0 (2.9 ± 0.7). History
was assessed; waist circumference, BP, cholesterol, triglycerides,
lipoproteins were measured; OGTT was performed with
assessment of insulin secretion and R-HOMA index. MS was
defined by WHO-definition. Chi-square, Mann–Whitney-U-test,
multiple logistic regression models for multivariate analysis were
used.
Results: Prevalence of MS was 29.9% (61/204) and subjects with
MS had significantly higher BMI-SDS (3.3 ± 0.5), WC and fasting
insulin. Among children with MS 14.8% had IGT and 91.8% - R-
HOMA>3.5. A positive family history for diabetes [OR 3.94
(1.45–10.72)], parental obesity with any of MS criteria (IGT,
hypertension, etc.) [OR 3.36 (1.04–10.58)], low birth weight [OR
2.43 (1.02–5.82)], obesity onset before the age of 6 years [OR 3.2
(1.16–8.06)] were defined as predictors for MS. Insulin resistance
(R-HOMA>3.5), severe obesity (BMI-SDS>3.0) and acanthosis
nigricans seem to be the ‘‘signs’’ of MS in children.
Conclusions: Presence of 2 and more definite predictors in obese
children leads to the dramatic increase of metabolic risk, therefore
preventive strategies should turn their special effort to the patients
of high risk group before suffering from metabolic syndrome.
Poster Session I: Diabetes Care, Education,
Psychosocial Issues I
P/070/WED
Preliminary study of the presence of depression in
children and adolescents with insulin-dependent
diabetes mellitus and those who are healthy
M.L. Macias1, M. Molinero de Ropolo1, R. Bauducco2 & J. Lorenzo2
1Santisima Trinidad Children¢s Hospital, Diabetes Section, Cordoba,
Argentina, 2Santisima Trinidad Children¢s Hospital, Cordoba, Argentina
Introduction: The data available as regards depression in children
and adolescents are limited. According to the Pan-American
Health Organization, it is the fourth cause of the loss of quality
of life because of the disability it generates, and for 2020 it will be
the second one (Pan-American Health Organization, 1996). The
study of the risk factors of depression in children with IDDM
(Insulin-Dependent Diabetes Mellitus) would give the possibility of
controlling some of them, and help to avoid a decompensation due
to ketoacidosis triggered by psychogenic problems.
Objective: To determine if there exist differences in the level of
depression (measured through a specific scale) between a group of
children and adolescents with IDDM and a group of children and
adolescents without IDDM.
Methodology: A semi-structured interview was carried out and the
Children Depression Scale, CDS, (Lang and Tisher, 2003). An
accidental group of 22 children was sampled.
Group with IDDM: Children and adolescents that are generally
treated in the Diabetes Department of Children¢s Hospital. 11
children with diagnosis of IDDM (7 girls, 4 boys), the average age
of that group was of 12.9 years old (R = 11.4–14.5).
Group without IDDM: The totality of participants of this group is
of 11 children (4 girls, 7 boys), the average age of the group was of
13.2 years old (R = 10.1–14.5).
Results: In those children with IDDM it was found a Depressive
Total greater than those children without IDDM, being P = 0.041
and being proved differences closer to the meaning in the items: -
Social Problems (P = 0.087) and - Several Depression Problems
(P = 0.061).
Conclusions: There exist meaningful differences in the level of
Depression between those children with diagnosis of IDDM when
compared to healthy children. The early detection of depression
associated with IDDM and its treatment would avoid the evolution
of this disorder towards chronicity, producing a greater
deterioration of the quality of life of the patients.
Poster Sessions
ª 2009 The Authors
52 Journal Compilation ª 2009 John Wiley & Sons A ⁄ S Pediatric Diabetes (2009) 10 (Suppl.11): 30–109
P/071/WED
Parent and children reported coping resources and
strategies in relation to daily diabetes-treatment
challenges considered on the basis of the salutogenic
''Sense of Coherence''– theory by Aaron Antonovsky
B.J. Bækkelie1,2 & A. Haugstvedt2
1Akershus University Hospital, Department of Pediatrics, Lørenskog,
Norway, 2Bergen University College, Bergen, Norway
Objective: To review research literature focusing parent and
children reported coping resources and strategies in relation to
daily diabetes-treatment challenges.
Methods: Relevant literature were found by searches in the
databases Cinahl, Medline, PsychINFO and SveMed. The
findings were viewed in the light of the salutogenic theory: Sense
of Coherence (SoC). The reported coping resources and strategies
were categorised into the 3 components of SoC: Comprehensibility,
manageability and meaningfulness.
Results: 5 relevant research-articles (published 2004–2007) were
found.
Comprehensibility: ‘‘Education and training in practical diabetes
management and up to date information on diabetes’’.
Manageability: ‘‘Organizing the every day life’’, ‘‘sharing
responsibility’’, ‘‘involvement and support from parents’’,
‘‘positive attitude toward diabetes and feeling accepted with
having diabetes’’.
Meaningfulness: ‘‘Cooperation between parents, child, healthcare
professionals, social networks and extended family’’, ‘‘quality in
the involvement within the family’’, ‘‘quality in the support from
healthcare professionals’’, ‘‘support from other families living with
diabetes’’, ‘‘the child first, diabetes second’’.
Conclusions: Implications of importance when working with
families with a child having diabetes within the theoretical
framework of this salutogenic model includes focus on following
issues: The context of the family, possibilities and potential
resources within the family, the capacity of the family to achieve
their goals, the way of behaving towards the family, the quality in
the relationship between healthcare professionals and the family
and support to promote development of a strong SoC in the child.
The findings of important resources and strategies for coping with
daily diabetes-treatment challenges in this study were associated
with having a strong SoC. For guiding and supporting families,
knowledge about how to achieve a strong SoC in a child is
important.
P/072/WED
Engaging lay and professional stakeholders in the
development of a training tool for health care
professionals to facilitate behaviour change in young
people with diabetes (The DEPICTED Study)
L.M. Lowes1, M. Robling2, J.W. Gregory3, K. Bennert4 & C. Crawley5,
The DEPICTED Study Team
1Cardiff University, Nursing Health and Social Care Research Centre,
Cardiff, UK, 2Cardiff University, Department of Primary Care & Public
Health, School of Medicine, Cardiff, UK, 3Cardiff University, Department
of Child Health, Cardiff, UK, 4University of Bristol, NIHR School for
Primary Care Research, Bristol, UK, 5Lay Research Team Member,
Cardiff, UK
Objective: To identify the consequences of involving lay and
professional stakeholders when developing a complex intervention.
Background: A training programme, addressing professional
consultation skills/strategies to optimise health behaviour change
in patients, was developed for health professionals caring for
children with diabetes. Its effectiveness will be tested across a range
of children’s diabetes services (the DEPICTED study).
Setting and participants: Three one-day meetings over ten months.
Lay participants included teenage and adult patients, parents and
voluntary sector representatives. Professional participants were
from primary care, paediatrics, clinical psychology, social work,
psychiatry, nursi ng and dietetics.
Method: Stakeholder involvement was at key developmental stages
of the trial intervention. Participants contributed to detailed design
of the intervention including assessment of feasibility, acceptability
and trial design. Activities included formal presentations and lay,
professional and mixed discussion groups. Participants completed
formal evaluations.
Results: Each meeting attended by 13–16 lay and 12–14
professional participants, who identified the need for and
contributed to the design of a patient-held tool, and influenced
the content of a professional training programme and outcome
questionnaire. Stakeholders valued the opportunity to contribute
to a research process, influence practice, be listened to and self-
reflect.
Conclusions: Professional and lay stakeholders can make
significant contributions to the design of complex interventions.
Challenges include integrating perspectives and priorities of lay and
professional participants, and matching group composition and
tasks. Clarity about individual roles and autonomy was vital, with
participants and researchers needing to understand from the outset
how stakeholders can contribute and the importance of considering
issues in a broad context, rather than from a personal perspective.
P/073/WED
Diabetes management in young people: rural compared
to an urban tertiary hospital in Queensland, Australia
E. Lang1, M. Rogers1, M. Harris1, M.N. Noud1, R. Greer2, M. Kamp3 &
A.M. Cotterill1
1Mater Children's Hospital, Queensland Diabetes Centre, Dept
Endocrinology and Diabetes, Brisbane, Australia, 2University of
Queensland, Brisbane, Australia, 3Queensland Health, Centre for
Healthcare Improvement, Brisbane, Australia
Significant changes in diabetes management have been introduced
for young people with diabetes aimed at improving diabetes
control by lowering HbA1c goals. Queensland has a widely
distributed population; with 40% living in rural and often remote
areas. Provision of appropriate diabetes specialist care is difficult.
Aims: The aims of this study were to: compare glycaemic control
between two groups, one from rural Queensland and the other
from the largest paediatric tertiary diabetes service in urban
Brisbane.
Methods: Health professionals caring for young people with
diabetes were asked to participate in a state-wide clinical audit in
2008. The audit collected data on every young person with diabetes
<18 years seen during a four-month audit period. This included
age at diagnosis, gender and HbA1c. A second audit of patients
attending the tertiary centre was undertaken with the collection of
additional data including HbA1c, insulin and C-peptide levels at
diagnosis to examine possible predictors of future long-term
glycaemic control.
Results: The majority of subjects in both groups had Type 1
diabetes (>98%). The mean age ± SD at diagnosis in the rural
group was 11.6 ± 3.8 years and 9.1 ± 4.2 years in the urban
tertiary group. There were 46% females in the rural group and
49% females in the tertiary group. The mean HbA1c ± SD in the
tertiary group was higher at 9.2 ± 1.5% than the rural group at
8.9 ± 1.5%. In the tertiary group biochemical indices at diagnosis
did not predict subsequent glycaemic control.
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Conclusions: Glycaemic control in both the rural and urban areas
of Queensland is unsatisfactory with HbA1c levels exceeding
current recommended targets of <7.5%. These results demonstrate
that we should not assume that therapeutic advances will, of
themselves, lead to optimal glycaemic control. In order to achieve
maximum benefit from therapeutic advances, changes must be
resourced, adopted, implemented and include on going education
and support.
P/074/WED
Burden of diabetes in CSII-treated adolescents
A. Lindholm Olinder1,2 & B. Smide2
1Stockholm South Hospital, Sachs Children Hospital, Stockholm,
Sweden, 2Uppsala University, Medical Sciences, Uppsala, Sweden
Objectives: To investigate the associations between higher burden
of diabetes, metabolic control, treatment satisfaction, quality of life
and perceived health in CSII treated adolescents with type 1
diabetes.
Methods: Data concerning burden of diabetes, metabolic control,
treatment satisfaction, quality of life and perceived health were
obtained from 91 CSII treated adolescents (aged 12–18), who were
regularly attending four different paediatric diabetes clinics in
Sweden. Burden of diabetes was measured with ‘‘Check your
Health’’. Perceived health and quality of life were measured with
Disabkids chronic generic and diabetes module self and proxy
version and with ‘‘Check your Health’’. Treatment satisfaction was
measured with the single question: ‘‘How satisfied are you with
your current treatment?’’.
Results: Approximately one third (32%) of the adolescents did not
perceive any burden of diabetes. The burden of diabetes was not
associated with HbA1c, but the adolescents with higher emotional
burden took fewer daily bolus doses (4.2 vs. 5.0, P = 0.02), there
was also a trend that they performed fewer self monitoring of
blood glucose per day (2.6 vs. 3.4, P = 0.056).
Those adolescents with higher physical, emotional and social
burden were less satisfied with the treatment (4.9 vs. 5.3, P = 0.02;
4.2 vs. 5.0, P = 0.02; 4.6 vs. 5.2, P = 0.01, scale 0–6). They
reported poorer self-perceived health in all domains. The parents to
the adolescents with high social burden perceived the adolescents¢
health better than what the adolescents did themselves.
Conclusion: It is important to identify adolescents who perceive a
high burden of diabetes in order to assist them with appropriate
help.
P/075/WED
Effectiveness of non prescriptive diet plan in children
with diabetes
A. La Loggia & L. Bivona
Health Service N. 2, Diabetes Unit for Children and Adolescents,
Caltanissetta, Italy
Aim: The involvement of all components of family in nutritional
counselling is a critical step of strategy of our Unit to improving
diet and lifestyle in diabetic youth. The model used is based on
Recommended Levels of Intake of Nutrients for Italian people and
mediterranean nutritional tradition. It proposes a plant-based diet,
typical of the centre of Sicily, rich in vegetables, fruits, legumes,
limiting animal aliments intake and the exclusive use of olive oil
instead of animal fat to dress foods.Aim of the study is to
investigate if a non-prescriptive diet plan in children with T1DM is
unfavourable in comparison with classic prescriptive diet plan,
paying particular attention to glycemic control, lipid profile and
BMI.
Methods: We conducted a longitudinal and 8-year retrospective
study based on a well-defined cohort of children with T1DM aged
<18 years followed-up every 3 months from our Unit beginning
from 1999 to 2007.The study included a total of 49 patients with
T1DM aged 16–19 years, the average duration of diabetes was
13 ± 4 years. During the study all the patients continued to
receive flexible multiple daily injection insulin therapy according to
basal-bolus plan. To investigate lipid profile we collected total
cholesterol, LDL, HDL and triglyceride levels once a year. To
asses metabolic control blood samples were collected for assay of
HbA1c every 3 months all years during the study.
Results: There were none abnormalities about lipid profile during
years collected. LDL, HDL, total cholesterol, triglyceride and BMI
values were normal and their trend was uniform or lower than
normal range of general people.
Conclusions: Our outcomes showed no differences between
diabetics and normal people at risk to develop metabolic
alterations. Non-prescriptive diet plan in children with T1DM,
isn’t unfavourable in comparison with classic prescriptive diet-plan
in particular regards the metabolic control which reflect
international data of reference, promoting wellness and
integration of the patients.
P/076/WED
Diabetologic education annual stage of diabetologic
education. 2001–2008 Hospital De NiÇos de la
Santsima Trinidad (Santsima Trainidad Children¢S
Hospital), Crdoba, Argentina
M.L. Macias1, M. Molinero de Ropolo2, L. Mignn2, I. Barreiro2,
M. Faraz2 & E. Sena2
1Santisima Trinidad Children¢s Hospital, Diabetes, Crdoba, Argentina,
2Santisima Trinidad Children¢s Hospital, Crdoba, Argentina
Objectives: To get to know the characteristics of the population
that attended to the meetings of the Annual Stage of Diabetologic
Education (CAED) during the years 2001 and 2008, in relation to:
age, gender, and attendance frequency.
Material and method: It was taken into account the data of the
attendance registers of the CAED stages of Children and
Adolescents with Diabetes and their families who received
assistance at the Santı́sima Trinidad Children¢s Hospital, from
the year 2001 to the year 2008. During this period there were
carried out 8 Annual Stages, with a total of 168 meetings, attended
by 615 children, 41.5% of which were male. Taking into account
the understanding possibilities, there were created three different
groups: From 0 to 8 years, from 9 to 13 years, and from 14 to
18 years.
Conclusions: a) The main attendance to the CAED meetings
during the years 2001–2008 belonged to the group from 9 to
13 years old who represents the 42.28% of the total of registered
patients. The attendance of the group 14–18 years old was of
36.26%. b) The females had greater attendance in the three
different groups during all the analyzed period of time.
P/077/WED
Attitude towards marriage in Indian adolescents with
type 1 diabetes
R. Khanna
Diabetes, Thyroid & Endocrine Care Centre, Amritsar, India
The multicentric international cross-sectional study was carried out
at 3 north Indian canters to assess the attitudes of unmarried
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adolescents aged 15 to 25 years with type 1 diabetes, as related to
marriage. 30 girls and 30 boys filled up a semi structured
questionnaire administered in OPD. All the 30 girls and 27/30
(90%) boys reported distress due to marriage related issues. 12
(40%) girls and 9 (30%) boys thought they would never get
married, while 18 (60%)girls and 11 (33%) boys felt it would be
difficult to find a life partner.
6 (20%) girls and 3 (10%) boys mentioned difficulty in carrying on
a friendship with a partner of the opposite gender, because of
diabetes.14 girls thought they would have to pay a higher dowry
because of their diabetic status, while 11 boys felt their dowry
would be less because of the same reason. 16 (53%) girls and 10
(80%) boys felt that uncontrolled diabetes could cause sexual
dysfunction, while 11 (37%) girls and 3 (10%) boys thought the
condition could reduce fertility. 3 girls reported worrying about
difficulty in managing future pregnancies.
All 30 (10%) girls and 24 (80%) boys said that distress related to
marriage related issues caused episodes of poor glycemic control
with 23 (77%) girls and 9 (30%) boys saying that this was a major
cause of poor control. No correlation was noted between distress
and age, socioeconomic status and rural/urban background in
either boys or girls. In conclusion, this paper reveals the high
prevalence of distress related to marriage in Indian adolescents
with type 1 diabetes.
P/078/WED
Summer camps for children with diabetes have a
valuable influence on the present life of the
participants
A. Okada1,2, M. Minami1,3 & Y. Nakamura1
1Fukuoka Young Hawks, Fukuoka, Japan, 2Okada Clinic, Fukuoka,
Japan, 3Clinic Masae Minami, Fukuoka, Japan
In Japan, more than 1000 children with diabetes now participate
annually in summer camps. In addition, thirty-six of these camps
(90%) lasts <5 days, however, our Fukuoka camp lasts 8 days.
There is also one day of hiking in the spring and fall, a Star Festival
in July, and a special X¢mas meeting is also held. Our main purpose
for these activities is to provide emotional suppport in order to help
such children improve their self-esteem, and self efficacy.
Objectives: To evaluate the influence of our activities on the
participants¢ present life.
Methods: A total of 320 persons participated in these camps from
1969 to 2003, excluding repeat participants. We sent questionnaires
to all of them and asked them to evaluate the influence of the camp
experience on their present life based on a score of 0 (least valuable)
to 5 (most valuable), and also describe the reasons for their
evaluation, and then return it. Forty questionnaires were returned
by the adressee anonymously. After one month, we obtained one
hundred replies. Thereafter, we analyzed the results.
Results: Grade 0 to 2 (less valuable) were 7%, grade 3 (not known)
15%. In addition, 78% of the participants gave score 4 and 5
(valuable, most valuable). In this group, many of the participants
wrote long explanations and it was obvious that the camp
experience had greatly influenced them. We believe that there
were 3 reasons for above results. First of all, the participants
realized that they were not the only persons with this disease, i.e.
they were not alone. The second reason is that began to feel less
fear or anxiety about their disease. The last reason is that the
participants began to think about life more deeply based on their
experiences at the camp.
Conclusions: As a result, 78% of the former participants who
responded to the questionnaire, and at least 28% of overall
participants (78 of 280) reported that these camps had made a
valuable contribution to their present life.
P/079/WED
Headmasters opinion on diabetes care at Swedish
schools
M. Hallman & G. Forsander
Sahlgrenska University Hospital, Div of Diabetes, Gothenburg, Sweden
Objectives: To complete a national survey on diabetes care in
Sweden with the attitudes, perceived burden and economical
distress of the headmasters of schools responsible for pupils with
diabetes.
Methods: All pediatric diabetes clinics in Sweden (n = 44) were
asked to randomly pick the name of four schools in their district
caring for at least one child with diabetes. A questionnaire was
distributed to the headmaster of schools caring for all together 196
children with diabetes 6–16 years of age.
Results: 69/106 questionnaires were received and possible to
evaluate. The answers represented all regions of Sweden equally
distributed. 96% of the headmasters felt secure and positive to
provide support for the children although concern was raised on
lack of sufficient medical knowledge and economical resources. All
but one headmaster were satisfied with the information given to the
school personell including him or herself. In most cases there was a
co-operation between the parents, the diabetes outpatient clinic
and the school nurse to deliver the information at the diabetes
diagnose of the child. 66% did not perceive any risk in caring for
children with diabetes during school time although 1 headmaster
expressed concerns for the school personell. 74% felt their
resources were good enough even during days of school
excursions. Some headmasters have contracted extra school
personell except for the teachers to fulfill their responsability for
the child with diabetes. At most schools the care was shared
between at least two adult persons.
Conclusions: Headmasters of schools in Sweden express a positive
attitude and willingness to fulfill their duty and resonsibility of
caring for children with diabetes during school time.
P/080/WED
Evaluation of a device of passage of the diabetic
teenager from the paediatric care structures to those of
the adults
L. Perrenoud, M. Castellsague, M. Dirlewanger & V. Schwitzgebel
Hopital Universitaire de Geneve, Geneve, Switzerland
Introduction: In 2001, a device of management of the passage, was
set up in our hospital, has fine to support and facilitate a better
follow-up of the young diabetic adult, as well as the continuity of
this long-term follow-up.
Objective: Evaluate the establishment of the device after 7 years.
Methods: Between 2001 and 2008, 25 teenagers, 10 girls (age
averages 16.8 years) and 15 boys (age averages 17.6 years)
benefited from the device. Criteria of inclusion: age more than
16 years old, followed bythe diabetology paediatrics for more than
2 years, agreement of the teenager and parents to participate at the
project. Strategies: use an index form of transfer filled with the
teenager, programming time to fill it, establishing a written
guideline which is coordinating by a professional. Criteria of
evaluation: evaluation of the impact,quality and satisfaction of the
index form of transfer and the device, counts young adults still
followed by a adult diabetologist, a number of hospitalizations
caused by the diabetes after the transfer.
Results: Impact and quality, first year, return of 7/7 evaluation
questionnaires of the index form, satisfaction, the index form of
transfer is at present included in the step of transfer. In September
2008, 25 teenagers continued to be followed by a diabetologist, 7
changed diabetologist, 3 were hospitalized because of the diabetes.
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Conclusions: The device improved the communication and the
collaboration between the various structures and placed the
teenager in the center of the step by allowing him to participate
in decision-making concerning himself. After the evaluation of the
project we To assure an optimal continuity of the care we do not
have to limit it to a simple ‘‘administrative’’ transfer, but insist on
the personal contacts between healthcare team (paediatricis and
adults diabetologists) and their patients because there is a risk that
the teenager is excluded from a medical follow-up
Poster Session II: Diabetes Care, Education,
Psychosocial Issues II
P/081/FRI
Application and evaluation of Arabic diabetes
educational program on diabetic patients & their
families
M.H.M.F. El-Hefnawy
National Institute of Diabetes & Endocrinology, Pediatric department,
Cairo, Egypt
Education for diabetic patients & their families about how to live
safe with diabetes and how to enjoy your life with diabetes is an
essential item during management of diabetes. The aim of this
work was to apply and evaluate the Arabic educational program
that had been built specifically for the Arabic diabetic patients &
their families. The program was explained for the nurse supervisors
and the junior doctors to prepare them to be as diabetes educators.
The program consisted of 234 slides with diagrams and sound to
explain every slide with musical background. The program had
been divided into o three sessions. First session contain explains to
definition of diabetes, classification of diabetes, diabetes in children
and adolescents, how to deal with acute complications of diabetes,
(hypoglycemia & hyperglycemia and diabetic ketoacidosis. The
second session contains summary of first session in addition to
management of diabetes including: change of life style, nutritional
therapy, oral and insulin therapy and how to deal with exercise,
school days and fasting with diabetes. The third session contains
summary of the previous tow sessions in addition to chronic
complications of diabetes and how to live without diabetic
complications. After application of every session there was an
open discussion with patients & their families. The program was
applied on 300 diabetic patients with pre-test questionnaire and
post-test questionnaire. The test result was 40% while the post-test
result was 90%. The program was applied twice through 3 months
on 100 patients and the post-test for them was 98%. There was a
highly significant difference between glycated HbA1c levels before
(HaA1c = 9.21 + 3.65%) and after application of the program
(HbA1c = 7.43 + 2.65%). It was recommended to apply this
program on all diabetic patients and their families and it was
advisable to repeat the application of the program periodically.
P/082/FRI
Animated 3D cartoon for the education of young
children with type 1 diabetes mellitus and their
families
D. Neumann1, B. Vavrinka2, I. Craigie3 & J. Jones3
1Charles University, Dpt. of Paediatrics, Hradec Kralove, Czech
Republic, 2Film School Zlin, Zlin, Czech Republic, 3RHSC Yorkhill,
Glasgow, UK
Objectives: Education of the youngest children with type 1
diabetes mellitus (T1DM) is particularly challenging. Booklets
and discussion may not be the optimum for very young diabetics
and, in fact, may be of more educational benefit to their parents.
We believe addressing educational messages directly to the children
improves their willingness to cooperate. We report a novel
educational tool - a series of five 3D cartoons lasting 5–
6 minutes each linked by a diabetic diary.
Methods: Collaboration between a diabetology team and a 3D
computer animator, who has T1DM himself, resulted in
animations, targetted at the youngest diabetic children. A simple
symbolism for young children is used: insulin is represented by
spoons, which are needed for the cells to ‘‘eat’’ sugars while lipids
look like spaghetti and cells ‘‘spit out’’ the ends - ketone bodies.
The colours of objects (e.g. ketone bodies are pink in the films as a
positive result on a urinalysis strip) emphasise the link between the
films and the real world experience of the children.
Part 1 describes normal glucose metabolism in a healthy body, as
part 2 diabetes and DKA. Parts 3–5 deal with: initial intravenous
therapy and PICU procedures aimed at reassuring children; the
switch to subcutaneous therapy; measurements and the daily
diabetic plan. In their diaries children use the stickers with happy
and sad cell characters from the cartoons to label their results. The
animation includes voices and songs to make learning from the
films more memorable. The diary includes scenes from the films
which can be coloured in to reinforce the message of the film.
Conclusion: The response we have obtained from families shows
that these cartoons are helpful for both children and, surprisingly,
their parents in understanding what is happening when a diagnosis
of T1DM is made, why and how their everyday lives will change





Post-Graduate education program for
dieticians – medical nutrition therapy in diabetes
G. Fayman1, I. Poraz2, M. Phillip1, Z. Stahal3 & I. Raz4
1Schneider's Children Medical Center of Israel, Petah Tikva, Israel,
2Shnieder Children Hospital, Petah Tikva, Israel, 3Nutrition Department
Isreal Ministry of Health, Jerusalem, Israel, 4The National Councils of
Diabetes, Tel Aviv, Israel
In the past decade, with the advent of new technologies and insulin
preparations, the need for dieticians specializing in the field of
diabetes became inherent. The Post-Graduate Education Program
for Dieticians was created in order to address the professional
needs of dieticians with the endorsement of the National Councils
of Diabetes and the recognition of the Israeli Ministry of Health.
The program included clinical and epidemiological aspects of
various types of diabetes and its complications, health promotion
and prevention of diabetes, clinical guidelines and tools for
decision making skills for the nutritional management of diabetes
throughout life. Special emphasis was placed on the behavioral
aspects of nutritional counseling. The dieticians practiced skills for
improving coping strategies in order to enhance adherence to the
treatment plan (i.e. motivational interviewing, cycle of change and
narrative approach). One hundred and fifty five dieticians from
hospitals and clinics throughout the country participated in the
first three education programs. All the participants completed the
24 weeks (168 academic hours) program with high attendance
rates. Certification was given after completion of the requirements
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and written examination. The participants evaluated the course
and rated it as excellent, stating that it improved their knowledge
and gave them tools for analysis and problem solving. This
educational program addressed the need to train dieticians in the
nutritional counseling of diabetes. Through knowledge and clinical
practice the dieticians enhanced their counseling skills of the
nutritional aspects of diabetes and thus promote therapeutic
patient education.
P/085/FRI
Serious life events in families of children with type 1
diabetes mellitus
A. Szypowska1, B. Zduńczyk2 & E. Pańkowska1
1Medical University of Warsaw, Warsaw, Poland, 2Clinical Pediatric
Hospital, Warsaw, Poland
Objectives: Stress is one of factors seen as contributing to diabetes
development.
The aim of this study was to assess incidence rate of serious life
events (SE) prior to diabetes diagnosis and examine if there is a
difference in occurrence of such events between families of children
with T1DM recognized at the age <5 years and >5 years.
Methods: There were included 347 participants: 123 parents of
children (67 girls, 56 boys) with T1DM onset at the age <5 years
with the mean age 3.1 SD 1.4 years (range 0–5) and 224 parents of
children (108 girls, 116 boys) with T1DM onset at the age >5 years
with the mean age 9.9 SD 2.8 years (range 6–17). Parents
completed a questionnaire during a routine visit in the outpatient
clinic. The questionnaire, especially constructed for the purpose of
this study, included questions about experience of SE which can
cause chronic stress (as seen in Posttraumatic Stress Disorder).
Statistical analysis was done using Fisher¢s Exact Test, Unpaired
t-test, P<0.05 was considered significant.
Results: The number of SE totaled to 243 (in 60% of families) SE
appeared more often within 2 year period before T1DM
recognition: in 47% vs. 13% of families (RR 0.3, 95% CI, 0.3–
0.4 P<0.0001). There was no difference in the number of families
of children with T1DM recognized at the age <5 years and
>5 years affected with SE 49% vs. 45% respectively. In both
groups parents divorce was the most common SE which occurs in
every 6th family. There was no statistical difference between groups
in the number of SE except grandparents death (RR 0.9, 95% CI,
0.8–1, P = 0,004).
Conclusion: Sixty percent of families with children with T1DM
have been affected by serious life events. The most serious life
events occurred in the families within 2 year period before T1DM
recognition. Children with T1DM onset at the age <5 years were
affected with the same number of serious life events as children
with diabetes recognized at later age.
P/086/FRI
Development of cooking classes and cookbook to meet
the needs of parents of children with coeliac disease
and diabetes
D. M. Burgess, K. Tull, C. M. Smart, P. Crock & B. King, Paediatric
Endocrine Team John Hunter Childrens Hospital
John Hunter Childrens Hospital, Paediatric Dietetics, Newcastle,
Australia
Introduction: (1) It is widely acknowledged that adherence to a
Gluten Free (GF) diet particularly for children with co-existing
diabetes is difficult, (2) Expert education by a Specialist Dietitian is
essential, Nutrition education encompasses food preparation, label
reading and awareness of nutrients at risk. (3) A strict lifelong GF
diet is the cornerstone of treatment for Coeliac Disease (CD) to
prevent comorbidities
Aim: To promote dietary adherence and improve quality of life by
a) Conducting GF cooking classes for parents/carers of children
with type1 diabetes and CD.
b) Developing a GF Diabetic cookbook.
Methods:
a) 28 families with a child with Type 1 diabetes and CD from the
Paediatric Diabetes clinic at the John Hunter Childrens
Hospital participated (6% of Clinic population).
b) A Needs Analysis was conducted using a standardised ques-
tionnaire to determine the content of the cooking classes and
cookbook.
c) 2 cooking classes were developed with key stakeholders,
recorded on DVD and evaluated. A request for favourite
family Gf recipes was sent out for inclusion in the cookbook.
d) All recipes in the cookbook have been trialled and analysed (4)
for carbohydrate, fat, energy and gluten content.
Results: The response rate to the Needs Analysis questionnaire
was 62% (n = 17). 100% of respondents (n = 17) requested
cookbook recipes, especially main meals, party food, school lunch
ideas and recipe modification. 59% (n = 10) were interested in
cooking classes. 8 families attended cooking classes. Evaluations
from the standardised questionnaire indicated that they were
highly useful. The cookbook has been endorsed by the Australian
Coeliac Society. The DVD and cookbook has so far been
disseminated to the 28 families and interested health professionals.
Conclusion: Cooking Classes and the cookbook have provided a
valuable educational tool for parents/carers of children with
Diabetes and CD. Parents enjoyed networking and described the
classes as very useful.
P/087/FRI
Use of a carbohidrate exchange system and its
influence on metabolic control in adolescents with
type 1 diabetes mellitus
A. Gomez-Rodriguez, R. Cardona-Hernandez, L. Suarez-Ortega,
A. Jaramillo-Villegas, C. Anguita-Fulla, M. Llobet-Garces & M. Torres-
Lacruz
Hospital Sant Joan de Du, Unit of Pediatric Diabetes, Barcelona,
Spain
Objectives: Carbohydrate counting is a technique commonly used
to quantify the total amount of carbohydrate (CHO) consumed at
a meal or snack. A modified exchange system is a technique where
carbohydrate-containing foods are classified in 10g servings. We
aimed to evaluate metabolic control, assesed by glycaeted
haemoglobin (HbA1c), in a cohort of adolescents with type 1
diabetes (T1DM) who followed a ration-based carbohydrate
exchange system (RBCES) compared with those who did not.
Methods: A telephonic survey to 40 adolescents (and/or their
parents) with T1DM (age range: 12–16 years) and a diabetes
duration of 2–4 years was performed. All subjects had been
instructed in RBCES at the moment of diabetes onset in the day-
care clinic. Patients with continuous subcutaneous insulin infusion
therapy were excluded.
Results: 33 of 40 subjects admitted to use the RBCES. Those
subjects who used it presented a better metabolic control respect to
those who did not (median HbA1c 8.2 vs. 10.6%; P = 0.003). In
the group of patients using RBCES, those who used the insulin-to-
CHO ratio presented a better metabolic control (P = 0.004).
Subjects measuring food with a balancer had a significantly better
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HbA1c respect to those who did not (P = 0.024). No significantly
differences were observed for gender or for the person who
performed the measurement (progenitor or adolescent).
Conclusions: Diabetes education is essential to achieve a good
metabolic control. This study confirms the importance of education
at the moment of diabetes onset and suggests that knowledge and
skills on ‘‘counting carbs’’ should be checked regularly.
P/088/FRI
Transition from pediatric to adult diabetes clinic:
evaluation by patients and parents
W. Asscherickx, M. Dejonghe, M. van Houten & K. Casteels
UZ Leuven, Dept of Pediatrics, Leuven, Belgium
Transferring adolescents with diabetes from pediatric to adult care
remains a challenge and the outcome is often unknown. The aim of
this study was to get more insight into the metabolic and
psychological effects of this transition on the patients and to
evaluate the effect on the parents. All patients transferred from our
university pediatric clinic to an adult centre for more than
12 months during the last five years were included (n = 55).
Parents were contacted by phone and a short interview was
performed. Afterwards, the patients were contacted by e-mail and
asked to send back a structured and standardized questionnaire.
The mean age of diagnosis of diabetes was 9.4 years. Mean age at
the time of the study was 21.2 years. Satisfaction with treatment
provided before and after transfer was assessed on a scale from 1 to
6 (1 = satisfied, 6 = not satisfied). On average the patients were
satisfied with their current treatment (mean 2). Comparing
previous and current health care, 20.6% of the patients expressed
the opinion that the treatment in the pediatric clinic had been more
satisfactory, 55.9% thought that their previous and present therapy
was not different and 23.5% was more happy with their new
doctor. Parents were also satisfied with the current treatment
(mean = 2) but judged the treatment in the adult clinic less
satisfactory in 32.07%, comparable in 60.4% and better in 7.5%.
As to the metabolic control, the post transfer HbA1c values
reported by the patients tended to increase in 44.4% and decrease
in 40.74%. From these data we conclude that most of our patients
have no problems with the transition from pediatric to adult care.
Parents however had more difficulties. Further study is necessary to
get more insight into the factors that influence these feelings and to
ameliorate the transition for both patients and parents.
P/089/FRI
Ten year evolution on diagnosis and treatment of type1
diabetes mellitus in an university center in S¼o Paulo,
Brazil
L.E. Calliari, M.S. Belhaus, H.P. Schechtman, E.F.A. Ribeiro,
M.T. Rodrigues, R.N. Romano, C.D.C. Faria, C. Kochi, O. Monte &
C. A. Longui
Santa Casa School of Medicine, Pediatrics, S¼o Paulo, Brazil
Many aspects of diabetes management changed in the last 10 years.
New methods of monitoring glycemia, intensified insulin treat-
ments
Objective: To evaluate changes on diagnosis and treatment of
children and adolescents with Type 1 Diabetes Mellitus (DM1) in
the last 10 years.
Methods: Patients followed in the outpatient clinic of Pediatric
Endocrinology of Santa Casa School of Medicine, São Paulo,
Brazil. Data of 1998 was taken from previous records (n = 193)
and data of 2008 from actual patients records (n = 132).
Comparing the results from 1998 against 2008, respectively, we
have: Chronological Age (CA): 12.3 years (±3.4) vs. 13.3 years
(±4.9) (P = ns); % of females: 55 vs. 50 (P = ns); CA at
diagnosis: 7.7 years (±4) vs. 6.8 years (±4) (P < 0.05); DKA at
diagnosis: 64% vs. 67% (P = ns); glucose values at diagnosis (mg/
dl): 478 (±215) vs. 497(±190) (P = ns); patients using NPH:
100% vs. 77% (P < 0.05); % of shots of NPH per day (1/2/3): 30/
70/0 vs. 12/44/44 (P < 0.05); presumed use of bolus insulin:12%
vs. 74%; HbA1c (%): 12.3(±3.4) vs. 9.8(±2) (P < 0.05). Another
important difference, non-numerically evaluated, refers to the self
monitoring method used: in 1998 it was done with Benedict
reaction in urine and now with capillary blood glucose, given by
the public health system. We observed that the age of diagnosis is
significantly lower, and that there was no reduction in the high
percentage of DKA, thus suggesting the need of increasing
awareness about the risk of diabetes in children. Regarding
diabetes treatment, we observed significant changes during these
last 10 years, being more intensive and better monitored, and
reaching a better metabolic control. Values of HbA1c achieved,
however, reinforce the need of more efforts to obtain an ideal
metabolic control.
P/090/FRI
Multi-centre audit shows similar glycaemic control on
different insulin regimes across three centres in
Northern England
M. Robinson & R. Barzegar
WWL Foundation Trust, Paediatrics, Wigan, UK
Introduction: Current national guidelines promote the use of basal
bolus regimes as being the most likely to deliver good glycaemic
control. We aimed to study the relationship between insulin regime
and HBA1C.
Methods: We chose three centres in North-West England: two
representing relatively deprived inner city populations and one
clinic from an affluent market town. Patient records were audited.
The last 3 HBA1C values from clinic were recorded along with the
insulin regimen. HBA1C values within four months of diagnosis
were not included.
Results: A total of 289 patients were identified as attending the
three clinics. 282 (98%) sets of case notes were studied. The mean
age of patient was 12.02 years and the average duration of diabetes
was 4.67 years. The overall mean HBA1C was 9.12. The two inner
city clinics had HBA1C averages of 9.14 and 9.46 whereas the
market town had a clinic average score of 8.81. The table below
shows the relationship between insulin regime and HBA1C. None
of these differences were statistically significant. Discrete analysis
within each centre showed similar results.






Twice daily 56.6 9.03
Basal bolus 29.2 9.05
Three times per day 9.6 9.73
Pump 4.6 9.4
Conclusion: Our study does not show an association between basal
bolus regime and ‘‘best’’ HBA1C. Indeed the children on a twice
daily regime were seen to have the lowest HBA1C. Further
research into factors influencing glycaemic control is needed.
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P/091/FRI
The use of insuflon can improve the early attitude to
diabetes when beginning with MDI at the onset of
diabetes
R. Hanas1, B. Lernmark2, P. Adolfsson3, A. Lindh4, J. Ludvigsson5,
K. kesson Elfvin6 & J. man7
1Uddevalla Hospital, NU Hospital Group, Dept. of Pediatrics, Uddevalla,
Sweden, 2Lund University, Unit for Diabetes and Celiac Disease,
Department of Clinical Sciences Malmç, Lund, Sweden, 3The Queen
Silvia Children's Hospital, Gothenburg, Sweden, 4Bors Hospital,
Bors, Sweden, 5Linkçping University, Div. of Pediatrics, Dept of
Clinical and Experimental Medicine, Linkçping, Sweden, 6Ryhov
Hospital, Dept. of Pediatrics, Jçnkçping, Sweden, 7rebro University
Hospital, Dept. of Pediatrics, rebro, Sweden
Aim: To investigate the use of indwelling catheters (Insuflon) from
the onset of diabetes when beginning with multiple daily injections
(MDI). Published results have shown a significant relief of pre-
injection anxiety and injection pain. The aim of this analysis was to
investigate the psychosocial adaptation to diabetes and diabetes-
specific family support.
Methods: Forty-one patients aged 8.1 ± 3.7 years (range 1–15)
participated in this open, controlled, randomized study. A local
anesthetic cream was used before all insertions. The control group
used insulin pens with standard needles. After one week, the
indwelling catheter group could choose regular injections but were
included in the ‘‘intention to treat’’ analysis. The family experience
was investigated using the Adaptation to Diabetes Scale (ADS) and
Diabetes Family Behavior Scale (DFBS) questionnaires which were
given to the families at one and six months after diagnosis. Both
scales have Likert scores from 1–5 and have been used from the age
of 7 years. Lower scores show a better adaptation to diabetes and
diabetes-related tasks. The ADS has 2 subscales: Attitude to
diabetes and Emotional difficulty with diabetes and the DFBS has
2 subscales: Guidance/control and Warmth/caring.
Results: Nine out of twenty children in the Insuflon group still
used the device after 6 months. 19 families of children aged 7–
15 years completed the questionnaires at one month and 15 at
6 months from diagnosis. Attitude to diabetes on the ADS scale
was lower for children using Insuflon for initiating insulin
injections at 1 month (12.3 ± 1.7 vs. 14.2 vs. 0.8, P = 0.007),
but at 6 months there was no difference. There was no difference on
the other ADS subscale, the DFBS as a whole or the DFBS
subscales.
Conclusions: Using an indwelling catheter as an injection aid when
using MDI from the onset of diabetes can improve the family
attitude to diabetes in the early phase, which can be explained by a
lower experience of injection pain.
Poster Session I: Diabetes Care, Education,
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P/092/WED
Dead in bed syndrome: should we be informing our
patients?
R.E. Besser1,2 & A.J. Hulse1
1Evelina Children's Hospital, St.Thomas Hospital, Department of
Paediatrics, London, UK, 2Peninsula Medical School, Peninsular
Clinical Research Facility, Exeter, UK
Introduction: Sudden nocturnal death in Type 1 diabetes, also
known as the ‘‘dead in bed’’ syndrome (DIBS), is an uncommon
event, accounting for up to 6% of deaths in young diabetic
patients, amounting to 2–6 cases per 10 000 patient years.
Anecdotal experience suggests some families would welcome
discussion on DIBS.
Aim: To determine the current practice of pediatric diabetes
clinicians in the UK concerning DIBS.
Method: Clinicians attending the UK Association of Children’s
Diabetes Clinicians 2008 meeting were asked to complete an
anonymous questionnaire. Information was collected on: duration
of clinical experience, number of cases of DIBS seen <20 years,
communication practices and reasons behind these decisions.
Results: 49/65 (75%) clinicians completed the questionnaire, of
which the majority (92%) were consultants, with a cumulative
diabetes experience of at least 562 years. 7 cases of DIBS (1 aged 5–
10 years, 3 aged 10–15 years and >15–20 years) were reported by
5 clinicians, amounting to 1 case per 80 years. 58/65 (89%) of
clinicians had not experienced a case. Nobody routinely discussed
DIBS, but did so after the parent or young person initiated it
(33%), opportunistically (31%) or not at all (33%). If discussed,
43% of clinicians felt that a consultant should be leading the
discussion, although many (33%) felt any member of the diabetes
team, should be doing so. Reasons for clinicians not informing
families included: causing unnecessary anxiety (67%), low
prevalence (41%), not enough known about DIBS (39%), it is
not preventable (31%) and not enough time in clinic (22%). 3/5
(60%) clinicians who had experienced a case of DIB syndrome had
changed their practice as a direct result.
Conclusions: This survey confirms that DIBS is an uncommon
event, and there is no consensus as to how and whether we should
discuss this sensitive subject. The majority of clinicians who had
experienced a case had changed their practice as a direct result.
Further exploration of families is recommended.
P/093/WED
Diabetes management at a tertiary university affiliated
center – how the adoption of ISPAD guidelines
changed achievements
W.R. Mladenov, V.M. Iotova, S. Galcheva, V. Boyadzhiev, G. Atanasova,
G. Dimova & V. Tzaneva
University Hospital St. Marina, Clinic of Pediatric Endocrinology,
Varna, Bulgaria
Varna Children’s Diabetes Center is established in 1989 and is
constantly striving for improvement of diabetes care. The aim of
the present study is to assess the diabetes management in 2007–
2008 following the adoption of the ISPAD Guidelines (2000 and
2006–2008), and to compare it with previous time-periods. A total
of 150 children and adolescents up to 18 years are under constant
care of a team of 2 doctors, 3 diabetes nurses and a psychologist.
The mean age of the patients in 2008 is 12.1 ± 4.0 years, mean
diabetes duration 4.4 ± 3.8 (0.1–15.0) years. On 2 daily injections
are 7.3% of the children, compared to 66% in 1995, 64.3% in 1999
and 12.3% in 2007. In 2007 four or more daily insulin applications
use 76.7% of the children, 63.7% with at least one insulin
analogue, and in 2008 - 82.0% of the children, 64.8% with at least
one analogue. The mean initial hospital stay is 21.3 days in 1986–
1988, 14.2 in 1996–1998, 11.0 days in 2007 and 8.1 days in 2008.
The number of regular visitors (more than 4 times per year)
increases from 20.8% in 1997 to 72.0–77.7% in 2007–2008
(P < 0.001), the mean number of visits in 2008 being 5.6 ± 2.6.
The patients performing 2 or more yearly HbA1c investigations
increase from 47.3% (2007) to 54.0% (2008). The mean HbA1c is
8.76 ± 2.1% in the III trimester of 2007 vs. 8.55 ± 2.3% in 2008,
when 36.4% had HbA1c<7.5%. All mean HbA1c values show
improvement from 2007 to 2008. The relative share of initial DKA
decreases from 30.1% in 1997 to 21.0% in 2008. The occurence of
severe hypoglycemia also decreases significantly - from 35.7% of
all patients (in 1997) to 1.3% in 2007–2008, while non-severe
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non-frequent hypoglycemia increases - 39.3%. Regular screening
determines mild neuropathy (ENG changes mainly) as the most
frequent microvascular complication (23.4% in 2007, 10.7% in
2008), and retinopathy as the less frequent - 5.0% of patients with
diabetes duration >5 years, all mild. These data will serve as a
basis for further improvement of care.
P/094/WED
Transition of care from paediatric to adult services in
type 1 diabetes adolescents: to be or not to be lost in
translation?
N. Tubiana-Rufi1,2, L. Du Pasquier1, P. Jacquin1, C. Guitard1, J. Houdan1,
J.-C. Carel1,2 & C. Levy-Marchal2
1Robert Debre Hospital, APHP, Endocrinology, Paris, France, 2INSERM
Unit 690, Paris, France
Transition of care in type 1 diabetes (T1D) adolescents involves
major medical and psychosocial challenges, with the risk of care
discontinuation and subsequent complications, which need to be
evaluated. A longitudinal study was conducted in T1D patients
from 6 paediatric and 9 diabetologic departments in the region of
Paris, France. Self-questionnaires were filled out by patients, and a
medical questionnaire by their physician, at their last visit in
pediatrics (T1) and in adult diabetes clinics 0.5–2 years later (T2).
61 patients (60% of regional rate of transition) aged 18.6 years
with T1D for 8.8 years, were included in the study at T1. Data were
available at T2 in 57 patients, mean delay T2/T1 = 1 year. Median
HbA1c did not differ at T2 vs. T1 (9 ± 2.2% vs. 8.9 ± 1.8%),
despite an increase in the number of injections (3.7 vs. 3.3 inj/day).
Number of DKA episods/year tended to be higher at T2 than T1 (5
vs. 2 patients, P = 0.06). Six patients had developed diabetic
retinopathy (DR) at T2 (HbA1c = 9.7 ± 1.2%, duration of
T1D = 11.2 ± 3.9 years). By comparison with patients without
DR, they were significantly older (20.2 vs. 19.4 years) and had
higher BMI (25.7 vs. 22.6). 14 patients (23%) were out of diabetes
follow up at the end of the study: 7 at the time of transition, who
never attended adult clinics despite an organization of transition; 7
others patients dropped out of adult clinics during the study. This
study emphasizes the risks of transition of care in T1D adolescents.
Poor glycemic control and occurrence of complications at this
critical period of development and duration of T1D require specific
cares and strategies. The high level of discontinuation in diabetes
care, requires a close supervision of patients at the time of
translation, by a collaborative organization between paediatric and
adult services, as well as an identification of high risk patients.
P/095/WED
NovoPen EchoTM for the delivery of insulin in
paediatric patients: a comparison of usability,
functionality and preference among patients, their
parents and healthcare professionals
B.S. Olsen1 & S.K. Lilleøre2
1Glostrup University Hospital, Department of Paediatrics, Glostrup,
Denmark, 2Novo Nordisk A/S, Global Medical Affairs, Copenhagen,
Denmark
Objectives: NovoPen EchoTM is a new durable insulin pen with an
innovative memory function. This study assessed the usability,
functionality and preference for NovoPen EchoTM versus
NovoPen Junior and Lilly HumaPen Luxura HD in paediatric
patients, their parents and healthcare professionals (HCPs).
Methods: Pens were evaluated in random order during 1:1
interviews in the three target groups (paediatric patients n = 79;
their parents n = 78 and HCPs n = 48) in Germany, France and
Canada. Subjects were asked to prepare each insulin pen and
perform injections into a foam cushion, providing feedback via a
standardised online questionnaire.
Results: On a 1–6 scale (1 = completely agree; 6 = completely
disagree), NovoPen EchoTM scored highly for design with its overall
appearance receiving the best ratings versus the other devices
(mean ± SD: NovoPen EchoTM 1.78 ± 0.87; NovoPenJunior
2.02 ± 0.93; Lilly HumaPenLuxura HD 2.38 ± 0.98). Also, 70%
of all participants found the size of NovoPen EchoTM ideal
(NovoPenJunior 54%; Lilly HumaPenLuxura HD 20%).
Setting up, adjusting and injecting with NovoPen EchoTM was
problem-free for almost all participants. NovoPen Echo’sTM
memory function scored well for meeting participants needs, with
78% of children, 83% of parents and 79% of HCPs rating it as 1–2
(1 = ‘‘meets my needs completely’’; 6 = ‘‘does not meet my
needs’’) and 89% of children and 94% of parents rating ease of
use as 1–2 (1 = ‘‘very easy’’; 6 = ‘‘very difficult’’). After using the
pens, NovoPen EchoTM was rated the best in terms of satisfaction
and 80% of paediatric patients rated it as their favourite pen
(NovoPenJunior 7%; Lilly HumaPenLuxura HD 12%).
Conclusions: The results confirm the high overall satisfaction with
NovoPen EchoTM among paediatric patients, their parents and
HCPs. The key features were the appealing design, ease of use and
memory function. These attributes are of particular importance for
promoting good treatment compliance, which is essential for this
paediatric patient group.
P/096/WED
Development of a social activities and independence
questionnaire (SAIQ) in paediatric diabetes as part of
the DECIDE Study
L.M. Lowes1, S. Channon2, J.W. Gregory3, M. Robling4, N. Harman5, The
DECIDE Study Group
1Cardiff University, Nursing Health and Social Care Research Centre,
Cardiff, UK, 2Cardiff and Vale NHS Trust, Paediatric Psychology Dept,
Cardiff, UK, 3Cardiff University, Department of Child Health, Cardiff, UK,
4Cardiff University, South East Wales Trials Unit, Department of Primary
Care & Public Health, School of Medicine, Cardiff, UK, 5Cardiff
University, South East Wales Trials Unit, Cardiff, UK
Background: Anecdotal evidence from clinical practice and some
qualitative work indicate that parents of children newly diagnosed
with diabetes often struggle to allow their children to participate in
normal social activities. However, no validated measure currently
exists.
Aim: To develop a social activities and independence questionnaire
(SAIQ) to measure the perceived impact of diabetes upon a child’s
social activities. The SAIQ has been developed for use in the
DECIDE study, a multi-centre randomised controlled trial that
will assess the impact of home and hospital management of type 1
diabetes on a number of outcome measures.
Method: SAIQ development involved the identification of relevant
activity areas by literature review and from a series of exploratory
qualitative interviews conducted with children/young people with
diabetes and parents. Purposive sampling strategy sought to
maximise response variation reflecting potential age and gender
differences in social activities.
Findings: Two overarching activity domains were identified:
activities related to school and activities not related to school.
Items were developed within these domains and responses scaled
according to how much diabetes affects the child’s participation in
an activity detailed. The draft SAIQ then underwent cognitive
debrief interviews with of parents and children aged 3–14 years
using concurrent verbal probing techniques.
Conclusion: Exploratory and subsequent debrief interviews of the
SAIQ provided evidence of content validity for the outcome
measure. The SAIQ will be further validated as part of the
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DECIDE study. This new measure of social activities and
independence in paediatric diabetes will provide valuable
information to help improve the care and quality of life of
children and young people with diabetes.
P/097/WED
The comparison of American and Slovenian diabetes
camp for adolescents with T1D
T. Polak1,2, N. Ursic Bratina2, M.M. Klemenčič Rozman1 & T. Battelino2
1University of Ljubljana, Faculty of Education, Department of Social
Pedagogy, Ljubljana, Slovenia, 2University Children's Hospital,
University Medical Centre Ljubljana, Ljubljana, Slovenia
Diabetes camps offer opportunities to promote positive youth
development through structured recreation activities and diabetes
education.
Objectives: To explore how diabetic adolescents with T1D
experience and evaluate the diabetes camp.
Method: In this cross-cultural research 42 American and 42
Slovenian adolescents with T1D aged between 12–18 years
completed a pre-structured evaluation questionnaire.
Results: The research has shown significant differences between
American and Slovenian adolescents in regard to contentment with
the program activities (t = 4.146, P = 0.000), group acceptance
(t = 5.199, P = 0.000), the staff (t = 4.285, P = 0.000) and
camp facilities (t = 3.580, P = 0.001). American adolescents are
more content with the activities, acceptance, support,
understanding and cooperation in the group as well as with the
staff, although also Slovenians evaluate their program and staff
positively. The American diabetes camp and has a greater variety
of activities and offers different age group sessions, in contrast to
the Slovenian camp where there is one session for children and
teenagers at the same time. There were no statistically important
differences found regarding HbA1c (t = 0.331, P = 0.742,
average value of American and Slovenian adolescents was 8.2%),
self-control (t = 0.144, P = 0.886) and camp¢s influence on
adolescent’s coping with T1D (t = 1.454, P = 0.150); they all
evaluate diabetes camp as an experience of positive influence on
their diabetes management and point out gaining self-confidence
and self-dependence. The positive experience of the camp could
also be seen in the result of high return rate for campers (100% of
Americans and 86% of Slovenians) and in their wish to become a
counsellor (88% of Americans and 71% of Slovenians).
Conclusion: Diabetes camps that meet the needs of adolescents
with T1D have a positive impact on their diabetes management,
self-confidence, and overall satisfaction with camp.
P/098/WED
To evolve a model group for care and social support to
people with type 1 diabetic in India
R. Shukla1 & D. Yagnik2
1Regancy Hospital, Endocrinology, Knanpur, India, 2Yagnik Diabetes
Care Centre, Kanpur, India
Objective: To evolve a model for the help of people with Type1
Diabetes in their socio-medical issues in Indian scenario.
Aim: Making life of people with Type 1 Diabetes smooth and
hurdle free through the model.
Method: There is no organized infrastructure in healthcare to help
people with Type1 diabetes
• We have formed a Non Government Organization (NGO) named
‘‘Society for Prevention and Awareness of Diabetes’’ (SPAD).
• We have been doing Regular meetings at the interval of 4 months
for last 12 years.
• Till now total meetings done 47 and 130 Type1 diabetic are
registered m/f 80/50 age 5–20 years.
• 70 were screened for the complications as per standard recom-
mendations and followed up.
We focus our meetings for following issues
Medical issues:
• Regular blood sugar monitoring, Self management of diabetes
mellitus
• Managing hypos, Traveling tips, Emphasis on screening of
complications.
Psychosocial issues:
• Focusing on the education, Encouraging (specially female
participant) them to be independent in life
• Learning from among themselves and achievers too help and
encourage them.
• Make them realize their potential, Helping in their marriages
Result: 11/70 developed nephropathy (24 hours urinary proteins
ranging 150–300 mg/day), 9/70 developed mild non proliferative
diabetic retinopathy
• Reversal took place in 8 out of 11 in nephropathy and 6 out of 9
in retinopathy
• Psychosocial issue-Male aged above 25, 8 of them are indepen-
dent and doing well in their respective fields. 5 of them are happily
married to non diabetic spouse and enjoying parent hood.
• Female aged 25 years 5 are working and leading independent
life have. They are nicely managing their diabetes. 5 girls
married 2 with diabetic spouse and 3 with non diabetic and
are doing well.
Conclusions: Similar models to be developed to help people with
Type1 Diabetes globally.
This model is very effective to help solely in developing countries
but also useful for developed countries.
P/099/WED
How much do diabetic children know about diabetes
and it¢s management
S. Lim & S. Arun
St John's Hospital, Paediatrics, Chelmsford, UK
Objective: To develop a knowledge base to target diabetes
education.
Methods: Questionnaire survey of children attending the
Children¢s Diabetes Clinic.
Qualitative data was scored to quantify knowledge. There was
focus on treatment of varying degress of hypoglycaemia and some
variables were correlated with HbA1c.
Results: 79 questionnaires (60%) were returned, 10 were not
analysed. There was good general knowledge about diabetes. 88%
knew what the target blood sugar was. 90% knew how to manage
mild/moderate hypoglycaemic symptoms. Only 68% knew how to
manage the situation of an extremely low blood sugar and being
unrousable. There appeared to be no relationaship between HbA1c
and knowledge of hypoglycaemia management (see graph). Level
of understanding of diet was suboptimal. 7% thought insulin was
not needed when ill. 87% were aware that there were long term
complications of diabetes. There was very variable management
strategies before exercise.
Conclusions: The need for a dedicated children¢s diabetes dietition
was clearly demonstrated. It also became apparent that the current
diabetes nurse was overstretched in her role with the ever
increasing numbers of children diagnosed annually. A structured
education programme would address alot of issues raised.
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P/100/WED
The influence of a hospital strike on the metabolic
control of children with diabetes
P.-E. Kofoed1,2, J. Thomsen1 & J. Ammentorp2
1Kolding Hospital, Department of Paediatrics, Kolding, Denmark,
2University of Southern Denmark, Initiative of Health Services
Research, Odense, Denmark
Objectives: In 2008 the nurses at the Department of Paediatrics at
Kolding Hospital were on strike. As the interval between
outpatient visits is essential for an acceptable metabolic control,
we decided to evaluate whether the strike lasting 2 months had a
negative effect.
Methods: HbA1c-values, routinely measured on a DCA at all
visits, from the two last visits before and the first two visits after the
strike were registered. Other information was found in the patient
files. Children with diabetes for <3 months prior to the strike were
excluded. Data are compared by t-tests or chi-square as
appropriate.
Results: A total of 155 children were included. The interval
between visits increased from a mean of 80 days before to 147 days
as a result of the strike (P < 0.0001), but normalized to 67 days
between the first two visits after the strike (P < 0.0001). At the two
visits just prior to the strike the mean HbA1c values were 8.13 (SD:
1.6) and 8.07 (SD: 1.5) (P = 0.39), while it increased to 8.48 (SD:
1.7) at the first visit (P < 0.0001) and 8.37 (SD: 1.5) at the second
visit following the strike (P = 0.14). The corresponding values
from the previous year were 8.25 (SD: 1.3), 8.18 (SD: 1.4), 8.22
(SD: 1.4), and 8.32 (SD: 1.5) (P > 0.05 for all possible
comparisons).For children with a baseline HbA1c of >10.0% no
increase in HbA1c during the strike was found.
Conclusion: As the HbA1c remained the same for the last visits
before the strike, the higher values at the first visit after the strike
confirm that the interval between visits is important for ensuring an
acceptable metabolic control. Even though the interval between
visits normalised after the strike, the HbA1c remained at the higher
level. Children with a very high HbA1c prior to the strike did not
experience any change in their metabolic control corroboration
previous findings at the same clinic. So even though the strike only
lasted 8 weeks it had consequences for the glycaemic control of the
children.
P/101/WED
A strike in the Danish hospitals: parents perception of
the impact on the control of children with diabetes
P.-E. Kofoed1,2, J. Thomsen2 & J. Ammentorp1
1University of Southern Denmark, Initiative of Health Services
Research, Kolding, Denmark, 2Kolding Hospital, Department of
Paediatrics, Kolding, Denmark
Objectives: To examine parents perception of an 8 weeks strike at
the Department of Paediatrics at Kolding Hospital we asked them
to fill in a questionnaire. The answers were compared to the HbA1c
measured just before and the change in HbA1c during the strike.
Methods: The questionnaire was pre-tested on six parents and the
parents were asked to fill it in at the first visit after the strike. The
HbA1c-values routinely measured on a DCA at all visits from the
last visit before and the first visit after the strike were registered.
Non-Danish speaking families and children with diabetes for
<3 months prior to the strike were excluded. Data are compared
by t-test or chi-square as appropriate.
Results: Of 152 questionnaires handed out 113 (74%) were
returned. Of these 48 (43%) stated to have needed help during
the strike, 36 (32%) had tried to contact the department, but for 13
(12%) in vane. Only 12 contacted their family physician. The 48
children stating to have been in need of help had a higher HbA1c
level before the strike than the rest (8.4% vs. 7.7%, P = 0.004),
but no difference in the mean increase in HbA1c was found (0.62%
vs. 0.40%, P = 0.30). The children to 49 parents (43.3%) claiming
that their diabetes had deteriorated due to the strike had a mean
HbA1c level just before the strike of 8.4% as compared to 7.6% for
the rest (P = 0.0009). Furthermore, the increase in HbA1c during
the strike was 0.76% and 0.24%, respectively (P = 0.01), and they
were more likely to have needed help (29/49 (59%) vs. (15/65
(23%).
Conclusion: Even during a strike lasting only 8 weeks, more than
40% of the parents felt they needed professional help. Most
contacted the department and the majority found they had received
the help requested. Almost half of the parents included found that
their children’s diabetes had deteriorated, corroborating the fact
that they had a greater increase in HbA1c that the other half, and
the fact that these parents had needed help more often than the
rest.
P/102/WED
''ESSEN-tial Cares in Diabetes'' food and nutrition
education program for mothers of children with
diabetes or with diabetes and celiac disease
A.V. Asaduroglu
Universidad Nacional de Crdoba, Human Nutrition and Alimentation,
Crdoba, Argentina
Diabetes Mellitus (DM) and Celiac Disease (CD) are chronic
disorders, the treatment of which is vitally important. The
incidence of DM type 1 and type 2 is increasing among children
and adolescents. The EURODIAB study shows that the prevalence
of type 1 DM in <15 years is increasing by more than 3%
annually, and more than 6% per year in children up to 4 years of
age. In the last decade and a half, the incidence of type 2 DM has
also increased worldwide, induced by obesity among children and
youth. Studies have shown a frequent association between CD and
type 1 DM, with a prevalence of 13.9%. The co-occurrence of both
diseases in children is not uncommon in our context, so they and
their families could benefit from an educational intervention
tailored to their needs.
Aims: - To provide tools that offer effective support to families and
to children with DM and CD to enable them to take control of
their treatment for the benefit of their health and quality of life
- To provide food and nutrition education geared to children with
DM or with DM and CD, and to their parents
- To promote healthy eating habits that foster proper growth and
development
- To give them the knowledge and skills necessary to effectively
carry out their treatment, and in particular the food and
nutrition plan
Direct targets: mothers / parents / grandparents
Indirect targets: children / families
Activities: Consist of educational workshops on child-focused food
and nutrition, theory and practice classes and preparation of
[Severe Hypoglycaemia Management]
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recipes, to promote a healthy diet that includes children in the
family menu.
It is a challenge to implement educational strategies and to produce
training material specifically for dealing with this pair of chronic
diseases that are so complex and rarely addressed together.
Poster Session II: Diabetes Care, Education,
Psychosocial Issues IV
P/103/FRI
Clinical application of fear hypoglycemia scale in type
1 diabetic children
M.J. Lopez, L. Escriva, M.M. Luis, R. Alpera & C. Collado
Hospital Clinico Universitario, Pediatric Endocrinology, Valencia, Spain
Aversive symptoms of hypoglycemia may result in phobic-like fear
of hypoglycemia. Kamps¢ Scale (CHI) is a reliable instrument in
the measurement of children’s hypoglycemia fear (HF).
Objectives: To evaluate this scale in our patients and to compare
its results with metabolic control, history of severe hypoglycemia
(SH) and number of capillary blood controls/day.
Methods: A cross-sectional survey was performed in 54 type 1
diabetic children (B/G: 28/26) attended in our Hospital, 7 to
18 years (11.1 ± 4.2). Inclusion criteria: diabetes duration
>6 months and at least 3 capillary blood controls/day. Average
HbA1c and history of SH were collected. The CHI was made by
the same interviewer. They were also interviewed directly about HF
(visual analogic scale, VAS).
Results: Average punctuation obtained by using CHI was
28.05 ± 8.21 (range 12–48), and it could be understood as not
much important fear, (maximum 60 points). Similar results were
obtained by VAS (5.26 ± 2.74), with a possitive tendency between
both assessments. There were not signifcative differences in CHI
between children with/without history of SH (P = 0.21). Three
separate constructs did not discriminate between HF, as similar
punctuations were obtained in all of them. Children do not admit
that they do more capillary blood controls due to HF. However,
there were significative differences between children with low and
high CHI punctuation: 4.71 ± 1.36 capillary glycemia/day vs.
5.89 ± 1.96 (P = 0.012).
Conclusions: CHI results were similar to direct evaluation of HF
(VAS). Both methods show a possitive tendency: the higher
hypoglycemia fear, the higher global scale punctuation is.
However, CHI is not able to discrimate between children with
severe hypoglycemia positive hystory. High CHI do not correlate
with a worse metabolic control. There are adaptative behaviors, as
tested by higher number of capillary blood controls per day, done
by children with higher punctuations. Its impact on diabetes
management remains nuclear.
P/104/FRI
The effectiveness of photographic educational material
on carbohydrate counting for adolescents with
diabetes – preliminary results
A.S. Gandolfo1, A.A. Ferraro2, D.V. Bastos3, B.A.J. Makluf3,
T.D. Manna1 & D. Damiani1
1Instituto da CrianÅa - HCFMUSP, Pediatric Endocrinology Unit, S¼o
Paulo, Brazil, 2Instituto da CrianÅa - HCFMUSP, Pediatric Departament,
S¼o Paulo, Brazil, 3Universidade Federal de Alfenas, Alfenas, Brazil
Objective: To present preliminary results from research to evaluate
the effectiveness of photographic educational material on
carbohydrate counting on diet for adolescents with diabetes.
Research method: Desired sample size of 60 adolescents with
diabetes at the Pediatric Endocrinology and Diabetes center.
Numbers based on partial sample of 32 adolescents, randomly
distributed between groups of those who received orientation on
carbohydrate counting with photographic educational material
and with a list of foods equivalent. Research followed 3 steps. First,
data was collected on age, gender, IMC, HbA1C, schooling, type
of educational material and parents average grade level; answer
sheets were applied to evaluate previous knowledge on
carbohydrate counting; orientation provided on counting with
photo material or list. Second, after a month of using the
educational material, a quiz by phone was conducted with the
sole intent to reinforce orientation. Third, two days later,
adolescents were directed to the experimental kitchen to interact
with portions of real food and provide answers on amount or
choice of carbohydrate. Statistical tools applied on partial data.
Results: The mean age was 13.70 ± 1.87 years, IMC
21.13 ± 2.79 kg/m2, schooling 8.06 ± 1.31 years, HbA1C
10.17 ± 1.95% and 71.87% female. Parents mean grade level
was middle school. Photo group accounted for 43.75% of partial
sample, and list group, 56.25%. Adolescents exposed to photo
material correct answers were 6.64 ± 2.71, slightly better than
those exposed to list of 6.05 ± 2.13, for a total of 11 questions.
Conclusion: A differentiated education strategy for these groups is
necessary to improve the control of the diabetes and the health of
the adolescents. The photographic educational material can convey
the information effectively and be used as alternative tool to
provide orientation on carbohydrate counting.
P/105/FRI
Diabetes self-care: perspectives of children and
adolescents
D. Koller1, D. Daneman2, S. Barrett2 & M. Small2
1Ryerson University, Early Childhood Education, Toronto, Canada,
2Hospital for Sick Children, Toronto, Canada
Objectives: Although studies have examined issues relating to
compliance, children¢s understanding of their disease and
perceptions around self-care are often not addressed. The main
purpose of the study was to explore and identify children¢s and
adolescents¢ understanding of their diabetes in relation to self-care.
The study also sought to identify processes that elicit or inhibit self-
care in youth.
Methods: This qualitative study employed an ethnographic
interpretive approach using descriptive narratives to illuminate
experiences of childhood diabetes and self-care. A sample of 46
participants between the ages of 5–18 with Type 1 diabetes were
recruited. Basic demographic data and individual interviews
comprised the data collection. Data were analysed using coding
methods by Strauss and Corbin (1998). To augment analysis, N-
Vivo data analysis software was used.
Results: Participants viewed self-care as an evolving process that
changes over the lifespan. However, young children lacked basic
knowledge regarding diabetes, and in some cases held
misconceptions about the disease, while older participants
expressed the need for more information on diabetes.
Participants identified concerns associated with having ¢lows¢ and
some shared their fears of dying as a result of having a severe ¢low¢.
Many participants wished for a cure while wanting to ¢take a break¢
from diabetes in order to lead a more normal life.
Conclusions: This research validates the significance of engaging in
conversations with youth which support their emotional and
educational needs. Accessing youth perspectives can lead to greater
participation in self-care and medical decision-making across the
lifespan. However, this type of discourse needs to occur at an early
Poster Sessions
ª 2009 The Authors
Journal Compilation ª 2009 John Wiley & Sons A ⁄ S Pediatric Diabetes (2009) 10 (Suppl. 11): 30–109 63
age in order to promote self-care behaviors. A major outcome of
this study includes the development of psychoeducational resource
for young children.
P/106/FRI
Adolescents view on hospital-delivered diabetes care
and a web based intervention
E. Boogerd1, C. Verhaak1 & C. Noordam2,3
1Radboud University Nijmegen Medical Centre, Psychology, Nijmegen,
Netherlands, 2Radboud University Nijmegen Medical Centre, Metabolic
and Endocrine Disorders, Nijmegen, Netherlands, 3Childrens Diabetes
Centre Nijmegen, Nijmegen, Netherlands
Objectives: The present study explored adolescents view on the
current outpatient diabetes care delivered in a tertiary care diabetes
centre. Information on the adolescents needs and wishes were used
as starting points for the development of a web-based intervention.
Method: Data were gathered by means of a focus group and 13
additional semi-structured interviews, among adolescents aged 13
to 18. Questions in the focus group and interviews focused on: 1)
adolescents problems regarding diabetes self-care, 2) support
offered by professional health caregivers and 3) adolescents
opinion on a web-based treatment as supplement to current
diabetes care. Audio recordings of focus group and interviews were
prepared for analysis through verbatim transcription.
Results: Findings suggest that adolescents are generally content
with their level of involvement in their treatment and decision-
making. Adolescents are less satisfied about accessibility of the
doctor and coordination of three-monthly visits. Especially
adolescents aged 15 years and older notice that a better fit to
their personal needs is required. More than half of the adolescents
in the interviews state they have little or no contact with peers with
diabetes, although recognizing that this can be of value to them.
Participants recognized the potential value of the internet as a key
medium in future diabetes care.
Conclusion: Adolescents report to be generally positive about the
delivered diabetes care and support the idea that a web-based
intervention improves accessibility of the diabetes team and contact
with peers with diabetes. This intervention is currently developed
and consists of a personalized page with treatment goals and a
functionality for personal contact with the diabetes team; peer
contact is facilitated through a chat application and an online
forum. Effects on adolescents diabetes knowledge, self-care,
glycemic control, quality of life and satisfaction with diabetes
care are being studied.
P/107/FRI
The influence on HbA1c of admission in a specialized
pediatric diabetes center
V. Serban1, A. Lacatusu2, L. Barna2, A.C. Sima1 & M. Rosu1
1University of Medicine and Pharmacy Victor Babes Timisoara,
Diabetes Clinic, Timisoara, Romania, 2Clinical Medical Center Cristian
Serban Buzias, Buzias, Romania
Aims: To assess the influence on HbA1c of admission in a national
center specialized in the evaluation, therapy and medical education
of children with T1DM. In Romania, this role is played by the
Clinical Medical Center ‘‘Cristian Serban’’ (CCS) for Evaluation
and Rehabilitation for Children and Youth, unique in the country,
located in Buzias, near Timisoara.
Patients and method: Between 1997 and 2008, at CCS, a number of
358 patients with T1DM aged between 0 and 18 years were
admitted three times, for an average of 12 days, at intervals
between 1 and 5 years. In all patients we performed frequent
daily glucose monitoring, glycemic profile, HbA1c
(immunoturbidimetric method, normal range 4.5–5.7%), eye
exam and albuminuria. Mean HbA1c was computed for each age
group at every admission and statistical difference was assessed
with Student t-test. Diabetes education was offered to children and
their accompanying family member and consisted in 8 theoretical
and practical lessons.
Results: Mean HbA1c for each age group and admission is
presented in the table. A significant decrease in HbA1c
(P < 0.05) from the first to the third admission is noticed in
almost all age groups, except for those between 11 and 14 years, in
whom the decrease is not significant. The decrease in HbA1c was
noticed regardless the type of insulin used or the number of insulin
injections.
Admission Age-group <7 7–10 11–14 15–18
1 No (%) 43 (12) 89 (24.8) 169 (47.2) 57 (16)
HbAc, mean € SD (%) 9.1 € 2.8 9.5 € 2.8 9.7 € 2.4 10.6 € 2.9
2 No (%) 33 (9.2) 62 (17.3) 160 (44.6) 103 (28.9)
HbAc, mean € SD (%) 8.7 € 1.6 9.0 € 2.3 9.4 € 2.1 9.8 € 2.3
3 No (%) 29 (8.1) 39 (10.8) 133 (37.1) 157 (44)
HbAc, mean € SD (%) 8.2 € 1.2 8.6 € 1.9 9.4 € 2.1 9.5 € 2.2
[HbA1c depending on age group and admission]
Conclusions: The hospitalization of children in CCS, where
diabetes education is the central activity, leads to a significant
improvement in glycemic control. The age-group 11–14 years
(puberty group) is the most difficult to manage.
P/108/FRI
What is the true impact of a diagnosis of coeliac
disease in children with type 1 diabetes?
E.L. Baker1 & D.P. Smith2
1Leeds Teaching Hospitals NHS Trust, Paediatrics, Leeds, UK, 2York
Hospital NHS Trust, Paediatrics, York, UK
Objectives: To study the effect the diagnosis and management of
coeliac disease has on glycaemic control, growth, and quality of
life, in children with both coeliac disease and type 1 diabetes.
Methods: 18 children with both coeliac disease and type 1 diabetes
were matched with one diabetic control without coeliac disease.
HbA1c levels and growth parameters were compared between the
groups. Responses to the PedsQl 3.0 questionnaire were also
obtained, together with responses to a non-validated coeliac
disease questionnaire to assess quality of life. Attempts were also
made to assess compliance with a gluten-free diet.
Results: No statistically significant differences in HbA1c were
found between groups, and no significant improvement or
deterioration in HbA1c was found after commencing the gluten-
free diet. There were no statistically significant differences in
growth parameters between groups, or in PedsQL quality of life
scores, except for higher scores relating to psychological problems
with management in control subjects (P = 0.028).
Regarding the coeliac disease questionnaire, responders reported
difficulties in maintaining a strict gluten-free diet, and 70% found it
harder to manage coeliac disease than diabetes. 50% reported that
they would have liked more information about coeliac disease on
diagnosis. 80% did not know of any long-term complications
associated with coeliac disease. In no case was there evidence of
regular coeliac disease review during diabetic clinic. Compliance
with a gluten-free diet appeared to be 67%.
Conclusion: No conclusive significant differences in glycaemic
control, growth, or quality of life scores were found. However,
our results highlight the need for coeliac disease to be addressed in
more detail during clinic to determine which of these children need
more support. Patient and parent education regarding coeliac
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disease should also be addressed regularly to ensure compliance is
maintained.
P/109/FRI
Paediatric ONSET-Study: impaired QoL in children and
depressed mood in mothers at onset of DMT1 in
children
K. Lange1, R. Coutant2, T. Danne3, T. Kapellen4, E. Pankowska5,
B. Rami6, B. Aschemeier3, S. Blsig3, R. Hartmann3, N. Krug1,
E. Marquardt3, K. Walte3 & O. Kordonouri3
1Hannover Medical School, Medical Psychology, Hannover, Germany,
2Centre Hospitalier Universitaire, Dpartement de Pdiatrie, Angers,
France, 3Children's Hospital auf der Bult, Center for Pediatric
Endocrinology and Diabetology, Hannover, Germany, 4Universittsklinik
und Poliklinik fr Kinder und Jugendliche, Leipzig, Germany, 5Medical
University of Warsaw, Department of Pediatric Diabetology and Birth
Defects, Warsaw, Poland, 6Medical University of Vienna, Dept. of
Pediatrics, Vienna, Austria
Aims: The diagnosis of DMT1 is a significant burden for children
and parents. The psychological implications of the diagnosis and
their determinants were investigated in the first year after
diagnosis. This is a part of the pediatric ONSET-Study about
sensor-augmented pump-therapy in 5 European pediatric diabetes
centers. Data on mother’s well-being and children’s quality of life
(QoL) following the diagnosis will be presented.
Method: Prospective study with children (aged 1–16 years),
randomized within 4 weeks of DMT1-diagnosis. 160 children
(age: 8.7 ± 4.4 J.; 47.5% girls). Mother’s psychological wellbeing
was assessed by the WHO-5 questionnaire. Children’s QoL was
evaluated in children via KIDSCREEN-27- and by parents via
KIDSCREEN-27-proxy-questionnaires.
Results: The mean sum-score of mothers in the WHO-5 (negative–
positive: 0–100) was 46.3 ± 22.8 with 55.3% of mothers with a
sum-score £48 indicating depressed mood. The mothers of the
children <6 years were significantly more affected than those of
older children. 69% of mothers with children <6 years. showed
symptoms of a depressed mood. T-Values of the children’s QoL
scores (parents perspective) for physical wellbeing (39.4 ± 9.8),
psychological wellbeing (40.1 ± 10.7), social integration
(44.7 ± 13.9) and school (46.3 ± 12.7) were significantly lower
than the European norm data (each P < 0.01). Children rated
their QoL according their parents assessments. Mainly
physiological (41.5 ± 8.9) and psychological wellbeing
(44.4 ± 10.7) were significantly impaired compared to European
norm data. After adjusting the data according to children’s age
there were no significant differences between the five diabetes
centers.
Conclusion: The high psychological burden of mothers, especially
of those with young children and the impaired Quality of life of
children diagnosed with diabetes underline the importance of an
integrated medical and psychosocial care in the first phase of
coping with the chronically disease.
P/110/FRI
Intensifying insulin treatment in type 1 diabetes:
evaluation over 10 years in 8176 children and
adolescents attending diabetes camps
J.-J. Robert1, I. Redon1, P. Taupin2 & M. Cahan3
1Universit Paris 5 - Hpital Necker - Enfants Malades, Diab	te de
lEnfant et de lAdolescent, Paris, France, 2Universit Paris 5 - Hpital
Necker - Enfants Malades, Laboratoire de Biostatistiques, Paris,
France, 3Aide aux Jeunes Diabtiques, Paris, France
Objectives: To establish a precise classification of insulin regimens
in children and adolescents with type 1 diabetes; to describe their
evolution over 10 years and the correlation with HbA1c, in a large
representative national sample of patients.
Patients and methods: The data base of the national association
which organizes diabetes camps allowed evaluating 8176 children
and adolescents (age 12.8 + 2.7 year, diabetes duration
5.2 + 3.4 year) at admission in summer camps between 1998 and
2007 (707–896/year). From the raw data including the type of
insulin (rapid, long and premixed; human or analog) at the several
times of the day (breakfast, lunch, afternoon, dinner, bedtime), 823
different combinations were found (128–216/year) and they could
be classified in 166 types of regimens (50–73/year), and 6 major
groups: <2 injections, 2 injections (3 subgroups), 2 injections plus
extras (3 subgroups), 3 injections (premixed and unclassified),
basal-bolus and pump.
Results: Over 10 years, the main changes were: shift from human
insulin to analogs; decrease of 2 injections from 42 to 19%; drop of
premixed from 21 to 4%; decrease of unclassified from 30 to 15%;
increase of basal-bolus from 13 to 48%, and of pump from <1 to
13%; changes depended on age and diabetes duration. Mean yearly
HbA1c varied from 8.24 to 8.53%. HbA1c was significantly higher
with regimens using exclusively premixed insulins, but there were
no differences between the other regimens (multivariate analysis).
HbA1c showed a significant but minor decrease, by 0.02% per
year, but the decrease was similar with premixed and other
regimens.
Conclusion: A major trend in intensifying insulin treatment in
children and adolescents with type 1 diabetes has been
accompanied by a modest improvement in HbA1c. No insulin
regimen has shown any better results, except over premixed
insulins.
P/111/FRI
Ethical concern of predictive newborn screening: a
utilitarian perspective
K.A. Robinson-Vincent
University of Toronto, Lawrence S. Bloomberg Faculty of Nursing,
Toronto, Canada
Background: Newborn screening tests for metabolic, endocrine,
and hematologic disorders currently present in infants (Kenner &
Moran, 2005; Green, Dolan, & Murray, 2006). Predictive newborn
screening has become widespread and tests for conditions that may
develop in the future.
Issue: WHO argues that newborns should be screened at risk for
developing widespread preventable disorders and whose costs of
treatment would be greater than those of screening. From a
utilitarian perspective, family members and healthcare providers
must anticipate potential risks and benefits for each alternative
action to identify the morally required or ‘‘ethical’’ action
producing the best outcomes (Rodney, Burgess, McPherson, &
Brown, 2004). Despite potential benefits of predictive newborn
screening, significant ethical issues arise: (1) limited predictability
of testing, (2) psychosocial risks, and (3) lack of prevention or
treatment available.
Conclusions: As a result of limited predictability and difficulty
ascertaining severity of tested conditions, there are no guarantees a
serious illness will develop. Further, children face several
psychosocial risks. Lastly, there may be lack of preventative
measures or treatment for diseases identified through screening.
Because of these ethical challenges, the utility of family members,
their children, and healthcare providers is reduced as a result of
predictive newborn screening.
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P/112/WED
Pediatric diabetes in an underserved area of central
India: challenges and discrimination
N. Agrawal1 & S. Agrawal2
1G. R. Medical College, Medicine, Gwalior, India, 2G. R. Medical
College, Obstet & Gynec, Gwalior, India
This paper reports on the Free Insulin Project for children with
type 1 diabetes in central India. 28 children and adolescents aged 2
to 22 years, including 20 boys and 8 girls, have enrolled in the
project. Of the 24 patients aged >6 years, 9 (37.5%) reported
missing their monthly visits more than 3 times in the preceding
year. These included 4 boys (25%) and 5 girls (62.5%), for reasons
varying from ‘‘insufficient money’’ (100%), ‘‘adults busy in
agricultural work and not available to accompany me’’ (55.5%)
and ‘‘school/ job pressures’’ (44.4%). The patients reported a high
level of discrimination at home, school and in society. All reported
verbal abuse (unwanted sympathy) by members of extended and
nuclear family. 8 boys (50.0%) and 6 girls (75.0%) reported verbal
abuse (scolding, taunting) by family members. All reported feeling
unwanted at some time or the other. 6 boys (37.5%) and 2 girls
(25%) were reported short temper ness. In the school, 6 boys
(37.5%) and 2 girls (25.0%) reported verbal abuse by classmates. A
significant percentage of respondents (25% boys, 37.5% girls)
reported verbal abuse at the hands of neighbors or religious
leaders. Of the 24 patients, 17(12 boys, 6 girls) had missed insulin
doses more than 10 times in the preceding 3 months. Many of them
did so because the insulin supply was inadequate to last the
months. 10 boys (62.5%) and 4 girls (50.0%) preferred premixed
insulin twice daily, as they did not like to inject themselves in
school. The rest were on basal - bolus regime. Only 2 boys (12.5%)
practising SMBG, 2–3 times a week. HbA1c estimation had been
done more than once in the preceding year for 8 boys (50.0%) and
3 girls (37.5%). This paper highlights the challenges and discrim-
ination faced by children with diabetes in Central India, and
focuses on the efforts being made by the diabetes care team to
provide quality care in an underserved area of the world.
P/113/WED
Is there a relationship between insulin regimen and
dietary intake in adolescents with type 1 diabetes?
V. Pais, I. Burkot, J. Buccino & D. Daneman
Hospital for Sick Children, Endocrinology, Toronto, Canada
Current literature indicates that adolescents with type 1 diabetes
(T1D) consume a diet high in total fat, saturated fat and
cholesterol, and low in fruit and vegetables and fibre. At present,
there is scarce information available describing the relationship
between insulin regimen and dietary intake in this population. This
study aimed to investigate and compare the impact of 3 insulin
therapies: three injections daily (TID), multiple daily injections
(MDI) and continuous subcutaneous insulin infusion (CSII) on
dietary intake of teens with T1D. We hypothesized that those on
MDI and CSII would be consuming more sucrose and carbohy-
drate (CHO) while those on TID would have higher intake of fat
and protein.
Results: Ninety-seven subjects between the ages of 14–18 years
were recruited during bi-weekly outpatient diabetes clinics and via
phone calls to eligible participants. Dietary intake information was
collected using the validated Youth/Adolescent Food Frequency
Questionnaire (Harvard School of Public Health), and analyzed for
Energy, CHO, Sucrose, Fibre, Protein, total fat, and saturated fat.
No significant differences were found between the groups on any of
the nutrients studied using ANNOVA. Calories P = 0.30,
carbohydrates P = 0.13, protein P = 0.71, fat P = 0.69,
sucrose P = 0.06, fibre P = 0.46. Univariate and
multiregression analysis with the independent variables was
performed and no significance was found. These data indicate
that the choice of insulin regimen is not a major factor in predicting
dietary intake.
P/114/WED
Explaining the relation between diabetes support and
diabetes stress in adolescents: the influence of
diabetes care autonomy, gender and age
J.A. Malik & H.M. Koot
VU University, Developmental Psychology, Amsterdam, Netherlands
Objective: Earlier reports (Malik & Koot, 2009, under review)
suggest that diabetes care adherence reduces diabetes stress and
enhances diabetes control, while diabetes stress impairs diabetes
control. Although diabetes support seems to enhance adherence, it
simultaneously increases diabetes stress. This study aims to explain
why. An established model indicating an important role of
diabetes-related stress in diabetes control (Malik & Koot, 2009)
was revised and adolescents autonomy was introduced as a
mediator between diabetes-specific support and diabetes stress.
Method: The study included 11–19 years old youngsters with type
1 diabetes. A total of 437 adolescents (54.8% girls; mean age
14.7 years; mean diabetes duration 6.1 years) participated in the
study. Metabolic control was assessed by measuring A1c and
adolescents filled out questionnaires during their visits in their local
clinics. Questionnaires for family members were sent and returned
by mail. Each hypothesis was tested using Amos version 7.0. Multi-
group analysis was conducted on the final model to test
generalizability of the model across gender and age.
Results: The final model presented good fit indices (i.e.,
X2(df = 19) = 37.19, GFI = 0.98, CFI = 0.96, RMSEA =
0.047) retaining all the existing regression paths significant.
Autonomy appeared to mediate between diabetes support and
diabetes stress, Diabetes support was related to reduced autonomy.
However, while increased autonomy was related to reduced
diabetes stress in boys and older adolescents, it was related to
increased diabetes stress in girls and younger adolescents. Diabetes
autonomy itself was strongly related to age (r = 0.64, P = 0.01).
Conclusion: Adolescent autonomy is the typical developmental
issue which explains the negative effect of diabetes-specific support
on diabetes-related stress for some groups, and thus should be
considered in development of treatment regimens.
P/115/WED
The impact of diabetes and celiac disease in the
quality of life in children and adolescents
M. Pugliese, F. Zani, B. Predieri, P. Appio, P. Bruzzi, G. Vellani, A.R. Di
Biase, R. Berri, F. Balli & L. Iughetti
University of Modena and Reggio Emilia, Pediatrics, Modena, Italy
Chronic diseases affect the quality of life (QOL), but no general
agreement exists on the relationship between the severity of the
disease and the QOL. On the other hand, few are data comparing
QOL in different chronic disease in the same clinical setting.
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Aims of the study were: 1) to investigate general and health related
QOL of children with diabetes (T1DM) and in patients with coeliac
disease (CD) 2) to compare the QOL in these 2 groups of patients.
We studied 67 outpatients: a) 35 with T1DM [(12 male: aged
13.0 ± 3.1 year; 23 female: aged 13 ± 2.8 year; mean duration of
T1DM 61 ± 47 months)], b) 32 with CD [(8 male: aged
10 ± 2.9 year; 24 female: aged 9 ± 2.6 year, mean duration of
CD 53 ± 38 months)] using the Paediatric Quality of Life Inven-
tory (PedsQL), a self-administered questionnaire. The PedsQL
Generic Core Scales is designed to measure health-related quality
of life (HRQOL) with 23 items subdivided in 4 scales (physical,
emotional, social, school). In T1DM patients we measured the
degree of metabolic control by glycated haemoglobin and in CD
patients the diet compliance with dietetic recall and laboratory
markers. T1DM patients showed a satisfactory metabolic control
(HbA1c 8.0 ± 0.87%). Twenty five out of 32 CD patients showed
a strict dietetic control. Considering the different items inside each
group we demonstrated that in T1DM patients the major concern
is related to emotional functioning, while in CD group school
functioning was the most impaired. Surprisingly children with CD
had a significantly lower QOL related to social functioning than
T1DM ones (P = 0.005). The same result was found for school
functioning. No difference was found for physical/emotional
functioning. These data disagree with common opinion that
children with CD have a better adaptation and functioning,
because the disease is generally considered less severe than diabetes.
It is conceivable that a multisciplinary approach to patients with
T1DM can be responsible for this difference.
P/116/WED
The efficacy of a group therapy program for teens with
elevated HA1c levels
L.A. Kaminsky & M.N. Watts
Alberta Children's Hospital, Diabetes Clinic, Calgary, Canada
The present study reports results from a group therapy program
for adolescents with poorly controlled diabetes and their parents.
Past research has identified that psychological treatments involving
motivational interviewing approaches appear promising in improv-
ing glycemic control in teens with diabetes, but are in need of
further research. Twelve adolescents (8 males and 6 females)
between the ages of 13–17 years (M = 15.1 years, SD = 1.4) with
poorly controlled diabetes attended an 8 week therapy group
informed by motivational interviewing and cognitive behavioral
approaches. Participants had been diagnosed with diabetes for
6.5 years on average (SD = 2.7) and had a mean Ha1c level of
11.61 (SD = 1.90) prior to their attendance in the group.
Adolescent’s self-reports regarding, self-efficacy, quality of life,
family support, symptoms of depression and their readiness,
confidence and level of importance placed on improving their
diabetes care were collected prior to their participation in the
group, at the end of eight group sessions and at two months follow-
up. Results indicated that the importance teen’s placed on
improving their diabetes care [t (11) = -3.17, P = 0.004] and
their self-efficacy regarding their diabetes care [t (11) = -3.75,
P = 0.003] increased from pre-group to the end of the group
sessions. Teens had a significant decrease in HA1c levels from pre-
group to follow-up 2-3 months after the end of the group sessions [t
(10) = 2.42, P = 0.036). Data from a therapy group in progress
involving 9 additional participants will also be included in the
presentation. Strategies around engaging adolescents and their
families in group processes will be discussed. In conclusion, the
study¢s results suggest that the described group therapy program
appears to be a useful approach in improving teens¢ Ha1c levels,
motivation and self-efficacy regarding their diabetes care.
P/117/WED
Is the factual nutritional intake of children and
adolescents with type 1 diabetes concordant to the
general recommendations? observation in a small
cohort in Austria
J. Kçhle, D. Meraner, E. Ruetzler, P. Gruenberger, B. Meisinger &
S.E. Hofer
Medical University of Innsbruck, Department of Pediatrics, Innsbruck,
Austria
Objective: The aim of this study was to evaluate the nutritional
intake of children and adolescents with type 1 diabetes and to
compare the factual intake to current ISPAD recommendations.
Daily intake of all nutrients was documented for 7 consecutive days
and retrospectively analyzed for the amount of carbohydrates,
protein and fat.
Methods: 62 children and adolescents with type I diabetes were
invited to report their daily nutritional intake over a week and were
asked to answer a questionnaire on their eating behavior. Based on
these self reported data the daily intake of carbohydrates, proteins
and fat was calculated and compared to the general nutritional
guidelines for young patients with type 1 diabetes (ISPAD
Consensus Guidelines).
Results: 25/62 (48% male, 52% female) questionnaires and
nutritional records were available for analysis. Mean age of this
cohort was 13.0 years (±4.3), mean diabetes duration was 4.3 years
(±2.8) andmeanHbA1c was 7.7% (±0.6). Intake of carbohydrates
was higher than recommended, 195.8 g/day (±49.5) vs. 130 g/day
(P < 0.0001), so was the intake of proteins 66.9 g/day (±18.8) vs.
39.7 g/day (±11.9) (P < 0.0001). Fat intake was lower than
recommended in the guidelines 19.1%/day (±27.7) vs. 30–35%/day.
Conclusions: The amount of carbohydrates was significantly higher
than suggested in the recommendations, sowas the intake of protein.
The elevated protein intake might be explained by a preference of
carbohydrate-free food intake in terms of snacks with sausages,
cheese and meat in Austria. The intake of fat was significantly
reduced in the observed group. This observation shows that the
factual nutritional intake is not concordant with the
recommendations. A widely spread information about nutritional
guidelines with well informed doctors and dietitians will result in a
higher level of awareness among young patients with type 1 diabetes.
P/118/WED
Diabetes care in Swedish schools – a national survey
S. Srnblad1, L. Berg2, I. Detlofsson1, . Jçnsson3 & G. Forsander4
1University Hospital rebro, rebro, Sweden, 2Sçdra 
lvsborgs
Hospital, Bors, Sweden, 3Swedish Diabetes Association, Stockholm,
Sweden, 4The Queen Silvia Children¢s Hospital, Gothenburg, Sweden
Objective: The aim of this national multi-center study was to
investigate the perceptions of diabetes care in school reported by
children and adolescents with type 1 diabetes and their parents.
Methods: Children that had completed preschool class or some
grade in the nine-year compulsory school during spring semester
2008 were asked to participate in this study. Data were collected
using separate questionnaires for the children and their parents. All
pediatric diabetes centers in Sweden (total population 7712 patients
with mean HbA1c 7.18%; Mono-S standard) were invited to
participate in the study. Each centre was asked to consecutively
include 5% of the diabetic population at their centre during
ordinary outpatient visit.
Results: Out of 44 eligible centers 41 were able to participate. The
participating centers represented 97% of the total pediatric diabetic
population. 317 children and adolescent and 323 parents answered
the questionnaires. The mean age of the patients was
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11.4 ± 2.7 years and HbA1c was 6.9 ± 1.2% (approximately
7.9%; DCCT standard). Continuous subcutaneous insulin
infusion was used by 37% of the participating children. 54% of
all children and adolescents did not have any school personal that
had the principal responsibility for the diabetes care during school
time. 50% of the parents believed that the knowledge about
diabetes care was to low among the teachers. 21% of the parents
gave regularly less insulin than needed in the morning because of
fear of hypoglycemia during school time. 40% of the children were
not sure if they could get help from school personal in case of
hypoglycemia.
Conclusions: This nation-wide study demonstrates serious
deficiencies in the support of self-care management to children
and adolescents with type 1 diabetes in Swedish schools. The lack
of support could lead to impaired school performances because of
increased time with hyperglycemia and consequently lower mental
performances.
P/119/WED
Quality of life of siblings of a child with type 1 diabetes
E. Goethals1, D. Verbrugghe2, T. Havermans1 & K. Casteels1
1University Hospital Leuven, Department of Pediatrics, Leuven,
Belgium, 2Katholieke Universiteit Leuven, Leuven, Belgium
Objectives: Diabetes is an illness that affects the whole family. To
date, little is known about the quality of life (QoL) of siblings of
children with type 1 diabetes: this study reports on siblings QoL
and the association between QoL and diabetes severity.
Methods: Thirty eight siblings (6–18 years, 23 boys) completed the
Child Health Questionnaire (CHQ-CF 87, Landgraf et al., 1999)
which includes 12 QoL domains. Siblings QoL was compared to
QoL ratings of a Belgian reference group. HbA1c-value and time
since diagnosis were noted.
Results: Siblings scored significantly higher on most QoL domains
compared to the reference group (e.g. less Bodily Pain, fewer
Behavioral Problems and higher Self-Esteem). No gender or age
effects were found. Higher HbA1c values were related to lower
scores on Family Activities (r = -0.38, P < 0.05). Time since
diagnosis was related to higher scores on Physical Functioning
(r = 0.44, P < 0.05) and General Health (r = 0.44, P < 0.01).
Conclusions: Siblings reported a good QoL, in many (7/12)
domains better than their peers. Lower scores on family related
domains may be due to the impact diabetes has on day to day
family functioning, especially for those families where diabetes
regulation is more of a challenge (higher HbA1c). The finding that
ratings on some QoL domains were higher with increasing time
since diagnosis may indicate that siblings adjust over time. As
siblings often play a supportive role for their brother/sister, future
studies should further investigate the impact of diabetes on siblings
and the association between illness severity and QoL. These data
may help to define the need for support for siblings.
P/120/WED
Effective treatment of hypoglycaemia in children with
type 1 diabetes: a randomised controlled clinical trial
L. McTavish1 & E. Wiltshire2
1Capital and Coast District Health Board, Diabetes and Endocrinology,
Wellington, New Zealand, 2University of Otago, Paediatrics, Wellington,
New Zealand
Effective treatment of hypoglycaemia in children with type 1
diabetes (T1D) is essential, but has a limited evidence base. Some
treatments patients choose (eg. jellybeans) may be less effective
than glucose. We hypothesised that glucose tablets would be most
effective in children with T1D and aimed to compare 4 common
treatments for hypoglycaemia in a randomised trial during a
diabetes camp. Written informed consent was obtained. Camp
leaders were trained in administering the research protocol and
used cross-calibrated blood glucose meters. Hypoglycaemia was
defined as blood glucose <4 mmol/l. We compared 4 treatments -
glucose tablets, jellybeans, orange juice and Mentos dragees. An
equivalent dose of glucose was calculated for each patient for each
treatment (0.3 g glucose/kg) and provided to each leader. Treat-
ment was randomly assigned for each episode of hypoglycaemia
using a sealed envelope. Glucose was measured at time 0, 2, 5, 10
and 15 minutes. If hypoglycaemia persisted treatment was repeated
and glucose measured at 25 minutes.
191 episodes of hypoglycaemia were recorded in 38 children (1–12
episodes per child), with 2 episodes excluded because of protocol
violations. Blood glucose at 15 minutes (P = 0.026) and change in
blood glucose at 10 (P = 0.034) and 15 (P = 0.005) minutes were
significantly different between treatment groups, with jellybeans
producing the lowest and slowest response. Glucose tablets
produced the greatest response, but did not differ significantly
from juice or mentos dragees. Repeat treatment was more often
needed with jellybeans (P = 0.058). Jellybeans are significantly less
effective treatment for hypoglycaemia than the other three treat-
ments. Mentos dragees are of similar efficacy to glucose tablets or
liquid glucose and are more palatable. Treatment with 0.3 g/kg of
glucose (in all but the jellybean group) effectively resolved
hypoglycaemia in most children, with 15 minutes often required
to normalise blood glucose.
P/121/WED
Evaluation of a combined blood glucose monitoring and
gaming system for motivation in children and young
adults with type 1 diabetes (T1DM)
M. Halvorson1, E. Cruz2, M.E. Riordan3, C. Varma4, H. Schachner5,
S. Pardo6, M. Viggiani5, J. Wallace7, J. Yu6, J.L. Parkes7, J. Aisenberg3,
T. Bailey4, F. Kaufman1 & G. Klingensmith2
1Childrens Hospital Los Angeles, Los Angeles, USA, 2Barbara Davis
Center, Aurora, USA, 3Hackensack University Medical Center,
Hackensack, USA, 4AMCR Institute, Escondido, USA, 5Bayer
HealthCare, Diabetes Care, Medical Affairs, Tarrytown, USA, 6Bayer
HealthCare, Diabetes Care, Clinical Trials Division, Statistics,
Tarrytown, USA, 7Bayer HealthCare, Diabetes Care, Clinical Trials
Division, Tarrytown, USA
Hypothesis: The coupling of a blood glucose (BG) meter and
gaming system (Bayer’s DidgetTM) designed to reward points for
short and long term BG testing based on the frequency of testing
and measured BG values would be clinically accurate and perceived
as motivating in BG home management.
Methods: The performance and acceptability of the system was
evaluated after IRB approval and informed consent/assent was
obtained. 147 subjects, 4–24 years old, with T1DM were enrolled
and completed one in-clinic visit; 58 subjects also participated in a
home-use test for 3–5 days.
Results: Accuracy was assessed for subjects by comparing subject
meter results to the health care professionals (HCP) meter results,
and for subjects ‡13 years, to YSI values obtained from deep finger
puncture. Subject and HCP values showed significant correlation,
R2 = 0.96, (n = 143); as did subject and YSI results, R2 = 0.94,
(n = 78). Two samples were taken both by the subject and the
HCP to evaluate precision. The correlation coefficient between
subject and HCP values was 98% (n = 286 samples) and between
subject and YSI values was 97.16% (n = 156 samples). CV was
5.9% and 7.2% for subject- and HCP-generated results,
respectively. 99% of points fell in the A or B range of the Parkes
error grid using YSI as the reference.Surveys were taken after
subjects played the game with the meter and game cartridge
connected to a Nintendo DS Lite in clinic and in a subset of
subjects at home.The majority (61.2%) of patients agreed or
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strongly agreed that the combined meter system would motivate
them to test their blood sugar more often and that it fulfilled a need
in diabetes management (53.3%) to enhance motivation.
Conclusion: An innovative BG meter system with connectivity to a
gaming system designed for youth was shown to be clinically
accurate and likely able to motivate children to monitor their blood
sugar levels more often, a key aspect required for effective T1DM
management.
Poster Session II: Diabetes Care, Education,
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HbA1c-values in 38750 Patients with pediatric onset of
type-1 diabetes: cross-sectional relationship to
demographic variables and longitudinal tracking from
diabetes onset to adulthood – results from the
German-Austrian multicenter DPV initiative
W. Sauseng1, M. Borkenstein1, J. Rosenbauer2, J. Herwig3, A.
Lemmer4, S.E. Hofer5, M. Holder6, J. Etspler7, A. Neu8 & R.W. Holl9
1Medical University of Graz, Department of Diabetes and
Endocrinology, Graz, Austria, 2Heinrich-Heine University of Dsseldorf,
German Diabetes Centre, Dsseldorf, Germany, 3Johann Wolfgang
Goethe-University of Frankfurt, University Children's Hospital,
Frankfurt, Germany, 4Medical Center of Erfurt, Department of
Pediatrics, Erfurt, Germany, 5Medical University of Innsbruck,
Department of Pediatrics, Innsbruck, Austria, 6Olgahospital,
Department of Pediatrics, Stuttgart, Germany, 7Altona Children¢s
Hospital, Department of Pediatric Diabetology, Hamburg, Germany,
8University of Tuebingen, University Children¢s Hospital, Tuebingen,
Germany, 9University of Ulm, Department of Epidemiology, Ulm,
Germany
Objectives: Metabolic control is a major issue in the longterm care
in patients with type-1 diabetes. Only few studies follow patients
longitudinally from a pediatric onset of diabetes until adulthood.
Methods: The DPV initiative is based on a computer-software for
standardized, prospective documentation of relevant quality
indicators for the process and outcome of diabetes care. Data are
collected in each treatment center, anonymized and analyzed
centrally. Inconsistent data are reported back to the centers for
correction. By March 2009, 299 centers (6 Austrian, 293 German)
contributed 601319 individual HbA1c measurements in 38750
patients with pediatric diabetes onset (mean age at onset:
8.74 years). The MOM-method was used to mathematically
adjust HbA1c-values to the DCCT normal range.
Results: Based on a cross-sectional analysis, the median HbA1c
during the most recent year was significantly related to gender
(adjusted mean +0.14% in females), age (<5 years: 7.9%, 5–
10 years: 7.8%, 10–15 years: 8.1% 15–20 years: 8.4%, >20 years:
7.8%), diabetes duration, migration background as well as various
aspects of insulin therapy. Metabolic control improved significantly
in the last 14 years (1995: 8.15%, 2008: 7.9%). After adjustment for
patient selection, center size and type, an additional 12% of HbA1c
variability was accounted for by center heterogeneity. 3520 patients
were followed from a pediatric onset of diabetes until adulthood. In
patients with diabetes onset <10 years, after adjustment of year of
manifestation, gender,migrationbackground,BMI, insulin therapy,
diabetes duration and treatment center, HbA1c during the first year
was a significant predictor ofHbA1c during adulthood (P < 0.005),
while HbA1c at onset was not (P = 0.93).
Conclusions: This extensive study on a large number of pediatric
patients with type-1-diabetes confirms relevant demographic
variables related to metabolic control, as well as tracking of




The effect of severe hypoglycemia and metabolic
control on academic skills in children with early onset
type 1 diabetes
R. Hannonen1, J. Komulainen2, R. Riikonen3 & T. Ahonen4
1Kymenlaakso Central Hospital, Department of Child Neurology, Kotka,
Finland, 2National Institute for Health and Welfare, Helsinki, Finland,
3University of Kuopio, Kuopio, Finland, 4University of Jyvskyl,
Department of Psychology, Jyvskyl, Finland
Objectives: In children with type 1 diabetes, early onset of illness is
associated with cognitive deficits. Also episodes of severe
hypoglycemia and poor metabolic control may have an influence
on cognitive development, but the previous results have been
controversial. Academic skills have been studied less than cognitive
functions, although deficient academic skills affect school
achievement and future possibilities of the children. This study
assesses the effects of early onset diabetes (EOD), severe
hypoglycemia (SH) and metabolic control on academic skills.
Methods: The study included 63 children with type 1 diabetes onset
before the age of 5 years and 92 control children without diabetes.
All the children were 9–10 years of age. Within the diabetes group,
37 had experienced SH (SH+ group) and 26 had avoided SH (SH-
group). The mean HbA1c during illness was the measure of
metabolic control. The children were assessed with the tasks of
reading, spelling and mathematics in the third grade at school.
Statistical analyses included ANCOVAS and correlation analysis.
Results: Both groups with EOD performed significantly poorer
than the control group in spelling accuracy, and SH- group was
significantly poorer than the control group in mathematics. Poorer
metabolic control was associated with poorer spelling accuracy. SH
was not negatively associated with academic performance.
Conclusions: Early onset of diabetes can adversely affect the
development of academic skills. In children with EOD, SH is not
associated with deficiency, but poorer metabolic control is
associated with less accurate spelling. However, it is possible that
diabetes complications may have interactive effects on cognitive
development, and it is therefore important to avoid extreme
fluctuations of plasma glucose.
P/125/FRI
Social discrimination against young people with
diabetes: using the bogardus social distance scale
N. Agrawal1, S. Kalra2 & S. Agrawal3
1G. R. Medical College & J A Griou of Hospitals, Medicine, Gwalior,
India, 2Bharti Hospital, Karnal, India, 3G. R. Medical College, Obstet &
Gynec, Gwalior, India
This multicentric, non interventional study was carried out to
quality the social discrimination faced by young people with
diabetes in north and central India. The Bogardus Social Distance
Scale, using vignettes based on diabetes, insulin-requiring diabetes
and tuberculosis, was used to assess social discrimination in three
cohorts: children with diabetes (n = 20; 14 male), first degree
relatives (aged >18) of children with diabetes (n = 50; 25 male),
and OPD patients, aged >18 years who had no family history of
diabetes (n = 50; 25 male). This scale measures social distance on
a scale of 1 to 7, with social discrimination being directly
proportional to the Bogardus score, and can be modified for any
social or clinical situation. An informed verbal consent was taken
from all respondents. Children rated the social distance for diabetes
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as 1.0 ± 0.0, for insulin requiring diabetes as 1.0 ± 0.0, and for
tuberculosis as 1.8 ± 0.63.
Relatives of children with diabetes rated social distance for diabetes
as 1.0 ± 0.0, for insulin-requiring diabetes as 1.8 ± 0.64, and for
tuberculosis as 2.1 ± 0.74. The control group ofOPDpatients rated
the social distance for diabetes as 1.0 ± 0.0, for insulin-requiring
diabetes as 2.1 ± 0.74, and for tuberculosis as 2.3 ± 0.68. All adult
respondents were specifically asked to assess the social distance for
insulin-requiring boys with diabetes, and insulin-requiring girls with
diabetes. The social distance was rated as 1.5 ± 0.53 for boys and
2.3 ± 0.82 for girls by relatives. OPD patients, rated the distance as
2.1 ± 0.74 for boys and 2.5 ± 0.71 for girls.
This exploratory study reveals the high level of social discrimina-
tion that insulin-requiring diabetes patients, especially girls, face in
a traditional society such as India.
P/126/FRI
The impact and management of type 1 diabetes in the
school setting in Italy: a survey of the parents¢ and
teachers¢ perceptions
L. Comerlati1, S. Zaffani1, L. Pinelli1, M. Cappa2, V. Carboniero3,
F. Cerutti4, V. Cherubini5, F. Chiarelli6, G. Chiumello7, M.I. Colombini8,
A. La Loggia9, P. Pisanti10, M. Vanelli11 & R. Lorini12
1Regional Center for Juvenile Diabetes - Department of Mother and
Child, Biology-Genetics, Section of Pediatrics, University of Verona,
Verona, Italy, 2Diabetes and Endocrinology Unit Bambino Ges
Children's Hospital - IRCCS, Roma, Italy, 3Medipragma, Roma, Italy,
4Paediatric Unit University of Torino-SCDU Diabetology, Torino, Italy,
5Paediatric Unit - University of Ancona, Ancona, Italy, 6Paediatric Unit,
``G.DAnnunzio'' University, Chieti, Italy, 7Paediatric Clinic S.Raffaele
Hospital University of Milan, Milano, Italy, 8Paediatric Department
Ospedale San Raffaele - Vita -Salute, University of Milan, Milano, Italy,
9Paediatric Diabetes Unit - Health Service N.2, Caltanissetta, Italy,
10Diabetes Committee of Italian Ministry of Health, Roma, Italy, 11Dept
of Paediatric University of Parma, Parma, Italy, 12Paediatric Clinic,
University of Genoa, G. Gaslini Institute, Genova, Italy
Objectives: This project was born in Italy as an investigation of
aspects emerged during the DAWN YOUTH PROJECT. This
study was designed to determine – how Italian parents and teachers
of 6–13 year-old children with type 1 diabetes manage diabetes
during school hours; - the responsibilities and training of school
staff regarding diabetes.
Methods: The study was made of a qualitative phase, followed by a
quantitative one, conducted through a semi-structured
questionnaire filled in by parents of children with diabetes who
attend primary or secondary schools and teachers and/or board
school staffs of the same types of schools.
Results: A total of 220 parent and 52 teacher questionnaires were
completed. For 43.6% parents diabetes had negatively influenced
school activities. For 31.9%of elementary school parents and 21.1%
of middle school parents there are some difficulties for school staff
with diabetes (underestimation, poor knowledge, shirking
responsibility, refusal of self-management of children). There is
very rarely a nurse present at school for insulin injection (3.6%) or a
teacher who will take responsibility for the treatment (2.9%). Most
of parents (55.9%) stated that school hadno fridge to storeGlucagon
or that they didn’t know if the school was equipped. Few teachers
(14.9%) answered they would resort to using Glucagon for an
urgency. Only 40.4% of teachers stated that they had received any
specific training, in 33.3% by the Diabetic Unit personnel.
Conclusions: Parents responses reflect insecurity with the care
available in school and indentify some problematic areas, like as
insulin injection and Glucagon use. Teachers appeared to feel
unsure about how to help children in daily management and
how to react in case of a serious hypoglycemia. The training of
school staff is unusual: both parents and school operators
expressed a need for training from qualified diabetes health care
professionals.
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The ''Edinburgh Sick Kids High HbA1C policy'' –
implementation, 1 year outcomes and comparison with
a historical control group
E. Johnston1,2, K. Noyes1, L. Marshall1, M. Ferrand3, H. Richardson1 &
L. Bath1,4
1Royal Hospital for Sick Children, Diabetes and Endocrinology,
Edinburgh, UK, 2Simpson Centre for Reproductive Health, Neonatal
Transport Service (South East Scotland), Edinburgh, UK, 3NHS Lothian,
eHealth, Edinburgh, UK, 4University of Edinburgh, Child Life and Health,
Edinburgh, UK
Objectives: To determine whether a formalised policy for
managing high HbA1c (>10%) improves glycaemic control.
Methods: A formal policy was introduced in Aug 2007 for all
children (£14 year) whose HbA1c was >10% at a clinic visit. The
policy involved a written and agreed management plan at week 0,
weekly phone contact, and staff review with repeat HbA1c at 6 &
12 weeks. If HbA1c remained >10%, with <1% decrease from
the initial HbA1c, a 5-day hospital admission was arranged. A
bespoke computer system was developed to facilitate auditing the
policy. HbA1c results were recorded while on policy and for 1 year
off policy. Data for patients with high HbA1c prior to initiation of
policy was obtained as a historical cohort. No other new policies
were introduced within this time period. No patients were exempt
from inclusion.
Results: From Aug 2007 until Mar 2009, 39 children had been
commenced on the policy and completed 1 year follow-up. Four
were admitted. Data for 27 historical controls was obtained for
comparison. Compared with the controls, there were no significant
difference (SD) in age, gender or time interval between samples for
Initial and 1 year HbA1c.
Conclusions: A formalised intervention for children with high
HbA1c appears to show significant and sustained improvement in
diabetes control at 1 year.
Fig.1 shows the results of all children commenced on the policy. A
SD (P < 0.001, z = -4.31) was found between the initial and
1 year result in the new policy group and not in the historical
cohort (P = 0.09, z = -1.694).
Figure 1. HbA1c (%) at set time points (Median/IQR).
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P/128/FRI
The ''diabetics'' software in adjusting prandial insulin
in patients treated with insulin pumps. the results of
RCT study
M. Blazik, A. Szypowska, D. Golicka, L. Groele & E. Pankowska
Medical University of Warsaw, Department of Paediatric Diabetology
and Birth Defect, Warsaw, Poland
Objectives: Postprandial hyperglycaemia due to errors made in
prandial insulin titrating results in elevated HbA1c and diabetes
complications. The aim of the study was to determine whether the
‘‘Diabetics’’ software as a tool in prandial insulin dosing
considering carbohydrate (CU) and fat-protein (FPU) units
influences postprandial glucose level in patients with type 1
diabetes treated with continuous subcutaneous insulin infusion
(CSII).
Methods: This 3-month, randomized, open-label study included 48
children, aged 1–18 years (mean age 11 ± 3.8) from outpatient
clinic of the Medical University of Warsaw. Patients were educated
in food counting with CU and FPU taken into account in prandial
insulin dosing and than subsequently, randomly allocated to the
experimental group (GA) which used the ‘‘Diabetics’’ programme
and group B (GB) which used caloric tables. The unpaired t-test
with Welch correction was used for statistical analysis.
Results: We noticed significant differences in glycaemia profile
including pre- and 2-hours post main meals glucose level between
groups. The significantly lower postprandial glycaemia values were
noted in GA after every main meal: results of post breakfast, lunch
and dinner mean glucose level (mg/dl) in GA vs. GB were:
148.0 ± 71.8 vs. 159.5 ± 84.7; P < 0.0001; 131.5 ± 68.8 vs.
149.9 ± 83.9; P < 0.0001; 132.1 ± 66.7 vs. 158.8 ± 90.8;
P < 0.0001, respectively. Despite the relevant lower values of
postprandial glycaemia, we did not observe statistically significant
differences in HbA1c levels and insulin requirement between
groups at the end of study (HbA1c 6.78% ± 0.9 in GA and
6.93% ± 0.73 in GB). Moreover, in GA 86.7% of children and
parents implement diabetics in daily practices.
Conclusions: Introducing the ‘‘Diabetics’’ and strategy of CU and
FPU in prandial insulin dosing results in improving postprandial
glucose level in children treated with CSII.
P/129/FRI
Diabetes camps in the phase of transition: adolescents
quality of life, metabolic control and satisfaction with
long-term care
K. Lange1, H. Sassmann1, C. Ziegler2, R. Landgraf3 & T. Danne2
1Hannover Medical School, Medical Psychology, Hannover, Germany,
2Children's Hospital auf der Bult, Center for Pediatric Endocrinology
and Diabetology, Hannover, Germany, 3Ludwig-Maximilians-Universitt,
Medizinische Klinik, Klinikum Innenstadt, Mnchen, Germany
Aims: Satisfaction with diabetes care, quality of life, diabetes-
related psychosocial burden and metabolic control of adolescents
and young adults were assessed during two German nationwide
camps for young people in 2006 and 2008.
Methods: A total of 409 participants of CAMP-D 2006 and 437
participants in 2008 aged 16–25 years. completed psychological
questionnaires (WHO-5; PAID; satisfaction with diabetes care (6-
point-rating scale with maximum = 1) and measurement of
HbA1c (DCA2000+). 129 young people participated in both
camps.
Results: Almost all participants were on intensified insulin therapy
with proportion of CSII increasing from 37% (2006) to 47%
(2008) (P < 0.01). At both camps mean HbA1c was 8.3 ± 2.0%
(37% / 40% of participants HbA1c <7.5%). Diabetes-related
psychosocial stress scored low (PAID total: 19.7 ± 13.6 vs.
22.1 ± 13.7; P > 0.1), in contrast overall psychological
wellbeing (WHO-5) was poor (mean 14.6 ± 4.6 vs. 14.7 ± 4.7;
P > 0.1). Multivariate analysis revealed systematic relationships
between HbA1c and subjective well-being and diabetes related
stress (each P < 0.05). All three variables were significantly related
to educational level and parents marital situation (divorced or
living together). Diabetes care was assessed positive (score each:
1.8 ± 1.0), psychosocial care (scores 2.6 ± 1.4 / 2.4 ± 1.2) was
less satisfying. In 2008, the 129 repeaters reported more motivation
in diabetes therapy, better diabetes specific self esteem and less
worries about their future as a result of CAMP D 2006.
Conclusion: Despite good equipment and qualified care, only
37% / 40% of the nationwide samples achieved the therapeutic
goal of HbA1c <7.5%. In one third of the young people subjective
emotional well-being was poor. Correspondingly, the participants
mentioned deficits in psychosocial care. A more personalized
concept of care that integrates the whole psychosocial situation and
burden of young people should be aspired. This multi-professional
team concept of pediatric care should be extended to young
adulthood.
P/130/FRI
Psychological well-being among youth with diabetes
and parents in the dawn youth study
M. Peyrot1,2, K. Lange3, T. Danne3, L. Deeb4, H.-J. Aanstoot5 &
S. Skovlund6, DAWN Youth Survey Group
1Johns Hopkins University, Medicine, Baltimore, MD, USA, 2Loyola
College, Baltimore, USA, 3Hannover Medical School, Hannover,
Germany, 4University of Florida, Gainesville, USA, 5Diabeter Diabetes
Center, Rotterdam, Netherlands, 6Novo Nordisk A/S, Copenhagen,
Denmark
Objectives: This study assessed the psychosocial and health care
factors associated with psychological well-being among young
adults with diabetes and parents of children/adolescents with
diabetes.
Methods: Data are from internet surveys of independent national
samples of: (1) parents (PA) of children/adolescents (age 0–18) with
diabetes (N = 4099) and (2) young adults (YA; age 18–25) with
diabetes (N = 1905) conducted for the multi-national Diabetes
Attitudes, Wishes and Needs (DAWN) Youth Study.
Psychological well-being was assessed by the WHO-5
(scores = 0–100). Multiple regression was used to assess the
significant (P < 0.05) independent associations with WHO-5,
controlling for country of residence and demographic and disease
characteristics.
Results: Among YA, WHO-5 was higher for respondents who
reported greater understanding and support from their health care
providers, higher satisfaction with friend support or family support
had higher WHO-5. Respondents reporting more successful
diabetes-specific coping had higher WHO-5; this association was
stronger than other factors in this model. Among PA, WHO-5 was
higher for respondents who reported more integrated diabetes care,
greater understanding and support from their health care
providers, and who participated more in decisions about their
child’s diabetes care. Respondents reporting higher satisfaction
with friend support or work support had higher WHO-5.
Respondents reporting more diabetes-specific burden (financial
and diabetes management responsibilities), worry about
complications and parent-child conflict over diabetes care had
lower WHO-5; the association with burden was stronger than other
factors in this model.
Conclusions: Many young adults with diabetes and parents of
children/adolescents with diabetes have less than optimal
psychological well-being. Most of the identified risk factors for
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poor well-being are modifiable and suggest promising strategies for
improving psychological well-being.
P/131/FRI
Coping mechanisms in adolescents with diabetes
S. Kalra1, A. Unnikrishnan2, A. Ahalawat3, S. Saluja4 & N. Agrawal5
1Bharti Hospital, Endocrinology, Karnal, India, 2Amrita Institute of
Medical Sciences, Endocrinology, Kochi, India, 3Bharti Hospital,
Clinical Research, Karnal, India, 4Bharti Hospital, Dietetics, Karnal,
India, 5Medical College, Gwalior, India
This multicentric, noninterventional study was done to assess
coping mechanisms utilized by adolescents with diabetes, and their
correlation with gender, glycemic control and duration of diabetes.
A total of 40 adolescents aged 13 to 18 formed the study group,
while 84 adults comprised the control. The Cognitive Emotion
Regulation Questionnaire (CERQ), 2006 was used to quantify
coping mechanisms. This questionnaire assesses 9 different coping
mechanisms. Subjects were divided into two groups, one showing
above average or higher degree, and the other showing average or
lower, of utilization, for each mechanism. The percentage of
subjects exhibiting above average or higher degree of each strategy
was taken for analysis. Adolescents were more likely to exhibit
positive mechanisms such as acceptance (65.00% vs. 47.61%),
refocusing (70.00% vs. 47.61%), refocusing on planning (55.00%
vs. 36.90%), and reappraisal (65.00% vs. 55.95%). Self blame and
other other-blame were much less common in adolescents (5.00%
each) than their adult counterparts (40.47% and 22.61%). Signif-
icant gender differences were noted in the study cohort. Boys
(n = 22) had higher rate of acceptance (81.81% vs. 44.44%).and
refocusing on planning (63.63% vs. 44.44%) than girls (n = 18).
Other-blame and self blame was noted only in adolescents residing
in urban areas, while rumination and catastrophizing were more
common in subjects from upper socioeconomic strata. This study
highlights the coping mechanisms used by adolescents, and the
effect of gender, residence and socioeconomic status in coping. This
can help plan individualized programmes for training in coping
skills for adolescents with diabetes.
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My Diabetes Playbox: a psychoeducational tool for
young children with diabetes
D. Koller1 & C. Shadd2
1Ryerson University, Early Childhood Education, Toronto, Canada,
2Hospital for Sick Children, Toronto, Canada
Objectives: Research has shown that engagement in self-care
around disease management needs to begin at an early age.
However, a recent study found that young children with Type 1
diabetes have very limited knowledge about their disease (Koller,
Daneman, Barrett & Small, in press, 2009). Hence, without
adequate knowledge regarding their disease, young children are
inhibited from engaging in self-care and medical decision-making
from an early age. The purpose of this presentation is to emphasize
the significance of providing adequate information regarding
diabetes to young children and to present a new and innovative
educational resource called: ‘‘My Diabetes Playbox’’. This tool is
specifically designed to address the learning needs of young children
with diabetes while encouraging self-care and emotional expression.
Methods: Following a review of study findings (Koller, Daneman,
Barrett & Small, in press, 2009), a team of health care professionals
from a large outpatient clinic and an early childhood educator
collaborated to design a developmentally appropriate tool for use
in educating young children with diabetes.
Results: Three key areas for education were identified. They
include: basic knowledge regarding diabetes, issues related to
appropriate self-care activities, and emotional and social support.
Conclusions: ‘‘My Diabetes Playbox’’ has been designed for use by
diabetes educators and parents of childrenwith diabetes. Sample kits
will be distributed to a number of clinics across Ontario (ON),
Canada.A research studywill evaluate the tool from the perspectives
of key stakeholders. In addition, ISPADconference attendeeswill be
asked toprovide informal feedback for further refinementof the tool.
It is hoped this resourcewill make a valuable contribution to the area
of diabetes education in paediatrics.
P/133/WED
The transfer of the young diabetic from paediatric to
adult diabetes service: the role of ''Caronte''
S. Chiaravalli1, I. Franzetti2, G. Bianchi1, A. Saporiti1, C. Costantini1 &
A. Salvatoni1
1Paediatric Clinic - University of the Insubria, Varese, Italy, 2Diabetes
Service - Ospedale di Circolo, Varese, Italy
Objectives: The transfer from paediatric to adult diabetes service
often results in 29–71% drop-out leading to deterioration of
metabolic control and complications (Kipps, Diabet Med, 2002).
We report our experience on transferring by a procedure agreed
upon the two services involved.
Methods: A total of 22 patients with T1D (14 M, age 21–33 years;
median 24.5 years) with duration of disease of 5 to 19 years, were
transferred from the paediatric to the diabetic adult clinic. A clinic
run by a single diabetologist (IF) and dedicated to the follow-up of
young diabetics was set up in the diabetic adult service. As the
paediatric service the young adult one was equipped with capillary
HbA1c test, software for downloading glucose monitoring
machines and computerized clinical records with the whole past
clinical history. The task of a paediatric diabetologist (SC),
jokingly called ‘‘Caronte’’ (see Dante Alighieri, Divina
Commedia), consisted in the following steps: a) set up the last
visit in the paediatric service explaining the transferring procedure,
b) introduce the patients to the colleague of the adult service at the
first examination, c) check the regular attendance of the patient to
the following two appointments, d) evaluate drop-out rate and
administer an evaluation questionnaire during the 4th visit. Role of
‘‘Caronte’’ was also to contact patients who did not attend the
visits for obtaining explanations.
Results: At present, after two years from the start of the project, 22
patients have completed step a) and b), 20 patients have completed
step c), 15 patients have completed the phase step d). Three patients
dropped out (14%), 2 after the 1st visit and 1 after the 3rd one.
Metabolic control didn’t change significantly during transfer.
Conclusions: In our experience the role of ‘‘Caronte’’ and the
availability of a diabetic clinic for young adults are crucial in
limiting the drop-out. A final judgment on the reliability of our
transfer procedure and patients satisfaction requires the
completion of the process.
P/134/WED
Is school a barrier to intensification of insulin therapy
in children with type 1 diabetes?
C. Sturrock, V. Ramsay, S. Bluff, M. Leslie & V. Alexander
Tayside Children's Hospital, Department of Child Health and
Paediatrics, Dundee, UK
Objectives: To review the use of insulin therapy in school by
children and adolescents with Type 1 Diabetes (T1D) in Tayside
and North East Fife, Scotland.
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Background: Current guidance (NICE, ISPAD) states that
intensive insulin therapy (IIT) be offered to children and young
people with T1D. This requires a lunchtime insulin dose. In the UK
there is reported resistance to this insulin regimen, particularly for
primary school (5–12 years) children.
Methods: We reviewed the number of children in our clinic on IIT
and estimated the number of episodes of insulin administration in
schools across four education authorities, in the last year. To
implement IIT an individualised management protocol is drawn up
(as per national guidance*) written jointly by parents, Paediatric
Diabetes Specialist Nurses (PSDN) and school staff. The PDSN
role is flexible, involving education of school staff using 1 to 1, or
group work. Schools delegate staff to perform duties. Emphasis is
on communication, reassurance on legal aspects and reducing need
for staff to make clinical decisions. Health advice is available from
PDSN via phone (office or mobile).
Results: A total of 215 children of 230 (93%, aged 3–18 years) were
on IIT (n = 182MDI; n = 33 CSII) including 67 of 73 (92%) aged
3–12 years (March 2009). The area has 242 schools of which 127
had input from PDSN because of at least 1 child with diabetes. In
addition the 9 youngest children attend pre-school nurseries. In the
last year there were c.43 000 episodes of insulin administration in a
nursery/school setting. There were no adverse events.
Conclusion: With a detailed, individualised education and support
programme for parents, pupils and school staff, IIT (MDI or CSII)
can be delivered successfully and safely in schools, with no extra
health staff on site. National Guidelines assist in policy
implementation. Over the next year we intend to assess how
insulin is administered in schools in detail.
*Administration of Medicines in Schools Scottish Executive 2001.
P/135/WED
The persistence of mood and posttraumatic stress
disorders among mothers of diabetic children and its
impact on their children's glycemic control: results of a
pilot prospective follow-up study
C. Kanaka-Gantenbein1, I. Kosteria1, D. Bastaki1, K. Pantelidou2,
G. Chrousos1 & M. Liakopoulou2
1University of Athens, First Department of Pediatrics, Athens, Greece,
2University of Athens, Department of Child Psychiatry, Athens, Greece
Objective: Mood and posttraumatic stress disorders (PTSD) have
often been reported among parents of diabetic children affecting
their children’s glycemic control. Aim of this study was to
investigate the presence and persistence of depression, anxiety
and PTSD among mothers of diabetic children and their impact on
their children’s diabetes.
Methods: The sample consisted of 123 children (54 boys), aged
10.9 ± 4.2 years, 51 newly diagnosed, 72 with long-standing
diabetes, all followed at the Diabetes Center of the First
Department of Pediatrics of Athens University. The mothers
mean age was 37.9 ± 6.6 years. Questionnaires used were the 17-
item PTDS scale, the Beck Depression Inventory (BDI), the
Spielberger’s modified Greek state-trait anxiety inventory (STAI)
and a Major Life Events one. Mothers of long-standing diabetics
filled the questionnaires once; mothers of newly diagnosed ones
filled them 1 and 6 months after diagnosis.
Results: State, depression and PTSD were significantly and
positively inter-correlated (correlation coefficients from 0.37 to
0.67, P < 0.001), indicating that greater PTSD levels are
accompanied with greater levels of depression and anxiety. A
significant negative correlation was found between PTSD and BDI
scales with mothers age (r = -0.22, P = 0.023 and r = )0.20,
P = 0.038, respectively), suggesting that younger mothers had
more severe impairments. A significant negative correlation was
found between PTSD and duration of disease (r = )0.23,
P = 0.046), indicating that mothers of newly diagnosed children
had more PTSD. On follow-up of newly diagnosed diabetics,
HbAIc reduction from baseline to 6 months was significantly
correlated with state (r = 0.69, P = 0.028) and PTSD (r = 0.75,
P = 0.012) at 6 months, indicating that better glycemic control is
associated with reduction of psychological burden.
Conclusions: Depression, anxiety and PTSD are frequent among
mothers of diabetic children, may persist over time aggravating
their children’s glycemic control.
P/136/WED
Predicting health and functional outcome from
psychological functioning at diagnosis with type 1
diabetes
A. Lin1, E. Northam1,2,3, D. Rankins1, P. Anderson1,3, G. Werther2 &
F. Cameron2
1Murdoch Childrens Research Institute, Melbourne, Australia, 2Royal
Children's Hospital, Melbourne, Australia, 3University of Melbourne,
Melbourne, Australia
Objectives: Caring for youth with type 1 diabetes by minimizing
psychosocial morbidity can be facilitated by early identification of
those at highest risk of poor psychosocial and metabolic outcomes.
Method: Participants: 123 (mean age 8.3) children recruited at
T1DM onset. 106 (mean age 20.5) were reassessed 12 years later.
Baseline measures: Parent-reported measures of family function
(FACES), parental psychopathology (GHQ), child temperament
(EAS) and child behaviour and emotional well-being (CBCL).
Follow-up measures: Self-reported current psychological function
(YSR/YASR), psychological distress (K6), and neurotic
personality (EPQ).
Results: Poor family cohesion was associated with increased
anxiety, withdrawal, thought problems and overall internalising
problems (P = 0.000) 12 years post diagnosis. Reduced family
adaptability was related to aggression (P = 0.041). There was a
strong relationship between behaviour problems at baseline and
psychological symptoms at 12 years – internalising, externalising,
aggression, anxiety, withdrawal, somatic concerns (P = 0.000),
attention, delinquency and thought problems (P < 0.05). High
emotionality of the child at diagnosis predicted externalising
behaviour problems at follow-up. There were no significant direct
associations between child temperament or psychological
functioning, parental psychopathology or family functioning at
diagnosis, and subsequent metabolic control. There was a trend
(P = 0.057) for those who reported a referral to mental health
services to have a poorer metabolic control history.
Conclusion: Behaviour problems and lower family cohesion at
diagnosis were associated with poor psychosocial outcome. The
trend for those requiring mental health services to have poorer
metabolic control suggests an indirect relationship between
psychological status at diagnosis and health outcome. The
established relationship with hospital care provides the perfect
opportunity for intervention with children and families at risk.
P/137/WED
5 mm needles in children and adolescents are
remarkably well tolerated, reliably inject into
subcutaneous fat and have minimal leakage at doses
up to 60 Units
P.L. Hofman1, T. Pinto1, R. Tehranchi2, M. Donsmark2, C. Jefferies1,
F. Mouat1 & W.S. Cutfield1
1University of Auckland, Liggins Institute, Auckland, New Zealand,
2Novo Nordisk, Copenhagen, Denmark
Objectives: Inadvertent intramuscular (IM) injections of insulin in
children and adolescents are common and cause variability in
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glycaemic control. While shorter needles reduce IM injections,
concerns about dermal injections and insulin leakage have been
raised. The aim of this study was to assess the injection technique
most reliably delivering insulin into subcutaneous (SC) fat using
NovoFine 5mm 32G needles.
Methods: Subjects had 8 injections of air (200 ml); 4 into the
lateral thigh and 4 into the abdomen using either angled or vertical
insertion and using either a pinched skinfold or no skinfold.
Immediately after each injection an assessment of injection depth
was made by ultrasonography. At a separate visit 20, 40 or 60 units
of test medium were injected using the same techniques into the
thigh and abdomen. Leakage was assessed by blotting the injection
site and weighing filter paper.
Results: A total of 117 children (age 6–19 years, 52% male, BMI
14.4–38.3) were recruited. The least IM injections occurred in
pinched angled abdominal injections (2%) and the highest in
unpinched vertical thigh injections (12%). IM injections were
associated with reduced SC fat thickness (P < 0.0001), BMI
(P < 0.0001) and male gender (P < 0.001). There was only one
dermal injection. No clear preference for injection technique was
shown, although the abdominal site was preferred over the thigh
(P = 0.01). The overall pain score was compared to a previous
study (n = 56) using 6 and 8 mm needles. The 5 mm needles were
much less painful (1.51 ± 0.5 cm vs. 2.51 ± 1.2 cm and
2.85 ± 1.6 cm for 6 and 8 mm needles respectively, P < 0.001).
Leakage studies using 20U (n = 102), 40U (n = 25) and 60U
(n = 45) of test medium showed similar and minimal loss equating
to less than 0.5U of insulin.
Conclusions: Angled insertion and pinched skinfold minimizes the
risk of IM injections. NovoFine 5 mm needles were much less
painful than longer needles and we recommend this length in all
children for insulin administration.
P/138/WED
Does parental perception of their child's quality of life
and diabetes knowledge matter in relation to improving
glycaemic control?
G. Elizabeth, J. Lovlin & M. Verghese
Hull Royal Infirmary, Hull, UK
Objectives: The purpose of this study is to evaluate the difference
between self assessed diabetes-specific QOL scores in children and
young adults when compared to parents. To ascertain the
relationship between parental knowledge of diabetes and
glycaemic control in children.
Methods: A total of 100 children and young adults aged 2–
17 years, with type 1 diabetes and their parents were handed
validated diabetes specific-PedsQL 3.0 questionnaires.Hba1c was
used as an indicator of glycaemic control. Parents of 48
participants completed the Modified ADKnowl [Audit of
Diabetes Knowledge] questionnaire.
Results: Mean HbA1c levels were 9.5 + 1.68%. The lowest mean
PedsQL scores were found in the 5–7-year old age group. Parental
scores were significantly lower (P < 0.01) compared to their
child’s. Fathers produced higher mean scores compared to
mothers. Both children and parents describe ‘‘going low’’ as the
most worrisome symptom. ‘‘Sticking to the diabetes plan’’ and
needle related pain has been rated as hurdles faced by children in
the treatment barrier scale. Mothers rate ‘‘tracking carbohydrates’’
and ‘‘taking insulin injections’’ as problematic in treatment
adherence. No relationship was found between parental
knowledge scores and their level of education. Glycaemic control
in children was not related to the education level of the parents.
Index of multiple deprivation scores in this population did not
show any effect on quality of life.
Conclusions: Diabetes related QOL was lower in parents of
children with diabetes compared to their children. Parental
knowledge of self management of diabetes is solely not enough.
Interventions aiming to improve outcomes in this population
should not only focus on disease related outcomes but also on
coping strategies for the family.
P/139/WED
A systematic, nationwide study of diabetes team
resources in paediatric departments
S. J. Kummernes1, T. Skrivarhaug1, C. Brunborg2, H. D. Margeirsdottir1
& K. Dahl-Jørgensen1, The Norwegian Childhood Diabetes Registry
1Oslo University Hospital, Ullevl, Pediatric Dept., Oslo, Norway, 2Oslo
University Hospital, Ullevl, Center for Clinical Research, Oslo, Norway
Aims: To assess the multidisciplinary resources allocated to
different paediatric departments treating diabetes in Norway and
the relation to key clinical outcome data. In 2007 The Norwegian
Diabetes Association recommended per 100 children: 1 full time
diabetes nurse educators, 1 fulltime consultant, one half-time
dietician, psychologist in 40% position and social worker in 20%
position.
Methods: Norway has a national surveillance childhood diabetes
registry. Each year all patients perform a systematic examination
according to WHO Basic Information Sheet. In 2007, 1853 patients
from all 26 departments participated, comprising more then 85%
of all patients in the country. HbA1c was measured in one central
laboratory for all patients. In a special data entry sheet was
registered: 1) number of different professions in each diabetes team,
2) how the team was organized, 3) number of children treated. To
secure the quality the data sheets were followed up with a phone
interview.
Results: A general nationwide deficit in resources was detected. 11/
26 departments had ‡100 children with diabetes. Only 36% (4/11)
of these hospitals had a multidisciplinary diabetes team. 15/26
departments had <100 children with diabetes. 53% (8/15) of these
hospitals had a diabetes team. A great variation in staffing was
detected: 4 (15%) departments had no dietician, 11 (42%) had no
psychologist, 7 (27%) had no social worker. Only 12/26 (46%) of
the departments had a multidisciplinary diabetes team according to
the recommendation. Mean HbA1c from all hospitals was 8.4%
(Hospital range 7.8–8.9%). Only 33% of the patients reach the
HbA1c target of 7.5%. However no significant difference in HbA1c
was found whether the centres has a defined diabetes team or not.
Conclusions: Less than half of the paediatric departments had
multidisciplinary diabetes team as recommended. Lack of
resources may contribute to that only one third of the patients
reach treatment goals of blood glucose control.
P/140/WED
''Check Your Health'' test of an instrument that
measures perceived health, quality of life and burden of
diabetes in young people with diabetes
G. Viklund
Uppsala UniversityUniversity, Medical Sciences, Uppsala, Sweden,
Astrid Lindgrens Children's Hospital, Stockholm, Sweden
One purpose with diabetes care in young people with diabetes is,
referring to ISPAD Consensus Guidelines 2007, to optimize health
and quality of life (QoL). Those Guidelines do also recommend
that: ‘‘assessment of developmental progress in all domains of QoL
should be conducted on a routine basis’’.
Objectives: The aim of this study was to test part 1 of the
instrument ‘‘Check your health’’ for reliability and validity in
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teenagers with diabetes. Part 1 measures ‘‘self-reported health’’ and
‘‘burden of diabetes’’, while part 2 measures self-care and
empowerment. The instrument is constructed as vertical
thermometer scales, and is fast and easy to complete.
Methods: A convenience sample of 204 teenagers, 12–17 years of
age, completed the questionnaires ‘‘Check your health’’ and
DisabKids when visiting the diabetes clinic. Forty-seven of 199
completed the questionnaires at home a second time, and mailed it
to the researcher.
Results: In the reliability test, the correlation between test and
retest was found to be satisfactory (0.94–0.62, except for social
burden, 0.41). Convergent validity was found to be moderate
(0.62–0.38), while the instrument showed good discriminant
validity, according to gender, metabolic control and disease
severity. The domain burden of diabetes turned out to be very
sensitive.
Conclusions: This study revealed that the first part of the
instrument ‘‘Check your health’’ showed clinical utility in
teenagers with diabetes. The reliability and validity tests of the
measure showed promising results in Swedish teenagers, and it can
probably be used in clinical settings. According to our results and
earlier studies one has to consider if the domain social burden
should be withdrawn. To further strengthen the convergent
validity, it should be compared to other QoL instruments, and to
obtain normative values, it has to be used in a larger context.
Keywords: Type 1 diabetes, adolescence, quality of life, health,
burden of diabetes.
P/141/WED
Diabetes UK, ACDC, BSPED and ABCD survey of
specialist paediatric and adolescent diabetes services
in the UK in 2008
C.A. Gosden1, K. Matyka2, J. James3, B. Turner1, P. Winocour4,
C. Walton5, D. Nagi6, R. Williams7, R.I.G. Holt8 & J. Edge9
1Diabetes UK, Healthcare Policy, London, UK, 2University Hospital,
Clinical Sciences Research Institute, Coventry, UK, 3University of
Leicester Hospitals NHS Trust, Diabetes Centre, Leicester, UK, 4QE11
Hospital, Welwyn, UK, 5Hull Royal Infirmary, Hull, UK, 6Pinderfields
Hospital, Edna Coates Diabetes & Endocrine Unit, Wakefield, UK,
7Swansea University, School of Medicine, Swansea, UK, 8University of
Southampton, Developmental Origins of Health and Disease Division
School of Medicine, Southampton, UK, 9Oxford Deanery Oxford
Children's Hospital, Postgraduate School of Paediatrics, Oxford, UK
Aims: To assess the provision of paediatric and adolescent diabetes
services in the UK and to compare changes in service delivery since
2002.
Methods: Questionnaires were sent to the lead paediatric
consultant from all identifiable UK paediatric and adolescent
diabetes services (n = 205). Questions were based on National
Institute for Health and Clinical Excellence (NICE) and Scottish
Intercollegiate Guidelines (SIGN) recommendations for diabetes
care in childhood. Results were analysed using parametric and
non-parametric tests and the framework approach for qualitative
data.
Results: 129 services (63%) returned questionnaires involving 220
clinics. Of these 70% offer newly diagnosed children and young
people with Type 1 DM a structured education programme. 95%
provide timely and ongoing opportunities to access information
about the development, management and effects of diabetes. 75%
always ensure HbA1c measurements are available at outpatient
clinics compared to 86% in 2002. All services offer multiple daily
injection regimens. 78% of services support insulin pump therapy,
of which 78% have a trained specialist team with, on average, 5
patients on a pump (median, range 0–69). 99% of services screen
for microalbuminuria and 100% screen for retinopathy compared
to 83% and 80% in 2002 respectively. Only 21% of clinics have a
psychological professional as an integrated member of the diabetes
team, compared to 20% in 2002. Services described lack of
resources to provide education, psychological support, dietetic,
nursing and medical time.
Conclusion: Paediatric and adolescent diabetes services are
challenged to provide high quality care in the context of rising
prevalence and increasingly complex insulin regimes. The
increased use of pumps will have implications for adult service
provision. Services have improved delivery in screening for
complications but the problem of inadequate psychological
support remains.
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The outcomes of cohorts in Japanese study group of
insulin therapy for childhood and adolescent diabetes:
the assessment by HbA1c standardization with JDS
master calibrators
M. Mochizuki1, J. Akatuka2, T. Kawamura3, N. Kikuchi4, T. Urakami5,
S. Sugihara6, N. Matsuura7, N. Sasaki2 & S. Amemiya2, Japanese Study
Group of Insulin Therapy for Childhood and Adolescent Diabetes:
JSGITCA
1Yamanashi University, Department of Pediatrics, Ymamanashi, Japan,
2Saitama Medial University, Saitama, Japan, 3Osaka City University
School of Medicine, Osaka, Japan, 4Yokohama City University Medical
Center, Yokohama, Japan, 5Nihon University School of Medicine,
Tokyo, Japan, 6Tokyo Women's Medical University Medical Center
East, Tokyo, Japan, 7Seitoku University, Tokyo, Japan
Objective: Since the Japanese Study Group of Insulin Therapy for
Childhood and Adolescent Diabetes (JSGITCA) has standardized
HbA1c numbers by JDS (Japan Diabetes Society) Master
Calibrators, we evaluated the changes of glycemic controls in our
cohorts.
Methods: In T1DM patients under 18-year old enrolled as the
2nd and 3rd cohorts in 2000 and 2008, respectively, A1C in 2nd
cohort was examined every 4 months. JDS Master Calibrators
have also IFCC A1C numbers. The A1C raw data at SRL were
evaluated and confirmed for standardizing accuracy by JDS
certified numbers in each period. In every season 4 patients
samples were measured at SRL and each institute. The validity of
each institute measurement was estimated by the absolute relative
difference (ARD). At the entry for 3rd cohort in 2008, A1C and
GA values were measured in patients and their non-diabetic
family members.
Results: (1) The average ARD of 23 times tests was 2.96 (0.26) %
(mean, SD), so that the measurement in each institute was well
standardized. (2) In the patients with their duration of 5 years or
more, A1C decreased in springs of 2002, 2006, 2008 in each years-
old group: 8–9 year old, 12–13 year old, 15–16 year old, as
follows: ex. the mean A1C in 12–13 year old, was significantly
decreased between 2002 and 2008, 8.07 (67.1) and 7.60 (62.2) in
JDS% (IFCC mmol/mol) numbers, respectively (P = 0.033). (3)
The mean A1C values as JDS% (IFCC mmol/mol) number were
8.10 (67.4) in spring, 8.01 (66.4) in summer and 8.18 (68.2) in
winter (P < 0.005). (4) The GA/A1C ratio was 3.2 (3.0–3.4)
(50 (25–75) %ile) in T1DM, significantly higher than 2.8 (2.7–2.9)
in family members. (5) In T1DM, GA showed a positive
correlation with A1C [A1C = 2.381 + 0.212 · GA (P <
0.0001, R2 = 0.0864)].
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Conclusions: We were able to show the improvement in A1C in
Japanese T1DM patients with seasonal changes in A1C value. The
simultaneous measurements of GA and A1C may be useful to
assess the degree of glycemic excursion and the trend in changes of
glycemic controls.
P/143/FRI
Type 1 diabetes mellitus: glycemic control and
complications in Turkish children and adolescents
D. Goksen Simsek1, Z. Aycan2, S. Ozen1, S. Cetinkaya3, C. Kara4,
S. Abali5, K. Demir6, . Tunc2, A. Ucakturk4, G. Asar1, F. Bas5,
E. Cetinkaya2, M. Aydın4, G. Karaguzel7, Z. Orbak8, Z. Siklar9,
A. Altincik6, A. Oktem7, B. Ozkan8, G. Ocal9, S. Semiz10, I. Arslanoglu11,
O. Evliyaoglu12, R. Bundak5 & S. Darcan1
1Ege University Faculty of Medicine Department of Pediatrics, Izmir,
Turkey, 2Dıskapi Education Hospital, Ankara, Turkey, 3Sami Ulus
Education Hospital, Ankara, Turkey, 4On Dokuz Mayis University
Faculty of Medicine Department of Pediatrics, Samsun, Turkey,
5Istanbul University Faculty of Medicine, Department of Pediatrics,
Istanbul, Turkey, 6Dokuz Eylul University Faculty of Medicine
Department of Pediatrics, Izmir, Turkey, 7Kardeniz Technical University
Medical Faculty Department of Pediatrics, Trabzon, Turkey, 8Ataturk
University Faculty of medicine Department of Pediatrics, Erzurum,
Turkey, 9Ankara University Faculty of Medicine Department of
Pediatrics, Ankara, Turkey, 10Pamukkale University Faculty of Medicine
Department of Pediatrics, Denizli, Turkey, 11Abant _Izzet Baysal
University Faculty of Medicine Department of Pediatrics, Bolu, Turkey,
12Kirikkale University Faculty of Medicine department of pediatrics,
Kirikkale, Turkey
Aim: To progress in the formation of a diabetes registry system
and to assess metabolic control, accompanying autoimmune
disease, chronic and acute complications of type 1 diabetic
children in Turkey a cross sectional, multi central study was
designed.
Material and methods: Metabolic control and complications were
described according to ISPAD consensus guidelines in children and
adolescents who were followed up in the year of 2007–2008.
Results: A total of 1032 type 1 diabetic children (50.5% female,
49.5% male) with a mean age of 12.5 ± 4.1 years and a mean
duration of diabetes of 4.7 ± 3.2 years were included. 32.1% of
the patients were prepubertal. When patients were grouped in
5 year age intervals according to age at diagnosis; 27.2% were
between 0–4.99 years, 42.5% were between 5 to 9.99 years and
27.9% were between 10 to 14.99 years and the rest was between 15
to 20 years. Mean HbA1c of the patients in the preceding year was
8.4 ± 1.6%. 30.5% of the patients HbA1c was <7.5, 32.6% was
between 7.5 and 9%, and 36.9% was >9%. 2.6% of the patients
had neuropathy, 1.4% had retinopathy, 5.4% had persistent
microalbuminuria and 0.3% had diabetic nephropathy. Mean
duration of diabetes and age of the patients with neuropathy,
retinopathy and nephropathy was significantly different than the
patients without complications (P < 0.01). Persistent
microalbuminuria and neuropathy was more frequent in pubertal
children than prepubertal children (P = 0.02 and 0.00). Twelve
percent of the patients had chronic lymphocytic thyroiditis, 0.1%
graves and 4.3% had celiac disease.5.2% of the patients had
ketoacidosis and 4.9% had severe hypoglycemia in the preceding
year.
Conclusion: One of the primary management goals in diabetes care
is to improve glycemic control, thereby limiting complications and
chronic conditions that arise secondary to the diabetes. Although
majority of the patients were using insulin analogues poor glycemic
control was common and chronic complications were seen.
P/144/FRI
Ketoacidosis in the diagnosis of type 1 diabetes
mellitus in Spain
M. Oyarzabal1, M. Chueca1, S. Berrade1, A. Sola1, R. Barrio2, B. Garcia3,
A. Gomez4, I. Gonzalez5, F. Hermoso6, M. J. Lopez7, C. Luzuriaga8,
I. Rica9, M. Rodriguez10 & M. Torres11
1Pediatric Hospital Virgen del Camino, Pamplona, Spain, 2Hospital
Ramn y Cajal, Madrid, Spain, 3Hospital Severo Ochoa, Madrid, Spain,
4Hospital Virgen del Rocio, Sevilla, Spain, 5Hospital La Paz, Madrid,
Spain, 6Hospital Clinico Universitario, Valladolid, Spain, 7Hospital
Clinico Universitario, Valencia, Spain, 8Hospital Marqus de Valdecilla,
Santander, Spain, 9Hospital Cruces, Bilbao, Spain, 10Hospital Miguel
Servet, Zaragoza, Spain, 11Hospital San Juan de Dios, Barcelona, Spain
Objetives: To identify the frequency and characteristics of
ketoacidosis (DKA) at onset of diabetes in children from 0 to
15 years of age between 2004 and 2008 at 11 paediatric diabetes
units.
Material and methods: Retrospective collection of data from case
reports on 1169 children (632 M/537 F) presenting diabetes
between 01/01/2004 and 31/12/2008. Mean age on diagnosis:
8 years (range 0.3–15). By age groups: 0-5 years, 25.7%; 5-
10 years, 46.2%; 10-15 years 28.1%.DKA as presenting
symptom is analyzed by age groups, gender, age at onset,
severity of DKA (ISPAD Consensus 2006–2007) and presence of
complications.
Statistical methods: chi-square, t-test, Anova.
Results: An increase is noted in the number of onsets of diabetes in
the course of the study (5%). DKA at onset in 39.5%, without
significant differences in the course of the study.The mean age of
those presenting DKA is significantly lower (7.4 ± 4.1 years of
age, P < 0.001). DKA in those under 5 years of age is 51.7%,
significantly greater than in the rest of the age groups (P < 0.01),
outstandingly so in those under 2 years of age (69%). Classification
of DKA (mild, moderate and severe) by age groups (<5 years/
>5 years), there is not significant differences (P > 0.05). There
has been no mortality and 3 related severe complications were
reported (1 cerebral oedema, 1 cerebral infarction and 1 femoral
vein thrombosis)
Conclusions: Type 1 diabetes continues to increase and the debut
with DKA is still very high in both number and severity. Following
the recommendations of the ISPAD, since January, 2009, this
Committee has been implementing the DKA prevention
programme at health centres, hospitals, schools and pharmacies.
Its results will be the subject of a forthcoming paper by this
Committee.
P/145/FRI
Prevalence of type 1 diabetes mellitus in children and
adolescents in Germany
J. Rosenbauer1, C. Bchle1, A. Stahl1, R.W. Holl2, M. Grabert2 &
G. Giani1, in cooperation with ESPED, DPV Initiative and German
Competence Network Diabetes mellitus
1German Diabetes Centre, Leibniz Centre at Duesseldorf University,
Institute for Biometrics and Epidemiology, Duesseldorf, Germany, 2Ulm
University, Institut for Epidemiology, Ulm, Germany
Objectives: Aim was to provide updated estimates on the
prevalence of type 1 diabetes based on the diabetes incicence
register of North Rhine-Westphalia (NRW), the most populous
German federal state.
Methods: Since 1996 newly diagnosed cases of Type 1 diabetes
have been ascertained with the North Rhine-Westphalian
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diabetes register by means of three data sources, the prospective
hospital-based active surveillance system ESPED, annual
inquiries among medical practices, and the computer-based
documentation system DPV founded for quality control and
scientific research in paediatric diabetes care. Completeness of
ascertainment was estimated by the capture-recapture-method.
Point and interval estimates (95%-CI) of prevalences (per
100 000 persons) were based on Poisson distribution. Age- and
sex-standardized prevalences were estimated by the direct
method. The effects of sex and age were assessed by Poisson
regression analysis.
Results: On 31.12.2007, 3946 and 6881 children and adolescents
with type 1 diabetes 0–14 or 0–19 years of age, respectively, were
registerd in NRW. The completeness of ascertainment was
estimated to be 98.6% (98.3–98.8%) and 98.1% (97.8–98.3%).
Prevalence estimates were 145.8 (141.3–150.4) and 184.3 (179.9–
188.7), respectively. Prevalences among boy and girls 0–14-years
old were quite similar (145.2 vs. 146.5, P = 0.799), a significant
male preponderance was observed in the age group 15–19 years
(292.0 vs. 260.7, P = 0.002). Prevalences in the age groups 0–4, 5–
9, 10–14, and 15–19 years were 34.2, 140.3, 248.1, and 276.7. In
Germany, there are approximately 16 400–17 400 (29 700–31 200)
children and adolescents with type 1 diabetes in the age group 0–14
(0–19).
Conclusions: At present, about 15 (19) out of 10 000 children
and adolescents in the age group 0–14 (0–19) have type 1
diabetes. Up to date diabetes prevalence estimates are a basic
requirement for the planning of public health resources of
diabetes care.
P/146/FRI
Frequency of type 1 diabetes mellitus in children and
adolescence in Ukraine
N. Zelinska1, V. Yakovenko2 & E. Globa1
1Ukrainian Scientifically Practical Center of Endocrine Surgery and
Transplantation of Endocrine Organs and Tissues, Kiev, Ukraine,
2Crimean State Medical University, Simferopol, Ukraine
Objectives: To determine a frequency of Type 1 Diabetes Mellitus
(T1DM) in children of different age groups as a part the tendency
of this state in the European countries.
Materials and methods: Target group: children 0–17 year old.
Methodology for selection: official statistical information on the
T1DM frequency in children in Ukraine during 2002–2007.
Results and conclusions: Approximately 1 child per 1000 children
(0–17 years old) has T1DM. During the analysis of different
geographical areas of Ukraine the phenomenon of west-east
‘‘gradient’’ was discovered. The frequency of T1DM per 10 000
is highest in eastern region and lowest in western region.
In Ukraine 7932 children 0–17 year old with T1DM were
registered in 2007. The greatest tendency of frequency growth
can be noticed in children 0–6 year old, that shows a trend toward
earlier age of onset.The frequency increases by 7% yearly on
average (from 1.1% in 2003 to 13.3% in 2005).
Also T1DM frequency raised in the age group 15–17 year old by
5% annually (from 1.7% in 2003 to 8.3% in 2006). Frequency
growth in 7–14 year old group and in a general group 0–17 remains
stable and increases only by 4% annually. The lowest frequency of
DM1 was determined in between 2003–2004. Because Ukraine is
5th in population in Europe the rise in T1DM suggests that the
European population in general is experiencing an increase in
T1DM.
P/147/FRI
Epidemiology of DKA in children and adolescents in
Moscow, 1996–2006
E.E. Petryaykina1, O.V. Dukhareva2, M.B. Antsiferov2, L.G. Dorofeeva2,
A.I. Novitskaya2, V.F. Pilyutik2, T.D. Mikhailova1, I.G. Rybkina1,
E.A. Pronina1, E.T. Mandzhieva3 & I.V. Garyaeva3
1Morozovskaya Children City Clinical Hospital, Endocrinology, Moscow,
Russian Federation, 2Moscow Endocrine Center, Moscow, Russian
Federation, 3Russian State Medical University, Moscow, Russian
Federation
Diabetic ketoacidosis (DKA) is the major cause of morbidity and
mortality in children with T1D. The challenge of urgent conditions,
regardless of how much time has passed since T1D was diagnosed,
is of great importance in Moscow region. The aim of this study was
to analyze the amount of children and adolescents suffering from
T1D and DKA in all severity degrees and stages of T1D. Data were
collected by Statistics Office of Moscow City Healthcare Depart-
ment. Incidence and prevalence of T1D and DKA in children of
Moscow region were analyzed. The incidence of T1D in Moscow is
rising, and slowly rising is the trend towards manifestation of T1D
through DKA. The rising trend in the amount of children and
adolescents suffering from T1D is less sharp than the trend of rising
in manifestations of T1D through DKA. The average annual
amount of new-onset T1D is 93 ± 14.5 children (5.1 ± 0.77% of
T1D patient 0–18 years). Average incidence of DKA is 50.6 ± 7.7
per 1000 T1D patients 0–18 years per year and 232.2 ± 31.9 per
1000 children and adolescents with new-onset T1D per year.
Among the patients with diagnosed T1D, 20.4 ± 6.5 DKA cases
are being reported each year. The number of children and
adolescents suffering from DKA has changed recently: from
72.75 ± 5.9 (50.5 ± 7.9 - 6.4% of them - were new-onset T1D
patients) in 1996–1999 and 90.5 ± 8.1 (54 ± 12.1 - 59.7%
new-onset) in 1999–2004 to 123.7 ± 20.5 (64.3 ± 14.7 - 52%)
new-onset in 2004–2006. Average percentage of children and
adolescents manifesting T1D through DKA is 61.4 ± 8.2%.Aver-
age annual rise of DKA incidence (per 1000 children and
adolescents with T1D) is 6 ± 1.1%.There is no significant increase
in DKA incidence in both new-onset (5 ± 11%) and diagnosed
T1D (4 ± 16%),calculated per 1000 patients per year. Annual
increase of DKA incidence in children and adolescents per 1000
patients per year is shown. Most of new-onset patients are being
taken to the hospital in DKA, so it’s necessary to increase
awareness of T1D in children, parents and doctors.
[T1DM frequency]
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Retrospective epidemiological study of patients
attended the pediatric outpatient clinic of national
institute of diabetes & endocrinology, Cairo, Egypt
M.H.M.F. El-Hefnawy1, A. Bassyouni2, I. Emara3 & A.I. Amin4
1National Institute of Diabetes & Endocrinology, Pediatric Department,
Cairo, Egypt, 2National Institute of Diabetes & Endocrinology, Internal
Medicine, Cairo, Egypt, 3National Institute of Diabetes &
Endocrinology, Biochemistry Department, Cairo, Egypt, 4National
Institute of Diabetes & Endocrinology, Clinical Pathology, Cairo, Egypt
The aim of this work was to do a retrospective epidemiological
study of the records of diabetic children attended the outpatient
pediatric clinic in NIDE. The files 0f 851 diabetic children were
examined retrospectively without any reference to the personal
data. Out of them, the files of 200 diabetic patients were also
studied for determination of chronic management results repre-
sented by the type of insulin regimen used and estimation of the
daily insulin dose per kg. We also assessed the outcome manage-
ment of acute ketoacidosis from the files of 200 patients admitted
to the ICU & inpatient departments. The results showed that there
is no statistical differences between male, (n = 424) to female,
(n = 427) distribution. The results of this retrospective study
showed that the mean age of onset of diabetes in children attended
the outpatient pediatric clinic of National Institute of Diabetes was
(mean = 8.37 ± 10.96 years). The present study showed also that
there was a decrease of age of onset of diabetes among diabetic
children as the age of onset between 5 and <10 years were the
highest percentage (46%). As regards the insulin regimen used by
the diabetic children, 17.5% used conventional insulin therapy,
11% used modified insulin therapy as they used regular insulin
before lunch, and 71.5% used basal-bolus insulin regimen. The
mean percentage of insulin unites per kgwas 1.00 ± 0.38 U/kg/day.
The mean BMI was = 24.54 ± 6.42, while the BMI distribution
was: 56% were with normal weight £ 25, 27% were overweight =
25 : < 30, 14% were obese = 30 : < 40 and only 3% were with
severe obesity where BMI ‡ 40. The study of control of diabetes
showed that the glycated HbA1c was <7% in 31%, 7–8% in 22%,
>8–9% in 14% and >9% in 33%. The above results showed also
that 13.0% of ketotic cases were with severe acidosis, 7.7% were
with moderate acidosis, and 32.4% were with mild acidosis.
P/149/FRI
The frequency of celiac disease in children and
adolescents with type 1 diabetes mellitus
K. Ulukan, A. Gven, P. Isguven & M. Yildiz
Gçztepe Educational and Research Hospital, Pediatric Endocrinology
Clinic, Istanbul, Turkey
Objective: Type 1 diabetes mellitus (T1DM) is associated with
celiac disease (CD). The aim of the study was to evaluate the
frequency for CD in our patients with T1DM.
Methods: Six hundred T1DM children were enrolled to the study.
The presence of CD was screened with IgA endomysial antibodies
(EMA), and IgA and IgG antigliadin antibodies (AGA) test.
Duodenal biopsy was performed to confirm CD.
Results: Seven patients (2 male, 5 female) were diagnosed CD. The
duration of diabetes was 76.5 ± 79.7 months and CD was
49.5 ± 37 months. At the diagnosis of CD patients had suffered
from malnutrition (n : 5), failure the thrive (n : 3), diarrhea (n : 4),
abdominal distension (n : 4), anemia (n : 2) and hypoglycemia
(n : 1). Weights of the patients before and after gluten-free diet
(GFD) were 24.2 ± 10 kg and 38 ± 15 kg. Heights of the patients
before and after GFD were 118.7 ± 24 cm and 137.9 ± 20 cm.
EMA was positive all patients. AGA IgA and IgG were positive in
five patients. Duodenal biopsy of the patients showed
intraepithelial lymphocytosis, villous atrophy, crypt hypertrophy
and increased chronic inflammatory cells in the lamina propria.
HbA1c of the patients before and after GFD were 9.5 ± 2.9% and
8.9 ± 2.8%. Daily insulin doses were increased after GFD
(0.78 ± 0.3 IU, 0.95 ± 0.3, respectively).
Conclusion: Screening for CD is performed particularly in patients
suffered from diarrhea, short stature and malnutrition in T1DM
population.
P/150/FRI
Seasonality of birth date, onset and autoinmunity of
children and adolescents with type 1 diabetes mellitus
L. Suarez-Ortega, R. Cardona-Hernandez, G.C. Jaimes-Parada &
M. Torres-Lacruz
Hospital Sant Joan de Du, Unit of Pediatric Diabetes, Barcelona,
Spain
Different studies have reported a seasonal pattern in type 1
Diabetes Mellitus (T1DM) showing the lowest incidence during the
warmer months and the highest incidence during the winter.
Aims: To establish in a cohort of children and adolescents with
T1DM the relationship between birth season and the frequency of
diabetes as well as the correspondence between seasonal variation
and elevated titles of antibodies respect to the onset of T1DM.
Methods: We analyzed the birth dates and the onset of 558
Caucasian pediatric subjects with T1DM in relation with the
distribution of seasons (spring, summer, autumn and winter).
Likewise, multiple comparisons were performed by ANOVA test
modified by Bonferroni regarding seasonality at diagnosis and the
onset and the positivity of glutamate decarboxylase autoantibody
(GAD), anti-tyrosine-phosphatase (IA-2) and b-cell-specific
autoantibodies to insulin (IAA) in patients where antibodies
determination at onset was available (n = 406).
Results: Thedistributionof cases of onset diabetes in our population
is similar in each of the seasons groups, as well as the distribution
obtained under the period of birth of these children. There were
no statistically significant differences between seasons, either global
or detailed. Statistically significant differences regarding the time
of the seasonal onset and positivity of antibodies were not present.
Conclusions: The pattern of seasonal fluctuations of diabetes was
not observed in epidemiological data of our sample. Knowing the
usual seasonal fluctuations and the peak incidence of T1DM in the
periods of autumn and winter, our study contrasts with those
argumenting these facts.
P/151/FRI
Mortality caused by DKA in children and adolescents of
Moscow, 1964–2008
E.E. Petraikina1, T.D. Mikhailova2, E.A. Pronina2, I.G. Rybkina2,
O.V. Dukhareva3, V.F. Pilyutik3, E.T. Mandzhieva4, I.V. Garyaeva4,
L.V. Demidova2 & A.P. Andreychenko3
1Morozovskaya State Clinical Hospital, Endocrinology, Moscow,
Russian Federation, 2Morozovskaya Children City Clinical Hospital,
Endocrinology, Moscow, Russian Federation, 3Moscow Endocrine
Center, Moscow, Russian Federation, 4Russian State Medical
University, Moscow, Russian Federation
Diabetic ketoacidosis (DKA) is the major cause of morbidity and
mortality in children with T1D.The challenge of urgent conditions,
regardless of how much time has passed since T1D was diagnosed,
is of great importance in Moscow region. The aim of this study was
to analyze lethality in children and adolescents with diagnosed
T1D in 1996–2006/ Data were collected by Statistics Office of
Moscow City Healthcare. Incidence and lethality rate in patients
with T1D were analyzed. The data were treated with Gaussian
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statistics. Mortality in children with T1D in Moscow in 1996–2005
was 0.12 per 100 000 children, and the only cause of their deaths
was DKA. The mortality rate is 0.1 ± 0.05% per year. According
to the latest Consensus Guidelines, mortality of 0.15–0.3% is
acceptable. In Moscow we have less lethal cases. The endocrinol-
ogy department of Morozovskaya Children City Clinical hospital
was established in 1964. The department is the center for urgent
endocrinology in Moscow. Up to 01.01.09, 15 963 patients were
treated in the department, 2586 of who were suffering from DKA
(16.2% from all the T1D patients of our department). Pitifully, 109
of them died (4.2%). Approximately 92% of all DKA cases in
Moscow become patients of our department (93.5% of DKA in
new-onset patients). Since 1976 we implement the methodic of
DKA treatment, developed by our doctors and based on the huge
experience we have. The share of lethal cases in overall amount of
treated DKA cases is going down since the department was
established: 26.9 ± 12.8% in 1964–1976, 4.5 ± 0.8% (6-fold
decrease) in 1977–1989 and 2.3 ± 1.2% (another 2-fold decrease)
in 1990–2008. The amount of lethal cases did not change
significantly, but the amount of treated cases increased. Mortality
in DKA cases remains a challenge of modern endocrinology. To
reduce mortality we should try to avoid DKA and at the same time
improve schemes of DKA treatment, and in both of these fields
further studies are needed.
Poster Session I: Diabetes Epidemiology II
P/152/WED
Extended family history of type 1 diabetes and its
effects on genotype and phenotype of children with
newly diagnosed type 1 diabetes
A. Mkinen1, T. Hrkçnen1, S. Ryhnen1, J. Ilonen2,3 & M. Knip1,4,
Finnish Pediatric Diabetes Register
1Scientific Laboratory, Hospital for Children and Adolescents, Helsinki,
Finland, 2Immunogenetics Laboratory, University of Turku, Turku,
Finland, 3Department of Clinical Microbiology, University of Kuopio,
Kuopio, Finland, 4Department of Pediatrics, Tampere University
Hospital, Tampere, Finland
Objective: To determine the prevalence of type 1 diabetes (T1D) in
1st and 2nd degree relatives of children with newly diagnosed T1D
and to characterize the effects of a positive family history on the
HLA genotype, signs of beta-cell autoimmunity and clinical
markers in the index case.
Methods: A total of 1488 children with T1D diagnosed under the
age of 15 years (median 8.2 year, 57% male) were included from
the Finnish Pediatric Diabetes Register. Data on family history of
T1D and metabolic decompensation at diagnosis was collected
using a structured questionnaire. Antibodies to beta-cell antigens
(GADA, IAA, IA-2A, ICA) and HLA genotypes were analyzed.
Results: 12.2% of subjects had a 1st degree relative with T1D
(father 6.2%, mother 3.2%, sibling 4.8%) and 12.0% an affected
2nd degree relative (6.0% from the paternal side, 6.5% from the
maternal). The fathers of children with a positive family history for
T1D carried a stronger HLA-conferred susceptibility (P < 0.001).
There were no differences in the signs of beta-cell autoimmunity
between familial and non-familial cases. Children without T1D in
their relatives had a longer duration of symptoms before diagnosis
(P = 0.011) and more often impaired consciousness at diagnosis
(P = 0.037) than those with an affected relative. In addition the
former had higher blood glucose (P < 0.001) and beta-OH-
butyrate levels (P < 0.001). They had also lower pH (P <
0.001) and more often ketoacidosis (P < 0.001) at diagnosis.
Conclusions: In accord with previous findings T1D was about two
times more common among fathers than mothers. The proportion
of index cases with an affected 2nd degree relative was similar to
that of children with an affected 1st degree relative. The higher
proportion of risk HLA genotypes in fathers of children with a
positive family history for T1D indicates that paternal HLA
genotypes contribute to the familial clustering of T1D. A positive
family history for T1D was associated with a milder metabolic
decompensation at diagnosis.
P/153/WED
Type 1 diabetes in a population-based cohort of Italian
twin
D. Iafusco1, L. Nistic	2, A. Galderisi1, R. Cotichini2, F. Prisco1,
V. Toccaceli2, M.A. Stazi2, C. Fagnani2 & R. Lorini3, Study Group on
Diabetes of Italian Society of Pediatric Endocrinology and Diabetology
1Second University of Naples, Department of Pediatrics, Napoli, Italy,
2Istituto Superiore di Sanit, CNESPS, Genetic Epidemiology Unit,
Rome, Italy, 3University of Genoa, Pediatrics, Genoa, Italy
Objectives: Estimate in the Italian population: (1) T1DM
concordance in monozygotic (MZ) and dizygotic (DZ) twins; (2)
in concordant pairs, recurrence risk ratio and disease discordance
time; (3) genetic and environmental components of susceptibility
variance to T1DM.
Methods: Twins were identified by a record linkage between the
Italian Twin Registry and a list of 10 701 T1DM patients, provided
by 34 Centres, affiliated to the Italian Study Group on Diabetes of
ISPED. Of the 124 T1DM twins so far identified, 70 (in 60 pairs
and 1 triplet) have already been enrolled. They are 31 males and 39
females, median age at diagnosis is 7.0 years (range 1–20 years).
Zigosity in same sex pairs has been assigned by standardized
questionnaire on physical resemblance: 18 are MZ and 44 DZ
(including 2 pairs from the triplet). Saliva for genetic studies and
DNA bio-banking has been so far collected from 54 pairs.
Results: Six MZ and 3 DZ pairs were concordant. Probandwise
concordances were 50.0% (95% CI 25.5–74.5) in MZ and 12.8%
(0–25.8) in DZ pairs (P = 0.008). Disease recurrence risk was 4
times higher in MZ than in DZ co-twins. In concordant pairs, the
second twins developed T1DM within a time range of 34 days -
5.2 years (median 1.1 years) if MZ, and of 0 days – 7 years
(median 4.7 years) if DZ. In discordant pairs, median follow up
times are 4.5 years (range: 0.4–19.0 years) for MZ and 6.3 years
(0.2–31.8 years) for DZ unaffected co-twins. Twins diagnosed
before 3 years had a higher mean birth weight than their unaffected
co-twins (2539 g vs. 2369 g, P = 0.4). Tetrachoric correlations
were 0.83 (0.65–0.94) for MZ and 0.49 (0.26–0.68) for DZ pairs.
Under an ACE model, heritability (A) was estimated at 0.67 (0.16–
0.93), while contributions of familial (C) and individual-specific (E)
environmental effects were 0.16 (0–0.56) and 0.17 (0.06–0.35),
respectively.
Conclusions: This study confirms substantial genetic contribution
to T1DM susceptibility, as already observed in Finnish and Danish
populations.
P/154/WED
Accelerated beta-cell destruction in preschool age
children with type 1 diabetes mellitus
M.Y. Jalaludin1,2, S.M. Willi1, K. Murphy1, S. Ratcliffe3 & W. Hei1
1Children's Hospital of Philadelphia, Endocrinology and Diabetes,
Philadelphia, USA, 2University of Malaya, Paediatrics, Kuala Lumpur,
Malaysia, 3University of Pennsylvania, Biostatistics and Epidemiology,
Philadelphia, USA
Background: Partial remission (PR) of type 1 diabetes mellitus
(T1DM) is characterized by reduced insulin requirements while
maintaining good glycemic control. The rate of PR has been
observed to be lower in preschool vs older children. We postulate
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that this observation is due to accelerated beta-cell destruction in
this group.
Objective: To compare the course of T1DM in young children to
that of older children.
Design/methods: All new onset TIDM children presenting to the
Children’s Hospital of Philadelphia from December 2002 to
December 2007 were assessed for islet cell antibodies [insulin
(IAA), glutamic acid decarboxylase (GAD), insulinoma antigen
(IA2)] and biochemical markers of disease severity (c-peptide, pH,
bicarbonate and HbA1c) at the time of T1DM diagnosis.
Comparison was made between preschool-age (<5 years) and
older (5–18 years) children. HbA1c and insulin total daily dose
(TDD) at 6, 12, 18 and 24-months of diagnosis were analyzed, with
PR defined as TDD < 0.5 units/kg/d and HbA1c < 8%.
Results: Of 688 T1DM patients, the 130 preschool age children
had significantly higher rates of DKA (P < 0.001) and IAA titers
(P < 0.001) but lower c-peptide (P < 0.001) and HbA1c
(P < 0.001) at diagnosis, compared to older children (n = 558).
However, they were noted to have lower GAD (P = 0.043) and
IA-2 (P < 0.001) antibody titers. Preschoolers also had
significantly higher HbA1c at 6 (P < 0.001) and 12 months
(P = 0.005). Partial remission was seen in 278 (40.4%) children
at 6 month. Preschoolers had significantly lower rate of PR
[n = 36, (27.7%)] compared to older children [n = 242 (43.4%),
P = 0.001)].
Conclusions: We conclude that preschool age children with T1DM
have a more rapidly progressive disease as evidenced by lower c-
peptide, higher rates of DKA and IAA titers. The lower HbA1c in
preschoolers suggested a shorter duration of hyperglycemia at the
time of diagnosis. Preshoolers also exhibited a lower rate of PR at
6 months.
P/155/WED
Prevalence of potential celiac disease in type 1
diabetes and in non diabetic celiac patients
P. Buono1, G. Cannavale1, O. Cavaliere1, D. Iafusco2, R. Auricchio1,
R. Troncone1 & A. Franzese1, Study Group of Diabetology of SIEDP
1Federico II University, Paediatrics, Naples, Italy, 2Second University of
Naples, Paediatrics, Naples, Italy
Celiac disease (CD) is frequently associated with Type 1 Diabetes
Mellitus (T1DM) with a mean prevalence of 4.5%. Screening tests
largely performed in all pediatric patients [antiendomysium (EMA)
and/or anti-tissue transglutaminase (TGase) antibodies] select
subjects who need to confirm CD diagnosis by biopsy. Subjects
with positive celiac-related antibodies and normal intestinal
mucosa were defined as CD-pot.
Aim: To compare the prevalence of CD-pot among EmA/TGase-
positive T1DM patients (Group A) and in non-diabetic celiac
patients (Group B).
Methods: All (A+B) patients presented EmA/TGase positivity
and underwent small bowel biopsy. Data of T1DM patients were
collected in 28 Italian Centres of Pediatric Diabetes. Data of non
diabetic CD patients were collected in 2 pediatric centres of Naples.
Results: Group A: 621 out 8671 T1DM patients (7.16%) presented
EmA/TGase positivity (age 13.7 ± 6.9, range 3–27), 546 with
compromised mucosa (CD, 6.3%), 75 with normal mucosa (CD-
pot 0.8%). Prevalence of CD-pot on all EMA/TGase positive
T1DM patients was 12%. Symptoms were present in 11 (15%):
abdominal pain (6), failure to thrive (3) and diarrhoea (2); 10
symptomatic patients (13.3%) observe a gluten-free diet. At first
serological positivity age was 8.67 ± 5.11. 14/75 (18.6%) had
another autoimmune disorder (12 thyroiditis, one multiple sclerosis
and one thrombocytopenia).
Group B: in non diabetic CD-patients (894) CD-pot were 126
(14.1%). Age 15.9 ± 6.9, range 7–29. Symptoms were present in
25 (20%): abdominal pain (15), failure to thrive (7) and diarrhea
(3); 12 symptomatic patients (10%) observe a gluten-free diet. Age
at first diagnostic positivity was 9.7 ± 4.1 (range 3–29). Six
patients presented also thyroiditis (5%).
Prevalence of CD-pot in patients positive celiac-related antibodies
is similar in T1DM and in non diabetic young population.
P/156/WED
Enterovirus and parechovirus infections in infancy and
development of autoimmunity
G. Tapia1, O. Cinek2, B. Grinde3 & K.S. Rønningen1
1Norwegian Institute of Public Health, Department of Genes and
Environment, Oslo, Norway, 2Charles University, Second Medical
Faculty, Prague, Czech Republic, 3Norwegian Institute of Public Health,
Department of Virology, Oslo, Norway
Objectives: The increase in Type 1 Diabetes (T1D) the last decades
can not be explained by genetic factors, but by unknown
environmental risk factors for T1D. The hygiene hypothesis
states that the lack of infections in early childhood is the reason
behind the increasing incidence of allergic diseases, and probably
also of T1D. The association between entero- and parechovirus
infections in early childhood and later development of
autoimmunity has been studied in a nested case-control study to
test if selected viruses are associated with development of
autoimmunity and to test the hygiene hypothesis.
Methods: Children with the highest genetic risk for T1D, enrolled
in the MIDIA project, were used in this study. In the MIDIA
project, stool samples are collected monthly until 3 years of age
and autoantibodies measured every 3 months in the first year of life
and then annually. Of the children followed in the MIDIA project,
27 subjects developed confirmed autoimmunity (positivity for 2 or
3 autoantibodies) or T1D and were assigned as cases. In addition,
54 healthy children matched for geographical location and age
were used as controls. The stool samples of these children (taken
from 2004 to 2008) were tested for the presence of Enterovirus
(EV), Human Parechovirus (HPeV) and Ljungan virus (LV) RNA
with real-time PCR.
Results: There was no LV detected in the stool samples tested, and
no differences in the prevalence of HPeV positive samples between
the cases (15.6%) and the controls (14.2%). There was, however, a
difference between the cases (14.9%) and controls (20.7%) in EV
positive samples [OR (independent samples) = 0.67, P = 0.96].
Conclusions: HPeV and EV infections are common and usually
asymptomatic in childhood. HPeV positivity did not show any
association with development of autoimmunity. There was,
however, a trend of more EV positive samples in the early
infancy of children without any sign of autoimmunity.
P/157/WED
Diabetes ketoacidosis at onset, changing with change
in incidence of diabetes?
U. Schierloh, O. Robaux, C. de Beaufort, M. Fichelle & Y. Rayane
Clinique Pdiatrique de Luxembourg, DECCP, Luxembourg, Luxembourg
Frequency of DKA at onset, varies between countries, but remains
an important risk factor for morbidity and mortality. It may be as
low as 0% after intensive campaigning. In Europe, it varies
between 26% and 67%. An increase in the incidence of t1dm may
lead to a greater awareness for its symptoms at onset. Therefore, a
retrospective study was undertaken to evaluate this in Luxem-
bourg.
Methods: Retrospective case record evaluation of t1dm in children
and adolescents (<20 years) in Luxembourg, diagnosed between
1989 and 2007 with or without dka at onset. All children, below
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20 years of age, diagnosed with t1dm at the paediatric clinic in
Luxembourg between 1989 and 2007 were included.
Results: Between 1989 and 2007, an important increase in
incidence has been observed with an incidence starting at 12
and increasing towards 20 new cases per 100 000 DKA in the first
years is present in about 7% of the children. Thereafter it
increases continuously towards 22% over the last 5 years. The
last 3 years, DKA has been complicated by cerebral oedema in 2
children, one with severe neurological damage and death in the
second child.
Discussion: DKA at onset of t1dm in children in Luxembourg
remains low. It is upsetting that over time an increased frequency
and severity is observed. Intensive campaigning will be needed to
create sufficient awareness in the general population, the school
and para/medical health care professionals to prevent diabetes
ketoacidosis.
P/158/WED
Nation-wide quality work in childhood-onset diabetes
– national childhood diabetes registry increases
awareness among paediatricians treating
childhood-onset diabetes
T. Skrivarhaug1, S.J. Kummernes1, A.K. Drivvoll1, C. Brunborg2,
H.D. Margeirsdottir1, P.R. Njølstad3, G. Joner1 & K. Dahl-Jørgensen1,
The Norwegian Childhood Diabetes Registry
1Oslo University Hospital, Ullevl, Pediatric Department, Oslo, Norway,
2Oslo University Hospital, Ullevl, Center for Clinical Research, Oslo,
Norway, 3University of Bergen, Department of Clinical Medicine,
Bergen, Norway
Objectives: Norway has one of the highest incidences of childhood-
onset diabetes in the world (>32 per 100 000). More than 95% of
all childhood-onset diabetes in Norway is Type 1 diabetes
(T1D).The Norwegian Childhood Diabetes Registry includes
data on new onset diabetes from 1973 and annual benchmarking
data since 2001. The goals of the Norwegian Childhood Diabetes
Registry: 1) surveillance of incidence of diabetes in children and
adolescent, 2) to improve the diagnostics and classification of the
disease, 3) to improve treatment, 4) surveillance of acute and late
complications, 5) maintain and further develop a network for
quality work among paediatric departments to ensure an equal
treatment, 6) stimulate diabetes research.
Methods: Registration of all new onset cases of diabetes, includes
clinical data, family history and blood samples. Standardized
annual registration of clinical data, complications screening,
diabetes treatment, and smoking. HbA1c measured in one central
laboratory for all patients. All paediatric departments in Norway
participate in this registration.
Results: In 2008, 306 patients age <15 years were diagnosed with
T1D and 2059 cases participated in the annual benchmarking
registration (98% T1D, 0.4% T2D, 1.3% MODY). Mean HbA1c
8.6% (range 7.9–9.1). 50% of the patients were treated with insulin
pump. 5% had been hospitalized with diabetes ketoacidosis. 6%
had had severe hypoglycaemia with unconsciousness and/or
convulsions. 1923 patients were screened for nephropathy; 0.4%
had persistent microalbuminuria, no proteinuria. 684 patients had
an eye examination; 0.2% had retinopathy, 0.1% had received laser
treatment.
Conclusions: Nation-wide childhood diabetes registries gives vital
information about incidence and changes in incidence, surveillance
of acute and late complications and screening procedures. The
registry maintains and further develops a network for quality work
among paediatric departments to ensure an equal treatment in
Norway.
P/159/WED
Prevalence of type 1 diabetes in North India: a
physician and chemist based district level assessment
S. Kalra1, B. Kalra2, A. Ahalawat3 & S. Saluja4
1Bharti Hospital, Endocrinology, Karnal, India, 2Bharti Hospital,
Diabetology, Karnal, India, 3Bharti Hospital, Clinical Research, Karnal,
India, 4Bharti Hospital, Dietetics, Karnal, India
Little work has been done on the prevalence of type 1 diabetes in
North India. This paper reports the prevalence of type 1 diabetes in
Karnal District of Haryana state, India as assessed by a hospital-
based registry and by inputs from chemists and other physicians.
Data of all type 1 diabetes patients attending the only endocrine
OPD in the region was analysed, and screened for patients living in
the district. All chemists in insulin business were contacted through
wholesalers of the drug and requested about details of children
purchasing insulin. Similarly all 18 paediatricians and 22 internists
working at other urban centres within the district were requested
for details of patients being treated by them. All names and
addresses were cross checked to avoid duplication.Population data
was taken from the 2001 national census. The survey revealed 79
male and 51 females with type 1 diabetes in the district. Of these 54
men and 36 women were from urban areas, while 25 men and 15
women were from a rural background. The overall prevalence of
type 1 diabetes in Karnal district was 10.20/100 000 population
(130/1 274 183), with a higher prevalence in urban areas: 26.6/
100 000 (90/337 842) as compared to rural areas: 4.27/100 000 (40/
936 341). Karnal City, with a population of 222 017, showed a high
prevalence of type 1 diabetes 31.9/100 000 (total 71 patients). The
prevalence in men was much higher (11.56/100 000 or 79/683 368)
than in women (8.6/100 000 or 51/590 815). Prevalence was 21.2/
100 000 (3/14 119) and 18.2/100 000 (2/10 931) in boys and girls,
aged 0 to 6 years respectively, yielding a total of 19.9/100 000 (5/
25 090). This work highlights the relatively high incidence of type 1
diabetes in North India, with a high male: female gender ratio, and
high urban: rural gradient, using a simple, economical methodol-
ogy. This methodology may be appropriate for assessing the
prevalence of diabetes in many developing nations.
P/160/WED
The application of ISPAD consensus guidelines in
determination of the specific etiology of DM among
patients at a children's hospital
C.S. Brousell, M. Deemedio, S. Dowshen, D. Doyle, G. Reeves &
K. Shoe
duPont Hospital for Children, Endocrinology, Wilmington, USA
Brief description: The clinical availability of assays for autoimmunity
‘‘markers’’ has important diagnostic and therapeutic implications.
These markers are usually present in the sera of children with recent-
onset type 1 Diabetes Mellitus (DM). The combination of screening
for antibody markers in new onsets, as well as the availability of
genetic studies todiagnose themajor formsofmonogenicdiabetes, has
enabled clinicians to determine a specific etiology in a much higher
percentage of children presenting with diabetes.
Objective: Assess the clinical impact of efforts to identify the
specific etiology of diabetes among patients in a children’s hospital
diabetes program.
Methods: In our practice of approximately 1000–1200 children and
adolescents with DM, it has been the standard of care to measure
autoimmunity ‘‘markers’’ (IAA, ICA, and GAD-65) in all new-
onset patients. Subsequently, in clinic follow-up, we evaluate the
etiology of DM in each of our patients by reviewing their initial
antibody ‘‘marker’’ results. If antibody negative and not clearly
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established as having insulin resistance-associated T2DM, we then
apply the consensus guidelines to evaluate for monogenic diabetes.
Results: Our poster presentation includes the following: A review
of the ISPAD criteria, case reports of 3 family pedigrees illustrating
change in diagnosis, the overall etiologic profile of the diabetes
population with categories of the identified mutations, and data on
patient responses to treatment changes that were made based on
determination of the specific etiology of diabetes.
Conclusions: Our review has identified 12 pediatric patients with
changes in diagnosis from T1/T2DM to monogenic mutations.
Correction of the original diagnosis has not only affected treatment
of the probands, but also 2–3 generations of family members.
Additional support and education is critical not only in pediatrics,
but in adult diabetes programs in order to offer comprehensive
diabetes management.
P/161/WED
Type 1 Diabetes (T1DM) in Polish children,
1983–2020 – incidence based on different predictive
models
P. Jarosz-Chobot1, J. Polanska2, A. Szadkowska3, A. Kretowski4,
E. Bandurska-Stankiewicz5, M. Ciechanowska6, G. Deja1,
M. Mysliwiec7, J. Peczynska4, J. Rutkowska5, A. Sobel-Maruniak8,
P. Fichna9, A. Chobot10 & M. Rewers11
1Medical University of Silesia, Katowice, Poland, 2System Engineering
Group,The Silesian University of Technology, Gliwice, Poland, 3Medical
University of Lodz, Lodz, Poland, 4Medical University of Bialystok,
Bialystok, Poland, 5University of Warmia and Mazury, Olsztyn, Poland,
6Collegium Medicum, Jagiellonian University, Cracow, Poland,
7Medical University of Gdansk, Gdansk, Poland, 8Povincial Hospital No
2, Rzeszow, Poland, 9Poznan University of Medical Sciences, Poznan,
Poland, 10Association for Children with Diabetes, Katowice, Poland,
11Barbara Davis Center, University of Colorado, Denver, USA
Objectives: In Poland as well as world-wide incidence of childhood
T1DM has been increasing. The aim of this study was to assess
present and future time trends in the incidence of T1DM in Polish
children and to develop different predictive models for the future.
Methods: Regional registers that covered 35% of the Polish
population ascertained prospectively using the EURODIAB
criteria incident cases of T1DM under the age 15 years, between
1989 and 2004. Linear and generalized additive modeling (GAM)
were used to predict the annual number of new cases in the overall
Polish population between 1989 and 2020.
Results: The primary study population consisted of 4268 incident
T1DM cases (2230 #, 2038 $). In 1989–2004, the average age-sex-
standardized incidence was 9.9/100 000/year (95% CI 8.5–11.6).
The incidence has increased more than 3-fold, from 5.2 to 17.2/
100 000/year, between 1989 and 2004. The incidence has increased
the most among children aged 5–9 years, on average by nearly 1.0/
100 000/year (95% CI 0.8–1.1). There was a significant non-linear
component to the time trend (P < 0.000001). The number of
Polish children predicted to develop T1DM between 2005 and
2020, assuming constant population size, was 20 993 and 32 375
for the linear model and GAM respectively. Datasets comparable
to the primary register, preceding or following the study period,
were analyzed to estimate GAM validity. The prediction errors of,
respectively, 5.1% and 1.2% for the Silesia and Lodz register
incidence in 1983–1988 validated the non-linear model.
Conclusions: Incidence of childhood T1DM in Poland has
increased during the recent 15-years 3-fold and is predicted to
increase additionally at least 3-fold between 2005 and 2020.
Concerning the increasing incidence, GAM seems to be a more
adequate predictive model for the near future.
Acknowledgment: The work was partially financed by KBN grant
no 402279134 and EUBIROD grant no 2007115.
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Study concerning the genetic background in the
infantile population with type 1 diabetes mellitus
P.I. Velea1, C. Paul1, E. Gai2, V. Paunescu3, I. Tamasan1, O.A. Velea1,
L. Mihu1 & O. Lebu1
1University of Medicine and Pharmacy V.Babes, Clinic II Pediatrics,
Timisoara, Romania, 2Clinical County Hospital, Laboratory of
Immunology, Timisoara, Romania, 3University of Medicine and
Pharmacy V.Babes, Department of Immunology, Timisoara, Romania
Introduction: Almost all genes proved to be associated type 1 DM
have a variable but quite increased prevalence also in the general
population.
Aims: 1. To detect class II HLA antigenes of susceptibility for type
1 DM in a group of type 1 DM children. 2. To study the
transmission of the genetic predisposition - by HLA alleles
determination- in the healthy family members of these children.
Material and method: The studied lot included two groups of
children: group A -14 cases (9 F, 5 M) and group B - 30 subjects, of
which 9 children with type 1 DM (4 F, 5 M) and 21 healthy
individuals representing their family members (siblings and non-
diabetic parents). In the studied lot we have determined the HLA
alleles. HLA typing used INNO-LIPA HLA-B DRB1 tests for the
allele group between DRB1*01 and DRB1*16. For the
interpretation of the results we used the ‘‘Dynal Biotech pattern
Matching Program S42’’ soft.
Results: In group A, in 11 patients type 1 DM we found the
DQB1*0201 alleles; of these 6 associated DQB1*03DGZ allele
while in 1 case we found DQB1*03CJB allele. In group B, typing of
HLA alleles in the type 1 |DM children revealed 5 cases with
DQB1*0201, 2 boys with DQB1*03 XX, 1 girl with DQB1*03
DGZ and 1 boy with DQB1*0501. Of the 3 nondiabetic siblings of
type 1 DM patients, 2 presented the same alleles like the one with
type 1 DM (DQB1*0201 and DQB1*03 XX respectively) while the
third was DQB1*0201 positive, concording with the alleles found
in parents,but different from those found in the type 1 DM child. In
parents allels varied from DQB1*0201 (8 of 30 cases – 26.66%) to
DQB1*06XX.
Conclusions: 1. The most frequently encountered alleles in type 1
DM patients in Romania are DQB1*0201 (alone or associated with
other alleles- 69.56%) and DQB1*03DGZ (34.78%) 2. The
Figure 1.
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expression of the susceptibility genes for type 1 DM is also found in
the non-diabetic population studied, meaning that genetic
susceptibility in not the single cause for the occurence of type 1 DM.
P/163/FRI
TSH Receptor autoantibodies in patients with type 1
diabetes mellitus
D. Witkowski1, E. Piontek1, E. Moszczyńska1 & R. Janas2
1The Children's Memorial Health Institute, Dept. of Metabolic Diseases,
Endocrinology and Diabetology, Warsaw, Poland, 2The Children's
Memorial Health Institute, Dept. of Radioimmunology, Warsaw, Poland
Objectives: Autoimmune thyroid disease (AITD) is the most
prevalent autoimmune disorder associated with type 1 diabetes
(T1D). The purpose of the study was to determine TSH receptor
autoatibodies (TSHR Ab) levels in the group of type 1 diabetic
pediatric patients with or without thyroid dysfunction.
Methods: In the group of 84 children with T1D, age 2–18 year
(11.3 ± 4.47), girls (58.3%), with T1D duration from 1 up to
11 year (2.89 ± 2.35) anti TSH receptor autoantibodies (TSHR
Ab), thyroid peroxidase antibodies (TPO Ab) and thyroblobulin
antibodies (TG Ab) levels were measured. TSHR Ab > 14 U/l,
TPO Ab > 50 U/ml, TG Ab > 70 U/ml were considered positive.
Radioreceptor assay for quantitative determination of TSHR Ab
was performed. TPO Ab and TG Ab levels were measured by
ELISA. In all children clinical, hormonal examination and thyroid
ultrasound, if necessary, were performed to establish thyroid
function.
Results: None of 84 children had TSHR Ab. (+) TPO Ab, (+)
TG Ab or both (+) TPO Ab and TG Ab determination were
present in 24 of 84 patients (28.6%). Girls (77.8%) had more
frequently raised antibodies than boys. (+) TPO Ab were present
in 13 children (15.5%) - in 2 of them subclinical hypothyroidism
was recognised and 1 patient was treated with L-thyroxine due to
hypo state. (+) TG Ab were present in 11 children (13.1%) - in 2 of
11 subclinical hypothyroidism was recognised, only 6 patients
(7.2%) were positive for both TPO Ab and TG Ab - in 2 of 6
children subclinical hypothyroidism was determined. Subclinical
hypothyroidism is recognised in 4 children with (-) TPO Ab and
TG Ab levels. The hyperthyroidism was determined in 1 patient
with (+) TPO Ab.
Conclusions: 1) TSH R Ab-based screening is not probably useful
at the beginning of autoimmune thyroid disease in type 1 diabetic
patients. 2) further studies should be conducted to study the
benefits of TSHR Ab determination particularly among those t
patients who have longer T1D duration.
P/164/FRI
Associated celiac disease in children and adolescents
with type 1 diabetes mellitus (DM1)
K. Kakleas1, C. Karayianni1, E. Paschali2, N. Kefalas3, A. Fotinou4,
M. Kanariou2 & K. Karavanaki1
1University of Athens, ''P.& A.Kyriakou'' Children's Hospital, Diabetic
Clinic, B  Pediatric Department, Athens, Greece, 2''Aghia Sophia''
Children's Hospital, Department of Immunology and Histocompatibility,
Athens, Greece, 3''P.& A.Kyriakou'' Children's Hospital, Department of
Pediatric Endocrinology, Athens, Greece, 4''P.& A.Kyriakou'' Children's
Hospital, Hormone Laboratory, Athens, Greece
Background: DM1 is associated with other autoimmune diseases,
among which is celiac disease (CD). The most reliable serological
marker for the screening of CD is the presence of tissue
transglutaminase antibodies (tTG).
Aims and methods: The aim of this study was: 1. To assess the
prevalence of CD in Greek children and adolescents with DM1, 2.
To evaluate its possible association with diabetes duration and
gender, 3. To study the effect of CD on growth and glycaemic
control. The study group included 144 DM1 children (male/female:
77/67), aged (mean ± SD) 12.3 ± 4.6years, with a diabetes
duration of 4.6 ± 3.9 years. During each hospital visit growth
and puberty was assessed. For the diagnosis of CD, tTG IgA
autoantibodies were measured.
Results: 9/144 DM1children (6.25%) were found to have tTG IgA
autoantibodies. These were predominantly girls [boys (5.6%) vs.
girls (11.8%), P = 0.049], with shorter height (htsds: -1.01 vs.
+0.21, P = 0.006), shorter diabetes duration (2.3 vs. 4.6 years,
P = 0.042) and similar HbA1c levels with the rest of the
DM1children (HbA1c: 7.75 vs. 8.15%, P = NS). Multiple
logistic regression analysis showed that the presence of tTG IgA
autoantibodies was only associated with female gender (OR: 1.50,
95% CI: 0.89, 22.31). Only 5/9 (55.5%) tTG IgA positive children
developed mild gastrointestinal symptoms, anaemia and growth
retardation. All children with high titres of tTG IgA underwent
celiac biopsy (4/9) and all had histological findings typical of CD.
In 1 child CD antibody positivity was diagnosed before DM1, in 4
children it was diagnosed simultaneously, and in 4 children it
followed DM1 diagnosis. No associations were found between CD
and parietal cells (APCA) or thyroid (anti-TG, anti-TPO)
autoantibodies.
Conclusion: CD seems to be more common in female children with
DM1 and may present early in the course of the disease. It usually
presents with mild symptoms or is asymptomatic. Thus the
importance of its early diagnosis by regular autoantibody
screening, is underlined.
P/165/FRI
Genetic characteristics in a small Romanian study
group with insulin-dependent diabetes from Constanta
county
C.M. Mihai1, I. Durbala1,2 & R.M. Stoicescu3
1 Ovidius'' University, Faculty of Medicine, Constanta, Romania, 2Cell
and Molecular Biology Department, Constanta, Romania, 3Ovidius''
University, Faculty of Farmacy, Constanta, Romania
Objective: The association of type 1 diabetes mellitus with certain
HLA alleles is well documented. The major genetic determinants
are alleles at HLA-DRB1 and DQB1 loci, harboring both
susceptible and protective haplotypes. The aim of this study is to
characterize our group of patients in respect with the HLA-DRB1
and DQB1 alleles.
Methods: HLA class II DRB1 and DQB1 alleles were determined
in 49 type 1 diabetes pediatric patients using specific
oligonucleotide typing after gene amplification of the second
exon. The class II genes profiles were analyzed according to the age
of onset. For this analysis the genotypes were referred to as high-
risk, carrying both high-risk haplotypes (DR3/DR4), carrying one
high risk haplotype, either DR3 and DR4, and carrying no high
risk haplotype.
Results: The high-risk genotype DR3/DR4 was found in 28.5% of
all patients, with similar higher frequency in the groups with onset
at 5–9 years and 10–14 years. Only one patient out of ten with the
onset in the interval 0–4 years had this high-risk genotype. The
DR4/Y genotype had the highest frequency in our group – 38.8%
of all patients, being most well represented in the 10–14 years at
onset group. The DR3/X genotype occurred in 30.6% of patients,
with the highest frequency in the 0–4 years at onset group, in five
out of ten patients. Only one genotype nonDR3/nonDR4 was
found in the group 0–4 years at onset.
Conclusions: Our group showed an unusual pattern of class II
HLA genes. Almost all patients - 48/49 - carried at least one high
risk haplotype. The DR4 haplotypes were found with a highest
frequency. This pattern is different from other Caucasian
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populations but was previously reported for other Romanian
populations probably accounting for the small number of cases
with onset before 4 years. The study will be continued by
increasing the group size and typing of healthy related controls.
P/166/FRI
The association CTLA-4 single nucleotide
polymorphisms (-318C/T and 49A/G) and HLA-haplotypes
in type 1 diabetes mellitus in Moscow population
L. Zilberman, T. Kuraeva, E. Titovich, I. Dedov & S. Prokofev
Endocrinological Research Centre, Moscow, Russian Federation
Introduction: Our previous research predisposed haplotypes to
type 1 diabetes mellitus (T1DM) were revealed in 8% of healthy
subjects in Moscow. Otherwise, 21% of diabetic patients did not
have predisposed haplotypes. Searching for other candidate genes
and its polymorphisms could shed light on the multiple inheritance
of T1DM.
Objectives: The aim of the present study is to investigate the
association of the genetic variants in the CTLA-4 and HLA-
haplotypes in T1DM.
Materials and methods: The analysis of HLA-haplotypes and
single nucleotide polymorphisms (SNP) of the CTLA-4 gene was
performed at 113 diabetic patients and 100 healthy subjects in MP.
Results: The RR of development T1DM is 4.93 at presence of
haplotype DRB1*04-DQA1*0301-DQB1*0302. The combination
of ag CTLA-4 A49G with DRB1*04-DQA1*0301-DQB1*0302
decreases RR to 0.21 (P < 0.05).
The combination of protective HLA-haplotypes DRB1*07-
DQA1*0201-DQB1*0201 with protective variant c/t CTLA-4
318C/T increases RR from 0.44 to 0.17.
The presence of neutral genotype nonDRB1*04-DQA1*0301-
DQB1*0302/nonDRB1*17 (03)-DQA1*0501-DQB1*0201 and aa
CTLA-4 A49G makes the genotype protective (RR = 0.24, P <
0.05). Interestingly, the presence of g + CTLA-4 A49G in combi-
nation with nonDRB1*04-DQA1*0301-DQB1*0302/nonDRB1*17
(03)-DQA1*0501-DQB1*0201 are associated with increasing RR
to 4.1 (P < 0.05). The presence of c/t CTLA-4 318C/T
with nonDRB1*04-DQA1*0301-DQB1*0302/nonDRB1*17 (03)-
DQA1*0501-DQB1*0201 are associated with RR = 0.18
(P < 0.05).
Conclusion: This data shows mutual influence of SNPs CTLA-4
gene and HLA-haplotypes on RR in development T1DM in MP.
P/167/FRI
Successful transfer from insulin to oral sulphonylurea
in a 3 year Saudi girl with a mutation in the KCNJ11
gene
M.J. Al-Mahdi1,2, A. Almutair3, M. Albalwi4 & K. Hussain5
1King Abdulaziz Medical City, National Guard Hospital, Pediatrics,
Riyadh, Saudi Arabia, 2Adan Hospital, Kuwait, Kuwait, 3King Abdulaziz
Medical City, National Guard Hospital, Pediatrics, Riyadh, Kuwait, 4King
Abdulaziz Medical City, National Guard Hospital, Molecular, Pathology
and Genetics Section, Riyadh, Saudi Arabia, 5Institute of Child Health,
Molecular Gentics Unit, London, UK
Neonatal diabetes mellitus is considered to be a rare disease that is
diagnosed in the first six months of life and can be either transient
or permanent. Recent advances in molecular genetics have shown
that activating mutations in KCNJ11 (the gene that encodes for the
Kir6.2 subunit of the KATP potassium channel of the pancreatic
b-cell) is a common cause of permanent neonatal diabetes mellitus.
Patients with mutations in this gene may respond to oral
sulphonyureas. In this case report we describe a three-year-old
girl with permanent neonatal diabetes mellitus with a mutation in
KCNJ11 gene (R201H) who was successfully transferred from
subcutaneous insulin to oral glibenclamide with marked improve-
ment in glycaemic control. This is the first successful switch from
insulin to oral sulphonylurea in a patient with the R201H mutation
in the Arabian Gulf.
P/168/FRI
Functional impairment of the pancreatic beta cells and
other endocrine tissues by iron overload due to
repetitive erythrocyte transfusions
J. Rohayem1, B. Tittel2, G. Hahn1 & A. Hbner1
1Dresden University of Technology, Children¢s Hospital, Dresden,
Germany, 2Dresden-Friedrichstadt Hospital, Center for Child Health,
Dresden, Germany
Objective: To present a rare form of diabetes resulting from
hemosiderosis and to illustrate the susceptibility of various
endocrine tissues to iron overload.
Methods: In a male patient suffering from Blackfan-Diamond
anaemia requiring monthly erythrocyte transfusions since the age
of seven years, endocrine function was assessed by history, basal
and functional studies.
Results: Despite treatment with desferoxamine since the age of
13 years, hypogonadotrophic hypogonadism was identified at age
15 when puberty did not occur spontaneously and testosterone
proved unsuccessful in stimulating the hyothalamo-pituitary axis.
Lack of the pubertal growth spurt despite testosterone replacement
therapy revealed partial growth hormone (GH) deficiency
confirmed by impaired overnight secretion of GH. Severe GH
deficiency was diagnosed at age 38 by GHRH-arginine testing.
Primary hypothyreoidism was treated with L-thyroxine from the
age of 19 years. At age 22 years, HbA1c was first documented to be
elevated to 7.2% despite ‘‘diluting’’ monthly transfusions. Despite
impaired fasting glucose and impaired glucose tolerance during
oGTT since then, HbA1c is stable with dietary restrictions only.
From the age of 24 years, repetitive episodes of hypocalcemia and
hyperphosphatemia were documented despite oral substitution of
calcium and vitamin D and normal renal function. PTH was
undetectable, indicating hypoparathyroidism. Hemosiderosis of the
anterior pituitary and the thyroid gland were visualized by MR
imaging.
Conclusion: Iron overload beginning in childhood induces
sequential impairment of puberty, growth, thyroid, parathyroid
and beta cell function. Diabetes progression into insulin
dependence seems to occur rather slowly in hemosiderosis.
Poster Session I: Diabetes Genetics,
Immunology II
P/169/WED
HLA-DQB1 alleles as immunogenetic markers of
inverse association between diabetes mellitus type I
and atopic asthma: a hypothesis
T. Papazoglou1, M. Dokopoulou1, E. Bozas1, P. Paschou1,
A. Constantopoulos2, E. Roma-Giannikou3, C.S. Bartsocas1 &
A. Gerasimidi-Vazeou4
1Pediatric Research Laboratory, Faculty of Nursing, University of
Athens, Athens, Greece, 2Second Pediatric Department, University of
Athens, ''P. and A. Kyriakou'' Children's Hospital, Athens, Greece, 3First
Pediatric Department, University of Athens, ''Aghia Sophia'' Children's
Hospital, Athens, Greece, 4Diabetes Center, First Department of
Pediatrics, ''P. and A. Kyriakou'' Children's Hospital, Athens, Greece
Objectives: Atopic diseases seem to occur less often than expected
in children with T1DM and vice versa. T1DM is a Th1 while atopic
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asthma is a Th2-mediated disease. HLA molecules play a key role
in the pathogenesis of T1DM and influence the type of the immune
response (Th1/Th2).
Methods: In order to study the incidence of predisposing/
protective for T1DM HLA-DQ(B1-A1) alleles in individuals with
atopic asthma, six HLA-DQB1 allele typing was performed in 96
asthmatic individuals, 129 children with T1DM and 1784 controls
with further typing of three DQA1 alleles in HLA-DQB1*0201,x
carriers.
Results: A lower incidence of the predisposing to T1DM alleles
DQB1*0201, DQB1*0302 (P < 0.001) and a higher incidence of
the protective ones DQB1*0301, DQB1*0602 and DQB1*0603
(P < 0.001 and P < 0.025 respectively) was found in asthmatic
children. The predisposing allele for atopic asthma was
HLA-DQB1*0301. The protective for T1DM genotype
DQB1*0201,*0301 was found in a higher incidence among the
asthmatic individuals compared with either T1DM patients or
controls. Asthmatic patients with the DQB1*0201,x genotype carry
the protective for T1DM DQA1*0201 allele in a higher incidence
compared with individuals with T1DM.
Conclusions: The difference in the genetic background may
contribute to the lower incidence of T1DM in children with
atopic asthma and vice versa. Children with asthma carry the high
risk alleles for T1DM in a lower incidence and the protective ones
in a higher incidence, compared with T1DM patients.
Furthermore, DQB1*0301 is an allele predisposing for atopic
asthma.
P/170/WED
Assessment of interleukin 18 in children with type 1
diabetes and their relatives: its relation to
autoantibodies
A. Abd El Baky1, S. Abd El Dayem1, H.A. Atwa2 & H. Rasmy3
1National Research Center, Cairo, Egypt, 2Faculty of Medicine, Suez
Canal University, Pediatric, Ismailia, Egypt, 3National Institute of
Health, Cairo, Egypt
Background: Interleukin 18 (IL18) proinflammatory cytokine, has
been implicated in a variety of pathological conditions such as
rheumatoid arthritis, T1DM & inflammatory liver disease.
Aim: To evaluate level of IL18 and antipancreatic autoantibodies
in a in children with T1DM & their brothers/sisters (relatives) for
early detection of the risk of development of T1DM.
Subjects and methods: Twenty six children with type1 diabetes (12
male &14 female) their mean age was (12 ± 0.77) years and mean
duration of disease was (3.8 ± 3.4 years) were included. Thirty
one of their healthy relatives who are still normo-glycaemic
without clinical or laboratory criteria of diabetes were included.
Forty six age & sex matched healthy children were served as a
control group. Fasting serum sample for assessment of fasting
blood glucose, anti-glutamic acid decarboxylase antibodies (Anti-
GAD65 Ab), tyrosine phosphatase antibodies (anti-IA2 Ab) and
anti insulin antibodies (IAA Ab) and Interleukin 18 were taken.
Relatives with 2 or more positive autoantibodies were considered
high risk for disease.
Results: Frequency of anti-GAD antibody was significantly higher
in patients with T1DM and their relatives than control, while anti
IA2 and IAA antibodies were significantly higher in patients with
type 1 diabetes than their relatives and control. One positive
antibody was found in (33.3%), two antibodies in (56.7%) and
three antibodies was found in (10%) of the unaffected relatives of
diabetic children.IL18 was higher in relatives of diabetic patients
than diabetic chilren and controls but it was not significant. No
significant difference in IL 18 between high and low risk relatives.
However only one of the high risk relatives discovered accidently to
have diabetes showed very high IL18 level.
Conclution: Serum IL18 seemed to be increased selectivly during
early clinical stage of type1diabetes. However, IL18 & at least two
autoantibodies should be studied on larger scale.
P/171/WED
Circulating nucleic acids as damage - associated
molecular patterns (Damps) in juvenile diabetes
G. Kocic, R. Kocic, L. Saranac, S. Zivic, D. Sokolovic, T. Jevtovic,
S. Stojanovic, J. Basic & A. Veljkovic
Medical Faculty, Nis, Serbia
The immune response may be triggered the pathogen-associated or
by damage-associated molecular patterns, derived from damaged
cells (PAMPs and DAMPs). The DAMPs, acting as ¢alarmins¢ and
¢endokines¢ initiate strong inflammatory response via activation of
antigen presenting cells, production of pro-inflammatory cytokines
(IL-1, TNF-a, IL-6, IL-8), cell adhesion molecules (ICAM-1,
VCAM-1) and by activation of vascular endothelium. DAMPs
mediate immune responses through the TLRs, RAGE and NOD1-
like receptors. In our previous reports increased level of circulating
ribonucleic acids (CRNAs) was documented to occur in juvenile
diabetes. Since the higher prevalence of various infectious diseases
is documented to develop in type 1 diabetic patients, the aim of the
present study is to evaluate possible modulation of immuno-
inflammatory cascade and antiviral response by circulating nucleic
acids as possible DAMP molecules in juvenile diabetes. Examined
groups were juvenile type 1 diabetic patients (n = 46) and control
children (n = 27). The immunomodulatory effect of circulating
nucleic acids was monitored on peripheral blood mononuclear cells
(PBMCs), isolated from 100 ml blood of one donor volunteer. The
PBMCs were treated with RNA samples purified from plasma of
juvenile diabetic patients and control healthy children. Corre-
sponding intact PBMC were incubated with physiological saline.
The Bcl2, Bax, NF-kB, MDA-5 and IRF-3 expression was
estimated after 4 hours of incubation. The Bcl2/Bax significantly
increased in PBMCs treated with the CRNAs of juvenile type 1
diabetes (1.30 vs. 0.64 in control children P < 0.05), followed by
the decreased NF-jB of 12.5%, and antiviral proteins, MDA-5 (by
-23.8%) and IRF-3 (by-14.9%). MDA-5/IRF-3 axis was docu-
mented to be a subject of down-regulation during the evasion of
viruses, important for development of diabetes. Supression of
signalling regulators of antiviral response may contribute to
increased susceptibility toward different pathogens.
P/172/WED
Type 1 diabetes incidence and prevalence of
predisposing and protective HLA-haplotypes in Russian
and Yakuts populations of Russian federation
E. Titovich1, L. Zilberman1, T. Kuraeva1, T. Shiryaeva1, S. Prokofiev2,
O. Ivanova1, V. Peterkova1 & I. Dedov1
1Endocrinology Research Center, The Institute of Pediatric
Endocrinology, Moscow, Russian Federation, 2Endocrinology Research
Center, Genetics and Immunology, Moscow, Russian Federation
Aim: To investigate prevalence of predisposing and protective
haplotypes in populations with different levels of type 1 diabetes in
different populations.
Material and methods: HLA-genotyping was performed in 984
subjects without type 1 diabetes and free from aggravating
heredity, as concerns this disease, in Russian (Moscow, Vologda)
in Yakutsk populations.
Results: According the Russian Federation (RF) Register data
type 1 diabetes incidence varies significantly among different RF
ethnic groups. Incidence rate in Moscow population can be
estimated as 12.3 cases; in Vologda population - 21.4 cases; in
Yakutsk one - 1.6 cases per 100 000 persons. No significant
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differences have been observed in prevalence of main predisposing
haplotypes (DRB1*04-DQA1*0301-DQB1*0302; DRB1*17 (03)-
DQA1*0501-DQB1*0201) in three populations (P > 0.05).
Protective haplotype DRB1*11-DQA1*0501-DQB1*0301was
found significantly more rarely in Vologda population (9.1%)
than in Moscow one (14.5%, P < 0.02). Lower prevalence of two
protective haplotypes: DRB1*11-DQA1*0501-DQB1*0301 and
DRB1*15-DQA1*0102-DQB1*0602/8 has been observed in
Yakutsk population comparing with Moscow one (7.8% vs.
14.5%, P < 0.02 and 2.0% vs. 9.7%, P < 0.001, respectively).
However protective haplotype specific for this group DRB1*09-
DQA1*0301-DQB1*0303 was isolated and was found in 11.8%
cases in Yakutsk population, comparing with 0.6% in Moscow one
(P < 0.001).
Conclusion: Differences in type 1 diabetes incidence rate of two
Russian populations (Moscow and Vologda) are likely determined
by unknown at present environmental factors. The low level of type
1 diabetes morbidity in Yakutsk population might be determined
by large differences in the way of life, environment factors and,
probably, protective haplotype presence.
P/173/WED
Gamma–Delta T lymphocytes (cdT) prevalence in
peripheral blood in children with new-onset diabetes
type 1 (DM1)
A. Zubkiewicz-Kucharska & A. Noczyńska
Medical Univeristy of Wrocław, Endocrinology and Diabetology for
Children and Adolescents, Wrocław, Poland
Aims: To investigate cdT cells mean % in peripheral blood in
patients with new-onset DM1, regarding duration of
hyperglycemia symptoms before presentation and severity of
DKA at onset.
Material and methods: A total of 18 patients: 10 boys and 8 girls,
3–17 years, x = 11.7 years. Diabetes symptoms duration 4–
120 days, x = 40 days. Exclusion criteria included inflammation,
neoplasm, and other autoimmune disease. Long symptomatous
period = lasting > 21 days. DKA: mild if venous pH < 7.3,
HCO3 < 18 mmol/l; moderate: pH 7.1–7.24, HCO3 10–15 mmol/
l; severe: pH < 7.1, HCO3 < 10 mmol/l.
Results: There were no differences in cdT and activated TcdCD69+
mean % in patients with long/short lasting diabetes symptoms
(n = 9/n = 9): 0.45–23.13, x = 8.813, SD = 4.612 and 0–0.43,
x = 0.098, SD = 0.104, respectively. Activated TcdCD25+ and
activated TcdCD56+ did not differ significantly in both groups, but
trends were marked: in pts with short symptoms duration
activated TcdCD25+ % was higher (0–0.1, x = 0.029,
SD = 0.033, vs. 0–0.02, x = 0.005, SD = 0.007), whereas
activated TcdCD56+ was higher in patients with long
symptomatous period (0–0.72, x = 0.112, SD = 0.227 vs. 0–
0.72, x = 0.256, SD = 0.264). cdT mean % in patients with no/
mild DKA (n = 13) was higher (P = 0.04) than in moderate/
severe DKA patients (n = 13): 0.45–23.13, x = 9.21, SD = 5.298
vs. 3.93–8.63, x = 6.10, SD = 1.960, respectively. Activated
TcdCD56+ and activated TcdCD69+ mean % did not differ
significantly, but trends were marked: in pts with no/mild DKA
were higher (0–0.72, x = 0.21, SD = 0.277vs. 0–0.25, x = 0.07,
SD = 0.104; 0–0.43, x = 0.09, SD = 0.126 vs. 0.02–0.13,
x = 0.06, SD = 0.040, respectively). Activated TcdCD25+ did
not differ (0–4.53, x = 0.233, SD = 0.984).
Conclusions: Lower activated cdTCD25+ number in pts with long
symptomatous period is probably due to cells migration from
peripheral blood to other tissues. Higher number of Tcd cells,
activated TcdCD56+ and activated TcdCD69+ in pts with
moderate/severe DKA might be due to their involvement in
immune reaction within pancreas.
P/174/WED
Patients with type 1 diabetes mellitus from the horn of
Africa: assessment of autoimmunity and HLA-
haplotypes in those living in Canada
B. Babic & D. Wherrett
Hospital for Sick Children, University of Toronto, Pediatrics, Division of
Endocrinology, Toronto, Canada
Background: There are few reports of type 1 diabetes (T1DM) in
children living in Ethiopia, Eritrea and Somalia (EES). However,
an increasing number of children of EES background are seen
withT1DM at our centre.
Objective: To characterize metabolic control, clinical features,
HLA haplotypes, and prevalence of islet antibodies (Ab) in
children with T1DM from EES background.
Methods: Patients aged £18 with T1DM from EES background,
were eligible for inclusion. There were no exclusion criteria. Data
collected included patient demographics, anthropometrics,
presenting symptoms, HbA1C, insulin regime, family history,
presence of other autoimmune disease or complications.
Investigations performed included: GAD65, ICA512 and ZnT8
Ab; T1DM related HLA haplotypes.
Results: A total of 43 patients (23 female) were included: 27
Somali, 9 Eritrean, 6 Ethiopian, & 1 of Ethiopian-Somali ethnic
background. 39/43 were born in Canada. Age was
11.8 ± 2.8 years. Duration of T1DM was 5.1 ± 3.3 years.
HbA1C was 9.2 ± 1.7% compared with 8.6 ± 2.0% for our
general clinic population (P = 0.023). 15/41 (36.5%) presented
with diabetic ketoacidosis (DKA), compared with 18% in the
province of Ontario. No patient had retinopathy or nephropathy.
4/43 had celiac disease. All patients were euthyroid. Ab results and
haplotypes are available for 40 patients. 15/40 had ‡1 diabetes
related Ab. 29/40 (72.5%) had HLA-DR3 haplotype, including 8/
40 with DR3/DR4.
Conclusions: No differences in clinical features are observed
between the study population and our general clinic population.
However, metabolic control in this population is significantly
worse. DKA at presentation appears to be more common in this
population. Interestingly, no patient had thyroid abnormalities.
There was a relatively large proportion of HLA-DR3. In general,
HLA haplotypes are similar to the general T1DM population.
Despite coming from a region of low diabetes prevalence, Africa,
typical HLA genetic susceptibility was found.
P/175/WED
HLA-DQB1 and DQA1 gene polymorphisms as genetic
factors of goint susceptibility to diabetes mellitus type
1 and autoimmune thyroid disease
T. Papazoglou1, E. Bozas2, D. Tsonopoulos2, A. Nikolou1, I. Androulakis2
& H. Tsoka-Gennata1
1Endocrinology Clinic, Department of Pediatrics, Aghia Sophia
Clildren's Hospital, Athens, Greece, 2Pediatric Research Laboratory,
Faculty of Nursing, University of Athens, Athens, Greece
Objectives: Type 1 diabetes mellitus (T1DM) is associated with
other autoimmune diseases, particularly with autoimmune thyroid
disease (AITD). The similar pathogenesis of T1DM and AITD as
well as their tendency to occur frequently within the same family
and in the same individual, suggest the involvement of common
genetic factors in their etiology. The aim of our study was to assess
the contribution of HLA-DQB1 and DQA1 gene polymorphisms
to AITD susceptibility among children with T1DM.
Methods: To this purpose, molecular typing of six HLA-DQB1
alleles (DQB1*0201,*0301,*0302,*0602,*0603,*0604) was carried
out, using the group-specific polymerase chain reaction
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amplification technique, to 18 patients with T1DM and AITD,
aged 11.07 ± 3.42 years, as well as to 100 patients with T1DM,
age and sex matched. Further typing of three DQA1 alleles
(DQA1*0201,*0301, *0201) was performed in HLA-DQB1 *0201,
x carriers. In our study group, T1DM was diagnosed at an age of
7.85 ± 1.98 years and AITD at an age of 8.92 ± 2.21 years.
AITD was diagnosed through positive antithyroid antibody testing
and ultrasound findings suggestive of the disease (heterogenity and
hypertrophy of the gland). The TSH levels at diagnosis were
5.11 ± 2.25 lIU/ml and the exogenous thyroxine requirements at
last examination were 1.6 lg/kg/day.
Results: A higher incidence of the HLA-DQB1*0302, 0301
genotype (P = 0.002, OR: 5.22) was found in patients with
T1DM and AITD compared to patients with T1DM without
AITD. The HLA-DQB1*0302 allele increases the risk of AITD in
patients with T1DM (P = 0.028, OR: 4.84). Patients with T1DM
and AITD with the DQB1*0201, x genotype carry the DQA1*0501
allele in a higher incidence compared to patients without AITD
(P = 0.003, OR: 2.87).
Conclusions: Our results support a share genetic susceptibility to
T1DM and AITD. The HLA-DQB1 and DQA1 gene
polymorphisms seem to modify the risk for AITD in patients
with T1DM.
Poster Session II: Diabetes Project in
Developing Country
P/176/FRI
Adolescent diabetes management: role of NGO's in
resource poor settings
D.S. Pramod
Health Alert Organization of India [NGO], Dhule, India, DS Mandali
Clinic, Dhule, India
Issues: Adolescent diabetes social stigma in India. Diabetics needs
proper guidance/information/treatment outlets. This is burning
issue in developing-nations like India. Hence we need to unite &
form comprehensive diabetes care & counselling policy plan at
ISPAD-2009-conference. Treatment options must be suitable for
developing-nations considering cost of Rx. Incorporating NGO’s
in such efforts very effective.
Methodology: Our 15-year-old NGO started Diabetes education in
rural India from 2005 as education & surveillance project to
analyze social & anthropological issues facing those affected by
adolescent diabetes. Total 62 adolescents enrolled by Feedback
questionnaires. Got their feedback on special needs, perceptions,
social attitude on diagnosis of diabetes. Factors like community-
inhibition, social-ostracism, economic-difficulties, marital discord,
non-availability of treatment-guidance centres, lack of trained-staff
analysed. Draft policy recommended to Govt-agencies.
Lessons learned: Adolescent diabetes management must include
nursing & psycho-social needs. NGO’s in diabetes education is cost
effective with better impact on young diabetics. Community mass
intervention projects proven useful in rural communities of
resource poor-nations. ISPAD-2009-conference-participants must
collaborate with NGO-activists to address this issue. Uniform
public health policy needed to implement & expand newer
strategies to include broader range of diabetes care-issues.
Recommendations: Promoting dialogue between Government and
NGO’s accelerates diabetes education/awareness programs in
economically poor populations. This would reduce difficulties
faced by young diabetics from Asian countries. It is essential that
WHO, ISPAD form common guideline manual on this issue
affecting developing-countries. We graphically present our NGO’s
project on diabetes education plan in four phases to 35th ISPAD-
2009-conference participants.
P/177/FRI
Modification of cardiovascular risk factors in children
and adolescents with diabetes and with overweight
and obesity in Belarus
Y. Vainilovich, L. Danilova, V. Morozik, O. Olshanskaja & M. Portnaja
Belarusian Medical Academy for Postgraduate Education,
Endocrinology, Minsk, Belarus
Objectives: The atherosclerotic process starts in childhood and its
progress is mediated by the presence of identified cardiovascular
(CV) risk factors. Aim of this study is to develop the interventional
strategies for modification of CV risk factors in high risk groups of
children and adolescents with type 1 (T1D) and type 2 diabetes
(T2D) and with overweight and obesity in Belarus by studying the
individual risk factors, lipids profiles and subclinical vascular signs
of atherosclerosis.
Methods: The project is planned in several stages. First we study
prevalence of overweight and obesity in school children and
adolescents aged 10–18 years from Minsk and analyze nutritional
patterns, physical activities and family history in those children and
in young patients with T1D and T2D. Then we investigate
prevalence of metabolic syndrome in children with overweight
and obesity. We also measure carotid intima-media thickness
(IMT) in children and adolescent with overweight and obesity and
with diabetes compared with control group. Based on analyses of
obtained CV risk factors we develop interventional programs for
managing high-risk groups of children and adolescents and
estimate their efficacy in a year period of intensive follow-up of
those groups.
Results: We obtained the preliminary data from screening of 341
school children age 10–18 years, M/F 151/190. Mean age and mean
BMI were not different between males and females, but estimated
percent of total fat was higher in females (P < 0.01). The
prevalence of overweight (BMI ‡ 90th percentile) was 10.9% in
total group (9.3% in males and 12.1% in females). The prevalence
of obesity (BMI ‡ 97th percentile) was 12.4% in total group
(higher in males 16.1% vs. 9.5% in females). Obesity defined as
estimated percent of total fat >25% in males and >30% in
females was found in 16% of males and in 19% of females.
Conclusion: The first results of the study demonstrate high
prevalence of overweight and obesity in school children in Belarus.
P/178/FRI
Type 1 diabetes in ''Have'' children in India –
experience and future of the insulin pump therapy
program in the state of Karnataka, India: successes,
failures and social engineering
B.N. Naik & A. Sharda
Samatvam Endocrinology Diabetes Center, Bangalore, India
India is a ‘‘continent’’ of striking extremes and contrasts: ancient to
ultra modern, very rich to abjectly poor, highly intelligent to totally
illiterate, and thus socially justified health care projects must reach
out to all sections of society. Our Insulin Pump Project (IPP) was
started in 2002; 1st Certified Insulin Pump Project in India; 8
Certified Pump Trainers (CPTs); 3 of them having T1DM and were
the initial pump users (1 doctor, 1 diabetes educator, 1 volunteer);
despite 20 eminent endocrinologists and hundreds of diabetologists
in our state, 90% of the total pump prescriptions in our state (Total
population is 53 m) come from our own practice of 2 endocrinol-
ogists.
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Program: Patients initiated = 36 (T1DM 30, T2DM 5, 2 DM 1);
Offered Pump in Clinic = 30; Pump sought by patients = 6; Drop
outs = 5. Reasons for going on pump: Recurrent severe
hypoglycemia = 8; Wide fluctuations in BG levels = 20;
Suboptimal DM control = 17; Micro/Macro vascular
complications = 4; Compromised lifestyle = 18; Infants and
neonates = 3; Eating disorders = 0; Pronounced dawn
phenomenon = 6; Needle phobia = 1; Pregnancy-
preconception = 1; Ketosis prone = 1;Competitive athletes = 0.
Age at DM diagnosis = 3 to 28 years; duration of diabetes = 0 to
32 years; age at pump initiation = 3 to 45 years; number of years on
pump = 1 to 7; number of basal rates/day = 4 avg; number of
boluses/day = 4 avg. Complications - problems on pump: Severe
hypoglycemia = 0; Metabolic deterioration DKA = 0; Site
infection/recurrent = 4; Site irritation = 6; Site failure/Cannula
occlusion = 6; Body image problem = 2; Insulin omission = 2;
Diabetes burnout = 1.
Conclusions: Insulin pump therapy is being increasingly accepted
in India; Indications, difficulties and limitations are similar to that
experienced in more affluent societies; increased awareness and
education of physicians and patients necessary for wider usage and
benefits; Technology improvements and cost reduction
(refurbished pumps, lower cost disposables) will facilitate. MAN,
MACHINE AND MONEY: ALL IMPORTANT.
P/179/FRI
Genetic risk and autoantibodies profile in children from
countries with low-incidence and high-incidence for
type 1 diabetes
M.E. Pinto
Cayetano Heredia Hospital, Endocrine Service, Lima, Peru, Cayetano
Heredia University, School of Medicine, Lima, Peru
Background: The incidence of type 1 diabetes (T1D) varies
considerably among countries. Peru has an incidence rate of
0.4 per 100 000 per year and Finland has the highest one in the
world (>50 per 100 000 per year). In the other hand, a steady
increase in the incidence of type 1 diabetes has been reported
worldwide, and this increase is particularly large in the youngest
age-group (0–4 years). The genetic risk for T1D conferred by
HLA haplotypes and the immunological profile are not well
established in children from countries with a low incidence of
T1D.
Aims: To compare the genetic risk for T1D and the immunological
profile between Peruvian newborns (low-incidence country) and
Finnish newborns (high-incidence country).
Methods: We will recruit participants from delivery units. All
newborn babies from the general population will invited to
participate. In Peru, the study will be conducted at the Cayetano
Heredia Hospital (Lima) and, in Finland, at the University
Hospital of Turku. We will collect cord blood spots for HLA-
DQB1 typing. The genotype DQB1*02/*0302 will be defined as a
high risk for T1D. Children at genetic risk for T1D will be invited
for follow-up. Visits will take place every 3–6 months until the age
of 2 years, and every 6–12 months thereafter. In this visits, we will
detected autoantibodies against insulin and glutamic acid
decarboxylase by specific radiobinding assays. Also, we will
measure insulin and plasma glucose. An informed consent will be
obtained from both parents and the protocol will be approved by
the Ethics Committee of the Cayetano Heredia University and the
University of Turku. Statistical analysis will be performed with
STATA software and a P-value <0.5 will be considered statistical
significant.
P/180/FRI
Did diabetes mellitus worsen already existing severe
marasmus or did marasmus cause diabetes in an
eleven-month-old severely malnourished infant in
Kenya?
L.W. Mungai & W. Ezekiel
University of Nairobi, Paediatrics and Child Health, Nairobi, Kenya
Marasmus is a serious worldwide problem that involves more than
50 million children younger than 5 years. It is more frequent in
children at this age because this period is characterized by
increased energy needs and increased susceptibility to viral and
bacterial infections. Weaning, which occurs during this period, is
often complicated by factors such as geography, economy, hygiene,
public health, culture and dietetics. Protein mass in organs can
decrease up to 30% in the most serious forms. The brain, skeleton,
and kidney are preserved, whereas the liver, heart, pancreas, and
digestive tract are first affected. Most children with type 1 diabetes
mellitus present with about 10% weight loss. However, they regain
their weight few weeks after insulin therapy is initiated. We present
a case of an 11-month infant diagnosed to have severe malnutri-
tion, dehydration and pneumonia until she went into coma. In the
process of looking for hypoglycaemia common in these patients a
diagnosis of diabetes ketoacidosis was made. The management of
marasmus and diabetes ketoacidosis are both standard but the
latter had to take priority without compromising nutritional
therapy. As one gives education to the parents of such an infant
the challenge one has is to separate the two diagnoses and explain
which condition occurred before the other.
P/181/FRI
Take action programme in Bangladesh
B. Zabeen, F. Mohsin, N. Nabi, N. Nahar & K. Azad
Bangladesh Institute of Research and Rehabilitation in Diabetes,
Endocrine and Metabolic Disorders (BIRDEM), Paediatrics, Dhaka,
Bangladesh
Bangladesh is one of the developing countries in the world and has
the lowest health care spending per capita making even basic
medical care unaffordable. It is estimated that over three million
people have diabetes in Bangladesh and few of them receive
optimum medical care. Bangladesh Diabetic Samity (BADAS)
provides excellent diabetic care through a central institute-
BIRDEM, which is a tertiary centre located in Dhaka. Over 2000
children and adolescents are registered here and most of them
getting free medical care. Take Action project in Bangladesh is an
initiative of WDF with joint collaboration of BADAS funded by
Novo Nordisk employees. The programme commenced with focus
on providing free insulin, syringes & urine strips to poor diabetic
children. Initially sixty children were enrolled but now it has
extended with hundred diabetic children with scope of monitoring
glycaemic control by free HbA1c twice yearly. Inclusion criteria
are: children <15 years, from poor socio-economic condition and
residents of Dhaka. Several recreational activities were organized.
A painting session was held where children expressed their feelings
about the impact diabetes has on their lives. A day trip to an
amusement park was also organized with children and their
families. Last year a rally was organized with them to commem-
orate the World Diabetes day.A camp was organized with the
children and families with diabetes care team of BIRDEM. The
purpose of the camp was to provide an educational as well as
recreational experience away from hospital and home in a relaxed
non-hospital atmosphere. The diagnosis of diabetes for a child is
devastating for a family both mentally and financially where most
of the people cannot afford their basic medical care. Take Action is
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helping these families & also contributing to BADAS in its mission
to provide free care to the poor diabetic children.
Acknowledgement: Novo Nordisk employees & WDF.
P/182/FRI
Diabetes mellitus type 1 in siblings
A.V. Stankovic, S. Sajic, N. Stanic, M. Nikolic, L. Stojanovic &
V.M. Zdravkovic
University Childrens Hospital, Endocrinology, Belgrade, Serbia
Serbia developed Diabetes registry in 2004. Since data at presen-
tation and follow up visits are entered, we wanted to see if this
database is suitable for research purposes. It is estimated that
<10% of siblings develop Diabetes Mellitus type 1 (DMT1).
Objectives: We wanted to find the percentage of families with more
than one child with DMT1 in our clinic population. The second
objective was to compare the presentation and clinical course in the
first year between the two siblings.
Methods: We analyzed the following data: duration of symptoms,
presence of ketones, HbA1c at the beginning, and at 3-month
interval in the first year and number of days of diabetes teaching.
Results: We were able to identify 9 families who had two children
with DMT1 among 412 patients included in the database.
We conclude that Diabetes registry could be useful for obtaining
the data and that the other possibilities for research should be
explored. We have 3% of families with more than one children with
DMT1 in our clinic. Although they presented earlier and with
better HbA1c compared to their sibling, we need to improve our
diabetes teaching.
Table [Presentation data]
First sibling Second sibling
Ketoacidosis/Ketones 7/9 2/4
Duration of symptoms (days) 28 8
HbA1c at presentation (%) 12.9 9.8
HbA1c at 12 months (%) 8.1 7.4
P/183/FRI
A project on diabetes in developing countries
M. Demir, DiabetClub
DiabetClub-Murat Demir, Diabet, Kocaeli, Turkey
Aim: To prevent from bad effects of diabetes by facilitating the
directing style with diabetes.
Target: To teach diabetes exercise programs with the target of
melting the fat in abdominal area. These education programs of
living with diabetes in a healthy way include diabetics, families and
people who provide services.
Method: We tested by surveys to check how well the diabetics and
the centres who provide services know about diabetes. We got
permissions from their connected centres which we saw some lack
of knowledge and we educated them by teaching them about
diabetes and we used the press to make a large participation. By
using SMS, we reached the diabetics, who were registered before by
pharmacies studies and area studies, to let them listen loudly, we
recorded the exercise program in CD and MP3 players. We made
blood tests to check if they do exercises regularly. For patients
whose results were high, we reorganized exercise programs to
educate them to use medicines in regular amounts and times and
we made them exercise together with other patients who use the
same pharmacies. We educated them to use the devices correctly
and to test regularly. We taught them to live in health with diabetes
in order to prevent them from being into depression after they test
by themselves. We also organized education seminars for the
relatives of diabetics to make them learn about the psychological
structures of the diabetics to help them live with diabetes alone.
Not only diabetes and their relatives joined these seminars but also
people who provides social services, medical product staffs,
diabetes education nurses and doctors joined.
Poster Session I: Monogenic Diabetes Forms
and Their Treatment
P/184/WED
Association between type 1 diabetes mellitus (T1DM)
and maturity onset diabetes of the young (MODY):
report of two cases
M. Scipione1, G. Maltoni1, S. Salardi2, S. Zucchini1, V. Mantovani3 &
A. Cicognani2
1S.Orsola-Malpighi Hospital, Pediatrics, Bologna, Italy, 2University of
Bologna, Pediatrics, Bologna, Italy, 3University of Bologna, Medical
Genetics Unit, Bologna, Italy
The onset of T1DM in subjects with MODY has been rarely
described. We report two patients affected by MODY who
progressively developed marked hyperglycemia.
Case 1: A 4-year-old girl was refered for glycosuria. Initial fasting
glucose was 99 mg/dl and HbA1c 6.6%. ICA and GADA were
negative, HLA DR3-DR6. Father, uncle and grandmother had
mild hyperglycemia, never requiring treatment. She was screened
for MODY 2 and a mutation in glucokinase gene was found
[IVS7 + 2T > A]. Her father and sister shared the same
mutation. Few months later, during an infectious disease, blood
glucose raised to 300 mg/dl. She was put on a combined therapy
with insulin and glybenclamide. A high titer of GADA was
detected. Her insulin requirement gradually increased from 0.4 to
0.8 U/Kg/day. The patient is the only affected member of the
family requiring a pharmacological treatment to maintain good
metabolic control (HbA1c 6.9%). C-peptide is 0.6 ng/ml after
onset of the GADA positivity.
Case 2: A 15-year-old boy treated with GH for GH deficiency for
6 months. During routinary tests blood glucose was106 mg/dl.
Family history was positive for autoimmune diseases
(connectivities, thyroiditis) and T2DM. HbA1c was 7.2%,
C-peptide 1.9 ng/ml. ICA and GADA were negative, HLA DR4.
Autoimmune thyroiditis was then diagnosed. The patient was
investigated for MODY 2 and MODY 3 and a mutation of HNF1
alfa gene was found [p.G31D (c.92G > A)]. The same mutation
was found in the mother. After 1 year due to a worsened metabolic
control (HbA1c 12.7%), autoimmunity was investigated and a mild
positivity for GADA and ICA was found. He was put on insulin
therapy (1 U/Kg/day). The boy showed an increasing positivity for
autoantibodies and an undetectable c-peptide. Present metabolic
control is poor (HbA1c 8.2%).
Conclusions: The diagnosis of MODY 2 or 3 does not exclude the
risk of developing T1DM. Autoimmunity should be investigated in
these patients if metabolic control unexpectedly worsens.
P/185/WED
Exocrine pancreatic insufficiency is rare in children
with type 1 diabetes
F. Rodieux, M. Dirlewanger & V. Schwitzgebel
Children Hospital Geneva - University of Geneva, Pediatric Endocrine
and Diabetes Unit, Geneva, Switzerland
Objective: Recent studies suggest a dysfunction of the exocrine
pancreas in 10–45% of patients with type 1 diabetes, which is often
not recognized in clinical practice, but may be easily diagnosed by a
the measurement of elastase concentration in the feces (FE). While
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most of the studies were done in adults, we determined the
prevalence of pancreatic exocrine dysfunction in children with type
1 diabetes using FE measurements.
Method: A total of 43 children and adolescents (20 boys, 23 girls,
mean age 10 years) with type 1 diabetes were consecutively
included in this prospective study. We screened for FE deficiency
and diagnosed severe exocrine dysfunction if FE was <100 lg/g,
moderate exocrine dysfunction if FE was between 100–200 lg/g,
no dysfunction if FE was >200 lg/g.
Results: FE was normal in 40 patients (93%), mildly decreased in
two patients (4.7%) and severely decreased in one patient (2.3%).
All three patients had no gastrointestinal complaints. The child
with severely decreased FE was further investigated to exclude
other diseases causing exocrine pancreas dysfunction such as cystic
fibrosis, Shwachman-Diamond syndrome and celiac disease.
Abdominal ultrasound showed an atrophic pancreas without
fatty infiltration. Pancreatic exocrine enzyme substitution was
introduced.
Conclusions: In our cohort, the prevalence of pancreatic exocrine
deficiency (moderate and severe) in children with type 1 diabetes
was low, at 7%. In the patient with the lowest FE level, a genetic
defect, such as mutation in the Hepatocyte Nuclear Factor 1 beta
(HNF1b) gene (MODY 5) should be considered. A mutation in the
Carboxyl-Ester Lipase (CEL) gene (MODY 7) is not likely to be
the cause, since pancreatic lipomatosis, a hallmark of this disease,
was absent. Diagnosis of type 1 diabetes should be revisited in
children with diabetes and severe pancreatic exocrine dysfunction.
P/186/WED
Genetic testing in patients with a clinical diagnosis of
maturity-onset diabetes of the young (MODY) – the
Australian experience
J.Y. Wu1, I.N. McGown1, T.B. Munce1, M. Harris2, O. Nyunt2,
A.M. Cotterill2 & D.M. Cowley1
1Mater Children's Hospital, University of Queensland, Clinical
Chemistry, Brisbane, Australia, 2Mater Children's Hospital, University
of Queensland, Paediatric Endocrinology, Brisbane, Australia
Objectives: Maturity-onset diabetes of the young (MODY) affects
about 2–5% of individuals with diabetes. In 2005, molecular
genetic testing for GCK, HNF1A and HNF4A, was introduced by
Mater Health Services, the only laboratory in Australia to offer
these tests. We report our experience in molecular diagnosis and
identification of MODY.
Methods: Testing of all three genes was carried out by bidirectional
DNA sequencing and Multiplex ligation dependent probe
amplification (MLPA). The probands clinical information were
obtained through discussions with their treating doctors and review
of medical charts. Relevant biochemistry results were obtained
through various laboratories where probands had attended.
Results: The number of requests for testing has increased steadily
from nine in 2005 to 53 in 2008. Out of the 50 patients referred to
our laboratory for testing, 15 were found to have 13 different
sequence variations. In addition 16 family members have also been
tested. Two sequence variants were found in HNF4A, including
one novel mutation; eight were found in GCK, including three
novel mutations; and three previously described mutations were
found in HNF1A. Thus of the probands, 20% have HNF4A, 53%
have GCK and 27% have HNF1A. There was a 71% positive
detection rate for MODY mutations in patients with a family
history of diabetes and absence of pancreatic auto-antibodies.
Conclusion: The majority of probands had an autosomal dominant
pedigree and all had absence of pancreatic auto-antibodies. The
relative frequency of MODY subtypes within Australia may differ
as our results only relate to patients clinically referred for genetic
analysis. Given the important implications of confirming the
clinical diagnosis of MODY and identifying the specific MODY
subtype we believe that genetic testing should be more widely
utilized in patients with an autosomal dominant pedigree who are
negative for pancreatic autoantibodies.
P/187/WED
An unexpected change of the treatment in children
with permanent neonatal diabetes
M. Mihu1, C.M. Mihai2 & R.M. Stoicescu3
1''MS Curie'' Children's Hospital, Pediatric Diabetology, Bucharest,
Romania, 2''Ovidius'' University, Faculty of Medicine, Constanta,
Romania, 3''Ovidius'' University, Faculty of Farmacy, Constanta,
Romania
Introduction: Neonatal diabetes mellitus is rare, and until recently,
most forms of permanent neonatal diabetes required lifelong
subcutaneous insulin for management.
Objective: Transition from subcutaneous insulin therapy to oral
sulfonylurea therapy in the in-patient setting was assessed in 4
patients with history of intrauterine growth retardation (IUGR);
hyperglycemia, glycosuria, osmotic polyuria, severe dehydration,
and failure to thrive, and the diagnosis of neonatal diabetes.
Methods: Initial therapy with insulin corrected the hyperglycemia
and allowed for catch-up growth. All these families had problems
with rapid fluctuations in blood glucose levels on insulin regimen
with twice-daily Detemir. Because of hypoglycemic episodes, it was
difficult to introduce much fast-acting insulin. Despite the lack of
genetic diagnosis, these patients were managed with a sulfonylurea
glyburide (glibenclamide).
Results: Our patients needed low doses of both insulin before
transfer (0.4 units · kg (-1) · day (-1); and sulfonylureas after
transfer (0.50–0.30 mg · kg(-1) · day(-1). HgbA1C decreased
from 8.2% on insulin to 6.5% on sulfonylureas. Glibenclamide
(glyburide) treatment was started at 4, 6 and 9 months and 4 years
of age and resulted in insulin being discontinued, lower overall
glycemia, reduced glucose fluctuations and reduced hypoglycemia.
Good control is still maintained after the discontinuation of
insulin, despite a reduction in the glibenclamide dose, from 0.5 to
0.3 mg · kg(-1) · day(-1) in one patient.
Conclusions: Oral sulfonylurea therapy was safe and effective in
our patients and may successfully replace treatment with insulin
injections, without significant side effects or increased
hypoglycemia. We assume that they carry mutations in KCNJ11
or ABCC8 genes, the only ones that can be treated long term with
oral sulfonylureas. Early molecular diagnosis is important in
patients with neonatal diabetes, because the treatment with
sulfonylureas could be started earlier.
P/188/WED
Smooth transition to glibenclamide treatment in an
Egyptian child with permanent neonatal diabetes due
to KCNJ11 (Kir6.2) mutation
N.S. Elbarbary
Ain Shams University, Pediatrics, Cairo, Egypt
Introduction: Neonatal diabetes may be defined as insulin-
requiring hyperglycemia that is diagnosed within the first three
months of life. It may be either transient or permanent that
requires treatment for life. Conditions that cause neonatal diabetes
have been identified. The pancreatic ATP-sensitive potassium
channel is a critical regulator of beta-cell insulin secretion.
Mutations in the KCNJ11 gene have recently been found to
cause diabetes in the neonatal period or early infancy. Such
mutations account for 30 to 58% of cases of permanent diabetes
diagnosed in patients under six months of age. Diabetes results
from impaired closure of KATP channel in response to increased
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intracellular ATP. Sulfonylurea closes the KATP channel by an
ATP-independent route and hence stimulates insulin release.
Aim: To assess the efficacy of oral Sulfonylurea in an Egyptian
child with permanent neonatal diabetes after switching from insulin
injection.
Case report: Our patient presented at age of 5 weeks with
hyperglycemia (656 mg/dl) and Ketoacidosis (pH: 6.99, HCO3:
6.5, Acetone :++) HbA1c = 10.2%, C-peptide <0.5 ng/ml
.Initially continuous I.V. insulin infusion was given. Afterwards,
R +NPH insulin in 3 daily doses; he was normoglycaemic at
2.25 IU/day. No other medical problems .His follow up HbA1c
ranged from 7.2–8.9% and insulin dose 0.63–0.78 (U/kg/day).At
age of 4.5 years Genetic screening of the Kir6.2 gene using PCR
revealed mutations at R201H. Insulin therapy was switched to oral
Glibenclamide tablets started at 0.05 mg/kg/12 hour and insulin
therapy could be terminated after 6 weeks. He is now on 0.46 mg/
kg/day (7.5 mg/day), HBA1c 6.8%, optimal glycemic profile.
Conclusion: The first permanent neonatal diabetes patient in Egypt
was found to have a genetic defect impairing KCNJ11 gene. Low
dose of Glibenclamide could sustain a good metabolic control with
marvelous improvement in quality of life after stopping insulin
injections.
P/189/WED
Wolcott-Rallison syndrome in a Brazilian child with
neonatal diabetes mellitus
T.D. Manna1, R.D. Savoldelli1, A.F. Reis2, D. Damiani1, C.
Kannengiesser3, C. Oudin4, C.S.V. Oliveira2, F. Kok1 & G. Velho5
1Instituto da CrianÅa HC-FMUSP, Pediatrics, S¼o Paulo, Brazil,
2Laboratory of Molecular Endocrinology, Federal University of S¼o
Paulo, S¼o Paulo, Brazil, 3Laboratoire de Biochimie Hormonale et
Gntique, APHP Hpital Bichat Claude Bernard, Paris, France,
4Laboratory of Molecular Genetics, Institut National de la Sante et de
la Recherche Medicale U-517, Dijon, France, 5INSERM Unit 561,
Hpital Saint-Vicent de Paul, Paris, France
Neonatal diabetes mellitus (NDM) is a rare condition defined as
persistent hyperglycemia occurring within the first 6 months of life.
Heterozygous activating mutations of KCNJ11 and ABCC8 are
responsible for approximately 50% of permanent NDM (PNDM)
but defects in several other genes (INS, IPF1, GCK, HNF1B,
FOXP3) have also been implicated.
Objective: Here we describe a Brazilian child with PNDM and
Wolcott-Rallison syndrome (WRS) due to a novel mutation in
EIF2AK3 gene.
Subject and methods: A eight and half-year-old boy, born from
first-degree cousins, was diagnosed with DM at two months of age
and since then he has been in insulin therapy. Anti-insulin, IA2 and
GAD autoantibodies were negative. Central hypothyroidism was
identified at that time. At the age of 2 years, he fractured the tibia
after a fall, bone X-ray demonstrated spondiloepiphiseal dysplasia
and diffuse osteopenia. Clinical diagnosis of WRS was established.
At the age of 6 years, type 4 renal tubular acidosis was identified
and, six months later, he had an episode of acute hepatic failure
triggered by an acute viral infection, with spontaneous recovery.
Viral hepatitis was excluded. He also presents developmental delay
with mild mental retardation and short stature with height of
95 cm (-6.6 SDS) and body weight of 15 kg (-5.68 SDS).
Results: Sequencing of the EIF2AK3 gene in genomic DNA
extracted from peripheral lymphocytes demonstrated a
homozygous C > T replacement at base pair c.1192, generating
a stop codon at position 398 (Q398*). Both parents were found to
be heterozygous for this mutation.
Conclusions: WRS (OMIM 226980) is a rare, autosomal recessive
disorder and to date, only around 40 cases of WRS have been
described. The clinical phenotype can be variable, but a
combination of neonatal diabetes mellitus, multiple epiphyseal
dysplasia, osteopenia, developmental delay, and hepatic and renal
dysfunction are typical. This is the first case of WRS reported in
Brazil.
P/190/WED
Metabolic control in a case of permanent neonatal
diabetes. insulin versus sulphonylurea
I. Micle, R. Giurescu, M. Marazan & E. Pop
Children Emergency Hospital Louis Turcanu, Timisoara, Romania
Aim of this case presentation is to compare insulin versus
sulphonylurea therapy in permanent neonatal diabetes mellitus
(PNDM). A particular case of diabetes mellitus (DM) with onset in
early infancy is presented. B. Sebastian 3 years old was first
admitted in our hospital hospital at the age of 3 months with the
diagnose of DM. His familial history revealed: No familial history
of diabetes; Second child, gestational age = 36 weeks; Birth
weight = 2550 g; The child was exclusively breast fed until the
age of 3 months then mixed. History of present illness: At
3 months diagnose of DM with ketoacidosis was established. The
HbA1c at onset was 15.2%. The patient received insulin therapy in
a multiple injection regimen. Insulin therapy was then switched to a
regimen of 2 injection, using Levemir. Insulin treatment lasted
7 months. Under insulintherapy, poor glycemic control was
obtained-high glycemic variations (54–437 mg/dl), frequent hypo-
glycemias, average glycemic value 129 ± 60 mg/dl, HbA1c 12.1%
after 1 month and 7.8% after 7 months of insulintherapy. At 10-
months old, based on clinical arguments for PNMD the child was
successfully switched to sulphonylurea treatment (1.8 mg/kg/d in
two prises). The insulin injections were progressively reduced in
3 days after beginning of the oral therapy.The clinical and
metabolic improvement was excellent without hypoglycaemias.
After six months of sulphonylureas: HbA1c is 6.6%: basal
glycaemia 113 ± 32 mg/dl, preprandial 143.38 ± 95 mg/dl and
postprandial glycaemia 124.35 ± 76 mg/dl, small glycemic varia-
tions 37.43 ± 49 mg/dl. Diabetes control is obtained with sulpho-
nylurea (0.16 mg/kg/d – 3 doses).At the age of 3 years genotyping
confirmed the diagnose of PNMD. Further parental genetic tests
are being performed.
Conclusions: The aetiology of DM with onset before 6 months of
age is genetic.The metabolic balance obtained is superior under
sulphonylurea therapy. It is the first case of PNDM treated with
oral antidiabetes in Romania.
P/191/WED
The challenges of diagnosis and treatment of MODY1
teenage girl
V.M. Iotova1, S. Ellard2, S. Galcheva1, V. Boyadzhiev1, W. Mladenov1 &
A. Hattersley3
1University Hospital St. Marina, Clinic of Pediatric Endocrinology,
Varna, Bulgaria, 2Royal Devon and Exeter Foundation Trust, Exeter, UK,
3Peninsula College of Medicine & Dentistry, Exeter, UK
We present a 19-year-old Bulgarian girl, born with normal weight
and length with unknown family history. At the age of 16 she was
referred to us because of progressive diabetic symptoms for
3 months, weight loss of 6 kg despite her increased appetite,
fasting blood glucose levels over 9.0 mmol/l, HbA1c 9.1% without
tendency to ketoacidosis. She had normal physical, pubertal and
mental development. Her BMI was 20 kg/m2, with no signs of
insulin resistance. After the admission her BGL varied from 10.0 to
21.8 mmol/l, normal electolytes, renal and liver function, dyslipi-
demia with increased triglycerides. The first urine analysis showed
mild glucosuria, without ketonuria or proteinuria. At the time of
diagnosis, her C-peptide level was in the normal range 1008 pmol/l
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(170–980), and the autoantibodies (GAD65, IA2, IAA) were
negative. Insulin therapy was started with rapid and long-acting
insulin analogues (1 IU/kg BW). In 1.5 months the insulin therapy
was ceased gradually after confirming the lack of autoimmunity
and oral treatment with Glipizide was initiated. After 1 month of
SUR treatment, her HbA1c decreased to 6.9%, but she complained
of midday hypoglycemia as low as 1.9 mmol/l. She then continued
the therapy with Diaprel SR, diet and physical activity. In 2-years
period her HbA1c varied between 6.9 and 7.1, sometimes up to and
9.5%, because of dietary mismanagement. Urine analyses remained
normal. The age of the patient, the clinical signs with the lack of
obesity, insulin resistance, tendency to DKA, and the absence of
autoimmunity and glucosuria were our diagnostic criteria for
MODY1 diabetes. In 2009 a genetic sequencing analysis was
performed and an HNF4A mutation (R244Q) was confirmed. This
mutation up to now has been reported only in 2 other families. The
diagnosis is important because our patient is pregnant and the
baby is at greater risk of macrosomia and neonatal hypoglycemia,
which raises further problems with the management of her
diabetes.
P/192/WED
Case report from Egypt: the use of continuous
subcutaneous insulin infusion in neonatal diabetes
with glucokinase mutation
K.Y. Eltonbary1, M. Salem1 & S. Ellard2
1Ain Shams University, Pediatrics, Cairo, Egypt, 2Peninsula Medical
School, Human Molecular Genetics, Exeter, UK
Preterm baby weighing 1200 gm with intrauterine growth retarda-
tion; born to a mother with gestational diabetes; entered the
Neonatal Intensive Care Unit (NICU) and during the 1st week, her
blood glucose levels showed persistent hyperglycemia without
ketosis and diagnosed as a case of neonatal diabetes. Insulin was
started in the NICU but with severe fluctuations and repeated
hypoglycemic attacks. Two months later, the patient was referred
to our university hospital and was started on continuous subcu-
taneous insulin infusion using (Medtronic 712 pump) resulting in
minimal blood glucsoe fluctuations and minimal hypoglycemia.
Genetic study was done to decide for further management and the
baby turned out to be homozygous for a novel missense mutation
H50D, in exon 2 of the GCK gene. This C > G mutation at
nucleotide 148 (c.148C > G) results in the substitution of the
amino acid aspartic acid (acidic charged polar) for histidine (basic
charged polar) at codon 50 (p.His50Leu).
Conclusion: Continuous subcutaneous insulin infusion is effective
in managing neonatal diabetes. Genetic analysis should be carried
out to every case with neonatal diabetes to give proper decision
about future management.
P/193/WED
The difficulties during complex treatment of secondary
diabetes in patient with familiar partial lipodystrophy
suspicion
D. Witkowski1, D. Rokicki1, M. Walewska-Wolf2, M. Szarras-Czapnik3,
J. Skawarzec1, R. Janas4 & E. Piontek1
1The Children's Memorial Health Institute, Dept. of Metabolic Diseases,
Endocrinology and Diabetology, Warsaw, Poland, 2The Children's
Memorial Health Institute, Gynecological Outdoor Clinic, Warsaw,
Poland, 3The Children's Memorial Health Institute, Endocrinological
Outdoor Clinic, Warsaw, Poland, 4The Children's Memorial Health
Institute, Dept. of Radioimmunology, Warsaw, Poland
Objectives: The insulin resistance is rather rare problem in
paediatric patients. Unfortunately, there are increasing number
of patients who do not benefit from typical sensitizers drug
treatment. The clinical problem is how to obtain or improve
metabolic control in case of severe insulin resistance.
Methods: A 15-year-old girl was admitted to the hospital due to
diabetes mellitus suspicion. The features of dismorphy, hirsutism,
primary amenorrhea were determined. Baby born with birth weight
of 2950 g. Psychosocial development was correct. In anamnesis
without typical features of diabetes, sudden loss of weight,
recurrent infections. In physical examination dismorphy features
(bird-like face), hirsutism, lack of subcutaneous fat, weight deficit,
acanthosis nigricans, clitoromegaly.
Results: Sever insulin resistance was associated with diabetes
mellitus. Fasting insulin level – 30 uIU/Ml, hyperinsulinemia
during OGTT > 308 uIU/Ml. Insulin secretion disorders were
detected upon IVGTT and glucagon test. Anti-GAD Ab and
IA2 Ab (-). The lipid disorders were present. Leptin level was
normal.In the beginning patient was treated with insulin.
Nowadays with insulin-sensitizing drugs like metformin and
glitasone. Regardless complex treatment good diabetic control
was not obtained: HbA1c min. level – 8.8%, max. level-12.2%.The
girls was regularly controlled in gynecological out-door department
due to primary amenorrhea in spite of correct development of
pubescence. In clinical examination: lanugo and clitoromegaly (I
after Prader). In hormonal examination: hiperandrogenism (›
testosteron level, › androstendion level), basic gonadotropin and
estrogen level within normal range. LHRH test indicates
adolescent phase with distinct LH answer. Menarche was
induced after approximately one year treatment.
Conclusions: Differential diagnosis: inherited syndromes with
insulin resistance. Impression: familial partial lipodystrophy.
- LMNA-FPLD2?, PPARG-FPLD3?
P/194/WED
Sulfonylurea treatment in a celiac girl with neonatal
diabetes (KCNJ11 R201H): impact of low compliance to
the gluten free diet
M. Delvecchio1, C. Zecchino2, M. F. Faienza2, A. Acquafredda2,
F. Barbetti3,4 & L. Cavallo2
1IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG),
Italy, 2University of Bari, Bari, Italy, 3Bambin Ges Hospital, Roma, Italy,
4University of Tor Vergata, Roma, Italy
Glibenclamide (GC) is absorbed mostly in the intestine. A celiac
girl with transient/remittent neonatal diabetes mellitus due to a
(R201H) KCNJ11 mutation started GC when 19.8 years old.
After the age of 20.5 years, the compliance was still good to the
GC but progressively worsened to the gluten free diet (GFD),
paralleled by a HbA1c increase. When 22-year-old, she had
constant hyperglycaemia and oligomenorrhoea. As the compli-
ance to GFD improved, the HbA1c levels decreased despite a
decrease also in GC dose, the anti-transglutaminase titre got
normal values. To test the hypothesis that malabsorption could
affect the GC absorption and thus the beta-cell function, an
OGTT was performed when 23.7-year-old (when good compliant
to the GFD) and compared with the OGTT performed when 20-
year-old (similar HbA1c level, poor compliance to the GFD,
higher GC dose). The new OGTT showed higher insulin levels,
especially during the 1st hour (23.7 years vs. 20 years, insulin
ratio: 0 1.5, 60 2.1, 120 1.1; insulin to plasma glucose ratio,
pmol/mmol, 20 years: 0 2.3, 60 1.2, 120 1.9; 23.7 years 0 2.8,
60 1.7, 120 1.7). Our case suggests that intestinal malabsorption
may affect the absorption rate of GC even in absence of
diarrhoea. This mechanism should be taken into consideration in
the management of patients on sulfonylurea to avoid hyper-
glycaemia or even ketoacidosis during intercurrent gastrointesti-
nal illness.
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Age (years) 19.8 20 20.3 20.6 22 22.3 22.5 23.5 23.7
Glibenclamide
(mg/kg/day)
0.39 0.41 0.51 0.51 0.40 0.34 0.34 0.35 0.35


























35 27 38 19 52 53 not
assayed
Weight (kg) 44.2 43.7 43.5 43.5 42.7 43.2 43.2 43.5 43.5
[Follow-up data]
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P/195/FRI
Early detection of glucose derangements in children
with cystic fibrosis under ten years of age
I. De Simone, V. Raia, A. Sepe, G. Valerio, F. De Gregorio, P. Buono,
G. Cannavale & A. Franzese
Federico II University, Paediatrics, Naples, Italy, 2University of Napoli
Parthenope, Naples, Italy
Background: It has been demonstrate that diabetes significantly
impairs clinical status in Cystic Fibrosis (CF) patients. Actually the
glucose derangements screening in CF-patients has being
performed only after ten years of age by means of OGTT.
Objective: To evaluate the prevalence of early glucose metabolism
derangements in CF- patients younger than 10 years of age.
Methods: Twenty-two out of 83 CF patients <10 years old,
followed by our Regional Care CF Center, were recruited for:
Fasting Hyperglycemia (1-FH) or Occasional Hyperglycemia
(3-OH) or HbA1c ‡ 5.5% (highest quintile: 18 patients). The
non-FH patients (n = 21) underwent OGTT and Continuous
Glucose Monitoring System (CGMS). All patients who did not
present DM or IGT according to WHO criteria, but with glucose
values ‡ 7.7 mmol during the tests were classified as abnormal
glucose tolerance (AGT).
Results: Impaired glucose metabolism was found in only three
patients according to WHO: 2 DM and 1 IGT (3.6%), while AGT
was found in others 11. The total prevalence of glucose
derangements in these patients is 16.9%.
Conclusions: Glucose derangements screening is indicated in CF
patients also under 10 years of age.
P/196/FRI
Hypomagnaesemia is associated with poorly controlled
diabetes patients in adolescents but not in children
A. Galli-Tsinopoulou, I. Maggana, M. Grammatikopoulou, S. Gourgoulia
& C. Stylianou
Medical School of Aristotle University of Thessaloniki, 4th Department
of Pediatrics, General Hospital Papageorgiou, Thessaloniki, Greece
Objective: Research has showed that the degree of metabolic
control influences serum magnesium concentrations in young
patients with type I diabetes. The present study aimed in
identifying differences in magnesium serum levels between
children and adolescents. The hypomagnesemia in diabetes is the
result of increased magnesium loss via urine, associated with
hyperglycemia.
Methods: Two-hundred and sixty youngsters with type I diabetes
mellitus were recruited from our outpatients Department (129
children and 131 adolescents). Blood samples were attained in
fasting condition. Optimal serum magnesium levels were defined as
1.9–2.5 mg/dl and values below or above these levels were
considered hypomagnesaemia and hypermagnaesemia,
respectively.
Results: The prevalence of hypomagnaesemia and hypermagn-
aesemia were similar in both age-groups (22.5% vs. 22.1% and
3.1% vs. 2.3% respectively). Overall 74.4% of the children and
75.6% of the adolescents demonstrated optimal serum magnesium
levels. No difference was observed in the mean HbA1c of each
magnesium category in the children, whereas in the adolescents,
significantly higher HbA1c levels were recorded in the
hypomagnaesemic compared to the normal magnesium level
group (P £ 0.008). Between age groups, adolescents in all
magnesium level category demonstrated higher HbA1c levels
(Table).
Table [HbA1c levels in each magnesium category (%)]
Children (n = 129) Adolescents (n = 131) P between age groups
Hypomagnesaemia 7.7 € 1.0 9.2 € 2.1 £0.006
Optimal magnesiumlevels 7.4 € 0.9 7.9 € 1.7 £0.016
Hypermagnesemia 7.1 + 0.2 9.0 € 0.8 £0.004
Conclusions: The results could be explained from a parental
influence in glycemic control in pediatric patients that has a
positive affect on HbA1c levels. On the contrary, during
adolescence, the will for individual management of diabetes,
appears to result in worse glycemic control. The results indicate
that in children, hypomagnaesemia is not influenced by glycemic
control.
P/197/FRI
Spinal muscular atrophy type I (Werdnig Hoffman
Syndrome) and diabetes mellitus: are there a possible
correlation in those two cases?
R. Liberatore Junior & A.C. Gusson
S¼o Jos do Rio Preto Medical School, Pediatric Endocrinology, S¼o
Jos do Rio Preto, Brazil
Objective: Spinal muscular atrophy type I (SMA) refers to one of
four autosomal recessive neuromuscular disorders characterized by
degeneration of the anterior horn cells of the spinal cord, leading to
symmetrical muscle weakness and atrophy. SMA is the second
most common lethal, autosomal recessive disease in Caucasians
after cystic fibrosis. We describe two children with SMA that
initially developed obesity and after that, diabetes mellitus.
Methods and results: The first case is a girl diagnosed at 6 months
after respiratory failure and hypotonic muscles since the neonatal
period. She has being living at the hospital since newborn and
developed muscular atrophy and a very important obesity at
11 years of age. After some days of excessive urine output, the
diagnosis of diabetes was made by two high glycemic dosages (267
and 272 mg/dl), anti GAD and IA2 were negative with a C peptide
level of 4.3. She was started on a restrict calorie and sugar free diet
and metformin. Even loosing weight she was still hyperglycemic
and only after insulin the glycemic levels were near normal. Her
brother has begun the same picture around 9 years except by the
fact that he was not so obese. Auto antibodies were also negative
and C peptide level was 1.6. He is on insulin. There were no other
cases of diabetes in the family. They were not using any
diabetogenic medication.
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Conclusion: We describe two siblings with SMA that developed
diabetes mellitus with no detected antibodies and C peptide
between normal and upper normal range. Those are the first
cases of diabetes mellitus on SMA patients described at the
literature.
P/198/FRI
Comparison of physical activity reported and measured
in T1D and his relation to insulin requirement and body
composition
F. Ciglia, C. Costantini, R. Cardani & A. Salvatoni
Paediatric Clinic - University of the Insubria, Varese, Italy
Objectives: It is considered that a regular practise of physical
activity contribute to reduce insulin requirement and improve
metabolic control in T1D patients. The amount, intensity and type
of physical activity reported by the patients is often unreliable. Aim
of the present study is to assess the real amount of spontaneous and
programmed physical activity and to evaluate his impact on
metabolic control and metabolic syndrome related parameters.
Methods: We study 19 T1D patients (12 boys) 7 to 21 years-old
(median 14) with a disease duration 4 to 155 months (median 50),
HbA1c 6.0 to 9.5 (median 7.1), insulin requirement 0.3 to 1.0 U/kg/
day (median 0.74). All patient were asked to wear an Arm Band
accelerometer for three consecutive days. The programmed
physical activity was self-reported by a questionnaire. All
recorded data were elaborated by Sense Wear Professional 6.1
software. Body composition was assessed by bio-impedance
analysis and skin folds. Cholesterol, HDL cholesterol,
triglycerides, blood pressure, height, weight and pubertal stages
were simultaneously evaluated in all patients.
Results: The time spent doing physical activity reported by the
questionnaire and measured by the accelerometer were not
correlate. Body weight adjusted TEE resulted significantly
correlated to the percentage of body fat mass evaluated by
skinfolds (P < 0.01). Mean HbA1c and insulin requirement (U/
kg) of the last twelve moths and metabolic syndrome related
parameters did not correlate to any physical activity parameter
either reported by the questionnaire or measured by the
accelerometer.
Conclusions: A reliable assessment of physical activity and his
putative favourable effect on metabolic control require a strict and
prolonged monitoring by subjective and objective tools. Three days
are a too short span to assess the real amount and intensity of
physical activity practised on average by a diabetic child or
adolescent.
P/199/FRI
Effect of zinc supplementation on insulin resistance
and components of the metabolic syndrome in
prepubescent obese children
M. Hashemipour1, R. Kelishadi2 & J. Shapouri1
1Endocrine & Metabolism Research Center, Isfahan University of
Medical Sciences, Pediatric Endocrinology, Isfahan, Iran, Islamic
Republic of, 2Isfahan Cardiovascular Research Center, Isfahan
University of Medical Sciences, Pediatric Preventive Cardiology,
Isfahan, Iran, Islamic Republic of
Objective: Because of the role of zinc in the metabolism of insulin,
the present trial assessed the effect of zinc supplementation in
comparison with placebo on insulin resistance and components of
the metabolic syndrome in prepubescent obese children.
Methods: This triple-masked randomized, placebo- controlled
cross-over trial was conducted among 60 obese Iranian children
in 2008. In addition to physical examination, fasting serum
Participants were randomly assigned to two groups of equal
number; one group received 20 mg elemental zinc and the other
group received placebo on a regular daily basis for 8 weeks.
Then, after a 4- week- wash-out period, the groups were crossed
over.
Results: The mean age of participants was 9.1 ± 1.1 years.After
receiving zinc, the mean fasting plasma glucose, insulin and
HOMA-IR decreased significantly; the mean body mass index
(BMI), waist circumference (WC), LDL-C and triglycerides (TG)
had a non-significant decrease. After receiving placebo, the
mean FPG, insulin and HOMA-IR increased significantly, and
the mean BMI, WC, LDL-C and TG had a non-significant
increase.
Conclusion: Zinc supplementation might be considered as a useful
and safe treatment to be added to lifestyle modification for
controlling cardiometabolic risk factors related to childhood
obesity.
P/200/FRI
IGFBP-1 the most sensitive and the earliest marker of
growth hormone axis abnormalities in children with
IDDM
M. Szalecki
Childrens Memorial Health Hospital, Clinic of Metabolism,
Endocrinology and Diabetology, Warsaw, Poland
The abnormalities of growth hormone axis play a great role in
IDDM patients in pathogenesis, of diabetes complications, insulin
resistance, dawn phenomenon and fat disorders.
The aim of the study was the evaluation of growth hormone in
urine and GHBP, IGF-1, IGF-2, IGFBP-1,2,3,6 and ghrelin in
blood of prepubertal children with IDDM and estimate the
influence of the kind of therapy.
Material and methods: A total of 67 patients and 15 age matched
healthy children were included into the study. All children were
prepubertal (T < 2), suffering for IDDM for more then two years,
without any coexisting diseases. All patients were divided into
groups according to the kind of therapy.22 were treated with
conventional insulin therapy (CIT),21 with multiple insulin
injection (MII) and 24 with continuous subcutaneous insulin
infusion (CSII).There were no statistically significant differentials
between groups as to the metabolic control, age, weight, height and
BMI. Blood and urine samples were taken between 7.30 and 8.30
am. In hospital in normoglycemia after the night without episodes
of hyper or hypoglycemia. All analysis were made by RIA or
ELISA commercial kits.
Results: IGFBP-1 concentration was the only factor which
different the IDDM children and control group in a statistically
significant way. IGFBP-1 concentrations were falling down with
the intensity of treatment (the lowest in CSII and the highest in
CIT patients).
Conclusions: 1. Metabolic control is the factor with the greatest
influence on the growth hormone axis. There have been proved
correlations between HbA1c value and concentrations of IGF-1,
IGFBP-1and IGFBP-6. 2. IGFBP-1 is the earliest and the most
sensitive marker of growth hormone axis abnormalities in children
with IDDM. 3. Intensification of treatment influences the
concentration of IGFBP-1.
Supported by a research grant KBN 378/PO5/2002/23.
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P/201/FRI
Treatment with insulin detemir or NPH insulin in
children aged 2–5 years with T1DM
N. Thalange1, A. Bereket2, J. Larsen3, L. Hiort Conradsen4 &
V. Peterkova5
1Norfolk and Norwich University Hospital, Jenny Linds Children's
Department, Norwich, UK, 2Marmara University School of Medicine,
Division of Pediatric Endocrinology and Diabetes, Istanbul, Turkey,
3Novo Nordisk, Insulin Medical and Science, Bagsvaerd, Denmark,
4Novo Nordisk, Biostatistics, Bagsvaerd, Denmark, 5Endocrinological
Research Centre, Institute of Paediatric Endocrinology, Moscow,
Russian Federation
This randomised, multinational, open-labelled, parallel-group trial
compared one year¢s treatment with insulin detemir (IDet) or NPH
insulin (NPH), both in combination with mealtime insulin aspart,
in subjects aged 2–16 years with T1DM. Of 348 randomised
subjects, 82 (23.6%) were 2–5 years, of which 42 received IDet and
40 received NPH, respectively. This abstract presents the findings
in this subset of children using descriptive statistics due to the low
subject number. Insulin titration targets for fasting/pre-prandial
plasma glucose were 4–7 mmol/l without hypoglycaemia, while
nocturnal targets were ‡3.6 mmol/l. Baseline characteristics (IDet
vs. NPH) were mean age: 4.3 vs. 4.5 years, diabetes duration: 2.2
vs. 2.1 years, males: 42.9% vs. 52.5%. In the IDet group, mean
HbA1c remained fairly stable (8.2% at baseline vs. 8.1% at one
year), while a slight increase was observed in the NPH group (8.1%
at baseline vs. 8.3% at one year). FPG decreased in both groups
(from 8.44 to 7.44 mmol/l with IDet and from 8.56 to 8.11 with
NPH). A lower mean rate (episodes per subject year) of 24-hour
hypoglycaemia was observed with IDet compared to NPH (50.6 vs.
78.3). The rate of nocturnal hypoglycaemia (22:00–07:00) was also
lower with IDet than with NPH (8.0 vs. 17.4). No severe
hypoglycaemic episodes were reported with IDet, while 3 subjects
reported 6 episodes with NPH. Change in weight SD score
standardized by age and sex was -0.17 with IDet and 0.03 with
NPH. A slightly lower proportion of subjects in this age group
reported adverse events with IDet than with NPH (69.0 vs. 77.5%).
None of these were severe with IDet and the majority was
considered unlikely related to trial product. Serious adverse events
were few; (5 with IDet, 7 with NPH). In conclusion, long-term
treatment with IDet in children aged 2–5 years resulted in similar
glycaemic control, a lower rate of hypoglycaemia, (especially at
night), less excessive weight gain and fewer adverse events
compared to NPH.
P/202/FRI
Insulin analogues and toddlers with diabetes
C.M. Mihai1, M. Mihu2, R.M. Stoicescu3, L. Mihai1 & A. Balasa1
1''Ovidius'' University, Faculty of Medicine, Constanta, Romania, 2''MS
Curie'' Children's Hospital, Pediatric Diabetology, Bucharest, Romania,
3''Ovidius'' University, Faculty of Farmacy, Constanta, Romania
Introduction: Effective control of blood glucose in toddlers with
diabetes can be difficult.
Unpredictable eating patterns, different levels of activity, frequent
ilnnesses and rapid growth spurts, along with the difficulties
associated with prolonged nocturnal fasting or food refusal are the
major factors that impact on blood glucose levels at this age.
Objective: To describe a case series of 14 patients under 3 years of
age treated with a pre- or post- meal short-acting analog insulin in
conjunction with glargine insulin before bed.
Material and method: Our previous rule was to administer free-
mixing insulin, once or twice daily. Due to difficulties with
unpredictable blood sugar control at this age, we decided to use
a multiple-injection regimen in 14 toddlers with diabetes.
Results: At initial presentation, out of 14 patients, 12 were
diagnosed with diabetic ketoacidosis and 3 with cerebral oedema.
HbA1c at diagnosis was between 8.5 and 10.2%. Other
characteristics in this age-group: a rapid and severe presentation,
a shorter duration of symptoms, less then a month, a reduced
duration of the partial remission phase (1–3 months), absent in 4
patients, higher insulin requirements in the first 6 months after
diagnosis. All had extremely variable blood sugar control with
unpredictable fluctuations. The patients were started on
Novorapid, three times a day with meals with glargine at
bedtime. Soon after this change, the HbA1c fell from 10.2 to
between 6.1 and 7.2% and there were fewer fluctuations in blood
glucose and less hypoglycemic episodes. The possibility to give
insulin after meals, allowed the timing of meals to be much less
critical for both children and parents; we encouraged a regular
meal pattern with complex carbohydrate-based meals to reduce the
risk of hypoglycemia.
Conclusions: Using the newer insulin analogues represents a more
targeted therapeutic and physiological approach to diabetes
management in toddlers and should be strongly encouraged.
P/203/FRI
The challenge of insulin and other problems of children
with diabetes in Arua-Uganda
J.N. Agnes
Arua Diabetes Association, Health, Kampala, Uganda
Background: Without insulin the averagely life span for a child
with diabetes is maximum one year. However, children with
diabetes are often unable to afford insulin.In Arua, Uganda, there
are 100 diabetic children in the age from 11…. to 20… years, most
of them from the 7 districts of west Nile. As part of the African
culture families sometimes believe in curses and bewitching, and
they tend to take the children to shrines for the first treatment,
before bringing them to the Health Units. However, in the health
units first priority is often given to treat Malaria, thereby
postponing diabetes treatment. And not all health centers have
refrigerators for insulin storage.
Method: The Arua district formed the Diabetic Association for the
districts of the west Nile region and Diabetic clinics were created.
Insulin is brought in by the association and made available to the
members but Glucometers are so far provided only in a few
districts.
– Currently we have about 50 trained health workers in 11 diabetes
clinics in west Nile region.
Health workers give diabetic talk how to inject insulin. Since most
of the communities believe children do not get diabetes, radio
broadcasts are given to improve the general awareness once in
while is not yet enough to preach the gospel of Diabetes in children
in Arua.
Results: About 80% children still die undiagnosed with Diabetes.
– Most parents and guardians see diabetes in children as an
expensive burden and as a result they are not well looked after,
hence about 90% dying at younger age. When inviting parents to
come for diabetic education, they in most cases tend to send their
children alone.
Conclusion: Diabetes in children is still a huge problem in Arua
due to lack of insulin, about 100% still miss insulin, only districts
hospital provide insulin which is not enough Parents, health
workers, and stake holders in the government need to work
together in order to make insulin available to all diabetic
children.In all the Hospitals and Health C.
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P/204/FRI
The Role of Reg1 in the regulation of AMP kinase in
yeast
S. Tabba
Children's Hospital of Pittsburgh/ UPMC, Pediatric Endocrinology,
Pittsburgh, USA
Objective: Function of AMP-activated protein kinase AMPK is
mediated by phosphorylation of its activation loop. Studies of
mammalian and yeast AMPK show that the dephosphorylation
reaction is the regulated step. In yeast, AMPK dephosphorylation
is mediated by PP1 phosphatase in complex with a regulatory
protein: Reg1. Reg1¢s role is poorly understood. We generated
specific mutations in Reg1 to clarify its role in regulating yeast
AMPK.
Method: We made targeted deletions of conserved domains in
Reg1. Their impact on AMPK function was measured. We also
made point mutations in a conserved motif known to be needed
for PP1 binding. Reg1 function was measured by determining
AMPK signaling outputs. Then, we used co-immuno-
precipitation assays to measure the ability of Reg1 to bind
AMPK and PP1.
Results: Deletion of conserved domains of Reg1 caused
dysfunction in AMPK, supporting the idea that PP1/Reg1
complex is needed for regulation. Deletions interfering with PP1
binding caused hyperactivation and hyperphosphorylation of
AMPK. Genes whose expression is under control of AMPK were
deregulated. In contrast, deletion of the C-terminal 278 amino
acids had no effect on Reg1 function; therefore this region is
dispensable for Reg1 function. Surprisingly, we found evidence
that AMPK and PP1 bind a common surface of Reg1, as all
deletions interfering with Reg1 binding to PP1 also interfered with
Reg1 binding to AMPK, and point mutations in the PP1 binding
motif also blocked binding to AMPK.
Conclusion: This study helps clarify the role of Reg1 in
regulating AMPK. We show that mutations interfering with
Reg1-PP1 binding also disrupt Reg1-AMPK binding. This
suggests that competition between PP1 and AMPK for Reg1
binding may be central to the regulation of AMPK. Further
study of Reg1 function in relation to AMPK may help formulate
drugs which would directly control it to treat obesity, type 2
diabetes mellitus, and the metabolic syndrome more effectively
than Glucophage.
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Urinary C-peptide/Creatinine ratio is a novel practical
approach for identifying paediatric diabetic patients
with endogenous insulin production
R.E. Besser1,2, A.J. Hulse2, B.A. Knight1, T.J. McDonald1,3,
B.M. Shields1, P. Bowman1 & A.T. Hattersley1
1Peninsula Medical School, Peninsular Clinical Research Facility,
Exeter, UK, 2Evelina Children's Hospital, St.Thomas Hospital,
Department of Paediatrics, London, UK, 3Royal Devon and Exeter NHS
Foundation Trust, Clinical Biochemistry, Exeter, UK
Introduction: Serum and 24-hour urinary C-peptide are useful for
measuring endogenous insulin secretion but both have practical
limitations.
Aim: To assess urinary C-peptide creatinine ratio (UCPCR) in a
single urine sample examining stability, correlation with 24 hour
UCP, discrimination between subtypes and identification of
diabetic children with endogenous insulin production.
Methods: 1) Stability of UCPCR was assessed and correlated with
24-hour collections in 21 adult controls. 2) Cutoff levels for
diagnostic discrimination were assessed in 21 adults with Type
1diabetes, (T1D; <30 year, diagnosed >3 year, insulin since
diagnosis), 45 with T2D (>35 year, no insulin for 1 year), and
18 with HNF1A MODY. 3) In 36 pediatric diabetic patients these
cutoff levels were used to identify non-T1D and endogenous insulin
secretion early in T1D.
Results: 1) UCPCR was stable at room temperature for 24-hour,
72-hour in boric acid and 72-hour at 4C. 2nd void fasting UCPCR
correlated with 24-hour UCP (r = 0.8, P < 0.001). 2) UCPCR
was lowest in T1D and highest in T2D:T1 (median (IQR) < 0.01
(< 0.01 – < 0.01), T2 2.4 (1.1–3.7), HNF1A 0.6 (0.4–1.0);
P < 0.00001). UCPCR < 0.2 had 95% sensitivity and specificity
for discriminating T1D. 3) 5/5 (100%) paediatric patients with non
T1D had UCPCR > 0.2. 13/31 (42%) with T1D had
UCPCR > 0.2. Patients with UCPCR > 0.2 had shorter
duration of diabetes (median (IQR) 0.5 (0.03–1.7) vs. 4.8 (3.3–
7.5) P < 0.001), lower insulin dose (0.8 (0.7–0.9) vs. 1.0 (1.0–1.2)
P = 0.011) and older age of diagnosis [9.7 (6.0–12.5) vs. 5.6 (1.9–
8.3) P = 0.006].
Conclusions: UCPCR is a stable, non-invasive measure that
correlates with 24-hour UCP in controls. UCPCR can
differentiate between subgroups of diabetes in adults. In children
preliminary studies show a UCPCR > 0.2 can detect non Type 1
diabetes and can detect early endogenous insulin secretion in the
first year following diagnosis. UCPCR has the potential to become
a simple easily performed measure of persistent endogenous insulin
production and warrants further investigation.
P/206/WED
Use of dried blood spots for the estimation of genetic
risk in type 1 diabetes mellitus (T1DM)
A. Giannattasio, U. Caruso, A. Salina, F. Napoli, C. Aloi, G. dAnnunzio &
R. Lorini
University of Genoa, IGG. Gaslini Institute, Genoa, Italy
Objective: T1DM incidence has increased worldwide over the past
30 years, expecially in children at early age. The major risk of
developing T1DM is carried by genes of HLA complex. Newborn
screening programm are based on dried blood spot (DBS) from
capillary blood taken at 5th day. DBSs are easy to store, handle
and well accepted. We evaluated a new assay based on time-
resolved fluorometry to identify HLA alleles related to T1DM.
[Reg1 Mutant Result Summary]
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Methods: DBSs samples from 256 newborns were tested for HLA
DRB1 and DQB1 alleles using time-resolved fluorimmunoassay
method. Results were compared with those from two multicenter
Italian studies aimed to identify subject at risk of T1DM and to
assess prevention strategies (DIABFIN and PREVEFIN).
Results: Among the 176 newborns belonging to the first group
(DIABFIN project) 6 subjects were classified as high risk for
T1DM, 99 as moderate risk and 71 were classified as low risk.
All subjects belonging to the second group (PREVEFIN project)
were classified as low risk.
The results obtained in blind by DELFIA on DBSs were similar
to those obtained by DIABFIN and PREVEFIN.
Conclusions: DELFIA method for genotyping on DBSs showed
an excellent sensitivity, specificity and efficiency compared with
conventional techniques. Moreover, this assay is less expensive,
and it can be easily performed on material already collected for
newborn screening programs.
P/207/WED
Postprandial glucagon levels associate with glycaemic
control in Danish children and adolescents with new
onset type 1 diabetes
M.-L.C.M. Andersen1, J. Svensson1, S. P
rksen1, J.V. Jørgensen2,
J. Thomsen3, T. Hertel4, P. Hougaard5, L. Hansen6 & H.B. Mortensen1
1Glostrup University Hospital, Department of Paediatrics, Glostrup,
Denmark, 2Aarhus University Hospital, Aarhus, Denmark, 3Kolding
Hospital, Kolding, Denmark, 4Odense University Hospital, Odense,
Denmark, 5University of Southern Denmark, Odense, Denmark,
6Glostrup University Hospital, Glostrup, Denmark
Glucagon release is often perturbed in patients with type 1 and
type 2 diabetes leading to a state of hyperglucagonaemia. The
role of hyperglucagonemia on metabolic control is not fully
understood. The aim of this study is to investigate the role of
glucagon on glycaemic control as assessed by stimulated blood
glucose, HbA1c and insulin dose adjusted HbA1c (IDAA1c) during
the first 12 months after diagnosis. A total of 130 Danish children
with newly diagnosed type 1 diabetes were followed for
12 months. A 90-minutes Boost-test was carried out at 1, 3, 6,
12 months after diagnosis to characterise the residual beta- and
alfa cell function. Stimulated glucagon, HbA1c and IDAA1c were
analysed in a repeated measurement model with stimulated blood
glucose, gender, age and stimulated C-peptide as explanatory
factors. IDAA1c was defined as: IDAA1c = HbA1c
(%) + [4 · insulin dose (U/kg/24hour)]. The postprandial levels
of glucagon were highly associated with the rise in postprandial
glucose levels (P = 0.0001). We also observed a significant
positive association between postprandial glucagon levels and
both HbA1c (est.: 0.18, P = 0.02) and IDAA1c (est.: 0.24 and
P = 0.03). In a multiple regression analyses for each visit alone
we found no significant relationship of glucagon and stimulated
blood glucose at 1 month. However, by 3, 6 and 12 months after
diagnosis where the residual beta cell function progressively
decrease the rise in postprandial glucose was associated with
increased glucagon levels (est.: 2.55, 2.78, 3.08 with corresponding
P-values: < 0.0001, 0.0191, 0.0016). Postprandial glucagon levels
associated significantly with HbA1c at 3 and 6 months (P = 0.05
and <0.0001) after diagnosis and with IDAA1c at 6 months
(0.0052). The rise in postprandial glucose associates with post-
prandial glucagon levels. Our data suggest that postprandial
glucagon associates with worsening of the glycaemic control.





Prevalence of celiac disease in a large cohort of young
type1 diabetic patients in Belgium
T. Mouraux & H. Dorchy
ULB University Children Hospital Queen Fabiola, Bruxelles, Belgium
Objectives: To analyse in a cohort of patients with type 1 diabetes
(T1D) the prevalence of celiac disease (CD) proved by biopsy, the
ages of onset of T1D and CD, the clinical symptoms, the HLA-DQ
genotype.
Methods: A total of 798 T1D (412 <18 years old and 386
>18 years old) are followed from the onset of diabetes. Yearly,
every patient was screened for thyroid antibodies (AB), striated
muscle AB, glomerular basal membrane AB, intrinsic factor and
antinuclear factor and for celiac markers [antigliadine
immunoglobulin (Ig) A, antigliadine IgG (AGG), IgA
antiendomysium (EMA)]. In case of EMA positivity or AGG
positivity with IgA deficiency, a jejunal biopsy was performed.
Results: CD was proved in 19 patients (prevalence: 2.38%). CD
was diagnosed before the onset of T1D in 3 patients. In the other
16 patients, T1D was diagnosed at a mean age of 5 year 2 month
and CD occurred after a mean 6 year 9 month after the onset of
T1D. CD was diagnosed before 18 year except in 2 patients. The
sex ratio was 1/1. HLA haplotype DR 3 was found in 94% of
patients and 50% were homozygous for DR 3. The heterozygous
HLA DQ genotype DR3/DR4 was found in 31% of cases. One
patient had clinical symptoms at diagnosis of CD. Once the
diagnosis of CD was confirmed, three patients reported some
digestive symptoms, and three other reported to feel better with a
gluten free diet. Among the 19 patients with CD, 47% had a
concomitant autoimmune disease or associated auto-AB. Anti-
thyroid AB were documented in 21% of patients, anti-nuclear AB
were present in 21% and two patients suffered of polyarthritis
(10%).25% of the cohort presented at diagnosis of CD a
concomitant infection by helicobacter pylori infection. 50% of
the patients followed a strict a gluten free diet and the celiac
markers became negative within the first few months of the
follow up.
Conclusion: To our knowledge, the originality of this longitudinal
study is an annual screening for CD and associated auto-immune
diseases since the onset of T1D.
P/210/WED
Can T2*magnetic resonance imaging predict the onset
of diabetes in beta-thalassemia major?
R.M. Matter1 & K.E. Allam2
1Ain Shams University, Pediatrics, Cairo, Egypt, 2Ain Shams University,
Radiology, Cairo, Egypt
Objectives: The study aimed to evaluate pancreatic iron overload
by T2*MRI in young beta Thalassemia major patients and to
correlate it with glucose disturbances, serum ferritin and hepatic
sidrosis.
Methods: Forty thalassemic (mean age 14 ± 3.19 years) patients
(20 non diabetic thalassemic patients, 10 diabetic thalassemia
patients, and 10 thalassemics with impaired glucose tolerance
(IGT) were recruited from Pediatric Hematology Clinic, Ain
Shams University, Cairo, Egypt in addition to 20 healthy age and
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sex matched controls (mean age13.6 ± 2.39 years). In addition to
clinical assessment, laboratory investigations included complete
blood count, Hb electrophoresis, liver function tests, serum ferritin
and glucose tolerance test. T2*MRI was performed with 1.5 T
scanner on pancreas and liver.
Results: Significant reduction in T2*signals of liver and pancreas
was shown in thalassemic patients compared to controls
(P < 0.0001). Both diabetic thalassemics and thalassemics with
IGT showed significantly lower T2*signals of pancreas compared
to thalassemics with normal glucose tolerance or controls
(P < 0.001, P < 0.0001respectively).However, no significant
difference was shown between diabetic thalassemics and
thalaasemics with IGT (P > 0.05). Significant correlation was
present between T2*values of liver and pancreas in studied patients
(P < 0.05).
Conclusion: T2*MRI can predict iron deposition in the pancreas.
Follow up of thalassemic patients using pancreatic T2*MRI may
help to prevent the development of overt diabetes by intensive iron
chelation therapy.
P/211/WED
A comparison of clinical and hormonal profile of PCOS
between adolescents with or without type 1 diabetes
mellitus – a pilot study
A. Zachurzok-Buczynska, A. Gawlik, G. Deja & E. Malecka-Tendera
Medical University of Silesia, Katowice, Poland
In women with type 1 diabetes mellitus (T1DM) nonphysiologic
insulin replacement therapy and hyperglycemia may affect pitui-
tary-ovarian axis and ovarian function leading to menstrual
disturbances and polycystic ovary syndrome (PCOS).
The aim of our study was to evaluate hormonal profile of
adolescent girls with T1DM and compare it to non-diabetic
controls.
Methods: We studied: 24 adolescent girls with T1DM using
intensive insulin treatment (mean HbA1c 7.0 ± 0.58%) – 6
meeting the criteria of PCOS (T1DM-PCOS group), 18 without
PCOS (T1DM group), 10 healthy adolescent girls with regular
menses (control group) as well as 17 adolescent girls with PCOS
without T1DM (PCOS group). In all girls basal and GnRh
analogue stimulated (Dipherelin 0.1 mg, s.c.) levels of androgens,
estradiol and gonadotropins were measured and pelvis ultrasound
was performed.
Results: In T1DM group compared to control group menarche
occurred 12 month later (13.0 ± 1.1 vs. 12.0 ± 0.9 year,
P = 0.03). Moreover significantly lower basal LH, basal and
stimulated DHEAS level as well as LH to FSH ratio were observed
in T1DM group compared with control group (2.3 ± 1.4 mIU/ml
vs. 5.0 ± 6.0 mIU/ml, P = 0.03; 146.0 ± 58.0 mg/dl vs.
229.0 ± 27.2 mg/dl, P = 0.02; 174.9 ± 67.4 mg/dl vs.
256.1 ± 66.8 mg/dl, P = 0.01; 0.48 ± 0.38 vs. 0.93 ± 0.73,
P = 0.02, respectively). There were no significant differences in
hormonal profile between T1DM-PCOS group and PCOS group
except significantly lower basal and stimulated DHEAS level in
girls with T1DM and PCOS compared to girls with PCOS
(162.0 ± 58.0 mg/dl vs. 250.0 ± 42.6 mg/dl, P = 0.09;
175.6 ± 72.4 mg/dl vs. 303.0 ± 94.5 mg/dl, respectively). It is
concluded that hormonal disturbances as well as delayed menarche
can occurred in adolescent girls with T1DM despite intensive
insulin treatment and good metabolic control. However the
hormonal profile of adolescent girls with T1DM and without
TIDM meeting the criteria of PCOS seems to be not very different.
Supported by MNiSW N407 015 32/0403.
P/212/WED
A case of methylmalonic acidemia mimicking diabetic
ketoacidosis in an infant
A. Guven1, N. Cebeci1 & E.H. Aktekin2
1Gçztepe Educational and Research Hospital, Pediatric Endocrinology
Clinic, Istanbul, Turkey, 2Gçztepe Educational and Research Hospital,
Pediatrics Clinic, Istanbul, Turkey
Background: Methylmalonic acidemia (MMA) is an inherited
organic acidemia usually present with recurrent episodes of acute
illness. A typical episode is ushered in with ketonuria and vomiting,
followed by acidosis, dehydration and lethargy, leading in the
absence of aggressive treatment, to coma and death. We report an
infant girl with MMA presented with diabetes symptoms.
Case report: A 13-months old girl complained of polydipsia,
diuresis and loss of weight. There was consanguinity between her
parents. Her height was 75 cm (25–50p), weight was 7.8 kg (3–
10p). She had clinical sings of diabetic ketoacidosis such as
dehydration, deep sighing respiration, smell of ketones, lethargy
and vomiting. Blood glucose was 482 mg/dl, venous pH: 7.0 and
HCO3: 3.3 mmol/l. Severe ketonuria was found. She was treated
with parenteral fluid, electrolyte and insulin infusion. After insulin
infusion, subcutaneous insulin was started and it was stopped due
to hypoglycemia in a week. Two days after her discharge, after
having a meal rich of protein, she was brought unconscious with
hepatomegaly, severe acidosis (pH: 7.06, HCO3: 5.7 mmol/l),
increased anion gap (32), ketonuria and mild hyperammonemia
(61 mmol/l). The absence of hyperglycemia and the presence of
neurologic findings suggested organic acidemia. MMA was
diagnosed because of metil malonic aciduria and elevated C3
carnitine esters. Cranial MRI revealed increased uptake of
radiocontrast material in the basal ganglia bilaterally. The
patient is still treated with low-protein diet, cyanocobalamin and
L-carnitine. Her neurologic regression was particular in motor
movements as shown by Denver test.
Conclusion: We emphasized the importance of including the
organic acid analysis in urine among the first line exams in
acutely ill children with severe acidosis. The definitive diagnosis is
important because it may allow a specific treatment and a favorable
evolution to prevent the sequelae.
P/213/WED
Bone age corresponds to chronological age at onset of
type 1 diabetes in youth
A. Messaaoui & H. Dorchy
Diabetology Clinic, University Children's Hospital Queen Fabiola,
Universit Libre de Bruxelles, brussels, Belgium
Introduction: There are only few data on skeletal maturation in
diabetic children and these are controversial: bone age (BA) has
been reported advanced or delayed. The aim of this study was to
compare chronological ages (CA) and BA and to evaluate the
impact of glycated hemoglobin (HbA1c) on BA at diagnosis of
type 1 diabetes.
Methods: This study included 496 diabetic patients [age
8.7 ± 4.0 years (mean ± SD)], 289 (58%) boys and 207 (42%)
girls, 376 (76%) age <12 years and 120 (24%) age ‡12 years.
Standing height was measured and transformed into standard
deviation score (SDS) according to the British 1990 growth
references. HbA1c levels and radiographies of left hands and
wrists were obtained at diagnosis of type 1 diabetes. BA was
determined according to Greulich and Pyle.
Results: At diagnosis, in the whole population, CA was
8.7 ± 4.0 years (mean ± SD) and BA 8.8 ± 4.3 years, in girls
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CA was 8.12 ± 4.1 years and BA 8.4 ± 4.4 years, in boys CA was
9.0 ± 3.9 years and BA 9.1 ± 4.2 years, in age <12 years CA
was 7.0 ± 3.2 years and BA 7.2 ± 3.5 years, and in age ‡12 years
CA was 13.8 ± 1.3 years and BA 14.0 ± 1.6 years. There was a
strongly significant correlation between CA and BA in the 496
patients (r = 0.967, P < 0.001). BA corresponded to CA: D (BA–
CA) [median (25th, 75th percentiles)] was in the whole group
0.0 years (-1.0, +1.0). There was no correlation between D (BA–
CA) and HbA1c (P: NS).
Conclusions: For each group the difference between CA and BA
was in the range of the standard deviations for BA. This study
showed that bone maturation is normal for age and gender and
independent of HbA1c at diagnosis of type 1 diabetes. These
findings are compatible with the fact that the mean duration of
typical symptoms of type 1 diabetes before diagnosis has been
evaluated to 3 weeks in children. The short exposure to important
insulin deficiency does not impair the mechanisms by which the
GH-IGF-I axis allows normal growth.
P/214/WED
Overweight adolescents: a group at risk for metabolic
syndrome (Tehran adolescent obesity study)
H. Moayeri, A. Rabbani, Z.-T. Keihanidoust, K. Bidad & S. Anari, Tehran
Adolescent Obesity Study
Tehran University of Medical Sciences, Tehran, Iran
Background: Metabolic syndrome not only is a serious problem for
adults, but is also afflicting an increasing number of children and
adolescents. This syndrome is a risk factor for type 2 diabetes
mellitus and cardiovascular diseases. The aim of this study was to
estimate the prevalence of metabolic syndrome in a sample of
Iranian adolescents.
Methods: A total of 554 overweight adolescents (aged 11–17 years)
participated in a community-based cross sectional survey.
Anthropometric examinations including height, weight, body
mass index, and blood pressure were assessed. A fasting blood
sample was taken for measurement of glucose and lipid profile.
Metabolic syndrome was determined by the definition released by
the National Cholesterol Education Program Adult Treatment
Panel III, which was modified for age.
Results: The overall prevalence of metabolic syndrome was 26.6%.
There was no gender difference in the distribution of metabolic
syndrome. When stratified by body mass index, 22.5% were
overweight (BMI‡95th percentile) besides having the criteria for
metabolic syndrome, while the remaining 4.1% of the adolescents
were at risk for overweight (BMI between 85th and 95th percentile)
together with metabolic syndrome. Hypertriglyceridemia was the
most common and high-density lipoprotein was the least common
constituent of metabolic syndrome.
Conclusion: This study suggests a high prevalence of metabolic
syndrome among overweight Iranian adolescents. This poses a
serious threat to the current and future health of Iranian youth.
P/215/WED
Reduced pain perception during injection with new
pen-needle technology: a randomized double-blinded
pediatric study
O. Kordonouri1, E. Marquardt1, R. Hartmann1, S. Blsig1, K. Walte1,
B. Aschemeier1, K. Lange2 & T. Danne1
1Kinderkrankenhaus auf der Bult, Hannover, Germany, 2Medizinische
Hochschule Hannover, Hannover, Germany
Objective: To investigate if the new double-tapered NANOPASS
33 Pen Needle (NP33; Terumo Cooperation, Japan) causes less
pain during injection as compared with an established pen needle.
Methods: A randomized study was performed in 96 patients
(63 male; mean age (±SD) 14.6 ± 3.0 years, diabetes duration
5.9 ± 3.9 years). An unblinded study nurse performed six pen
injections per patient with or without test medium (Diluting
Medium, Novo Nordisk; 0.1 U/kg) using NP33 and customary
needles (CF6; Clickfine universal 6, Ypsomed, Switzerland) in a
randomized sequence on both thighs. The quantity of injection
site leakage was captured by filter paper (mean diameter).
Subjective pain perception was assessed using a visual analog
scale (VAS, 0–100 mm; 100 very painful) with both, patient and
investigator, being blinded to the study procedure. VAS scores
of both thighs were averaged and given as mean ± SEM.
Differences in pain perception and leakage were assessed by
paired t-test.
Results: Applying injections with test medium, the VAS pain
ranking was 16.8 ± 1.7 with NP33 vs. 18.2 ± 1.9 with CF6
(P = 0.164). VAS scores were 16.1 ± 3.7 vs. 25.6 ± 4.0
(P = 0.008) in children younger than 12 years, 12.5 ± 2.5 vs.
19.2 ± 3.1 (P = 0.056) in those with diabetes duration <3 years,
and 12.0 ± 1.8 vs. 17.5 ± 2.9 (P = 0.037) in children with
multiple daily injections (NP33 vs CF6, respectively). Without
test medium, no significant differences were found between NP33
and CF6. Post-injection leakage was comparable with both needles
(2.8 ± 1.8 mm vs. 2.6 ± 1.9 mm, P = 0.214) and not correlated
with pain ranking. With both needles, neither technical problems
nor adverse events were reported.
Conclusion: Concerning application and safety, the quality of the
new needle is as high as in a commonly used one. Our data indicate,
however, that the usage of the double-tapered needle is of clinical
advantage in pediatric patients to reduce sensation of pain during
injection.
The study was supported by an unrestricted grant from Terumo
Europe N.V.
P/216/WED
PCOS and hyperandrogenic disorders – a problem in
adolescent girls with type 1 diabetes mellitus and good
metabolic control
G. Deja, A. Zachurzok-Buczynska, A. Gawlik & E. Malecka-Tendera
Medical University of Silesia, Katowice, Poland
In adult women with type 1 diabetes mellitus (T1DM) increased
prevalence of hirsutism and polycystic ovary syndrome (PCOS)
connected with poor glucose level control have been described. The
aim of our study was to estimate the prevalence of PCOS and its
components in adolescent girls with T1DM with respect to their
metabolic control.
Methods: A total of 24 adolescent girls with T1DM (mean age
15.8 ± 1.2 years, mean gynecological age 33.0 ± 10.7 months,
mean diabetes duration 6.6 ± 3.73 years, mean HbA1c for the
whole treatment 7.0 ± 0.58%), treated with multiple insulin
injections (62.5%) or insulin pump (37.5%), were studied. In all
girls, evaluation of hirsutism and menstrual disorders were
performed and basal as well as GnRh analogue stimulated
(Dipherelin 0.1 mg, s.c.) levels of androgens and gonadotropins
were measured. PCOS was diagnosed according to ESHRE/ASRM
criteria.
Results: Six (25%) girls fulfilled the criteria of PCOS and some
components of PCOS were found in another 6 (25%) girls
[menstrual disturbances in 1 (4%), hirsutism in 1 (4%),
polycystic morphology of the ovaries in 2 (8%), elevated
testosterone and/or androstenedione level in 4 (16%)]. There was
also a significant correlation between increase in testosterone level
after stimulation and BMI z-score (r = 0.54, P = 0.026).
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Relationship between PCOS occurrence and the type of insulin
therapy, T1DM duration, daily insulin dose per kg, mean HbA1c
for the last year and the T1DM’s span was statistically
insignificant. However, significant correlations between
stimulated testosterone level and mean HbA1c for the last year
(r = 0.61, P = 0.006) and mean HbA1c for the T1DM’s span
(r = 0.47, P = 0.04) was found. Surprisingly insulin pump
therapy was significantly associated with polycystic morphology
of the ovaries occurrence (r = 0.55, P = 0.006). It is concluded
that clinical and/or biochemical components of PCOS can be
found relatively often also in good metabolic controlled
adolescent girls with T1DM. Supported by MNiSW N407 015
32/0403.
P/217/WED
Benefits of intra-peritoneal insulin administration in a
child with severe insulin-induced lipoatrophy
M.N. Noud1, E. Renard2, C. McBride3, A.M. Cotterill1 & M. Harris1
1Mater Children's Hospital, University of Queensland, Paediatric
Endocrinology & Diabetes, Brisbane, Australia, 2Centre Hospitalier
Regional Universitaire Montpellier, Montpellier, France, 3Mater
Children's Hospital, University of Queensland, Paediatric Surgery,
Brisbane, Australia
Objective: Insulin-induced lipoatrophy can compromise glycaemic
control and reduce quality of life in children with Type 1 diabetes
mellitus (T1DM). This case report describes the benefits of intra-
peritoneal insulin in a child with severe insulin-induced
lipoatrophy.
Results: The male patient, diagnosed with T1DM at 1.3 years,
developed local inflammatory reactions to sub-cutaneous insulin
injections within the first 6 months of treatment. The injection sites
eventually developed lipoatrophy. A range of insulin preparations,
including administration via continuous subcutaneous infusion
(CSCI), were trialled without success. Local co-administration of
dexamethasone also did not result in any long-term improvement.
Pork insulin, either via CSCI or multiple daily injections, was
associated with less lipoatrophy than previous insulin protocols.
However CSCI sites often lasted <48 hours and were often
associated with abscess formation. An increasing HbA1c (11.6%)
combined with difficulty delivering insulin subcutaneously resulted
in a trial of intraperitoneal insulin delivered by a Diaport.
DiaPort (Roche Diagnostics – not yet approved for routine use
in Australia) is a device implanted in the abdominal wall to which a
replaceable peritoneal catheter is attached on one side and a
portable insulin pump is linked on the other side. The insulin pump
was used to deliver U-100 Insuman Regular insulin (Sanofi-
Aventis, Paris, France) according to standard pump guidelines.
This led to a dramatic improvement in glycaemic control (HbA1c
8.4%) and improved quality of life.
Conclusion: The intra-peritoneal route of insulin administration
should be considered when severe insulin-induced lipoatrophy
compromises glycaemic control in patients with T1DM.
We would like to thank Roche Diagnostics Australia, The Mater
Foundation, Brisbane for enabling this to occur and also Sanofi-
Aventis for continued supply of insulin.
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Continuous subcutaenous insulin infusion for children
with type 1 diabetes: an audit of the singleton hospital
paediatric
G. Phillips, D. Evans & L. Pritchard
Singleton Hospital, Swansea, UK
Aims: This study sought to document the local success of a recent
clinical audit of the Continuous Subcutaenous Insulin Infusion
(CSII) service at Singleton Hospital.
Methods: 20 of 160 (12.5%) children with type 1 diabetes are
currently treated with CSII therapy at Singleton hospital. Of these
20 CSII therapy patients, four use Personal Continuous Glucose
Monitoring (CGM) with Carelink Personal.
Results: CSII therapy improved glycaemic control by 10%, with
HbA1c reducing on average from 9.5 ± 1.1% to 8.6 ± 1.4%
(P < 0.001). Glycaemic control improved in 89% of patients on
CSII therapy. CSII therapy patients that used the CGM function
and Carelink Personal reduced their HbA1c from 9.1 ± 1.0%
to 7.3 ± 1.0%. Hypoglycaemic severity reduced in 56% of
patients. Admissions to hospital for hypoglycaemia fell from 2
on Multiple Daily Injection therapy to 0 on CSII therapy but this
didn’t reach statistical significance (P = 0.08). The total number
of admissions to hospital for hyperglycaemia fell from 11 on
MDI therapy to 2 on CSII therapy with a minimum yearly cost
saving of £11,691 (P < 0.05). Outpatient care visits reduced from
a total of 80 in year prior to CSII therapy to 12 in the after CSII
therapy was initiated (P < 0.001), at a cost saving to the NHS of
£5,984.
Conclusion: A significant improvement in glycaemic control has
been noted in children with type 1 diabetes treated with CSII
therapy. If sustained, the cost savings would offset a considerable
proportion of the additional costs required for CSII therapy. An
additional benefit was noted when CGM and Carelink Personal
was used.
P/219/FRI
Reducing the time spent outside euglycaemia using the
freestyle navigator continuous glucose monitoring
system under home use conditions in young adults
T. Kracht1, H.W. de Valk2, K. Walte1, R. Geldmacher3, L. Sçlter3, W. von
dem Berge3, K. Lange4, O. Kordonouri1 & T. Danne1
1Kinderkrankenhaus auf der Bult, Hannover, Germany, 2University
Medical Centre, Utrecht, Netherlands, 3Diabetes Zentrum
Hannover-Nord, Hannover, Germany, 4Hannover Medical School,
Hannover, Germany
Objectives: This study was designed to investigate the use and
impact of the FreeStyle Navigator Continuous Glucose
Monitoring System under home use conditions in self-
management of type 1 diabetes.
Methods: A 20 day-masked phase, when real-time data and alarms
were not available, was compared with an unmasked phase for the
next 40 days for a number of specified measures of glycaemic
variability by paired t-test. HbA1c (DCA 2000) and a
hypoglycaemia fear survey was recorded at the start and end of
the study.
Results: A total of 48 patients with type 1 diabetes were included
(mean age 35.7 ± 10.9, range 18–61 years; diabetes duration
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17.0 ± 9.5 years). Two patients did not complete the study for
personal reasons. Comparing masked (all 20 days) and unmasked
(last 20 days) phase the time spent outside euglycaemia was
reduced from 11.0 to 9.5 hours/day (P = 0.002) glucose SD from
63 to 57 mg/dl (P < 0.001), hyperglycaemic time (>180 mg/dl)
from 10.3 to 8.9 hours/day (P = 0.0035), Mean Amplitude of
Glycaemic Excursions (MAGE; peak to nadir) by 10%
(P < 0.001), High Blood Glucose Index by 18% (P = 0.0014)
and GRADE Score by 12% (P = 0.0013). Hypoglycaemic time
(<70 mg/dl) decreased from 0.70 to 0.64 hours/day without
statistical significance (P > 0.05). Mean HbA1c fell from
7.9 ± 1.1% at baseline to 7.1 ± 1.1% (P < 0.001). In the
Hypoglycaemia Fear Survey the patients tended to take less
snacks at nighttime wearing the sensor.
Conclusions: Home use of the FreeStyle Navigator Continuous
Glucose Monitoring System has a positive effect on self-
management of diabetes. Thus, continuous glucose monitoring
may serve as a useful tool to decrease glycaemic variability.
P/220/FRI
CSII with real time continuous glucose monitoring
versus traditional CSII: the comparative results
A. Emelyanov, T. Kuraeva & V. Peterkova
Endocrinology Research Center, The Institute of Pediatric
Endocrinology, Moscow, Russian Federation
A new insulin pumps with integrated real time glucose monitoring
appeared in clinical practice in recent years. This devices promises
the achievement of better metabolic control in diabetic patients.
Objective: To evaluate the results of metabolic control in two
group patients, receiving continuous subcutaneous insulin infusion
with real time continuous glucose monitoring (CSII RT) and
continuous subcutaneous insulin infusion with self monitoring of
blood glucose (CSII SMBG).
Materials and methods: A total of 45 patients (21 M/ 24 F) with
diabetes type 1 aged 5–22 years (12.1 ± 5.4 years) and duration of
disease 3–14 years (7.3 ± 2.9 years) took part in this study. The
patients were divided in two groups -CSII RT (n = 22) and CSII
SMBG (n = 23), having no difference in age, duration of diabetes
and HbA1c levels. The insulin pumps ‘‘Minimed 722 Paradigm
Real Time’’ and short-acting insulin analog (Aspart) were used in
CSII RT group. The insulin pumps ‘‘Minimed 712’’ and insulin
analog (Aspart) were used in CSII SMBG group. Glucose self-
control was performed 4–6 times in a day. All patients stayed in
hospital for 10–14 days before start of study and visited clinic at
least 1 time in 3 month during 1 year for correction of insulin
therapy. HbA1c level before and in 3, 6, 12 month after the start of
study, the frequency of severe hypoglycemia and diabetic
ketoacidosis were analyzed.
Results: HbA1c level before insulin pump was 9.1 ± 1.77% in
CSII RT and 9.2 ± 2.0% in CSII SMBG. HbA1c level in 3, 6, 12
was 7.9 ± 1.29%, 7.9 ± 2.3%, 7.8 ± 1.94% in CSII RT group
and 8.6 ± 1.8%, 8.9 ± 2.6%, 8.9 ± 1.5% in CSII SMBG group
respectively. None of patients suffered from episodes of severe
hypoglycemia during the evaluation period. Diabetic ketoacidosis
occurred in 2 patients due catheter occlusions in CSII RT group
and 2 patient in CSII SMBG.
Conclusion: Insulin pump therapy with real time continuous
glucose monitoring significantly improves the metabolic control,
in comparison with traditional CSII therapy.
P/221/FRI
Type 1 diabetes and recreational scuba diving – one
controversial activity where continuous glucose
monitoring could improve safety
P. Adolfsson1, H. rnhagen2 & J. Jendle3,4
1Institute for the Health of Women and Children, The Sahlgrenska
Academy at Gothenburg University, Department of Pediatrics,
Gothenburg, Sweden, 2Swedish Sports Diving Federation, Farsta,
Sweden, 3Faculty of Health Sciences, rebro University Hospital,
rebro, Sweden, 4Endocrine and Diabetes Center, Karlstad, Sweden
Objectives: It is estimated that 100 000 individuals from 10 million
(1%) active divers are on insulin treatment. In some countries, type
1 diabetes is a contraindication to diving. Is it possible to identify
individuals at risk of having hypoglycaemic events during scuba
dive? Is it possible to use CGMS related to scuba dive?
Methods: Twenty-four individuals, 12 T1DM and 12 healthy
controls, were studied during 5 recreational scuba dives on 3
consecutive days. Prior to the first dive each individuals¢ glucose
monitor was downloaded with Diasend (Aidera, Göteborg,
Sweden). Plasma glucose measurements were performed in a
monitoring schedule related to each dive. CGMS were used during
all days and all dives.
Results: One hundred and seventeen dives were performed. The
number of hypoglycaemic episodes pre- or post-dive were related
to the duration of diabetes, r = 0.83 and P = 0.01, the percentage
of SMBG values below target (<72 mg/dl) during two weeks prior
to dive, r = 0.65 and P = 0.02, and total duration below low limit
(<70 mg/dl) measured by CGMS. The overall MAD within the
group with diabetes was 14.4 ± 6%. Hypoglycaemia pre- and post
dive was detected with a positive predictive value of 0.39 and a
sensitivity of 0.64. Hypoglycaemia was significantly more common
post dive, during evening and night compared to daytime when
diving was performed, P < 0.005.
Conclusion: The use of downloaded SMBG values together with
CGMS during days of diving makes it possible to detect those
suitable and not suitable for diving. The CGMS was used with
accuracy in such difficult conditions as scuba diving and provided
robust information on glucose variations. In the future, real time
continuous glucose monitoring could be used before as well as
during diving in order to reach the goal of safer diving for those
having type 1 diabetes.
P/222/FRI
Experience of use insulin pump in treatment of
0–3 years children with DM 1
N. Zelinska1 & L. Nifontova2
1Ukrainian Centre of Endocrine Surgeries MOH of Ukraine, Paediatric
and Adolescents Endocrinology, Kyiv, Ukraine, 2National Children's
Specialised Hospital MOH of Ukraine, Pediatric Endocrinology, Kyiv,
Ukraine
Achievement of optimal glycemic control at the smallest patients,
treated with basis-boluses insulin therapy, is very difficult. It is
connected with frequent (to 8 times a day) feeding of children, need
for repeated boluse insulin injections, particular mode of the day,
danger of hidden hypoglycemias, etc.
Materials and methods: Within last 2th years, we used for
treatment of this children insulin pump ‘‘DANA Diabecare IIS’’
(SOOIL Development Co., South Korea). This pump were applied
at 15 children at the age from 1 month till 3th years with the
experience of disease from 0 till 2th years. Advantages of this pump
is low weight (60 gm) and 0.01 U/hour basal increment that
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allowed correct by hours delivery of basal insulin with minimal
doses. Efficiency of treatment were estimated each 3 months and
based on a glycemic control: fasting glycemia, postprandial and
night glycemia, HbA1c level, hypoglycemias rates, including night
ones, physical development of children, daily dose of insulin. The
CGMS was applied to selection of an optimal dose of insulin in a
mode of pump insulin therapy and was very useful in diagnostics of
night undetected hypoglycemia and estimations of glycemic index
of dairy mixes and food.
Results: Optimal and suboptimal glycemic control has been
reached for all children within 2–3 months. Blood glucose levels
was within 4.8–10.5 mmol/l. HbA1c was decrease at all patients
from 11.3 ± 2.6% to 8.5 ± 1.8%. Rates of light hypoglycemias
decreased from 15 episodes to 5 per month, as well as postprandial
glycemias (caused by fast absorption of dairy mixes) on
7.3 ± 2.8 mmol/l – as a result of adequate insulin boluse on
each food intake. Was lesser frequency of injections (1 per 4–
5 days). It was possible to impose the minimum dose of insulin
(0.01 U/hour) including unplanned eating.
Conclusions: Pump insulin therapy can be recommended the
smallest patients with DM1, as an optimal insulin therapy.
P/223/FRI
Our initial experience with insulin pump treatment
M.M. Konstantinova
University Pediatric Hospital, Endocrinology, Diabetes and Genetics,
Sofia, Bulgaria
Objectives: 1. To evaluate the effect of the insulin pump treatment
on the glycemic control.
2. To analyze the effectiveness of the used algorithm for the insulin
dose adjustment and education.
Methods: A total of 19 Bulgarian diabetic children started insulin
pump /Medtronic/ treatment since March 2007. The age ranged 3–
17 years, mean age 7.83 + 3.9 years, 9 boys and 10 girls. with
duration of the disease between 6 months and 12 years. The
algorithm for the adjustment of the insulin dose was the following:
The used total insulin dose before starting the pump was decreased
by 20%. The starting basal dose was 50% of the calculated daily
dose. We have used 4–6 different basal rates corresponding to the
physiology of the insulin secretion with the lowest rate 2–4 a.m.
and 2–4 p.m. The insulin sensitivity index was calculated using the
rule of 80. The carbohydrate/insulin ratio was calculated by the 500
rule. The education was structured in 2 steps including the bolus
wizzard.
Results: Most of the patients started on pump did not need
significant correction of the initially calculated dose which proved
the accuracy of the used algorithm for the dose. The patients with
poor control HbA1c ‡10% needed elevation of the insulin dose
during the following 3–7 days. HbA1c decreased from 8.8%
+1.75 before the start of the pump treatment to 7.17% +1.59
for the last evaluation, proving the effectiveness of the pump
treatment.
There were 3 episodes of ketonuria caused by ceasing of the insulin
infusion. There were no severe hypoglycemias in neither of the
patients. The youngest diabetics below 6 years of age are the most
compliant with the pump therapy.
Conclusion: Insulin pump treatment gives the best opportunity for
the most physiological adjustment of the insulin dose to the
changing individual insulin needs. Proper education and
compliance are critical for achievement of all the advantages of
the pump.
P/224/FRI
Italian (retrospective) survey on continuous
subcutaneous insulin infusion (CSII) in children and
adolescents with type 1 diabetes mellitus
D. Iafusco1, I. Rabbone2, S. Toni3, F. Lombardo4 & R. Lorini5, Study
Group on Diabetes of Italian Society of Pediatric Endocrinology and
Diabetology ISPED
1Second University of Naples, Paediatrics, Napoli, Italy, 2University of
Turin, Turin, Italy, 3University of Florence, Juvenile Diabetes Centre,
Florence, Italy, 4Univesity of Messina, Paediatrics, Messina, Italy,
5University of Genoa, Paediatrics, Genoa, Italy
Over the past few decades, continuous subcutaneous insulin
infusion (CSII) is increasing popularity. A first national survey
(1) showed that more than 3000 adult and paediatric T1DM
patients were on CSII in Italy in 2006 and that CSII was still
increasing.In 2008 the Italian Society of Paediatric Endocrinology
and Diabetology (ISPED) convened a panel of expert physicians
for a reasoned translation of the International Recommendations
on CSII in pediatric T1DM (2).Some adaptations were necessary in
order to take into account certain peculiarities of the diet, timing of
meals and life style. Before publishing these guidelines ISPED
established to collect retrospective data on the number of pumps
used in Italian patients, from 1th Jan 2003 to 31th Dec 2007.
Methods: Data were collected with a questionnaire about all
patients, aged 0–18 years, who started CSII therapy during the
study period.
Results: Northern Area: data were collected in 263 patients (133M/
130F) from 30 Centers; other 7 Centers (23.3%) didn’t have
patients treated with pump. From 2003 to 2007 patients with CSII
increased 4 times (from 22 to 86%).Centre Area: data were
collected in 227 patients (116M/111F) from 15 Centers. Other 5
Centers (33%) didn’t have patients treated with pump. In the five
years of the study CSII increased of 60%.Southern Area: data were
collected in 109 patients (45M/64F) from 14 Centers.No patients
were treated with pump in 7 Centers (50%). The number of pump
prescriptions increased 8 times in 5 years. Islands Area (Sicily and
Sardinia): data were collected in 188 patients (96M/92F) from 2
Centers; 3 Centers didn’t have patients with pump. In all Italian
Areas the most representative age of patients with pump was 11–
15 years.
Conclusion: CSII is increasing in Italian paediatric diabetic
patients. The adolescent age group (11–15 years) is the most
representative, but CSII therapy is used also in pre-school age
children.
References:
1. DiabResClinPract 2006, 74: 130–134.
2. Act Biom 2008, 79(1): 57–64.
P/225/FRI
Sensor-augmented pump therapy in neonatal diabetes
S. Guilmin-Crpon, E. Bismuth, L. Pantalone, J.-C. Carel & N. Tubiana-
Rufi
Robert Debr Hospital, APHP, Paediatric Endocrinology and
Diabetology, Paris, France
Management of neonatal diabetes is particularly difficult, due to
the small dose of insulin to deliver, irregularities in feeding and risk
of hypoglycemia. Insulin pump therapy using diluted insulin (U10)
allows the delivery of very low doses of insulin matching with the
specific nutritional needs of neonates (frequent meals) and reaches
the therapeutic goals of neonatal diabetes: weight catch-up and
good metabolic control without hypoglycaemia. However, close
blood glucose monitoring with at least 10 glycemic measures a day
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is necessary to adjust the basal rate and boluses. We used sensor-
augmented pump therapy (Paradigm 522 RealTime, Medtronic
Minimed) (PRT) after initial intravenous management in a
4 months old infant with neonatal diabetes revealed by ketoacido-
sis. During the first week of PRT, access to glucose measurements
in real time facilitated close insulin adaptation to nutritional
changes (number and volume of bottles, flour fortification),
allowing a rapid and satisfactory catch-up weight (50 g/day).
Total insulin daily dose increased from 0.48 at day-2 of pump to
1.22 U/kg/day at day-7 of pump (basal rates: 0.03 U/h on the
night, 0.07 U/h on the day; 22% of total daily dose, and 5 boluses
per day). Insulin doses adjustments in real time allowed an
excellent metabolic control: glucose average of 288 measures/day
on PRT at day-2 = 190 ± 52 mg/dl, and at day-
7 = 125 ± 30 mg/dl, without any hypoglycaemia (0 measurement
<70 mg/dl). In conclusion, sensor-augmented pump therapy was
well tolerated, allowing achievement of a favourable nutritional
and metabolic outcome in a case of neonatal diabetes, while
avoiding hypoglycaemia and reducing the number of capillary
blood glucose measurements to 3 per day.
P/226/FRI
Influence of insulin pump-therapy on diabetes
complications at child with DM 1 (clinical case)
N. Pogadayeva1, N. Zelinska1 & L. Nifontova2
1Ukrainian Centre of Endocrine Surgeries MOH of Ukraine, Paediatric
and Adolescents Endocrinology, Kyiv, Ukraine, 2National Children's
Specialised Hospital MOH of Ukraine, Pediatric Endocrinology, Kyiv,
Ukraine
Progress heavy chronic complications of children with DM1 is an
actual modern problem. It induces to search the ways of their
prevention.
Materials and methods: Under supervision there was a 15-year-old
girl with DM1. Duration DM1 was 13 years. She had different
complications: nonalcoholic steatosis hepatis, hyperlipidaemia
(cholesterol: 7.8 mmol/l, triglyceride: 3.2 mmol/l), diabetic
nephropathy IV (proteinuria 1.1 g/day), secondary arterial
hypertension, general oedema, retinopathy I, diabetic peripheral
motor neuropathy, growth failure (-4 SD, growth velocity: 1.5–
2 cm/year), delayed puberty (II stage by Tanner), bone age:
10 years. HbA1c was 13.2%. She has 5–6 accident severe diabetic
ketoacidosis per year. She got insulin at daily dose 42 IU (1.4 IU/
kg).
Results: For the improvement of glycemic controls treatment by
an insulin pump (MiniMed Medtronic 508, Medtronic MiniMed,
USA) with insulin Aspart was begun. During 2 years a girl grew
up on 15 cm (the delay of growth diminished to -2.5 SD),
menstrual cycle has been normalized, liver and lipid profile were
normalized, neither proteinuria nor microalbuminuria was not
exposed, retinopathy was not found. Dynamics of HbA1c every
6 month was 12.2%; 11%; 7%; 17%. Insulin daily dose went
down to 22 IU (0.6 IU/kg/day). During 2 years there were no
DKA accident.
Conclusions: Use of insulin pump therapy at child leads to
prevention of the acute complications and regression of chronicle
diabetes complications, even at vibrations of HbA1c.
Poster Session I: Pumps and Sensors
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Discontinuation of insulin pump treatment in children,
adolescents and young adults. a multi-center analysis
based on the DPV database in Germany and Austria
S.E. Hofer1, B. Heidtmann2, K. Raile3, E. Froehlich-Reiterer4,
E. Lilienthal5, M. Berghaeuser6 & R.W. Holl7, DPV Science Initiative and
the German Working Group for Insulin Pump Treatment in Paediatric
Patients
1Medical University of Innsbruck, Department of Pediatrics, Innsbruck,
Austria, 2Childrens Hospital Wilhelmstift, Department of Pediatrics,
Hamburg, Germany, 3Charite Berlin, Department of Pediatrics, Berlin,
Germany, 4Medical University of Graz, Department of Pediatrics, Graz,
Austria, 5Ruhr University of Bochum, Department of Pediatrics,
Bochum, Germany, 6University of Muenster, Department of Pediatrics,
Muenster, Germany, 7University of Ulm, Institute of Epidemiology, Ulm,
Germany
Objectives: Insulin pump therapy is well established in the
treatment of children and adolescents with type 1 diabetes. Most
studies focus on outcome parameters like HbA1c, hypoglycemia
and quality of life, whereas few reports address patients who
discontinue pump therapy. This survey focuses on the
discontinuation rate of insulin pump treatment in the pediatric
and young adult age group.
Methods: The prospective multi-center DPV (electronic diabetes
patient documentation system) database has been established since
1990 and is broadly used in Germany and Austria. All pump users
among the participating centers documented since 1995 were
included in this analysis.
Results: A total of 11 710 patients with type 1 diabetes were
recorded as treated with insulin pumps. In total 463 patients (4%)
switched from insulin pump treatment to multiple daily injections
(MDI). In the group of patients who stopped with pump treatment,
the mean duration of pump therapy was 1.7 years
(SE ± 0.06 years), 60.5% were female. Subdivided into age
groups, the discontinuation rate was lowest in the age group
<5 years (0.1%), followed by the groups aged 5–10 years (0.3%),
15–20 years (0.8%) and >20 years (0.8%). The group aged 10–
15 years showed the highest rate of discontinuation (2%).
Conclusions: The discontinuation rate of insulin pump therapy is
in general low (4%). The younger the patients at the time of
initiating insulin pump treatment, the lower is the discontinuation
rate. The highest rate was seen in adolescents aged 10–15 years.
Girls stopped insulin pump treatment more often than boys (60.5%
vs. 39.5%).
P/228/WED
The diasend system as continuous educational tool in
the management of type 1 diabetic children treated
with continuous subcutaneous insulin infusion
R. Schiaffini, P. Ciampalini, A. Migliaccio, I.P. Patera, L. Pecorelli,
T. Bufacchi & M. Cappa
Bambino Ges Hospital, Endocrinology and Diabetology, Rome, Italy
Several studies reported a mean HbA1c reduction of 0.5–1% after
one year of CSII treatment in children with type 1 diabetes
(T1DM). Recently new methods of teleassistance developed, but
only little data on paediatric age is available.
The aim of the study was to compare a conventional method versus
a teleassistance approach in the follow-up of children with T1DM
treated with CSII.
Research design: Forty-five diabetic children (mean age:
11.6 ± 3 years) started CSII during 2008 and were randomly
assigned to a conventional follow-up arm (22 patients;
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11.9 ± 3.3 years) or to a telemedicine arm (23 patients;
11.1 ± 3.2 years) with daily/weekly download of glycaemic
values and pump settings. Patients from the telemedicine group
used the Diasend device; it is a system that allows diabetic staff to
store and monitor patients glucose readings and insulin pump
doses with a complete overview of the transmitted information,
24 hours a day. At 3 months interval HbA1c levels were evaluated
as indicator of efficacy.
Results: No differences in terms of glycometabolic control have
been reported between the groups (mean HbA1c decrease at
6 months 0.3% and 0.35% respectively in conventional vs. Diasend
group). In particular, the HbA1c values at 0, +3 and +6 months
were similar in the two arms of treatment (7.9, 7.6 and 7.6% vs. 7.9,
7.62 and 7.55%, respectively in the conventional and telemedicine
group). Instead, compared to conventional group, patients using
Diasend demonstrated a significantly shorter time to reach correct
basal infusion (41 vs. 60 days), insulin to CHO ratio (51 vs.
62 days) and insulin sensibility factor (29 vs. 37 days). These data
demonstrated the efficacy, in terms of glycometabolic control and
quality of care, of an integrated system of continuous insulin
infusion and teleassistance. Continuous tele-education is useful in
order to rapidly obtain a stable basal profile and insulin to charbo
ratio and probably a long term better glycometabolic control.
P/229/WED
Reducing glycaemic variability and Hba1c with the
Dexcom Seven.2 continuous glucose monitoring
system in children and young adults with type 1
diabetes (T1D)
T. Kracht1, O. Kordonouri1, N. Datz1, C. Scarabello1, K. Walte1,
S. Blaesig1, R. Geldmacher2, W. von dem Berge2, R. Hartmann1, H.
Chico3, B. Matsubara3, A.K. Balo3, T. Danne1 & K. Nakamura3
1Kinderkrankenhaus auf der Bult, Hannover, Germany, 2Diabetes
Zentrum Hannover-Nord, Hannover, Germany, 3DexCom Inc., San
Diego, USA
Objectives: To investigate the use and impact of the DexCom
Seven.2 continuous glucose monitoring system (CGMS) under
home use conditions in self-management of diabetes.
Methods: The study was for 63 days of continuous sensor wear in
56 patients (50% male, mean age 14.0 ± 4.7 years, diabetes
duration 5.5 ± 3.5 years) with T1D at home. 40 patients
(71.4%) were on CSII, the remaining on MDI. Real-time data,
trend arrows and threshold alarms were not available for the first
21 days (masked phase A) but for the following 42 days (unmasked
phase B). In the unmasked phase, subjects were instructed to make
treatment decisions based on CGM-data except during
hypoglycaemia or rapidly changing glucose values when
confirmatory capillary BG test was performed prior to self-
management decisions. The primary endpoint was to evaluate
improvement in glycaemic variability between both phases of the
study and therefore both were compared for a number of specified
measures of glycaemic variability by paired t-test. HbA1c was
recorded by DCA 2000 at start and end of the study.
Results: All but one patient completed the study. HbA1c decreased
significantly from 7.9 ± 1.5% at baseline to 7.5 ± 1.0% at the
end of the study (P < 0.001), with 39 patients (70.1%) showing an
improvement of HbA1c. At present CGMS-data of 9 patients were
analyzed. Comparing phase A and B, these 9 patients had an
increase of time spent inside the target zone (70–180 mg/dl) from
53.9% to 64.4%. There were reductions in mean glucose from
181.1 mg/dl to 159.8 mg/dl, as well as in glucose SD from 67.9 to
60.7 mg/dl. No relevant adverse events occurred; no serious
adverse events were reported.
Conclusions: These data clearly indicate that the use of the
DexCom Seven.2 CGMS in children and young adults with
T1D has a beneficial effect on self-management of diabetes
concerning glycaemic control and glycaemic variability.
P/230/WED
The optimal type of bolus following a ''Mediterranean''
meal in children and adolescents with type 1 diabetes
(T1DM) using insulin pump therapy (CSII)
A.E. Scaramuzza1, D. Iafusco2, M. Macedoni3, D. Spiri1, A. Bosetti4,
E. Giani3, A. De Palma3, A. Gazzarri3, C. Mameli3, S. Mazzantini3,
L. Santoro3 & G.V. Zuccotti3
1University of Milano - Luigi Sacco Hospital, Paediatrics, Milano, Italy,
2Second University of Naples, Paediatrics, Naples, Italy, 3University of
Milano - Luigi Sacco Hospital, Paediatrics, Milano, Italy, 4University of
Milano - Luigi Sacco Hospital, Dietetics, Milano, Italy
Objectives: Last year we observed that the best bolus for a pizza
margherita meal is 30/70 dual wave bolus (DWB) extended over
6 hours. Because of this, we start to consider that for a
‘‘Mediterranean’’ meal (MM) a DWB might be better than a
simple bolus (SB). We compare a SB with different kind of DWB in
order to identify the optimal one in case of a MM.
Methods: We evaluated 26 children, aged 5–23 years (mean
15.4 ± 4.8 years) with T1DM from 9.7 ± 4.9 years, BMI
22.0 ± 4.4 kg/m2, with CSII (insulin requirement 0.76 ± 0.14
U/kg/day). Each patient utilized the following 6 aspart regimens on
3 consecutive days, and glucose values were recorded with SMBG:
a) a SB (100% of insulin (I) given immediately) injected 15 min
before meal; b) a SB (100% of I given immediately) injected just
before meal; c) 4-hour DWB (50% of I given immediately and 50%
given over a 4-hour period) injected 15 min prior meal; d) 4-hour
DWB (50% of I give immediately and 50% given over a 4-hour
period) injected just before meal; e) 4-hour DWB (70% given
immediately and 30% given over a 4-hour period) injected 15 min
before meal; and f) 4-hour DWB (70% given immediately and 30%
given over a 4-hour period) injected just before meal. Total CHO
was kept constant for each meal; I dose was calculated according to
glycaemic value and CHO, using ISF and INS : CHO ratio,
personalized for each patient.
Results:
Conclusion: 70/30 DWB extended over 4-hour period following a
MM injected 15 minutes before provided significantly less
postprandial hyperglycemia during the 4-hour period. SB could
be used only if given 15 minutes before meal, even if we observed a
rise in glycaemic values in the last 2 hours of the study.
P/231/WED
Increase dose of insulin controls postprandial glycemia
for products with a high glycemic load in children with
type 1 diabetes
L. Groele, A. Szypowska, M. Błazik, D. Golicka & E. Pańkowska
Medical University of Warsaw, The Second Department of Paediatrics,
Warsaw, Poland
Background: Scientific data show that 60% of patients with
diabetes don’t achieve a target level of HbA1c. One of the
determent factor is postprandial hyperglycemia and difficulties on
adjusting insulin dose for meals with high glycemic index and load.
Aim: To assessment potential effects of using the raised insulin-
carbohydrate ratio (ICR) for products with a high glycemic load in
children and young people with type 1 diabetes.
Materials and methods: Study with randomisation using open label
method with stratyfication of a group according to the age. A total
of 70 children and adolescents, aged from 4 to 18 years out of
remission phase treated with CSII received increased 30%-grA, or
normal ICR-grB dose of insulin for a cornflakes with milk for
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breakfast. During following 2 hours glucose level was measured
from capillary in 0, 15, 30, 45, 60, 90, 120.
Result: The experimental group (A) and control group (B) were
similar with regard to duration of diabetes- grA:6,15 years,
grB:5,09 years P = 0.164; SDS BMI-grA:0.79 IU/kg/d,
grB:0.69 IU/kg/d P = 0.0569; and basal insulin-grA:37.26% of
TDD, grB:39.73% of TDD P = 0.4572. Significantly elevated
glycemia was noted in control group in 45 and 60 minutes after
breakfast. Distinction (D) between glucose level in 0 and 40 come
to 180.19 mg/dl in grB vs. 69.5 mg/dl in grA P < 0.001 and in 0–
60 come to 187.8 mg/dl in grB and 69.65 mg/dl in grA P < 0.001.
The hypoglycemia episodes has occurred occasionally in both
group- 7 (11%) in grA, and 5 (8%) in grB P = 0.75-during
120 minutes observation.
Conclusion: Raised insulin–carbohydrate ratio (ICR) for products
with a high glycemic load allows to reach recommended
postprandial glycemia level in children with type 1 diabetes
without elevated risk for hypoglycemia.
P/232/WED
The RealTrend Study: Effect of continuous glucose
monitoring on metabolic control in addition to pump
therapy in poorly controlled type 1 diabetic patients
M. Nicolino1, V. Sulmont2, N. Bendelac1, Y. Reznik3, B. Guerci4,
E. Renard5, H. Hanaire6, N. Jeandidier7 & D. Raccah8
1University Hospital, Pediatric Endocrinology, Lyon, France, 2Children
Hospital, Reims, France, 3Cote de Nacre Hospital, Endocrinology, Caen,
France, 4University Hospital, Endocrinology, Nancy, France, 5University
Hospital, Endocrinology, Montpellier, France, 6University Hospital,
Endocrinology, Toulouse, France, 7University Hospital, Endocrinology,
Strasbourg, France, 8Sainte Marguerite Hospital, Endocrinology,
Marseille, France
Background and aims: Efficacy of insulin pump augmented with
continuous glucose monitoring (CGM) versus Continuous
Subcutaneous Insulin Infusion with standard self-monitoring of
blood glucose has not yet been determined.
Materials and methods: In this randomized, controlled, multi-
center trial, 132 adults and children with type 1 diabetes,
insufficiently treated with multiple daily insulin injections
(A1c ‡ 8%) were assigned to a 6 months treatment in one of 2
study arms: PRT arm, fitted with the Paradigm REAL Time
System (Medtronic insulin pump with integrated CGM), or CSII
arm, fitted with an insulin pump and conventional blood glucose
self-monitoring.
Results: HbA1c was analyzable for 115 patients (46 children, 69
adults) of the full analysis population (FAS) and improved between
baseline and study end in the two groups (PRT, n = 55,
)0.81% ± 1.09; CSII, n = 60, -0.57% ± 0.94; P = 0.087). A
per protocol (PP) analysis of 91 patients (35 children, 56 adults)
who wore sensors over 70% of the time (as required by the
inclusion criteria) showed a significant difference in A1c reduction
between groups (PRT; n = 32; -0.96% ± 0.93, CSII, n = 59;
)0.55% ± 0.93, P = 0.004). Ancillary analyses revealed a
significant decrease in HbA1c levels between the screening visit
and the end of the study (PRT -1.14 ± 1.21, P < 0.001; CSII
group -0.57 ± 0.91, P < 0.001), as well as a significant difference
in favor of the PRT group (P = 0.006) for the entire study
population as well for the per protocol population (PRT -
1.23 ± 1.08, P < 0.001; CSII -0.55 ± 0.90, P < 0.001; inter-
group comparison: P < 0.001). In PRT group, CGM
hyperglycaemia parameters decreased in line with HbA1c,
without increased hypoglycaemia.
Conclusion: In both FAS and PP populations HbA1c decreased in
both study arms after treatment was changed fromMDI to CSII or
PRT, but improved significantly more in the PRT group when
patients wore the CGM more than 70% of the time versus CSII.
P/233/WED
Children on insulin pump treatment need specialized
follow-up to achieve sustainable long-term good
metabolic control – distressing results from 2 years
follow-up data on CSII treatment
A.-L. Sandstrçm1, G. Viklund1, P. Bang2 & E. rtqvist2
1Astrid Lindgrens Children's Hospital, Pediatric Diabetes Clinic,
Stockholm, Sweden, 2Karolinska Institutet, Dept of Women and Child
Health, Stockholm, Sweden
Objectives: The use of continous subcutanous insulin infusion
(CSII) in children with T1DM is increasing. Cross-sectional results
from the Swedish national diabetes quality registry (Swediabkids-
NDR) show no difference in HbA1c between CSII and MDI
(multiple daily injection) treated patients, in spite of a more
physiological insulin delivery with CSII. There is a lack of long-
term follow-up results for CSII. The aim of the present study was
to retrospectively assess long-term metabolic control after start of
CSII treatment in different age groups, compared with sex, age and
HbA1c-matched MDI treated controls.
Methods: A total of 90 children (age 1.8–19, 50% girls) who
started CSII between November 2004 and November 2006 were
devided into age groups: £8.9 (n = 22), 9–10.9 (n = 14), 11–12.9
(n = 25) and ‡13 (n = 29) years. HbA1c analyzed 12 and
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6 months before, at start and 6, 12 and 24 months after initiation
of CSII were collected.
Results: After 6 months of CSII mean HbA1c had decreased
0.3%, 0.3%, 0.7% and 0.4% in the different age groups (mean
decrease 0.5%, P = 0.004). Between 6 and 24 months CSII
treatment HbA1c increased with 0.1%, 1.0%, 0.8%, and 0.5%
respectively (mean increase 0.5%, P = 0.003). When analyzing the
different age groups children older than 9 years at CSII initiation
increased HbA1c significantly after the first 6 months of better
metabolic control (mean increase 0,7%, P = 0.003). Comparison
with controls and national Swedish results in different age groups
are presently performed.
Conclusions: CSII treatment results in significantly lower short-
term HbA1c. However, only in young children, starting CSII
before the age of 9, the improved metabolic control for the
following 2 years is sustained. Specialized follow-up programs are
needed to achive sustainable good metabolic control when older
children start CSII. We propose a program with more active
parental continued support and involvement.
P/234/WED
Continuous Glucose Monitoring System (CGMS):
clinical interest and acceptability in children with type
1 diabetes mellitus
F. Brioude, M. de Kerdanet & S. Nivot-Adamiak
CHU de Rennes, UF dEndocrinologie et diabtologie Pdiatrique,
Dpartement de Mdecine de lEnfant et de lAdolescent, Rennes,
France
Aims: We studied the interest of Guardian RT system as a ‘‘tool
for patient’’ (which can bring the patient information to be used by
himself) and as a ‘‘tool for physician’’, its acceptability, and its
impact on metabolic control.
Methods: A total of 61 paediatric patients, diagnosed with type 1
diabetes for more than one year, used the device for 12 consecutive
days. 12 patients agreed for a second period 3 months later.
Acceptability and interest in therapeutic education were evaluated
by a questionnaire, based on the CGMS-SAT questionnaire, at the
end of the recording period. We checked for HbA1c level and
hypoglycaemias frequency after 6 months.
Results: CGMS is seen as helpfull by our patients (doses
adjustment, fear about hypoglycaemia). But they did not
consider that device as a way to improved their diabetes care.
Acceptability of that device is poor (feeling of less freedom,
uncomfortable...). Fifty-four percent of them did not want to use
it again in its current form, but 91% of them would agree in the
future if improved. CGMS also helped the physician (to improve
insulin dosing, to bring out unidentified situations such as night
nibbling or dawn phenomenon). HbA1c didn’t decrease
6 months after the recording period (7.9% vs. 7.77%), but
hypoglycaemias frequency decreased (10.9 hypoglycaemias for
100 blood glucose tests vs. 16). Patients with initial HbA1c over
8% improved their HbA1c (8.00% vs. 8.78%, P < 0.05), such
as children with two recording periods (7.68% vs. 8.17%,
P < 0.05).
Conclusion: Impact on metabolic control is higher in initially poor
controlled patients and with more intensive use of the CGMS.
CGMS is seen as usefull both for the patients and the physician,
and could be able to bring them help to improve metabolic control.
Our study shows that although patients expressed a real interest
about the principle of this device, it would deserve some
improvements to make it more acceptable for patients.
Poster Session II: Type 2 Diabetes in Children
P/235/FRI
Obesity prevention at preschool age ''Fit von klein
auf - Health Tool Kit'': results of a randomized
intervention study in 827 children
C. Ziegler1, B. Aschemeier1, A. Tewes1, E. Sadeghian1, E. Marquardt1,
K. Lange2 & T. Danne1
1Kinderkrankenhaus auf der Bult, Diabetes Centre for Children and
Adolescents, Hanover, Germany, 2Hanover Medical School,
Department of Medical Psychology, Hanover, Germany
Background: The effects of the primary prevention program of
obesity, Gesunde Kindergärten in Niedersachsen - Fit von klein
auf’’ were investigated in a sample of 33 kindergartens all over the
Federal State of Lower Saxony in Germany.
Methods: Eligible institutions were randomized to an intervention
and a control group with a cross-over after one year. The
intervention contained a health tool kit focussing on physical
exercise combined with professional support by a nutritionist and
psychologist during parent groups. Outcome parameters included
height, weight, motor performance (MOT 4-6), health related
quality of life (Kiddy-Kindl 4–7 years) as well as socio-
demographic data.
Results: The study included 827 children (426 intervention group
vs. 401 control group) with a mean age of 4.6 ± 0.4 years, 51.6%
male. Ethnic minorities were sufficient represented (14.5% had
non-German parents). At baseline the mean BMI-SDS was
0.08 ± 1.02, (7.2% overweight; 4.4% obese). After 12 months
the BMI-SDS of the intervention group declined 0.04 SDS,
whereas the BMI-SDS of the control group increased 0.11
(P < 0.001). 12 months after intervention the BMI-SDS of the
intervention group continued to decline by 0.03 SDS. The effect of
the intervention was stronger in those intervened earlier. At the end
of the study 44% of the obese or overweight group had reached
normal weight. Motor performance gains of the intervention group
were higher than those of the control group (3.93 vs. 2.56 points,
P < 0.001) increasing further by 2.49 points 12 months after
intervention. Again the effect of the intervention was stronger in
those intervened earlier. No effect of the intervention was seen on
the health related quality.
Conclusion: This study provides evidence that an intervention for
obesity prevention is feasible at preschool age. It leads to sustained
beneficial effects regarding BMI and motor performance. Thus,
obesity and diabetes prevention can be started before entering
primary school.
P/236/FRI
Baseline and the 2nd year-survey characteristics of
child- and adolescent-onset type 2 diabetes: a
longitudinal nationwide survey on the development of
diabetic complications in Japan
Y. Uchigata1, N. Tajima2, R. Nishimura3, N. Yoshioka4, T. Urakami5,
N. Kikuchi6, A. Takeda7, T. Okada8, E. Araki9 & Y. Iwamoto10
1Tokyo Women's Medical University, Diabetes Center, Tokyo, Japan,
2Jikei University School of Medicine, Division of Diabetes,
Endocrinology and Metabolism, Dept of Internal Medicine, Tokyo,
Japan, 3Jikei University School of Medicine, Tokyo, Japan, 4Hokkaido
University Graduate School of Medicine, Sapporo, Japan, 5Nihon
University School of Medicine, Tokyo, Japan, 6Yokohama City
University Medical Center, Yokohama, Japan, 7Tottori Prefectural
Central Hospital, Torroti, Japan, 8Kochi Mominoki Hospital, Kochi,
Japan, 9Kumamoto University, Kumamoto, Japan, 10Tokyo Women's
Medical University School of Medicine, Tokyo, Japan
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Wide scanning of the long-term diabetic complications of such
patients has demonstrated that 12% developed severe diabetic
vascular complications in their thirties in one diabetes-specific
hospital. Therefore, a longitudinal nationwide survey of the
development of diabetic complications was started from 2007.
688 after the second year survey was subjects in this study: 501
by 274 Internists /187 by 34 Pediatricians and male/female of
groups under 19 (U) and over 20 (O) age at registry were
179/170 and 153/186, respectively. First of all, % of female
patients whose mother had type 2 diabetes was significantly
larger than that of the male whose mother had (P < 0.03). The
detection rates by urine glucose screening in the school of U and
O groups were 60%/75% (m/f) and 45%/75% (m/f), and the
max BMI values in U and O groups were 30/29 (m/f) and 31/29
(m/f), respectively. The waist circumferences (cm) in U and O
groups were 96/89 (m/f) and 96/84 (m/f), respectively. HOMA-
IR index was related to BMI. Such obese patients with type 2
diabetes were also hypertensive and dyslipidemic. Among
patients without insulin treatment, fasting IRI in O group was
significantly lower than in U group both in male and female.
Photocoagulation therapy was performed in 35 patients and
clinical nephropathy was observed in 17 patients. One patient
had one toe amputation already. There was a deterioration of
retinopathy in 19 and nephropathy in 48 patients. In conclusion,
children and adolescent with type 2 diabetes were obese with a
tendency of hypertension and dyslipidemia regardless of gender,
suggesting that metabolic syndrome might be excited at the
upper stream before the development of diabetes. Although some
of them had microvasular complications, nobody had cardio-
vascular diseases. Microvascular complications may precede
macrovascular complications in Japanese patients with type 2
diabetes.
P/237/FRI
Inflexion of the glucose disposition vector among
insulin resistant children may be a sign of early beta
cell insufficiency
T.J. Wilkin1, B. Storey2, A. Jeffery1, B. Metcalf1 & L. Voss1
1Peninsula Medical School, Plymouth, UK, 2University of Dundee,
Dundee, UK
Aim: Blood glucose is controlled by the interaction between insulin
sensitivity (S) and insulin secretion (B), whose vector can be plotted
over time. We tracked the vector of children who were insulin
sensitive, and compared it with that of children who were insulin
resistant.
Methods: BMI (kg/m2), HOMA-%S and HOMA-%B were
recorded annually from 5 to 12 years in 258 healthy children
(144 boys) from the EarlyBird cohort, grouped according to
quartile of insulin sensitivity at 5-years (lowest Q1, highest Q4).
Results: BMI SDS (+0.16 Kg/m2, P < 0.01) and glucose
(+0.6 mmol/l, P < 0.001) rose progressively from 5 to 12 years.
BMI of Q4 was lower than Q1 (P < 0.02), HOMA-%S
(predictably) higher (P < 0.02), and HOMA-%B lower
(P < 0.03) throughout. The vector of Q4 shifted only slightly in
response to the loss of S associated with puberty. The vector of Q1,
on the other hand, traced an early loss of B followed by an acute
switch in direction at 7-year with subsequent fall in S.
Conclusions: The inflexion appears to be a feature of early insulin
resistance, and may correspond to a weakening of glucose control
associated with adjustment to beta cell loss. Importantly, it does
not appear to be a normal event, and could represent early beta cell
pathology in contemporary children.
P/238/FRI
Associations of weight at birth, weight at diagnosis,
and family history of diabetes in children with T2DM in
the Tokyo metropolitan area
A. Yoshida1, T. Urakami1, J. Suzuki1, S. Takahasi2 & H. Mugishima2
1Nihon University School of Medicine, Pediatrics, Tokyo, Japan, 2Nihon
University School of Medicine, Tokyo, Japan
Several studies in adults have shown the prevalence of type 2
diabetes mellitus (T2DM) to be inversely associated with birth
weight. On the other hand, some recent studies in childhood
T2DM demonstrated a U-shaped relationship between birth weight
and the risk of developing T2DM. We studied the associations of
weight at birth, weight at diagnosis, and family history of diabetes
in children with T2DM in the Tokyo Metropolitan Area. 103
Japanese children, 41 males and 62 females aged 12.7 ± 1.7 years
at diagnosis, with T2DMwere analyzed in the birth weights, weight
at diagnosis, age at diagnosis and family history of T2DM. They
were diagnosed as having T2DM through the urine glucose
screening program in the Tokyo Metropolitan Area. 75.3% of
patients with T2DM were obese at diagnosis. 67.9% had a family
history of T2DM in second- and first-degree relatives. The mean
weight at birth was 3278.0 ± 609.6g. 7.9% of the patients had low
birth weights (<2500 g) and 10.9% had high birth weight
(>4000 g). There is no significant correlation between the mean
age at diagnosis of T2DM and birth weights. The frequency of high
birth weight in children with T2DM was significantly higher than
that in control group (P < 0.0001), however, there is no significant
difference of the frequency of low birth weight between children
with T2DM and control group (P = 0.5389). There was no
significant correlation between the birth weight and weight at
diagnosis of T2DM. Patients with family history of T2DM have
higher birth weights than those without family history of diabetes,
but not significant (3316.8 ± 651.6 vs. 3188.9 ± 494.8,
P = 0.3268). There was no significant difference of the frequency
of family history of T2DM among birth weights in the patients.
High birth weights may cause insulin resistance more severe than
low and normal birth weights, which could be the risk factor for
future T2DM. Family history of T2DM could be associated with
developing T2DM, but does not affect the birth weight in children
with T2DM.
P/239/FRI
The first report on the prevalence of impaired fasting
glucose and type 2 diabetes in a population-based
sample of overweight/obese children in the middle east
M.H. Moaddab1,2, R. Kelishadi3, M. Hashemipour2, N. Arabi2 &
M. Amini2
1Isfahan University of Medical Sciences, Isfahan, Iran, Islamic
Republic of, 2Isfahan Endocrine and Metabolism Research Center,
Isfahan, Iran, Islamic Republic of, 3Isfahan Cardiovascular Research
Center, Isfahan, Iran, Islamic Republic of
Background: Type 2 diabetes mellitus (DM2) is increasing in
young population because of high prevalence of obesity in this age
group. Obese children with impaired fasting glucose (IFG) are at
increased risk for developing diabetes. The aim of this study was to
determine the prevalence of IFG and DM2 for the first time in a
representative sample of Iranian children and adolescents with
obesity.
Methods: A total number of 672 overweight and obese Iranian
children, aged 6–19 years (mean, 12.89 ± 3.10 years) selected
from 7554 students, were included in this cross-sectional,
population-based study. Fasting plasma glucose (FPG) and lipid
profile were measured in all participants. Oral glucose tolerance
Poster Sessions
ª 2009 The Authors
Journal Compilation ª 2009 John Wiley & Sons A ⁄ S Pediatric Diabetes (2009) 10 (Suppl. 11): 30–109 107
test and insulin level were measured in those children with IFG
(100£ FPG <126 mg/dl). Insulin resistance defined by HOMA-IR
more than3.10.
Results: The prevalence of IFG and DM2 were 4.61% (31 persons;
mean age, 13.23 ± 3.58 years) and 0.14% (1 person; age,
18.00 years), respectively. There was no significant difference in
lipid profile between IFG group and other children. Impaired
glucose tolerance and insulin resistance were detected in 3 and 6
participants with IFG, who consisted 0.4%and 0.8% of total obese
and overweight students, respectively.
Conclusion: Although the prevalence of DM2 is low in Iranian
obese children and adolescents, IFG is not uncommon. Preventive
measures notably lifestyle modification and regular screening of
FPG should be considered to these children.
P/240/FRI
Type 2 diabetes mellitus and impaired glucose
tolerance in obese children
P.I. Velea1, C. Paul1, I. Tamasan1, L. Mihu2, O.A. Velea1 & O. Lebu1
1University of Medicine and Pharmacy V.Babes, Clinic II Pediatrics,
Timisoara, Romania, 2Clinical County Hospital, Clinic II Pediatrics,
Timisoara, Romania
Aim: Monitoring of the obese patients, aiming for the detection of
type 2 DM in early stages in the youth.
Material and method: Within 2006–2009, we studied 45 children
and adolescents with primary obesity in whom other causes of
obesity were excluded (genetic, endocrine, central nervous,
chromosomial). In the studied group we monitored: positive
familial hystory for DM, suggestive clinical elements for insulin-
resistance (obesity, acanthosis nigricans) and biologically we
assesed the OGTT every six months.
Results and discussions: We found positive family history of type 1
and/or type 2 DM in 12 cases. Depending on the weight excess at
the moment of first visit: 15 cases presented mild obesity, 18 cases
medium obesity while 12 cases were severely obese. Neither one
presented clinical symptoms of diabetes mellitus. At the first visit
fasting blood glucose was normal in all cases. Considering the
results at the OGTT, 12 cases were diagnosed as having impaired
glucose tolerance. HbA1c level was normal. In all cases we
recommended hypocaloric diet with low carbohydrates amount,
divided into 6 meals /day. After 3 years of following-up, 3 cases
(2 girls and 1 boy) of pubertal age, were diagnosed as having type 2
DM, considering their high blood glucose levels (above 250 mg%)
at 2 hours after the glucose loading, within the OGTT. The
metabolic desequilibrium was confirmed by the increased level of
HbA1c in all 3 cases. All 3 children had positive family hystory for
DM. Anti GAD 65 and ICA were negative in these 3 children. In
the 3 cases we initiated therapy with Metformin 2 · 500 mg/day. 3
months after starting the therapy, HbA1c levels decreased
(HbA1c < 6% - 2 cases, HbA1c = 6.5% in the 3rd case).
Conclusions: 1. Obesity in the child represents a factor of insulin
resistance that may favour the occurence of type 2 DM. 2. The
onset of type 2 DM at puberty confirms the ideea that puberty
represents a precipitating factor for the occurence of type 2 DM.
P/241/FRI
Experience of the using analog insulin at neonatal
diabetes
L. Kapusta1 & A. Solntsava2
1Belorussian State Medical University, Minsk, Belarus, 2Republic
Hospital, Endocrine Health Centre, Minsk, Belarus
Introduction: Permanent neonatal diabetes mellitus (PNDM) will
concern to group of rare diseases. Starting preparation of
treatment is application of traditional insulins (Actrapid and
NPH). Application of analog insulins is debatable.
Purpose: It was research aim to reveal efficiency of replacement of
traditional insulins on analog (ultrashort and long acting) in
pediatric practice at PNDM at children of breast-feeding age.
Methods: Patient from PNDM, diagnosis is revealed in 1 month.
Child from 3 pregnancies, 2 sorts, birthweight 1330 g, growth-
47 cm. at mother gestational diabetes (daily doze of insulin
24 units/day). Child has plural malformations: anemia of 2
degrees, hypochromic, mixed genesis; inguinal hernia;
malabsorption syndrome; congenital anomaly of urinary tracts;
delay of rates of general development.
Results: Treatment was begun with Actrapid and NPH since by
establishments of diagnosis. Starting doze of insulin of Actrapid
makes 0.6 units/day, NPH – 1.3 units/day. Level HbA1c in
condition treatment makes 12.1%. Daily glycemium from 23.1 to
15.4 mmol/l. Glucosuria make ++. Hormonal inspections: TSH-
6.3 mE/L (norm 0, 3–4, 1), IGF-1 – 19.3 ng/ml (norm 49–171),
C-peptide – 31.1 pmol/l (norm 110–1110). In age 1 year child is
transferred on analog insulins (Lispro and Lantus). Daily doze of
Lispro 4–4.5 units/day and Lantus 1, 5 units/day. HbA1c makes
8.6% through 3 months. Daily glycemium from 8.1 to 10.4 mmol/l.
Conclusions: Application of analog insulins (ultrashort and long
acting) it lets to reach target levels of daily glycemium and
parameters of long-term metabolic control at sick from PNDM.
P/242/FRI
Type 1, type 2 and double diabetes in Caucasian
children and adolescents
A. Szadkowska, I. Pietrzak, K. Wyka, B. Mianowska, O. Wegner,
A. Zmysłowska, E. Czerniawska & W. Młynarski
Medical University of Lodz, Department of Pediatrics, Oncology,
Hematology and Diabetology, Lodz, Poland
The aim of this study was to evaluate a relationship between insulin
secretion and insulin sensitivity in children with new onset of
diabetes mellitus (DM) to determine the type of diabetes.
Methods: A total of 72 patients with new onset of DM aged from
7.7 to 17.9 years were included into the study. Insulin secretion was
estimated on the base of the serum C-peptide concentration.
Euglycemic–hyperinsulinemic clamp was performed to estimate
insulin sensitivity - glucose disposal rate (M value). ICA were
measured by indirect immunofluorescence and anti-GAD
autoantibodies - by ELISA.
Results: C-peptide levels ranged from 0.03 to 1.50 pmol/l. C-
peptide level was above normal range in 2 patients, in normal range
- in 19 individuals, and below normal range - in 51. Correlations
between C-peptide and: patients age (r = 0.33; P = 0.005) and
BMI-SDS (r = 0.45; P < 0.001) were found. M values were
between 1.5 to 14.0 mg/kg/min. In 26 individuals (36.1%) insulin
resistance was recognized (M value £ 5.5 mg/kg/min.). The
negative correlation was found between M value and patients age
(r = -0.54, P < 0.001) and BMI-SDS (r = -0.56, P < 0.001).
Hyperbolic relationship was found between insulin secretion and
isulin sensitivity (R = 0.7, P < 0.001). 37 patients (51.4%) were
positive for ICA and 55 (76.4%) - for anti-GAD antibodies. In 2
patients type 2 diabetes was diagnosed (insulin secretion > normal
range + insulin resistance + no autoantibodies), in 46-type 1
diabetes (insulin secretion < normal range + normal insulin
sensitivity ± autoantibodies), and in 24-double diabetes (insulin
secretion below or in normal range + insulin
resistance ± autoantibodies).
Conclusion: In Caucasian children and adolescents type 2 DM is
rare, but in many patients with initially diagnosed type 1 DM
insulin resistance is present. In patients with coexistence of insulin
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secretion disturbances and insulin resistance ‘‘double type’’ DM
should be recognized.
P/243/FRI
Distinctive features of a combination of components of
a metabolic syndrome at children and teenagers with
type 2 diabetes
Y. Grigorenko, A. Solnceva & M. Vishnevskaya
Belarusian State Medical University, Minsk, Belarus
8–45% of patients with diabetes at children¢s age have not immune
forms of disease.
Aim: We aimed to examine combination of type 2 diabetes (Dt2)
with separate components of a metabolic syndrome (MS) in
children’s.
Materials and methods: This cross-sectional study involved 84
children with Dt2 (m/f = 38/46, middle age 15.28 ± 1.38 years).
All patients were conducted to biochemical blood analysis, lipido-
gram, glucose levels and insulin before and after glucose loading.
Results: Separate components of MS are found out in patients
with Dt2: an arterial hypertension (AH) - at 53 from 84 patients,
abdominal adiposity (AA) - at 76, hyperlipidemia (HL) - at 49,
hyperuricemia - at 2. Isolated Dt2 - in 12 (1st group); combination
Dt2 with AA, AH and HL - in 42 patients (2nd group). Blood
pressure systolic was (135 ± 4.8) higher in 2nd group then in 4th
group where AH was not combined with AA and HL (P < 0.05).
In 3 group the total cholesterol (TH) (4.98 ± 1.96 mmol/l) was
higher than in group with Dt2+AO (5th group) (P < 0.05).
Triglycerides level (1.88 ± 0.95 mmol/l) was higher in 2nd group
with MS (Dt2 + AA + AH + HL), than in 6th group
(Dt2 + AA + HL) (P < 0.05). Level of cholesterol high density
more low in 5th group than in 4th (28 ± 2.9 mmol/l) (P < 0.02).
Pure insulin higher in 2nd group (34 ± 3.2 U/l) unlike 1, 3, 4, 5,
6th groups (P < 0.01, P < 0.01, P < 0.01, P < 0.01, P < 0.05
accordingly). Glucose/insulin before and 2 hours after loading
were significantly below 6th group (7.5 ± 1.9 and 4.9 ± 1.3) then
in 3rd group (18.96 ± 3.8 and 10.53 ± 2.1) (P < 0.01 and
P < 0.05 accordingly). Mean blood pressure systolic
(132 ± 4.6), the blood pressure diastolic (88.5 ± 7.8), BMI
(32.3 ± 1.1 kg/m2), TH (4.76 ± 1.76 mmol/l) significantly higher
in combination of Dt2 + AA + AH (P < 0.05).
Conclusions: Dt2 is most often combined with AA + AH + HL
in children and teenagers. Combination of two or three
components of MS deviates mostly (abdominal fat distributions,
lipidograms), than in Dt2 group with one of these factors.
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